SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain and Structure information: based on WT protein Annotated databases Deep learning-based pathogenicity predictions Folding stability-based pathogenicity predictions Sequence/structure-based pathogenicity predictions Phase Separation Evolutionary/physical properties Molecular Dynamics-based analysis DOI
Domain IUPred2 ANCHOR2 AlphaFold MobiDB PhosphoSitePlus ClinVar gnomAD ESM1b AlphaMissense FoldX Rosetta Foldetta PremPS REVEL PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PSMutPred PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation
Score Prediction Score Prediction pLDDT disorder disorder LTP HTP KL PTM Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences IP RF SP RF Prediction PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.942T>G
F314L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that F314L is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-6.004Likely Benign0.998Likely PathogenicLikely Pathogenic0.87Ambiguous0.10.82Ambiguous0.85Ambiguous1.21Destabilizing0.336Likely Benign-4.85Deleterious0.992Probably Damaging0.987Probably Damaging1.30Pathogenic0.05Affected0.22040.3089201.0-34.02
c.3739A>G
R1247G
2D
AIThe SynGAP1 missense variant R1247G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and AlphaMissense‑Optimized, whereas the majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) predict a pathogenic impact; ESM1b is uncertain and SGM‑Consensus is labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta results are unavailable. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.625-7.920In-Between0.724Likely PathogenicLikely Benign0.195Likely Benign-5.58Deleterious0.980Probably Damaging0.721Possibly Damaging1.70Pathogenic0.00Affected0.30470.2327-3-24.1-99.14
c.3739A>T
R1247W
2D
AIThe SynGAP1 missense variant R1247W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome. No Foldetta stability result is available. Overall, the balance of evidence points to a pathogenic classification for R1247W, and this assessment does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.625-9.694Likely Pathogenic0.676Likely PathogenicLikely Benign0.159Likely Benign-6.38Deleterious1.000Probably Damaging0.982Probably Damaging1.68Pathogenic0.00Affected0.09630.25242-33.630.03
c.3740G>A
R1247K
2D
AIThe SynGAP1 missense variant R1247K is reported in gnomAD (6-33446732‑G‑A) and has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are SIFT and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar classification to contradict this assessment. Thus, based on current predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.6256-33446732-G-A42.48e-6-4.713Likely Benign0.179Likely BenignLikely Benign0.082Likely Benign-2.39Neutral0.122Benign0.064Benign1.80Pathogenic0.00Affected3.7750.34280.2175230.6-28.01
c.3740G>C
R1247T
2D
AIThe SynGAP1 missense variant R1247T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score, which is labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic. No Foldetta stability result is available. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not conflict with ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.625-6.302Likely Benign0.598Likely PathogenicLikely Benign0.206Likely Benign-4.79Deleterious0.980Probably Damaging0.783Possibly Damaging1.71Pathogenic0.00Affected0.15430.2403-1-13.8-55.08
c.3740G>T
R1247M
2D
AIThe SynGAP1 missense variant R1247M is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts a benign effect, whereas the SGM‑Consensus remains pathogenic; Foldetta data are unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.625-6.347Likely Benign0.589Likely PathogenicLikely Benign0.239Likely Benign-4.79Deleterious1.000Probably Damaging0.961Probably Damaging1.68Pathogenic0.00Affected0.10390.21220-16.4-24.99
c.3741G>C
R1247S
2D
AIThe SynGAP1 missense variant R1247S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic,” and Foldetta data are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for R1247S. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.625-6.935Likely Benign0.851Likely PathogenicAmbiguous0.209Likely Benign-4.79Deleterious0.961Probably Damaging0.721Possibly Damaging1.72Pathogenic0.00Affected0.28020.19770-13.7-69.11
c.3741G>T
R1247S
2D
AIThe SynGAP1 missense variant R1247S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic,” and Foldetta data are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for R1247S. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.736850Disordered0.374141Uncertain0.8750.5570.625-6.935Likely Benign0.851Likely PathogenicAmbiguous0.209Likely Benign-4.79Deleterious0.961Probably Damaging0.721Possibly Damaging1.72Pathogenic0.00Affected0.28020.19770-13.7-69.11
c.1291C>A
L431M
2D
AIThe SynGAP1 missense variant L431M (ClinVar ID 4327026) is not found in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, AlphaMissense‑Optimized, and Foldetta, whereas premPS, polyPhen‑2 (HumDiv and HumVar), and SIFT all predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign majority; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. No predictions or stability results are missing or inconclusive. Overall, the majority of computational evidence indicates that the variant is most likely benign, which contradicts the ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.094817Structured0.374755Uncertain0.9590.3000.0001-7.471In-Between0.375AmbiguousLikely Benign0.18Likely Benign0.30.50Ambiguous0.34Likely Benign1.07Destabilizing0.102Likely Benign-1.50Neutral0.995Probably Damaging0.849Possibly Damaging2.94Benign0.02Affected0.07480.312142-1.918.03
c.1291C>G
L431V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L431V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are FoldX, premPS, PROVEAN, and polyPhen‑2 HumDiv. Four tools (Rosetta, Foldetta, ESM1b, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 1‑to‑1 split between benign and pathogenic signals, and Foldetta also yields an uncertain outcome. Overall, the balance of evidence—including the higher number of benign predictions and the benign call from the most accurate tool—suggests that the variant is most likely benign. This conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.094817Structured0.374755Uncertain0.9590.3000.000-7.949In-Between0.505AmbiguousLikely Benign2.17Destabilizing0.01.50Ambiguous1.84Ambiguous1.32Destabilizing0.093Likely Benign-2.58Deleterious0.861Possibly Damaging0.332Benign3.04Benign0.20Tolerated0.13770.3198210.4-14.03
c.1292T>A
L431Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431Q resides in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming agreement among pathogenic predictions and the high‑accuracy tools, the variant is most likely pathogenic; this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000-12.399Likely Pathogenic0.986Likely PathogenicLikely Pathogenic2.69Destabilizing0.02.37Destabilizing2.53Destabilizing1.99Destabilizing0.493Likely Benign-5.40Deleterious1.000Probably Damaging0.992Probably Damaging2.92Benign0.01Affected0.10360.1088-2-2-7.314.97
c.1292T>C
L431P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431P (ClinVar ID 661045.0) is reported as Pathogenic and is not present in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the overwhelming consensus of pathogenic predictions and the ClinVar designation, the variant is most likely pathogenic, with no contradiction to its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000Likely Pathogenic 1-14.222Likely Pathogenic0.996Likely PathogenicLikely Pathogenic6.78Destabilizing0.311.59Destabilizing9.19Destabilizing2.29Destabilizing0.659Likely Pathogenic-6.39Deleterious1.000Probably Damaging0.998Probably Damaging2.91Benign0.05Affected3.37290.34840.2163-3-3-5.4-16.04222.462.80.10.00.10.0XPotentially PathogenicThe iso-butyl side chain of Leu431, located in an α helix (res. Met414-Glu436), packs against other hydrophobic residues in an interhelix space (e.g., Val434, Leu435, Leu696, Leu711) in the WT simulations. While the backbone amide group of Leu431 forms an H-bond with the carbonyl group of His427, the cyclic five-membered pyrrolidine ring of Pro431, lacking the necessary amide group, cannot do the same. Thus, although the cyclic five-membered pyrrolidine ring of Pro431 packs almost as favorably as the side chain of Leu431 in the hydrophobic niche, the residue swap causes the α helix to partially unfold in the variant simulations.
c.1292T>G
L431R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000-14.777Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.45Destabilizing0.04.76Destabilizing4.11Destabilizing1.93Destabilizing0.654Likely Pathogenic-5.47Deleterious0.997Probably Damaging0.833Possibly Damaging2.93Benign0.00Affected0.11910.0730-3-2-8.343.03
c.3736A>C
K1246Q
2D
AIThe SynGAP1 missense change K1246Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as “Likely Benign.” In contrast, the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that K1246Q is most likely benign, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.625-0.718Likely Benign0.107Likely BenignLikely Benign0.071Likely Benign-0.43Neutral0.961Probably Damaging0.721Possibly Damaging2.66Benign0.06Tolerated0.37080.0740110.4-0.04
c.3736A>G
K1246E
2D
AIThe SynGAP1 missense variant K1246E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” consensus. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is consistent with the lack of any ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.625-2.052Likely Benign0.305Likely BenignLikely Benign0.127Likely Benign0.80Neutral0.910Possibly Damaging0.630Possibly Damaging2.89Benign1.00Tolerated0.33280.0514010.40.94
c.3737A>C
K1246T
2D
AIThe SynGAP1 missense variant K1246T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also as likely benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence—including the consensus of multiple independent predictors and the high‑accuracy tools—supports a benign classification for K1246T, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.625-1.970Likely Benign0.263Likely BenignLikely Benign0.101Likely Benign-2.19Neutral0.980Probably Damaging0.782Possibly Damaging2.65Benign0.02Affected0.20320.20650-13.2-27.07
c.3737A>G
K1246R
2D
AIThe SynGAP1 missense variant K1246R is reported in gnomAD (ID 6‑33446729‑A‑G) and has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as “Likely Benign.” High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and the Foldetta stability analysis is unavailable. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.6256-33446729-A-G16.20e-7-2.444Likely Benign0.097Likely BenignLikely Benign0.026Likely Benign-0.86Neutral0.031Benign0.017Benign2.66Benign0.04Affected3.7750.37900.051523-0.628.01
c.3737A>T
K1246M
2D
AIThe SynGAP1 missense variant K1246M is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a benign likelihood; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for K1246M, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.625-3.663Likely Benign0.311Likely BenignLikely Benign0.136Likely Benign-2.81Deleterious0.998Probably Damaging0.961Probably Damaging2.60Benign0.01Affected0.09380.25980-15.83.02
c.3738G>C
K1246N
2D
AIThe SynGAP1 missense variant K1246N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT uniformly predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the preponderance of evidence from multiple independent predictors points to a benign effect for K1246N, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.625-2.506Likely Benign0.518AmbiguousLikely Benign0.125Likely Benign-1.39Neutral0.980Probably Damaging0.721Possibly Damaging2.66Benign0.02Affected0.33160.0940100.4-14.07
c.3738G>T
K1246N
2D
AIThe SynGAP1 missense variant K1246N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT uniformly predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the preponderance of evidence from multiple independent predictors points to a benign effect for K1246N, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.750527Disordered0.375382Uncertain0.8870.5640.625-2.506Likely Benign0.518AmbiguousLikely Benign0.122Likely Benign-1.39Neutral0.980Probably Damaging0.721Possibly Damaging2.66Benign0.02Affected0.33160.0940100.4-14.07
c.853T>A
C285S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285S has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas a majority of the remaining predictors (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default) indicate a pathogenic impact. The remaining tools (FoldX, Rosetta, Foldetta, ESM1b, AlphaMissense‑Optimized) return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.149In-Between0.868Likely PathogenicAmbiguous0.73Ambiguous0.10.75Ambiguous0.74Ambiguous1.20Destabilizing0.507Likely Pathogenic-8.09Deleterious0.997Probably Damaging0.994Probably Damaging1.90Pathogenic0.08Tolerated0.52100.2038Weaken0-1-3.3-16.06
c.853T>C
C285R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. All other evaluated predictors—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms a likely pathogenic status, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Consequently, the preponderance of evidence points to a pathogenic effect for C285R, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.127Likely Pathogenic0.981Likely PathogenicLikely Pathogenic-0.47Likely Benign0.2-0.63Ambiguous-0.55Ambiguous1.53Destabilizing0.583Likely Pathogenic-9.66Deleterious0.999Probably Damaging0.998Probably Damaging1.83Pathogenic0.04Affected0.19470.1453-4-3-7.053.05
c.853T>G
C285G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a pathogenic interpretation: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict deleterious effects. Tools that assess protein stability (FoldX, Rosetta, Foldetta) and AlphaMissense‑Optimized return uncertain results, providing no clear evidence for or against pathogenicity. High‑accuracy assessments further support a likely pathogenic verdict: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta remain inconclusive. Overall, the consensus of the majority of predictors indicates that the variant is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.937Likely Pathogenic0.859Likely PathogenicAmbiguous1.26Ambiguous0.01.57Ambiguous1.42Ambiguous1.50Destabilizing0.564Likely Pathogenic-9.86Deleterious0.999Probably Damaging0.996Probably Damaging1.78Pathogenic0.04Affected0.35090.2922-3-3-2.9-46.09
c.854G>A
C285Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and Rosetta. Those that agree on a pathogenic effect include SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are Foldetta, premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for C285Y. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.210In-Between0.895Likely PathogenicAmbiguous3.66Destabilizing1.1-2.33Stabilizing0.67Ambiguous0.53Ambiguous0.484Likely Benign-8.67Deleterious0.999Probably Damaging0.998Probably Damaging1.88Pathogenic0.18Tolerated0.14130.36890-2-3.860.04
c.854G>C
C285S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and SIFT, whereas premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. Predictions from FoldX, Rosetta, ESM1b, AlphaMissense‑Optimized, and Foldetta are inconclusive. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic classification; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the preponderance of evidence points to a pathogenic effect for C285S, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.149In-Between0.868Likely PathogenicAmbiguous0.73Ambiguous0.10.75Ambiguous0.74Ambiguous1.20Destabilizing0.499Likely Benign-8.09Deleterious0.997Probably Damaging0.994Probably Damaging1.90Pathogenic0.08Tolerated0.52100.2038Weaken0-1-3.3-16.06
c.854G>T
C285F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285F is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, and AlphaMissense‑Optimized, whereas a majority of tools (SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic outcome; Foldetta is uncertain. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence (12 pathogenic vs. 3 benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.397Likely Pathogenic0.716Likely PathogenicLikely Benign3.27Destabilizing1.1-1.72Ambiguous0.78Ambiguous0.35Likely Benign0.500Likely Pathogenic-8.84Deleterious0.999Probably Damaging0.998Probably Damaging1.81Pathogenic0.12Tolerated0.16260.4007-4-20.344.04
c.855C>G
C285W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C285W is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and Rosetta, whereas pathogenic predictions are made by SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy subset confirms this trend: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenicity, and Foldetta remains uncertain. No prediction tool is missing or inconclusive enough to alter the overall assessment. Consequently, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.017Likely Pathogenic0.969Likely PathogenicLikely Pathogenic3.35Destabilizing1.1-2.28Stabilizing0.54Ambiguous0.61Ambiguous0.327Likely Benign-8.97Deleterious1.000Probably Damaging0.998Probably Damaging1.78Pathogenic0.11Tolerated0.19340.3697-8-2-3.483.07
c.985C>A
R329S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R329S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Stability‑based methods (FoldX, Rosetta, Foldetta, premPS) yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as Uncertain. Overall, the majority of available predictions support a pathogenic impact. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-10.731Likely Pathogenic0.984Likely PathogenicLikely Pathogenic1.80Ambiguous0.30.78Ambiguous1.29Ambiguous0.78Ambiguous0.192Likely Benign-3.36Deleterious0.653Possibly Damaging0.226Benign4.07Benign0.04Affected0.28860.36250-13.7-69.11
c.985C>G
R329G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R329G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, while pathogenic calls are made by FoldX, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments give an overall pathogenic signal: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta is inconclusive. Taken together, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-12.426Likely Pathogenic0.927Likely PathogenicAmbiguous2.21Destabilizing0.31.58Ambiguous1.90Ambiguous0.92Ambiguous0.204Likely Benign-4.78Deleterious0.653Possibly Damaging0.293Benign4.03Benign0.04Affected0.31470.3037-3-24.1-99.14
c.985C>T
R329C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R329C is reported in gnomAD (ID 6‑33437890‑C‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, Rosetta, Foldetta, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Two tools remain inconclusive: premPS and AlphaMissense‑Optimized. The high‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta) as benign. Overall, six tools favor pathogenicity versus five favor benign, with one uncertain. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.2506-33437890-C-T21.24e-6-9.433Likely Pathogenic0.865Likely PathogenicAmbiguous0.44Likely Benign0.10.40Likely Benign0.42Likely Benign0.69Ambiguous0.313Likely Benign-5.70Deleterious0.999Probably Damaging0.825Possibly Damaging3.98Benign0.00Affected3.41150.35530.2921-3-47.0-53.05
c.986G>A
R329H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R329H is listed in ClinVar with an uncertain significance (ClinVar ID 2074400.0) and is present in gnomAD (ID 6‑33437891‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result and is treated as unavailable evidence. Overall, the balance of predictions favors a pathogenic impact, which does not contradict the ClinVar uncertain status but suggests the variant is more likely deleterious.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250Uncertain 16-33437891-G-A21.24e-6-10.154Likely Pathogenic0.769Likely PathogenicLikely Benign2.53Destabilizing0.70.71Ambiguous1.62Ambiguous0.82Ambiguous0.155Likely Benign-3.17Deleterious0.995Probably Damaging0.778Possibly Damaging4.04Benign0.05Affected3.41150.29550.1961201.3-19.05220.481.40.10.10.20.3UncertainThe guanidinium group of Arg329, located at the end of an anti-parallel β sheet strand (res. Ala322-Asp330), faces the negatively charged lipid bilayer surface. While the residue swap does not cause any apparent negative effects on the protein structure in the variant simulations, it could adversely affect the SynGAP-membrane association in reality. The positively charged Arg329 side chain forms hydrogen bonds with other loop residues (e.g., Ser371, Asp338) that are expected to dynamically interact with the membrane head group region. However, this phenomenon is beyond the scope of the solvent-only simulations to unravel. Notably, histidine can also be double protonated and positively charged, but this alternative protonation state was not considered in the variant simulations.
c.986G>C
R329P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R329P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of algorithms predict a pathogenic outcome: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score is “Likely Pathogenic,” and premPS is uncertain. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenicity. Overall, the evidence overwhelmingly points to a pathogenic effect for R329P, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-14.528Likely Pathogenic0.965Likely PathogenicLikely Pathogenic3.06Destabilizing0.24.99Destabilizing4.03Destabilizing0.73Ambiguous0.350Likely Benign-4.28Deleterious0.902Possibly Damaging0.544Possibly Damaging4.00Benign0.01Affected0.22150.40990-22.9-59.07
c.986G>T
R329L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R329L has no ClinVar entry and is not reported in gnomAD. Consensus from standard prediction tools shows a split: benign calls come from REVEL, FoldX, FATHMM, and polyPhen‑2 HumVar, while pathogenic calls arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. Predictions marked uncertain (Rosetta, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of tools lean toward pathogenicity, but the folding‑stability evidence suggests a benign effect. Given the lack of ClinVar annotation, there is no contradiction. The variant is most likely pathogenic based on the preponderance of pathogenic predictions, though the benign folding‑stability result introduces uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-10.186Likely Pathogenic0.907Likely PathogenicAmbiguous-0.09Likely Benign0.40.53Ambiguous0.22Likely Benign0.54Ambiguous0.219Likely Benign-4.81Deleterious0.653Possibly Damaging0.361Benign4.02Benign0.01Affected0.18270.4121-3-28.3-43.03
c.2116G>A
E706K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E706K is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM all classify the change as benign. In contrast, ESM1b and AlphaMissense‑Default predict a pathogenic impact. Tools that return uncertain results—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—do not provide decisive evidence. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic versus two benign calls). High‑accuracy assessments are likewise ambiguous: AlphaMissense‑Optimized is uncertain, Foldetta is uncertain, and the SGM Consensus remains inconclusive. Overall, the preponderance of evidence points to a benign effect, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.200174Structured0.377033Uncertain0.9290.3630.000Uncertain 1-10.519Likely Pathogenic0.833Likely PathogenicAmbiguous1.17Ambiguous0.10.51Ambiguous0.84Ambiguous0.08Likely Benign0.080Likely Benign-1.51Neutral0.345Benign0.028Benign4.15Benign0.52Tolerated3.47100.20650.451101-0.4-0.94187.149.20.00.00.40.1XUncertainThe carboxylate side chain of Glu706, located at the end and outer surface of an α-helix (res. Thr704-Gly712), forms a salt bridge with Lys710 and a hydrogen bond with its own backbone amino group at the helix end in the WT simulations. Although Lys706 is unable to make these transient interactions in the variant simulations, there is no apparent negative effect on the protein structure due to the residue swap. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2116G>C
E706Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E706Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are AlphaMissense‑Default and ESM1b. Rosetta and Foldetta provide uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta also yields an uncertain outcome. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.200174Structured0.377033Uncertain0.9290.3630.000-8.171Likely Pathogenic0.588Likely PathogenicLikely Benign0.44Likely Benign0.00.61Ambiguous0.53Ambiguous-0.14Likely Benign0.059Likely Benign-1.00Neutral0.433Benign0.051Benign4.13Benign0.31Tolerated0.09410.3831220.0-0.98
c.2117A>C
E706A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E706A has no ClinVar entry and is not reported in gnomAD. Prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all predict benign. Only polyPhen2_HumDiv suggests pathogenicity, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy methods reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of ClinVar classification or gnomAD observation. Thus, the variant is most likely benign, and this is consistent with the lack of ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.200174Structured0.377033Uncertain0.9290.3630.000-4.604Likely Benign0.443AmbiguousLikely Benign0.80Ambiguous0.00.48Likely Benign0.64Ambiguous-0.12Likely Benign0.117Likely Benign-0.81Neutral0.613Possibly Damaging0.180Benign4.20Benign0.65Tolerated0.34130.40890-15.3-58.04
c.2117A>G
E706G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E706G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar all classify the substitution as benign or tolerated. Only polyPhen2_HumDiv predicts a pathogenic effect. Tools with uncertain outcomes—AlphaMissense‑Default, FoldX, Rosetta, and Foldetta—do not provide a definitive assessment. High‑accuracy predictors reinforce the benign consensus: AlphaMissense‑Optimized reports a benign change; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the majority of evidence supports a benign impact, and this conclusion is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign, and this is not contradictory to ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.200174Structured0.377033Uncertain0.9290.3630.000-5.289Likely Benign0.535AmbiguousLikely Benign1.22Ambiguous0.01.32Ambiguous1.27Ambiguous0.12Likely Benign0.071Likely Benign-1.71Neutral0.931Possibly Damaging0.138Benign4.07Benign0.23Tolerated0.27810.36140-23.1-72.06
c.2117A>T
E706V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E706V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Two tools, FoldX and Foldetta, give uncertain or inconclusive results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the majority of predictions lean toward a benign impact, and this assessment does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on the available computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.377033Uncertain0.9290.3630.000-9.306Likely Pathogenic0.667Likely PathogenicLikely Benign1.05Ambiguous0.00.30Likely Benign0.68Ambiguous0.05Likely Benign0.099Likely Benign-2.63Deleterious0.555Possibly Damaging0.109Benign4.07Benign0.16Tolerated0.05280.4275-2-27.7-29.98
c.2118A>C
E706D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E706D is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the consensus SGM score (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign effect. No tool predicts pathogenicity. High‑accuracy assessments likewise support a benign outcome: AlphaMissense‑Optimized is benign, the SGM Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. **Thus, the variant is most likely benign, and this prediction does not contradict any ClinVar status (none is available).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.200174Structured0.377033Uncertain0.9290.3630.000-4.216Likely Benign0.087Likely BenignLikely Benign0.22Likely Benign0.00.02Likely Benign0.12Likely Benign-0.16Likely Benign0.182Likely Benign-0.01Neutral0.000Benign0.000Benign4.17Benign0.41Tolerated0.16810.2726320.0-14.03
c.2118A>T
E706D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E706D is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the consensus SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts pathogenicity. High‑accuracy assessments further support a benign effect: AlphaMissense‑Optimized predicts benign, the SGM Consensus indicates “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. With all evidence pointing to a neutral impact and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.200174Structured0.377033Uncertain0.9290.3630.000-4.216Likely Benign0.087Likely BenignLikely Benign0.22Likely Benign0.00.02Likely Benign0.12Likely Benign-0.16Likely Benign0.182Likely Benign-0.01Neutral0.000Benign0.000Benign4.17Benign0.41Tolerated0.16810.2726320.0-14.03
c.1453C>A
R485S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R485S is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. In contrast, the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Tools that return uncertain results are Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for R485S, which is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.125Uncertain 1-15.603Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.40Likely Benign0.11.07Ambiguous0.74Ambiguous0.82Ambiguous0.609Likely Pathogenic-5.97Deleterious1.000Probably Damaging1.000Probably Damaging1.93Pathogenic0.00Affected0.29680.32660-13.7-69.11
c.1453C>G
R485G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R485G is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID: 6‑33438485‑C‑G). Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tools predict a benign outcome. Uncertain or inconclusive predictions come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the evidence strongly favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.1256-33438485-C-G16.20e-7-15.777Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.84Ambiguous0.11.60Ambiguous1.22Ambiguous0.98Ambiguous0.631Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging1.92Pathogenic0.00Affected3.37350.31400.2678-2-34.1-99.14
c.1453C>T
R485C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R485C (gnomAD ID 6‑33438485‑C‑T) is listed in ClinVar with an uncertain significance. Functional prediction tools largely disagree: benign calls come from Rosetta and premPS, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus is labeled likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. With the majority of evidence pointing to pathogenicity and no contradictory data from ClinVar, the variant is most likely pathogenic, although ClinVar has not yet reached a definitive classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.125Uncertain 26-33438485-C-T95.58e-6-14.294Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.00Ambiguous0.10.26Likely Benign0.63Ambiguous0.44Likely Benign0.597Likely Pathogenic-7.96Deleterious1.000Probably Damaging1.000Probably Damaging1.90Pathogenic0.00Affected3.37350.33500.2762-4-37.0-53.05225.599.6-0.10.0-0.30.2XUncertainThe guanidinium group of Arg485 is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. The side chain of Arg485 acts as the “arginine finger” of SynGAP, playing a crucial role in Ras-GTPase activation. Consequently, the residue swap inhibits the conversion of GTP to GDP at the enzyme’s active site. Although no negative effects on the protein structure are observed during the simulations, no definite conclusions can be drawn due to the critical role of Arg485 in GTPase activation.
c.1454G>A
R485H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R485H missense variant is listed in ClinVar as Benign (ClinVar ID 3707943.0) and is present in the gnomAD database (gnomAD ID 6‑33438486‑G‑A). Functional prediction tools that agree on a benign effect are Rosetta and Foldetta, while the majority of tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the preponderance of evidence points to a pathogenic effect, which contradicts the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.125Likely Benign 16-33438486-G-A138.05e-6-13.628Likely Pathogenic0.948Likely PathogenicAmbiguous0.77Ambiguous0.10.12Likely Benign0.45Likely Benign1.13Destabilizing0.618Likely Pathogenic-4.97Deleterious1.000Probably Damaging0.998Probably Damaging1.93Pathogenic0.00Affected3.37350.29900.1602021.3-19.05
c.1454G>C
R485P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R485P is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return pathogenic or likely pathogenic scores. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.125-16.356Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.26Destabilizing0.36.86Destabilizing6.06Destabilizing0.56Ambiguous0.692Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging1.94Pathogenic0.00Affected0.20590.39410-22.9-59.07
c.1454G>T
R485L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R485L is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus—predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which is currently unreported. Thus, the variant is most likely pathogenic based on the available computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.125-15.807Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.23Likely Benign0.20.14Likely Benign0.19Likely Benign0.39Likely Benign0.631Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging1.92Pathogenic0.00Affected0.17150.3784-3-28.3-43.03
c.2131C>A
L711M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta reports an uncertain stability change, which is treated as unavailable evidence. Overall, the majority of individual predictors (six pathogenic vs. five benign) and the available high‑accuracy results lean toward a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.308712Structured0.377436Uncertain0.9500.3640.000-9.368Likely Pathogenic0.679Likely PathogenicLikely Benign0.39Likely Benign0.01.11Ambiguous0.75Ambiguous1.40Destabilizing0.216Likely Benign-1.86Neutral1.000Probably Damaging1.000Probably Damaging3.34Benign0.00Affected0.07550.275842-1.918.03
c.2131C>G
L711V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L711V is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441596‑C‑G). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as likely pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which does not conflict with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000Uncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign3.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing0.170Likely Benign-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.5090.13180.3010120.4-14.03
c.2132T>A
L711Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. Tools that predict a pathogenic effect include FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM Consensus, and Foldetta; Rosetta is uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. No predictions are missing or inconclusive. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-11.792Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.93Destabilizing0.01.68Ambiguous2.31Destabilizing1.63Destabilizing0.388Likely Benign-5.67Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected0.10410.0488-2-2-7.314.97
c.2132T>C
L711P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L711P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-12.128Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.70Destabilizing0.18.15Destabilizing6.93Destabilizing2.09Destabilizing0.375Likely Benign-6.59Deleterious1.000Probably Damaging1.000Probably Damaging3.28Benign0.00Affected0.33000.0986-3-3-5.4-16.04
c.2132T>G
L711R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711R lies in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming majority of computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-14.009Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.71Destabilizing0.03.98Destabilizing3.85Destabilizing2.13Destabilizing0.432Likely Benign-5.71Deleterious0.999Probably Damaging0.992Probably Damaging3.35Benign0.00Affected0.13450.0488-3-2-8.343.03
c.820C>A
L274M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Foldetta, PROVEAN, and AlphaMissense‑Optimized, whereas those that agree on a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Three tools (Rosetta, premPS, and ESM1b) returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting benign. Overall, the majority of predictions (seven pathogenic vs. four benign) and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.066181Structured0.377483Uncertain0.8660.1950.250-7.386In-Between0.658Likely PathogenicLikely Benign0.24Likely Benign0.20.74Ambiguous0.49Likely Benign0.81Ambiguous0.512Likely Pathogenic-1.77Neutral1.000Probably Damaging0.999Probably Damaging0.04Pathogenic0.01Affected0.08100.220242-1.918.03
c.820C>G
L274V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while both the SGM‑Consensus and Foldetta (combining FoldX‑MD and Rosetta outputs) predict pathogenicity. No predictions are missing or inconclusive. Overall, the preponderance of evidence from multiple independent tools points to a pathogenic impact for L274V. This conclusion is consistent with the lack of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-5.634Likely Benign0.593Likely PathogenicLikely Benign2.13Destabilizing0.62.22Destabilizing2.18Destabilizing0.99Ambiguous0.378Likely Benign-2.56Deleterious0.999Probably Damaging0.994Probably Damaging0.10Pathogenic0.02Affected0.14480.1860210.4-14.03
c.821T>A
L274Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274Q is reported in ClinVar with an uncertain significance (ClinVar ID 1810279.0) and is not found in gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while Rosetta remains inconclusive. No tool predicts a benign outcome. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250Uncertain 1-15.518Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.54Destabilizing0.31.74Ambiguous2.14Destabilizing1.97Destabilizing0.774Likely Pathogenic-5.42Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected3.38190.11280.0688-2-2-7.314.97245.91.80.00.00.10.2XXXPotentially PathogenicThe aliphatic side chain of Leu274, located in a β hairpin loop (res. Glu273-Lys278) connecting two anti-parallel β sheet strands, packs against multiple hydrophobic residues facing the β sheet (e.g., Ala271, Leu327, Tyr280, Val306). The hydrophilic carboxamide group of the Gln274 side chain is not suitable for this hydrophobic niche, causing nearby residues to adjust to make room for the hydrophilic glutamine. Additionally, a new hydrogen bond forms with the backbone carboxyl group of Arg272 in another β strand (res. Glu273-Arg259).As a result, the backbone amide group of Ala399 and the carbonyl group of Arg272, which connect two β strands at the β sheet end, form fewer hydrogen bonds in the variant than in the WT simulations. Although no major secondary structure disruption is observed in the variant simulations, the residue swap could profoundly affect the C2 domain folding, as the hydrophobic packing of Leu274 is crucial for maintaining the loop's contact with the rest of the C2 domain. Lastly, because the Leu274-containing loop faces the membrane surface, the residue swap could also negatively impact the SynGAP-membrane association.
c.821T>C
L274P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool in the dataset predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-14.667Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.62Destabilizing1.54.49Destabilizing5.06Destabilizing1.66Destabilizing0.804Likely Pathogenic-6.30Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected0.35350.0625-3-3-5.4-16.04
c.821T>G
L274R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274R is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available predictions and stability analyses are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-17.691Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.61Destabilizing0.83.15Destabilizing3.38Destabilizing1.56Destabilizing0.807Likely Pathogenic-5.45Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected0.14040.0488-3-2-8.343.03
c.2113A>C
K705Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K705Q missense variant (ClinVar ID 3699560.0) is listed as “Uncertain” in ClinVar and is present in gnomAD (variant ID 6‑33441372‑A‑C). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (benign), FATHMM (benign), and PROVEAN (benign)—also yields a benign classification; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the preponderance of evidence supports a benign impact for K705Q, and this conclusion does not contradict the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.134866Structured0.379324Uncertain0.9220.3640.000Uncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign0.142Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.47100.30630.1014110.4-0.04
c.2113A>G
K705E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K705E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Optimized, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta predicts a benign stability change. Overall, the majority of evidence (9 benign vs. 4 pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.134866Structured0.379324Uncertain0.9220.3640.000-9.371Likely Pathogenic0.704Likely PathogenicLikely Benign0.10Likely Benign0.0-0.09Likely Benign0.01Likely Benign0.47Likely Benign0.075Likely Benign-1.53Neutral0.935Possibly Damaging0.537Possibly Damaging3.33Benign0.14Tolerated0.26010.0789010.40.94
c.2114A>C
K705T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain calls are made by FoldX and AlphaMissense‑Optimized. High‑accuracy assessments indicate that the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts a pathogenic effect, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign outcome. Overall, the balance of evidence leans toward a pathogenic interpretation, and this assessment does not conflict with ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-8.617Likely Pathogenic0.826Likely PathogenicAmbiguous0.60Ambiguous0.00.04Likely Benign0.32Likely Benign0.17Likely Benign0.272Likely Benign-4.05Deleterious0.995Probably Damaging0.991Probably Damaging3.38Benign0.02Affected0.12990.26120-13.2-27.07
c.2114A>G
K705R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K705R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate a benign or likely benign outcome. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Thus, the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.134866Structured0.379324Uncertain0.9220.3640.000-4.679Likely Benign0.126Likely BenignLikely Benign0.10Likely Benign0.00.35Likely Benign0.23Likely Benign0.18Likely Benign0.094Likely Benign-1.66Neutral0.960Probably Damaging0.545Possibly Damaging3.33Benign0.06Tolerated0.34560.078932-0.628.01
c.2114A>T
K705M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by Rosetta and AlphaMissense‑Optimized. The high‑accuracy consensus (SGM‑Consensus) aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and yields a pathogenic verdict (3/4 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence points toward a pathogenic impact, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-9.595Likely Pathogenic0.939Likely PathogenicAmbiguous-0.13Likely Benign0.00.53Ambiguous0.20Likely Benign0.17Likely Benign0.306Likely Benign-3.65Deleterious1.000Probably Damaging0.997Probably Damaging3.26Benign0.00Affected0.07240.30570-15.83.02
c.2115G>C
K705N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705N is listed in ClinVar (ID 872011.0) as Pathogenic and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, Rosetta, premPS, FATHMM) and pathogenic predictions (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default). Uncertain results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as Likely Pathogenic, and Foldetta also yields an uncertain stability change. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, which aligns with its ClinVar classification and does not contradict the reported status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000Likely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign0.183Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.47100.24800.1124100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2115G>T
K705N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K705N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Three tools (FoldX, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments further support a pathogenic interpretation: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic”; AlphaMissense‑Optimized remains uncertain, and Foldetta is also uncertain. Overall, the balance of evidence favors a pathogenic effect for K705N, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign0.183Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.47100.24800.1124100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.943A>C
N315H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N315H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.118441Structured0.379740Uncertain0.8620.2530.125-6.374Likely Benign0.156Likely BenignLikely Benign0.29Likely Benign0.20.22Likely Benign0.26Likely Benign0.28Likely Benign0.258Likely Benign-2.15Neutral1.000Probably Damaging0.999Probably Damaging1.91Pathogenic0.76Tolerated0.16080.7296210.323.04
c.943A>G
N315D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and FATHMM. The remaining tools (FoldX, premPS, AlphaMissense‑Default) are inconclusive. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority; and Foldetta predicts a benign stability change. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.118441Structured0.379740Uncertain0.8620.2530.125-5.667Likely Benign0.536AmbiguousLikely Benign1.27Ambiguous0.6-0.30Likely Benign0.49Likely Benign0.88Ambiguous0.229Likely Benign-2.41Neutral0.999Probably Damaging0.995Probably Damaging2.02Pathogenic0.45Tolerated0.19720.4488210.00.98
c.943A>T
N315Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. The high‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence slightly favors a pathogenic interpretation, with six pathogenic‑predicted tools versus five benign‑predicted tools, and the high‑accuracy consensus leaning pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-8.303Likely Pathogenic0.339Likely BenignLikely Benign-1.03Ambiguous0.5-0.85Ambiguous-0.94Ambiguous-0.10Likely Benign0.420Likely Benign-3.81Deleterious1.000Probably Damaging0.999Probably Damaging1.93Pathogenic1.00Tolerated0.06130.6732-2-22.249.07
c.944A>C
N315T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Two tools, premPS and ESM1b, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of individual predictors (six benign vs. four pathogenic) and the Foldetta result support a benign classification, while the SGM Consensus suggests pathogenicity. Thus, the variant is most likely benign based on the preponderance of evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.118441Structured0.379740Uncertain0.8620.2530.125-7.071In-Between0.211Likely BenignLikely Benign0.31Likely Benign0.1-0.36Likely Benign-0.03Likely Benign0.62Ambiguous0.333Likely Benign-2.91Deleterious0.999Probably Damaging0.995Probably Damaging1.95Pathogenic0.53Tolerated0.14710.8068002.8-13.00
c.944A>G
N315S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.118441Structured0.379740Uncertain0.8620.2530.125-4.847Likely Benign0.068Likely BenignLikely Benign0.85Ambiguous0.20.78Ambiguous0.82Ambiguous0.68Ambiguous0.250Likely Benign-1.84Neutral0.999Probably Damaging0.992Probably Damaging2.03Pathogenic0.60Tolerated0.40220.7395112.7-27.03
c.944A>T
N315I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant N315I is not reported in ClinVar and is absent from gnomAD. In silico predictors that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, and AlphaMissense‑Optimized. Predictors that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; Foldetta, which integrates FoldX‑MD (uncertain) and Rosetta (benign), is considered unavailable. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-9.666Likely Pathogenic0.500AmbiguousLikely Benign-0.72Ambiguous0.4-0.17Likely Benign-0.45Likely Benign0.36Likely Benign0.496Likely Benign-5.19Deleterious1.000Probably Damaging0.999Probably Damaging1.90Pathogenic0.43Tolerated0.07630.7235-2-38.0-0.94
c.945C>A
N315K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315K is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and Foldetta. Tools that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No other high‑accuracy tool provides a conclusive result. Overall, the majority of predictions (seven pathogenic vs. five benign, with two uncertain) indicate that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-10.380Likely Pathogenic0.872Likely PathogenicAmbiguous-0.03Likely Benign0.10.08Likely Benign0.03Likely Benign0.87Ambiguous0.340Likely Benign-3.27Deleterious0.999Probably Damaging0.996Probably Damaging1.98Pathogenic0.54Tolerated0.22680.643610-0.414.07
c.945C>G
N315K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315K is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and Foldetta. Tools that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence (seven pathogenic vs. five benign, with two uncertain) points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-10.380Likely Pathogenic0.872Likely PathogenicAmbiguous-0.03Likely Benign0.10.08Likely Benign0.03Likely Benign0.87Ambiguous0.340Likely Benign-3.27Deleterious0.999Probably Damaging0.996Probably Damaging1.98Pathogenic0.54Tolerated0.22680.643610-0.414.07
c.1060G>A
A354T
2D
AIThe SynGAP1 missense variant A354T is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only FATHMM predicts a pathogenic effect. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign result. No predictions or folding‑stability analyses are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.381329Uncertain0.8820.3350.125-2.812Likely Benign0.070Likely BenignLikely Benign0.37Likely Benign0.70.11Likely Benign0.24Likely Benign-0.52Ambiguous0.097Likely Benign1.72Neutral0.002Benign0.001Benign1.75Pathogenic0.45Tolerated0.17310.649610-2.530.03
c.1060G>C
A354P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A354P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, SIFT, and FATHMM, while Rosetta and premPS are inconclusive. The high‑accuracy consensus from AlphaMissense‑Optimized and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) both indicate a benign outcome, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Overall, the majority of evidence points to a benign effect for A354P, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.381329Uncertain0.8820.3350.125-5.971Likely Benign0.239Likely BenignLikely Benign2.66Destabilizing0.21.55Ambiguous2.11Destabilizing0.57Ambiguous0.241Likely Benign-1.66Neutral0.001Benign0.002Benign1.76Pathogenic0.04Affected0.22590.58841-1-3.426.04
c.1060G>T
A354S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A354S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Taken together, the overwhelming majority of evidence indicates that A354S is most likely benign, and this conclusion is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.381329Uncertain0.8820.3350.125-3.005Likely Benign0.081Likely BenignLikely Benign0.02Likely Benign0.10.27Likely Benign0.15Likely Benign-0.10Likely Benign0.071Likely Benign0.28Neutral0.005Benign0.001Benign1.76Pathogenic0.21Tolerated0.28290.511711-2.616.00
c.1061C>A
A354D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A354D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Those that predict a pathogenic effect are FATHMM and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, and Rosetta) return uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors a pathogenic interpretation. Foldetta’s stability prediction is uncertain. Overall, the majority of consensus tools lean toward a benign effect, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely benign based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.203355Structured0.381329Uncertain0.8820.3350.125-7.914In-Between0.725Likely PathogenicLikely Benign0.22Likely Benign0.11.10Ambiguous0.66Ambiguous0.57Ambiguous0.087Likely Benign-1.49Neutral0.255Benign0.053Benign1.75Pathogenic0.07Tolerated0.17590.13450-2-5.344.01
c.1061C>G
A354G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A354G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. Predictions marked uncertain (Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, while Foldetta’s stability analysis is inconclusive. Overall, the majority of evidence points to a benign impact for A354G, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.381329Uncertain0.8820.3350.125-4.285Likely Benign0.113Likely BenignLikely Benign0.41Likely Benign0.01.24Ambiguous0.83Ambiguous0.65Ambiguous0.037Likely Benign-1.87Neutral0.146Benign0.038Benign1.75Pathogenic0.05Affected0.25630.477710-2.2-14.03
c.1061C>T
A354V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A354V is not reported in ClinVar and is present in the gnomAD database (variant ID 6‑33437966‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. The high‑accuracy consensus methods support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Predictions from FoldX and Rosetta are inconclusive and are treated as unavailable. Overall, the majority of evidence indicates that A354V is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.381329Uncertain0.8820.3350.1256-33437966-C-T16.26e-7-6.223Likely Benign0.122Likely BenignLikely Benign0.65Ambiguous0.1-1.02Ambiguous-0.19Likely Benign0.18Likely Benign0.027Likely Benign-1.11Neutral0.146Benign0.038Benign1.81Pathogenic0.05Affected3.38240.14290.6388002.428.05
c.634T>A
S212T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S212T is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include FoldX and FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With most evidence pointing to deleterious effects and no conflicting ClinVar annotation, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-11.473Likely Pathogenic0.939Likely PathogenicAmbiguous0.32Likely Benign0.22.03Destabilizing1.18Ambiguous0.58Ambiguous0.767Likely Pathogenic-2.58Deleterious0.956Probably Damaging0.931Probably Damaging5.79Benign0.01Affected0.10770.6284110.114.03
c.634T>C
S212P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S212P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX and FATHMM, whereas the remaining tools—REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict it to be pathogenic. High‑accuracy methods give consistent pathogenic results: AlphaMissense‑Optimized scores it as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a destabilizing, pathogenic effect. With the overwhelming majority of tools supporting pathogenicity and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-13.051Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.02Likely Benign0.96.30Destabilizing3.16Destabilizing0.90Ambiguous0.809Likely Pathogenic-4.13Deleterious0.995Probably Damaging0.979Probably Damaging5.75Benign0.01Affected0.18590.56791-1-0.810.04
c.634T>G
S212A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S212A has no ClinVar record and is not listed in gnomAD. Prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, Foldetta, PROVEAN, and FATHMM, while pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta predicts benign stability. Overall, the majority of conventional tools lean toward pathogenicity, whereas the most reliable high‑accuracy methods are either benign or inconclusive. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.158265Structured0.381517Uncertain0.8460.2780.125-8.890Likely Pathogenic0.869Likely PathogenicAmbiguous-0.13Likely Benign0.10.13Likely Benign0.00Likely Benign0.75Ambiguous0.752Likely Pathogenic-2.48Neutral0.956Probably Damaging0.931Probably Damaging5.83Benign0.01Affected0.46390.4509112.6-16.00
c.635C>A
S212Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S212Y is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include FoldX, FATHMM, and premPS. In contrast, a majority of tools predict a pathogenic impact: REVEL, SGM‑Consensus, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, is inconclusive for this variant. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence from multiple in silico predictors indicates that S212Y is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-14.812Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.43Likely Benign0.52.32Destabilizing1.38Ambiguous0.22Likely Benign0.819Likely Pathogenic-5.15Deleterious0.995Probably Damaging0.986Probably Damaging5.76Benign0.00Affected0.05550.6120-3-2-0.576.10
c.635C>G
S212C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S212C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include FoldX, premPS, and FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictions that are inconclusive are Rosetta and Foldetta. The high‑accuracy consensus methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence from multiple independent predictors indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-11.656Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.16Likely Benign0.10.98Ambiguous0.57Ambiguous0.47Likely Benign0.840Likely Pathogenic-4.29Deleterious0.999Probably Damaging0.990Probably Damaging5.73Benign0.00Affected0.07850.62700-13.316.06
c.635C>T
S212F
2D
AIThe SynGAP1 missense variant S212F is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include FoldX, FATHMM, and premPS, whereas the majority of other in‑silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score (Likely Pathogenic) predict a pathogenic outcome. The remaining tools, Foldetta and Rosetta, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall consensus of the majority of predictors and the high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.381517Uncertain0.8460.2780.125-14.029Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.11Likely Benign1.60.88Ambiguous0.50Ambiguous-0.02Likely Benign0.820Likely Pathogenic-5.15Deleterious0.995Probably Damaging0.986Probably Damaging5.76Benign0.00Affected0.05030.6259-3-23.660.10
c.1219C>A
Q407K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q407K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Two tools, FoldX and premPS, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is unavailable because FoldX is uncertain and Rosetta alone is benign. Overall, the majority of evidence points to a pathogenic impact for Q407K. This conclusion is not contradicted by ClinVar status, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.109221Structured0.382522Uncertain0.9160.2710.000-14.893Likely Pathogenic0.765Likely PathogenicLikely Benign0.61Ambiguous0.10.19Likely Benign0.40Likely Benign0.93Ambiguous0.246Likely Benign-3.42Deleterious0.863Possibly Damaging0.773Possibly Damaging3.96Benign0.07Tolerated0.16560.350411-0.40.04
c.1219C>G
Q407E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q407E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b all predict a pathogenic outcome. AlphaMissense‑Default, FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools and the SGM Consensus support a pathogenic classification, while a minority predict benign. No ClinVar entry exists to contradict these predictions. Thus, the variant is most likely pathogenic based on the available computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.109221Structured0.382522Uncertain0.9160.2710.000-12.631Likely Pathogenic0.466AmbiguousLikely Benign0.50Ambiguous0.11.68Ambiguous1.09Ambiguous1.30Destabilizing0.243Likely Benign-2.66Deleterious0.989Probably Damaging0.930Probably Damaging3.96Benign0.03Affected0.11990.2000220.00.98
c.1220A>C
Q407P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q407P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact; premPS is uncertain and is not counted. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of these predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.109221Structured0.382522Uncertain0.9160.2710.000-13.578Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.04Destabilizing0.52.07Destabilizing2.56Destabilizing0.88Ambiguous0.515Likely Pathogenic-5.40Deleterious1.000Probably Damaging0.999Probably Damaging3.88Benign0.02Affected0.17860.43520-11.9-31.01
c.1220A>G
Q407R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q407R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. With two of the three high‑accuracy methods indicating benign and the remaining one pathogenic, the overall evidence leans toward a benign classification. This conclusion does not contradict ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.109221Structured0.382522Uncertain0.9160.2710.000-13.263Likely Pathogenic0.693Likely PathogenicLikely Benign0.15Likely Benign0.20.09Likely Benign0.12Likely Benign0.65Ambiguous0.340Likely Benign-3.52Deleterious0.909Possibly Damaging0.889Possibly Damaging4.02Benign0.17Tolerated0.13470.159611-1.028.06
c.1220A>T
Q407L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q407L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Four tools are uncertain (AlphaMissense‑Default, FoldX, Rosetta, Foldetta). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, more tools predict pathogenicity than benign, and the high‑accuracy consensus leans pathogenic. Therefore, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.109221Structured0.382522Uncertain0.9160.2710.000-12.730Likely Pathogenic0.558AmbiguousLikely Benign-0.65Ambiguous0.2-0.69Ambiguous-0.67Ambiguous0.35Likely Benign0.359Likely Benign-6.32Deleterious0.939Possibly Damaging0.838Possibly Damaging3.91Benign0.02Affected0.05850.4977-2-27.3-14.97
c.1221G>C
Q407H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q407H (C2 domain) has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict pathogenicity: premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is uncertain. No evidence from FoldX, Rosetta, or Foldetta supports a benign outcome. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.109221Structured0.382522Uncertain0.9160.2710.000-10.526Likely Pathogenic0.830Likely PathogenicAmbiguous0.59Ambiguous0.00.61Ambiguous0.60Ambiguous1.10Destabilizing0.206Likely Benign-4.51Deleterious0.982Probably Damaging0.947Probably Damaging3.88Benign0.01Affected3.38280.12050.3154030.39.01
c.1221G>T
Q407H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q407H is listed in ClinVar with an uncertain significance (ClinVar ID 2772184.0) and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and FATHMM, while pathogenic predictions are made by premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions marked as uncertain include FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for Q407H. This conclusion does not conflict with the ClinVar designation of uncertain significance, which remains unresolved pending further evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.109221Structured0.382522Uncertain0.9160.2710.000Uncertain 1-10.526Likely Pathogenic0.830Likely PathogenicAmbiguous0.59Ambiguous0.00.61Ambiguous0.60Ambiguous1.10Destabilizing0.206Likely Benign-4.51Deleterious0.982Probably Damaging0.947Probably Damaging3.88Benign0.01Affected3.38280.12050.3154030.39.01
c.808G>A
E270K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E270K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools give uncertain results: Foldetta (a combined FoldX‑MD/Rosetta stability assessment) and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta remains uncertain. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, which is consistent with the lack of ClinVar reporting and gnomAD absence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-14.466Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.06Likely Benign0.22.26Destabilizing1.10Ambiguous0.71Ambiguous0.530Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.995Probably Damaging1.68Pathogenic0.01Affected0.22960.425101-0.4-0.94
c.808G>C
E270Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270Q missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, and premPS, whereas the majority of tools predict pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates several high‑accuracy predictors, classifies the variant as Likely Pathogenic. High‑accuracy methods give the following results: AlphaMissense‑Optimized is Uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Uncertain. Rosetta alone is Uncertain, and Foldetta’s uncertainty reflects limited stability change evidence. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.096Likely Pathogenic0.886Likely PathogenicAmbiguous0.00Likely Benign0.21.00Ambiguous0.50Ambiguous0.46Likely Benign0.418Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging1.65Pathogenic0.03Affected0.10440.4015220.0-0.98
c.809A>C
E270A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools cluster into three groups: benign predictions are made only by premPS; pathogenic predictions are made by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; and three tools (FoldX, Rosetta, Foldetta) give uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points to a deleterious effect. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-13.618Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.64Ambiguous0.20.77Ambiguous0.71Ambiguous0.41Likely Benign0.547Likely Pathogenic-5.52Deleterious0.999Probably Damaging0.995Probably Damaging1.61Pathogenic0.01Affected0.41220.39510-15.3-58.04
c.809A>G
E270G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E270G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic. Rosetta also predicts pathogenicity, while FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. No tool predicts a benign effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-13.759Likely Pathogenic0.968Likely PathogenicLikely Pathogenic1.23Ambiguous0.22.37Destabilizing1.80Ambiguous0.61Ambiguous0.576Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.996Probably Damaging1.63Pathogenic0.00Affected0.32540.38760-23.1-72.06
c.809A>T
E270V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E270V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess sequence conservation and structural impact uniformly classify the substitution as pathogenic: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return pathogenic scores. No tool predicts a benign effect. Uncertain results are reported only by FoldX, Rosetta, Foldetta, and premPS, which are not considered evidence for or against pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic”; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is inconclusive. Overall, the consensus of available predictions indicates that E270V is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-15.969Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.38Ambiguous0.61.88Ambiguous1.63Ambiguous-0.52Ambiguous0.574Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.998Probably Damaging1.53Pathogenic0.00Affected0.06720.4498-2-27.7-29.98
c.810G>C
E270D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Rosetta. Tools with inconclusive results—FoldX, Foldetta, and premPS—are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.954Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.52Ambiguous0.12.15Destabilizing1.84Ambiguous0.91Ambiguous0.379Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.60Pathogenic0.02Affected0.19080.2540320.0-14.03
c.810G>T
E270D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, and the SGM‑Consensus (which is “Likely Pathogenic”). Predictions that are inconclusive or uncertain are FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus also indicating a likely pathogenic outcome, while Foldetta’s stability analysis is uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E270D, and this conclusion is consistent with the lack of ClinVar annotation (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.954Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.52Ambiguous0.12.15Destabilizing1.84Ambiguous0.91Ambiguous0.383Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.60Pathogenic0.02Affected0.19080.2540320.0-14.03
c.667A>C
T223P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T223P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as Uncertain. No other high‑accuracy tools provide a definitive prediction. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.070400Structured0.382605Uncertain0.8670.3160.125-13.707Likely Pathogenic0.974Likely PathogenicLikely Pathogenic0.42Likely Benign0.33.45Destabilizing1.94Ambiguous0.67Ambiguous0.898Likely Pathogenic-4.54Deleterious0.838Possibly Damaging0.367Benign5.72Benign0.01Affected0.14640.37280-1-0.9-3.99
c.667A>G
T223A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T223A is listed in ClinVar with an “Uncertain” status and is present in the gnomAD database (ID 6‑33435518‑A‑G). Functional prediction tools that agree on a benign effect include FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL and PROVEAN. Predictions that are inconclusive are Rosetta, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also resolves to benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.070400Structured0.382605Uncertain0.8670.3160.125Uncertain 16-33435518-A-G31.86e-6-7.076In-Between0.316Likely BenignLikely Benign0.30Likely Benign0.10.77Ambiguous0.54Ambiguous0.74Ambiguous0.574Likely Pathogenic-3.36Deleterious0.231Benign0.058Benign5.74Benign0.09Tolerated3.41130.29820.3031102.5-30.03186.444.00.00.00.00.0XXUncertainThe introduced residue Ala223 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the hydroxyl group of the Thr223 side chain in the WT protein, the methyl side chain of Ala223 cannot form hydrogen bonds with nearby residues Thr228 and Lys207. Without these hydrogen-bonding interactions at the β sheet surface, the secondary structure element becomes unstable and partially unfolds in the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.667A>T
T223S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 T223S is listed in ClinVar as a variant of uncertain significance and is present in the gnomAD database (ID 6‑33435518‑A‑T). Functional prediction tools that reach consensus classify the variant as benign: FoldX, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity include REVEL, PROVEAN, and SIFT. Predictions that are inconclusive or uncertain are Rosetta, premPS, AlphaMissense‑Default, and ESM1b. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, Foldetta is benign, while the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 1‑to‑1 split between benign and pathogenic calls. Overall, the majority of evidence points to a benign effect, which does not contradict the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.070400Structured0.382605Uncertain0.8670.3160.125Conflicting 26-33435518-A-T31.86e-6-7.714In-Between0.410AmbiguousLikely Benign0.26Likely Benign0.10.50Ambiguous0.38Likely Benign0.62Ambiguous0.535Likely Pathogenic-2.86Deleterious0.421Benign0.058Benign5.80Benign0.02Affected3.41130.23880.297211-0.1-14.03200.717.3-0.20.20.00.0XUncertainThe introduced residue Ser223 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Its hydroxyl group forms hydrogen bonds with nearby residues Thr228 and Lys207 in the variant simulations, similar to the hydroxyl group of Thr223 in the WT simulations. These hydrogen-bonding interactions at the β sheet surface contribute to the stability of the secondary structure element and may prevent it from unfolding. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.668C>A
T223K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T223K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools, premPS and AlphaMissense‑Optimized, are uncertain and therefore treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the balance of evidence leans toward a benign impact, with no contradiction to the ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.070400Structured0.382605Uncertain0.8670.3160.125-12.084Likely Pathogenic0.853Likely PathogenicAmbiguous-0.30Likely Benign0.10.42Likely Benign0.06Likely Benign0.93Ambiguous0.810Likely Pathogenic-4.60Deleterious0.267Benign0.086Benign5.78Benign0.01Affected0.07930.24620-1-3.227.07
c.668C>G
T223R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T223R has no ClinVar entry and is not reported in gnomAD. Functional prediction tools show a mixed profile: benign calls come from FoldX, Rosetta, Foldetta, polyPhen‑2 HumVar, SIFT, and FATHMM, while pathogenic calls arise from REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy consensus (SGM Consensus) favors pathogenicity (3/4 votes pathogenic), whereas Foldetta predicts benign stability. Because the majority of individual predictors lean benign and the high‑accuracy consensus is split, the overall assessment remains inconclusive. The variant is most likely benign, but the presence of several pathogenic predictions and the SGM Consensus result indicates that pathogenicity cannot be ruled out. This conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.070400Structured0.382605Uncertain0.8670.3160.125-12.079Likely Pathogenic0.794Likely PathogenicAmbiguous-0.36Likely Benign0.1-0.27Likely Benign-0.32Likely Benign0.75Ambiguous0.827Likely Pathogenic-4.62Deleterious0.561Possibly Damaging0.178Benign5.73Benign0.06Tolerated0.07080.2407-1-1-3.855.08
c.668C>T
T223I
2D
AIThe SynGAP1 T223I variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that clearly indicate benign impact include FoldX, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity are REVEL and PROVEAN. Predictions that are inconclusive (Rosetta, Foldetta, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, while Foldetta remains uncertain. Overall, the majority of definitive predictions support a benign effect. Thus, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.070400Structured0.382605Uncertain0.8670.3160.125-6.543Likely Benign0.356AmbiguousLikely Benign-0.24Likely Benign0.8-0.99Ambiguous-0.62Ambiguous0.30Likely Benign0.640Likely Pathogenic-4.09Deleterious0.010Benign0.005Benign5.93Benign0.07Tolerated0.05690.53930-15.212.05
c.778G>A
V260I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260I missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome, while ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts benign. Overall, the consensus of the majority of tools, including the high‑accuracy methods, points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-7.525In-Between0.104Likely BenignLikely Benign-0.16Likely Benign0.10.27Likely Benign0.06Likely Benign-0.14Likely Benign0.404Likely Benign-0.85Neutral0.994Probably Damaging0.970Probably Damaging5.83Benign0.19Tolerated0.05590.3704430.314.03
c.778G>C
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar) and ESM1b. The high‑accuracy assessment shows AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and Foldetta predicts a benign effect on protein stability. No prediction is missing or inconclusive. Overall, the evidence points to a benign effect for V260L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign0.532Likely Pathogenic-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated0.07300.436021-0.414.03
c.778G>T
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign0.532Likely Pathogenic-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated0.07300.436021-0.414.03
c.779T>A
V260E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V260E is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact on protein stability. Overall, the majority of computational evidence points toward a pathogenic interpretation, and this conclusion is not contradicted by the ClinVar status. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.254060Structured0.382651Uncertain0.8880.2590.250-9.516Likely Pathogenic0.667Likely PathogenicLikely Benign-0.02Likely Benign0.10.32Likely Benign0.15Likely Benign1.10Destabilizing0.848Likely Pathogenic-3.66Deleterious0.999Probably Damaging0.991Probably Damaging5.79Benign0.09Tolerated0.08460.1636-2-2-7.729.98
c.779T>C
V260A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260A missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote), and Foldetta. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta—all indicate a benign outcome. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-3.271Likely Benign0.407AmbiguousLikely Benign0.38Likely Benign0.00.02Likely Benign0.20Likely Benign0.81Ambiguous0.487Likely Benign-1.41Neutral0.994Probably Damaging0.970Probably Damaging5.87Benign0.33Tolerated0.26760.190300-2.4-28.05
c.779T>G
V260G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FATHMM and AlphaMissense‑Optimized, while the majority of tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. FoldX, Rosetta, and Foldetta are uncertain and therefore not considered evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans pathogenic (3 pathogenic vs. 1 benign). Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for V260G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-9.300Likely Pathogenic0.644Likely PathogenicLikely Benign1.00Ambiguous0.31.86Ambiguous1.43Ambiguous1.40Destabilizing0.817Likely Pathogenic-4.20Deleterious0.991Probably Damaging0.999Probably Damaging5.76Benign0.00Affected0.18440.1949-1-3-4.6-42.08
c.1423C>G
R475G
2D
AIThe SynGAP1 missense variant R475G is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict pathogenicity. Only Rosetta and AlphaMissense‑Optimized return uncertain results, and no tool predicts a benign outcome. High‑accuracy methods provide a consistent view: AlphaMissense‑Optimized is uncertain, SGM‑Consensus indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenicity. Taken together, the overwhelming majority of evidence supports a pathogenic classification for R475G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.382696Uncertain0.8520.2610.000-14.466Likely Pathogenic0.939Likely PathogenicAmbiguous2.39Destabilizing1.01.64Ambiguous2.02Destabilizing1.11Destabilizing0.697Likely Pathogenic-6.53Deleterious1.000Probably Damaging1.000Probably Damaging-1.41Pathogenic0.00Affected0.27790.2310-3-24.1-99.14
c.1423C>T
R475W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R475W is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33438455‑C‑T). Prediction tools that agree on a benign effect include only Foldetta, whereas the remaining tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) uniformly predict a pathogenic impact; FoldX, Rosetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a pathogenic effect, which does not contradict the ClinVar “Uncertain” classification but suggests that the variant is more likely pathogenic rather than benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.382696Uncertain0.8520.2610.000Uncertain 16-33438455-C-T16.20e-7-13.235Likely Pathogenic0.962Likely PathogenicLikely Pathogenic1.44Ambiguous0.4-0.92Ambiguous0.26Likely Benign0.56Ambiguous0.725Likely Pathogenic-7.56Deleterious1.000Probably Damaging0.995Probably Damaging-1.45Pathogenic0.00Affected3.39280.12310.27852-33.630.03266.939.60.00.00.00.1XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation.In the variant simulations, Trp475 moves and stacks with Arg479 on the proceeding α-α loop, disrupting the terminal end of the α-helix. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1424G>A
R475Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R475Q is listed in ClinVar with an uncertain significance and is present in gnomAD (variant ID 6-33438456‑G‑A). Prediction tools that indicate a benign effect include AlphaMissense‑Optimized, Foldetta, and Rosetta. Those that predict a pathogenic effect comprise SGM Consensus, SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Default; FoldX and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of evidence points toward a pathogenic impact, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.382696Uncertain0.8520.2610.000Uncertain 26-33438456-G-A53.10e-6-12.087Likely Pathogenic0.721Likely PathogenicLikely Benign0.71Ambiguous0.10.12Likely Benign0.42Likely Benign0.82Ambiguous0.632Likely Pathogenic-3.65Deleterious1.000Probably Damaging0.991Probably Damaging-1.32Pathogenic0.01Affected3.39280.21900.1926111.0-28.06253.652.70.00.0-0.80.0XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation. In the variant simulations, Asn475 forms a hydrogen bond with Arg479 on the proceeding α-α loop. The absence of Phe476/Arg475 stacking and the Arg475-Glu472 salt bridge weakens the integrity of the terminal end of the α-helix during the variant simulations. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1424G>C
R475P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R475P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: benign‑predicting algorithms are not present, while pathogenic‑predicting tools—including REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—all classify the substitution as pathogenic. High‑accuracy assessments corroborate this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic effect. Consequently, the variant is most likely pathogenic based on the available computational evidence, and this assessment does not contradict any ClinVar status, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.382696Uncertain0.8520.2610.000-16.637Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.93Destabilizing0.45.40Destabilizing4.17Destabilizing1.02Destabilizing0.835Likely Pathogenic-6.53Deleterious1.000Probably Damaging1.000Probably Damaging-1.43Pathogenic0.00Affected0.19430.32950-22.9-59.07
c.1424G>T
R475L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R475L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from REVEL, SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score, whereas only Rosetta predicts a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as uncertain. With the preponderance of pathogenic calls and no conflicting evidence from ClinVar or population databases, the variant is most likely pathogenic, and this assessment does not contradict the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.382696Uncertain0.8520.2610.000-13.074Likely Pathogenic0.928Likely PathogenicAmbiguous1.49Ambiguous0.4-0.47Likely Benign0.51Ambiguous0.55Ambiguous0.806Likely Pathogenic-6.40Deleterious1.000Probably Damaging0.999Probably Damaging-1.40Pathogenic0.00Affected0.15800.3428-3-28.3-43.03
c.643G>A
G215S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G215S is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining pathogenic predictors (SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all indicate pathogenicity. Uncertain results come from Rosetta, Foldetta, and premPS. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta remains uncertain. Overall, the variant is most likely pathogenic based on the consensus of predictive tools, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.382818Uncertain0.7910.2910.000-9.067Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.30Destabilizing0.31.20Ambiguous1.75Ambiguous0.55Ambiguous0.864Likely Pathogenic-5.05Deleterious1.000Probably Damaging0.998Probably Damaging5.66Benign0.02Affected0.27010.576110-0.430.03
c.643G>C
G215R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G215R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of algorithms (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. Four methods (FoldX, Rosetta, Foldetta, premPS) return uncertain results and are not considered evidence for either side. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, while Foldetta’s stability prediction is inconclusive. Taken together, the preponderance of evidence points to a pathogenic effect for G215R. This conclusion is consistent with the absence of a ClinVar entry and does not contradict any existing database annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.382818Uncertain0.7910.2910.000-12.654Likely Pathogenic1.000Likely PathogenicLikely Pathogenic1.75Ambiguous0.11.25Ambiguous1.50Ambiguous0.56Ambiguous0.823Likely Pathogenic-6.84Deleterious1.000Probably Damaging0.999Probably Damaging5.71Benign0.01Affected0.10480.4890-3-2-4.199.14
c.643G>T
G215C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G215C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are premPS and FATHMM; those that agree on a pathogenic effect include SGM‑Consensus, REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta gives an uncertain result and is listed separately. High‑accuracy methods all predict pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Based on the overwhelming agreement among both general and high‑accuracy predictors, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.382818Uncertain0.7910.2910.000-12.295Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.39Destabilizing0.21.76Ambiguous2.08Destabilizing0.33Likely Benign0.869Likely Pathogenic-7.69Deleterious1.000Probably Damaging1.000Probably Damaging5.56Benign0.00Affected0.12740.4640-3-32.946.09
c.644G>A
G215D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G215D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SIFT, PolyPhen‑2 (HumDiv and HumVar), PROVEAN, REVEL, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, and FoldX—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta, which evaluates protein‑folding stability, yields an uncertain result. No other high‑confidence tool contradicts the pathogenic prediction. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.382818Uncertain0.7910.2910.000-9.884Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.23Destabilizing0.30.91Ambiguous1.57Ambiguous0.57Ambiguous0.807Likely Pathogenic-5.98Deleterious1.000Probably Damaging0.998Probably Damaging5.71Benign0.02Affected0.18880.29471-1-3.158.04
c.644G>C
G215A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G215A is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The only tool predicting a benign outcome is FATHMM. Predictions that are uncertain or inconclusive are Foldetta, Rosetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta is uncertain. Overall, the majority of evidence indicates that G215A is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.382818Uncertain0.7910.2910.000-8.930Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.36Destabilizing0.21.35Ambiguous1.86Ambiguous0.59Ambiguous0.874Likely Pathogenic-5.08Deleterious0.999Probably Damaging0.995Probably Damaging5.61Benign0.02Affected0.38970.5525102.214.03
c.644G>T
G215V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G215V is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining twelve tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the variant as pathogenic. premPS is uncertain and does not influence the consensus. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.382818Uncertain0.7910.2910.000-12.960Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.69Destabilizing0.25.41Destabilizing4.55Destabilizing0.53Ambiguous0.884Likely Pathogenic-7.66Deleterious1.000Probably Damaging0.998Probably Damaging5.56Benign0.00Affected0.10870.4777-1-34.642.08
c.1498C>A
L500M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The premPS score is uncertain. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; Foldetta predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive because it yields a 2‑to‑2 split. No other high‑accuracy predictions are available. Overall, the majority of high‑accuracy tools lean toward a benign interpretation, and this assessment does not contradict the lack of ClinVar reporting. Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.066181Structured0.382942Uncertain0.8930.1500.000-9.945Likely Pathogenic0.301Likely BenignLikely Benign0.15Likely Benign0.0-0.09Likely Benign0.03Likely Benign0.92Ambiguous0.590Likely Pathogenic-1.99Neutral1.000Probably Damaging1.000Probably Damaging-1.36Pathogenic0.01Affected0.07100.220242-1.918.03
c.1498C>G
L500V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L500V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on benign effect include SIFT and AlphaMissense‑Optimized, whereas a majority of tools predict pathogenicity: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Predictions that are inconclusive are FoldX, Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple independent predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000-12.963Likely Pathogenic0.379AmbiguousLikely Benign1.92Ambiguous0.00.81Ambiguous1.37Ambiguous1.11Destabilizing0.565Likely Pathogenic-2.98Deleterious0.998Probably Damaging0.992Probably Damaging-1.24Pathogenic0.11Tolerated0.12050.1860210.4-14.03
c.1499T>A
L500Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500Q has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized. All other evaluated predictors—SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently classify the variant as pathogenic. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are treated as unavailable. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized (benign) stands alone, whereas the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic. Foldetta remains uncertain. Overall, the preponderance of evidence from multiple independent pathogenic predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000-13.431Likely Pathogenic0.649Likely PathogenicLikely Benign1.92Ambiguous0.11.78Ambiguous1.85Ambiguous1.49Destabilizing0.878Likely Pathogenic-5.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.35Pathogenic0.00Affected0.09500.0488-2-2-7.314.97
c.1499T>C
L500P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500P is listed in ClinVar (ID 2708686.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000Pathogenic 1-15.898Likely Pathogenic0.996Likely PathogenicLikely Pathogenic5.91Destabilizing0.38.90Destabilizing7.41Destabilizing1.92Destabilizing0.894Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging-1.37Pathogenic0.01Affected3.37350.31030.0625-3-3-5.4-16.04
c.1499T>G
L500R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as pathogenic include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts a benign effect; the benign group is empty. Predictions that are uncertain or inconclusive are Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overwhelming agreement among pathogenic predictors and the lack of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000-15.576Likely Pathogenic0.789Likely PathogenicAmbiguous2.23Destabilizing0.11.04Ambiguous1.64Ambiguous1.11Destabilizing0.794Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.998Probably Damaging-1.02Pathogenic0.03Affected0.12040.0488-3-2-8.343.03
c.1486G>A
E496K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E496K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FoldX, whereas the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. Uncertain predictions come from Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Overall, the evidence strongly favors a pathogenic classification for E496K, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-15.795Likely Pathogenic0.961Likely PathogenicLikely Pathogenic0.38Likely Benign0.11.77Ambiguous1.08Ambiguous0.76Ambiguous0.743Likely Pathogenic-3.58Deleterious0.999Probably Damaging0.994Probably Damaging-1.40Pathogenic0.04Affected0.18100.352801-0.4-0.94
c.1486G>C
E496Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E496Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). In silico predictors that classify the variant as benign include FoldX, Foldetta, premPS, SIFT, and AlphaMissense‑Optimized, whereas those that predict pathogenicity are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default; Rosetta is inconclusive. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized indicates a benign effect, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenicity, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign impact. Overall, the majority of predictions (8 pathogenic vs. 5 benign) and the consensus of high‑accuracy methods lean toward a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-11.868Likely Pathogenic0.651Likely PathogenicLikely Benign0.13Likely Benign0.10.61Ambiguous0.37Likely Benign0.50Likely Benign0.586Likely Pathogenic-2.68Deleterious0.998Probably Damaging0.993Probably Damaging-1.36Pathogenic0.15Tolerated0.08840.3262220.0-0.98
c.1487A>C
E496A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E496A missense variant is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include Rosetta, Foldetta, premPS, SIFT, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. FoldX is uncertain and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. Overall, the majority of predictions (8 pathogenic vs. 5 benign) indicate a pathogenic effect. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-11.159Likely Pathogenic0.598Likely PathogenicLikely Benign0.68Ambiguous0.00.23Likely Benign0.46Likely Benign0.47Likely Benign0.681Likely Pathogenic-4.87Deleterious1.000Probably Damaging0.999Probably Damaging-1.41Pathogenic0.09Tolerated0.28060.35480-15.3-58.04
c.1487A>G
E496G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E496G missense variant is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess the variant’s effect fall into two groups: no tool predicts a benign outcome, while eight tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic effect. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus remains likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the preponderance of evidence points to a pathogenic effect, contradicting the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000Uncertain 1-13.529Likely Pathogenic0.850Likely PathogenicAmbiguous1.83Ambiguous0.11.76Ambiguous1.80Ambiguous0.92Ambiguous0.825Likely Pathogenic-6.16Deleterious1.000Probably Damaging0.999Probably Damaging-1.45Pathogenic0.02Affected3.37350.24350.34730-23.1-72.06173.9103.10.00.0-0.70.0XXPotentially PathogenicGlu496 is located in the α-helix (res. Leu489-Glu519), and its carboxylate group forms salt bridges with the neighbouring residues Lys492 and Arg499 in the WT simulations. Glu496 also forms a hydrogen bond with Ser449 on an opposing helix (res. Val441-Ser457). In the variant simulations, Gly496 cannot form these salt bridges, which could weaken the secondary structure. Additionally, the loss of the hydrogen bond with Ser449 on the opposite helix can weaken the tertiary structure assembly. Moreover, glycine is an α-helix breaker, and it is seen to weaken the integrity of the helix as the hydrogen bonding between the backbone atoms of Gly496 and Ala493 breaks down. Also, due to its location at the GAP-Ras interface, the interaction of Glu496 with Arg499 and Lys492 might play a role in complex association and stability, which cannot be fully addressed using the SynGAP solvent-only simulations.
c.1487A>T
E496V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E496V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Foldetta, and premPS, while pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized is Uncertain; SGM‑Consensus remains Likely Pathogenic; Foldetta, a folding‑stability predictor that integrates FoldX‑MD and Rosetta outputs, classifies the variant as Benign. Because the variant is not present in ClinVar, there is no clinical annotation to contradict the computational evidence. Overall, the preponderance of pathogenic predictions, including the consensus score, suggests that E496V is most likely pathogenic, though the conflicting high‑accuracy folding stability result indicates uncertainty that warrants further functional validation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-14.290Likely Pathogenic0.873Likely PathogenicAmbiguous0.17Likely Benign0.1-0.67Ambiguous-0.25Likely Benign0.26Likely Benign0.823Likely Pathogenic-6.16Deleterious0.999Probably Damaging0.996Probably Damaging-1.43Pathogenic0.02Affected0.05560.3746-2-27.7-29.98
c.1488G>C
E496D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E496D missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain predictions come from Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a unanimous majority of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.000-10.552Likely Pathogenic0.922Likely PathogenicAmbiguous0.43Likely Benign0.21.78Ambiguous1.11Ambiguous1.18Destabilizing0.583Likely Pathogenic-2.78Deleterious0.996Probably Damaging0.989Probably Damaging-1.45Pathogenic0.04Affected3.37350.15760.1912230.0-14.03
c.1488G>T
E496D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E496D is reported in gnomAD (ID 6‑33438520‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions are provided only by FoldX, whereas the remaining tools—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—classify the change as pathogenic. Uncertain results come from Rosetta, Foldetta, and AlphaMissense‑Optimized and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.383296Uncertain0.9450.1790.0006-33438520-G-T21.24e-6-10.552Likely Pathogenic0.922Likely PathogenicAmbiguous0.43Likely Benign0.21.78Ambiguous1.11Ambiguous1.18Destabilizing0.583Likely Pathogenic-2.78Deleterious0.996Probably Damaging0.989Probably Damaging-1.45Pathogenic0.04Affected3.37350.15760.1912230.0-14.03
c.2110A>C
S704R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704R is not reported in gnomAD and has no ClinVar entry. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. FoldX, Rosetta, and Foldetta provide uncertain stability results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the evidence points to the variant being most likely pathogenic, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-9.417Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.81Ambiguous0.10.92Ambiguous0.87Ambiguous0.31Likely Benign0.178Likely Benign-2.65Deleterious0.997Probably Damaging0.822Possibly Damaging3.53Benign0.05Affected0.07140.30380-1-3.769.11
c.2110A>G
S704G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of reliable predictors indicate a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.096677Structured0.383620Uncertain0.9280.3630.000-7.827In-Between0.169Likely BenignLikely Benign1.05Ambiguous0.11.33Ambiguous1.19Ambiguous0.53Ambiguous0.091Likely Benign-2.25Neutral0.981Probably Damaging0.514Possibly Damaging3.42Benign0.07Tolerated0.22240.3378100.4-30.03
c.2110A>T
S704C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Other stability‑based tools such as FoldX, Rosetta, and premPS also return uncertain results. Overall, the majority of individual predictors lean toward pathogenicity, and the high‑accuracy consensus also supports a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.096677Structured0.383620Uncertain0.9280.3630.000-10.438Likely Pathogenic0.423AmbiguousLikely Benign1.56Ambiguous0.10.98Ambiguous1.27Ambiguous0.52Ambiguous0.251Likely Benign-3.52Deleterious0.997Probably Damaging0.789Possibly Damaging3.40Benign0.01Affected0.07890.46120-13.316.06
c.2111G>A
S704N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704N is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33441370‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while premPS and AlphaMissense‑Default are inconclusive. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Overall, the majority of evidence points to a benign effect, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.096677Structured0.383620Uncertain0.9280.3630.000Conflicting 46-33441370-G-A271.67e-5-5.917Likely Benign0.421AmbiguousLikely Benign0.48Likely Benign0.1-0.12Likely Benign0.18Likely Benign0.54Ambiguous0.058Likely Benign-0.49Neutral0.771Possibly Damaging0.275Benign3.39Benign0.08Tolerated3.47100.09110.375411-2.727.03233.2-29.1-0.10.0-0.10.1XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. However, in the variant simulations, the carboxamide side chain of Asn704 achieves more lasting and numerous hydrogen-bonding interactions with the residues at the helix end, such as Glu706, Ala707, and Leu708. Consequently, the residue swap could strengthen the α-helix secondary structure integrity at the helix end, which could have either positive or negative effects on its function.
c.2111G>C
S704T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. Only polyPhen‑2 HumDiv predicts a pathogenic effect, while FoldX remains inconclusive. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Overall, the aggregate evidence indicates that S704T is most likely benign, which is consistent with its ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.096677Structured0.383620Uncertain0.9280.3630.000Uncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign0.071Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.47100.10360.4674110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.2111G>T
S704I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704I lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of other in silico predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) report a pathogenic or likely pathogenic outcome. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy methods specifically give AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-14.222Likely Pathogenic0.978Likely PathogenicLikely Pathogenic1.63Ambiguous0.11.32Ambiguous1.48Ambiguous0.29Likely Benign0.232Likely Benign-4.05Deleterious0.997Probably Damaging0.758Possibly Damaging3.49Benign0.02Affected0.07270.4798-1-25.326.08
c.2112C>A
S704R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus confirms Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result, providing no additional evidence. Overall, the preponderance of evidence from multiple independent predictors indicates that S704R is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-9.417Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.81Ambiguous0.10.92Ambiguous0.87Ambiguous0.31Likely Benign0.200Likely Benign-2.65Deleterious0.997Probably Damaging0.822Possibly Damaging3.53Benign0.05Affected0.07140.30380-1-3.769.11
c.2112C>G
S704R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). FoldX and Rosetta give uncertain results, and Foldetta (a combined FoldX‑MD/Rosetta stability assessment) is also uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic; this conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-9.417Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.81Ambiguous0.10.92Ambiguous0.87Ambiguous0.31Likely Benign0.200Likely Benign-2.65Deleterious0.997Probably Damaging0.822Possibly Damaging3.53Benign0.05Affected0.07140.30380-1-3.769.11
c.871T>A
Y291N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291N is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy methods corroborate this: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-13.599Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.82Destabilizing0.63.37Destabilizing3.10Destabilizing2.16Destabilizing0.533Likely Pathogenic-7.43Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.01Affected0.22550.0499-2-2-2.2-49.07
c.871T>C
Y291H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291H is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: the single benign prediction comes from REVEL, while all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict pathogenicity, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a likely pathogenic verdict; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a destabilizing, pathogenic effect. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-8.749Likely Pathogenic0.986Likely PathogenicLikely Pathogenic2.13Destabilizing0.22.61Destabilizing2.37Destabilizing1.56Destabilizing0.355Likely Benign-4.04Deleterious1.000Probably Damaging0.999Probably Damaging1.77Pathogenic0.02Affected0.24030.049902-1.9-26.03
c.871T>G
Y291D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic outcome. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. With all available evidence pointing to a damaging effect and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-17.570Likely Pathogenic1.000Likely PathogenicLikely Pathogenic4.13Destabilizing0.63.86Destabilizing4.00Destabilizing1.91Destabilizing0.650Likely Pathogenic-8.19Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.01Affected0.43000.0331-4-3-2.2-48.09
c.872A>C
Y291S
2D
AIThe SynGAP1 missense variant Y291S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). All evaluated in silico predictors classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions or stability results are missing or inconclusive. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-11.928Likely Pathogenic0.992Likely PathogenicLikely Pathogenic3.47Destabilizing0.84.47Destabilizing3.97Destabilizing2.01Destabilizing0.588Likely Pathogenic-7.31Deleterious1.000Probably Damaging0.998Probably Damaging1.83Pathogenic0.02Affected0.48500.2079-3-20.5-76.10
c.872A>G
Y291C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291C is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000Uncertain 1-8.997Likely Pathogenic0.967Likely PathogenicLikely Pathogenic2.90Destabilizing0.43.51Destabilizing3.21Destabilizing1.35Destabilizing0.505Likely Pathogenic-7.37Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.01Affected3.38230.30530.25270-23.8-60.04205.266.10.10.0-0.40.4XXPotentially PathogenicThe phenol group of the Tyr291 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against hydrophobic residues of the C2 and PH domains (e.g., Leu317, Leu286, Leu284, Pro208, Val209). The phenol ring of Tyr291 also forms favorable Met-aromatic stacking with the methyl group of Met289. In the variant simulation, the thiol group of the Cys291 side chain is not as suitable for the hydrophobic inter-domain space as the phenol ring of Tyr291. Consequently, the structural unity of the PH domain is weakened and ultimately unfolds in the second simulation. Moreover, the residue swap might result in severe detrimental effects on the C2 domain structure and the C2-PH domain tertiary structure assembly during folding.
c.872A>T
Y291F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign) all predict a neutral impact. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic effect, while premPS remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Overall, the majority of evidence supports a benign classification, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.173081Structured0.383842Uncertain0.9120.2510.000-4.095Likely Benign0.305Likely BenignLikely Benign-0.43Likely Benign0.1-0.10Likely Benign-0.27Likely Benign0.71Ambiguous0.148Likely Benign-2.31Neutral0.999Probably Damaging0.992Probably Damaging1.77Pathogenic0.27Tolerated0.23620.3441734.1-16.00
c.1027G>A
V343I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343I is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33437932‑G‑A). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to “Likely Benign” (3 benign vs. 1 pathogenic). High‑accuracy assessments are consistent: AlphaMissense‑Optimized is benign; the SGM‑Consensus is likely benign; and Foldetta, combining FoldX‑MD and Rosetta outputs, is benign. Overall, the collective evidence strongly supports a benign classification, and this does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.291804Structured0.383911Uncertain0.8820.4970.250Uncertain 26-33437932-G-A16.20e-7-6.020Likely Benign0.117Likely BenignLikely Benign-0.27Likely Benign0.0-0.04Likely Benign-0.16Likely Benign-0.39Likely Benign0.020Likely Benign-0.14Neutral0.159Benign0.084Benign1.98Pathogenic0.27Tolerated3.37250.10950.4536430.314.03240.2-26.9-0.20.2-0.20.2XPotentially BenignThe iso-propyl side chain of Val343, located in an anti-parallel β sheet strand (res. Gly341-Pro349), is packing against multiple hydrophobic residues of the C2 domain (e.g., Leu327, Leu274, Val365). In the variant simulations, the sec-butyl side chain of Ile343 is basically able to form the same interactions as valine due to its similar hydrophobic profile. The residue swap also does not seem to cause negative effects on the protein structure based on the simulations.
c.1027G>C
V343L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. Only FATHMM predicts a pathogenic outcome, while FoldX and Rosetta provide uncertain results and are therefore not considered decisive. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of ClinVar reporting.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.291804Structured0.383911Uncertain0.8820.4970.250-6.268Likely Benign0.310Likely BenignLikely Benign-0.93Ambiguous0.20.66Ambiguous-0.14Likely Benign0.16Likely Benign0.033Likely Benign-1.09Neutral0.005Benign0.013Benign2.12Pathogenic0.64Tolerated0.13610.500821-0.414.03
c.1027G>T
V343F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by REVEL and premPS, whereas pathogenic predictions are made by SIFT, polyPhen‑2 (HumDiv and HumVar), PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. No evidence from FoldX or Rosetta alone is available. Overall, the majority of predictions support a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-10.709Likely Pathogenic0.799Likely PathogenicAmbiguous1.51Ambiguous0.41.28Ambiguous1.40Ambiguous0.23Likely Benign0.324Likely Benign-3.37Deleterious0.976Probably Damaging0.759Possibly Damaging1.61Pathogenic0.01Affected0.09150.4552-1-1-1.448.04
c.1028T>A
V343D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, PROVEAN, ESM1b, FATHMM, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. Rosetta and Foldetta, which evaluate protein‑folding stability, also predict a pathogenic outcome, while FoldX remains uncertain. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta is pathogenic. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-15.523Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.57Ambiguous0.23.40Destabilizing2.49Destabilizing1.73Destabilizing0.530Likely Pathogenic-5.62Deleterious0.996Probably Damaging0.930Probably Damaging1.59Pathogenic0.00Affected0.17810.2261-2-3-7.715.96
c.1028T>C
V343A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and AlphaMissense‑Optimized, whereas the remaining tools—SGM‑Consensus, FoldX (uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenicity. Overall, the preponderance of evidence points to a pathogenic effect for V343A, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-8.088Likely Pathogenic0.588Likely PathogenicLikely Benign1.66Ambiguous0.12.33Destabilizing2.00Destabilizing1.69Destabilizing0.218Likely Benign-3.15Deleterious0.826Possibly Damaging0.551Possibly Damaging1.63Pathogenic0.01Affected0.31370.330100-2.4-28.05
c.1028T>G
V343G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic. AlphaMissense‑Optimized is uncertain, providing no definitive direction. High‑accuracy assessments further support pathogenicity: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Thus, the preponderance of evidence indicates that V343G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.291804Structured0.383911Uncertain0.8820.4970.250-11.332Likely Pathogenic0.926Likely PathogenicAmbiguous2.49Destabilizing0.14.40Destabilizing3.45Destabilizing1.68Destabilizing0.421Likely Benign-5.84Deleterious0.898Possibly Damaging0.996Probably Damaging1.60Pathogenic0.00Affected0.19820.3341-1-3-4.6-42.08
c.1015A>C
K339Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K339Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, and Foldetta. Those that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of evaluated tools (8 pathogenic vs. 4 benign) indicate a pathogenic effect. This conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.447574Structured0.384153Uncertain0.5350.4650.250-10.952Likely Pathogenic0.863Likely PathogenicAmbiguous0.06Likely Benign0.0-0.50Ambiguous-0.22Likely Benign-0.02Likely Benign0.458Likely Benign-3.06Deleterious0.982Probably Damaging0.824Possibly Damaging1.90Pathogenic0.04Affected0.40410.1012110.4-0.04
c.1015A>G
K339E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K339E missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect include PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.447574Structured0.384153Uncertain0.5350.4650.250-14.284Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.13Likely Benign0.1-0.03Likely Benign0.05Likely Benign0.40Likely Benign0.482Likely Benign-3.00Deleterious0.939Possibly Damaging0.670Possibly Damaging1.92Pathogenic0.03Affected0.34210.0882010.40.94
c.1016A>C
K339T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K339T missense variant is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools are split: benign calls come from FoldX, Rosetta, Foldetta, premPS, and SIFT, whereas pathogenic calls are made by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments further highlight this discordance: the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect, whereas Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, predicts a benign impact. AlphaMissense‑Optimized returned an uncertain result and is treated as unavailable. Overall, the majority of robust predictors lean toward pathogenicity, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.447574Structured0.384153Uncertain0.5350.4650.250-10.061Likely Pathogenic0.910Likely PathogenicAmbiguous0.32Likely Benign0.00.10Likely Benign0.21Likely Benign-0.04Likely Benign0.512Likely Pathogenic-4.73Deleterious0.991Probably Damaging0.795Possibly Damaging1.94Pathogenic0.10Tolerated0.19000.30200-13.2-27.07
c.1016A>G
K339R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K339R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. No predictions or stability results are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.447574Structured0.384153Uncertain0.5350.4650.250-5.773Likely Benign0.120Likely BenignLikely Benign-0.15Likely Benign0.10.46Likely Benign0.16Likely Benign0.08Likely Benign0.134Likely Benign-2.05Neutral0.046Benign0.040Benign1.94Pathogenic0.48Tolerated0.41970.097632-0.628.01
c.1016A>T
K339M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K339M missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX and premPS, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools with uncertain or inconclusive results are Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for K339M. This conclusion is not contradicted by ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.447574Structured0.384153Uncertain0.5350.4650.250-13.387Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.23Likely Benign0.00.88Ambiguous0.56Ambiguous-0.37Likely Benign0.575Likely Pathogenic-4.95Deleterious0.999Probably Damaging0.964Probably Damaging1.92Pathogenic0.01Affected0.09670.35410-15.83.02
c.1017G>C
K339N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K339N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect include PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of evidence points to a pathogenic impact for K339N, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.447574Structured0.384153Uncertain0.5350.4650.250-11.117Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.20Likely Benign0.00.35Likely Benign0.28Likely Benign0.00Likely Benign0.410Likely Benign-3.88Deleterious0.991Probably Damaging0.864Possibly Damaging1.91Pathogenic0.02Affected0.32240.1158100.4-14.07
c.1017G>T
K339N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K339N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta stability outputs) predicts a benign effect. Overall, the majority of evidence points toward a pathogenic impact for K339N, and this conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.447574Structured0.384153Uncertain0.5350.4650.250-11.117Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.20Likely Benign0.00.35Likely Benign0.28Likely Benign0.00Likely Benign0.410Likely Benign-3.88Deleterious0.991Probably Damaging0.864Possibly Damaging1.91Pathogenic0.02Affected0.32240.1158100.4-14.07
c.1258T>A
F420I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, while pathogenic calls are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-12.567Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.88Destabilizing0.03.64Destabilizing3.26Destabilizing1.25Destabilizing0.330Likely Benign-5.46Deleterious0.575Possibly Damaging0.059Benign3.22Benign0.02Affected0.18640.2113101.7-34.02
c.1258T>C
F420L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that predict a pathogenic effect comprise the SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evaluated predictors (six pathogenic vs. five benign) indicate that F420L is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-8.432Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.76Ambiguous0.01.41Ambiguous1.59Ambiguous1.04Destabilizing0.262Likely Benign-5.39Deleterious0.009Benign0.005Benign4.22Benign0.39Tolerated3.37290.20530.3016201.0-34.02231.113.20.00.0-0.10.0XPotentially BenignIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). In the variant simulations, the iso-butyl side chain of Leu420 also packs into the hydrophobic inter-helix niche, but due to its smaller size, the resulting steric interactions are not as favorable as with phenylalanine. In short, the residue swap does not cause severe effects on the protein structure based on the variant simulations.
c.1258T>G
F420V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic outcome: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts Pathogenic; the SGM‑Consensus itself is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts Pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy tool consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-11.849Likely Pathogenic0.990Likely PathogenicLikely Pathogenic3.42Destabilizing0.13.35Destabilizing3.39Destabilizing1.58Destabilizing0.402Likely Benign-6.41Deleterious0.495Possibly Damaging0.191Benign3.16Benign0.01Affected0.20380.2022-1-11.4-48.04
c.1259T>A
F420Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420Y is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show mixed results. Benign predictions come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic predictions are reported by premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive. High‑accuracy assessments indicate that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) classifies the variant as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta remain uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-12.138Likely Pathogenic0.941Likely PathogenicAmbiguous1.18Ambiguous0.10.96Ambiguous1.07Ambiguous1.31Destabilizing0.228Likely Benign-2.80Deleterious0.306Benign0.100Benign3.09Benign0.03Affected0.16090.149873-4.116.00
c.1259T>C
F420S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420S (ClinVar ID 981441.0) is reported as Pathogenic in ClinVar and is not present in gnomAD. Prediction tools largely agree on a deleterious effect: all listed predictors except FATHMM return a pathogenic or likely pathogenic call. The single benign prediction comes from FATHMM. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts Pathogenic. No predictions or folding‑stability results are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000Likely Pathogenic 1-13.231Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.34Destabilizing0.15.73Destabilizing5.54Destabilizing2.14Destabilizing0.544Likely Pathogenic-7.43Deleterious0.998Probably Damaging0.938Probably Damaging3.09Benign0.00Affected3.37290.41670.0200-3-2-3.6-60.10213.357.80.00.0-0.40.1XPotentially PathogenicIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). Although no large-scale adverse effects are seen in the variant simulations, the polar hydroxyl group of Ser420 is not suitable for the hydrophobic inter-helix space. Thus, the residue swap could affect protein folding. In theory, the introduced hydroxyl group could also lower the α helix integrity by H-bonding with the backbone atoms of neighboring residues in the same α helix. However, no such effect is seen in the variant simulations.
c.1259T>G
F420C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420C is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity largely agree: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. When grouped by consensus, the benign prediction is singular (FATHMM), whereas the pathogenic predictions comprise the remaining eleven tools. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-11.931Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.31Destabilizing0.15.11Destabilizing4.71Destabilizing2.49Destabilizing0.500Likely Pathogenic-7.40Deleterious0.998Probably Damaging0.869Possibly Damaging3.09Benign0.00Affected0.24580.0662-4-2-0.3-44.04
c.1260T>A
F420L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that predict a pathogenic effect comprise the SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evaluated predictors (six pathogenic vs. five benign) indicate that F420L is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000-8.432Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.76Ambiguous0.01.41Ambiguous1.59Ambiguous1.04Destabilizing0.146Likely Benign-5.39Deleterious0.009Benign0.005Benign4.22Benign0.39Tolerated3.37290.20530.3016201.0-34.02231.113.20.00.0-0.10.0XPotentially BenignIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). In the variant simulations, the iso-butyl side chain of Leu420 also packs into the hydrophobic inter-helix niche, but due to its smaller size, the resulting steric interactions are not as favorable as with phenylalanine. In short, the residue swap does not cause severe effects on the protein structure based on the variant simulations.
c.1260T>G
F420L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F420L is listed in ClinVar (ID 1397885.0) with an “Uncertain” clinical significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Those that predict a pathogenic effect comprise premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑based methods (FoldX, Rosetta, Foldetta) yield inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus also as pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points toward a pathogenic impact, which does not contradict the ClinVar “Uncertain” status but suggests the variant is more likely pathogenic rather than benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.384475Uncertain0.9740.2550.000Uncertain 1-8.432Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.76Ambiguous0.01.41Ambiguous1.59Ambiguous1.04Destabilizing0.146Likely Benign-5.39Deleterious0.009Benign0.005Benign4.22Benign0.39Tolerated3.37290.20530.3016201.0-34.02231.113.20.00.0-0.10.0XPotentially BenignIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). In the variant simulations, the iso-butyl side chain of Leu420 also packs into the hydrophobic inter-helix niche, but due to its smaller size, the resulting steric interactions are not as favorable as with phenylalanine. In short, the residue swap does not cause severe effects on the protein structure based on the variant simulations.
c.2134G>A
G712S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact comprise FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Uncertain results come from premPS, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive and therefore unavailable. Overall, the majority of evidence points to a pathogenic effect for G712S. This conclusion does not contradict ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.384858Uncertain0.9470.3650.000-7.942In-Between0.422AmbiguousLikely Benign2.30Destabilizing0.14.79Destabilizing3.55Destabilizing0.62Ambiguous0.282Likely Benign-4.84Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.02Affected0.28620.450110-0.430.03
c.2134G>C
G712R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G712R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors—PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, SIFT, ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, Rosetta, and the SGM Consensus—classify it as pathogenic. Two tools, FoldX and premPS, return uncertain results. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta each predict a deleterious effect. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.000-11.776Likely Pathogenic0.963Likely PathogenicLikely Pathogenic1.75Ambiguous0.04.68Destabilizing3.22Destabilizing0.82Ambiguous0.458Likely Benign-6.58Deleterious1.000Probably Damaging0.999Probably Damaging3.35Benign0.01Affected0.12290.4482-3-2-4.199.14
c.2134G>T
G712C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712C is catalogued in gnomAD (6‑33441599‑G‑T) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441599-G-T16.20e-7-11.376Likely Pathogenic0.829Likely PathogenicAmbiguous2.54Destabilizing0.05.72Destabilizing4.13Destabilizing0.56Ambiguous0.516Likely Pathogenic-7.75Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected3.5090.15130.3947-3-32.946.09
c.2135G>A
G712D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G712D is catalogued in gnomAD (ID 6‑33441600‑G‑A) but has no ClinVar entry. In silico predictors show mixed results: benign calls come from REVEL, SIFT, and FATHMM, while pathogenic calls are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain predictions are reported by premPS and AlphaMissense‑Optimized. The high‑accuracy consensus tools give a pathogenic verdict: AlphaMissense‑Optimized is inconclusive, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Overall, the majority of reliable predictors and the consensus methods lean toward a pathogenic effect, and this assessment does not conflict with ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441600-G-A16.20e-7-8.211Likely Pathogenic0.946Likely PathogenicAmbiguous2.87Destabilizing0.15.37Destabilizing4.12Destabilizing0.90Ambiguous0.320Likely Benign-5.69Deleterious1.000Probably Damaging0.999Probably Damaging3.67Benign0.12Tolerated3.5090.21460.2533-11-3.158.04
c.2135G>C
G712A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 G712A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Two tools report uncertainty: premPS and AlphaMissense‑Default. High‑accuracy assessments further refine the picture. AlphaMissense‑Optimized classifies the variant as benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign verdict (2 benign vs. 1 pathogenic vote). Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Because the majority of conventional predictors (7/11) indicate pathogenicity, the overall consensus leans toward a pathogenic impact, despite the mixed high‑accuracy results. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.384858Uncertain0.9470.3650.000-6.444Likely Benign0.553AmbiguousLikely Benign2.89Destabilizing0.14.98Destabilizing3.94Destabilizing0.70Ambiguous0.281Likely Benign-4.99Deleterious0.999Probably Damaging0.991Probably Damaging3.44Benign0.02Affected0.39930.4105102.214.03
c.2135G>T
G712V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, while the majority of tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.000-10.466Likely Pathogenic0.877Likely PathogenicAmbiguous3.79Destabilizing0.06.18Destabilizing4.99Destabilizing0.79Ambiguous0.410Likely Benign-7.55Deleterious1.000Probably Damaging0.999Probably Damaging3.32Benign0.00Affected0.13950.3712-1-34.642.08
c.946A>C
N316H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N316H is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, and AlphaMissense‑Optimized. Tools that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts a benign effect; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (pathogenic), FATHMM (pathogenic), and PROVEAN (pathogenic), indicates a likely pathogenic outcome; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign impact. FoldX and premPS are inconclusive. Overall, the balance of evidence from the majority of prediction tools points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-8.141Likely Pathogenic0.440AmbiguousLikely Benign0.72Ambiguous0.40.07Likely Benign0.40Likely Benign0.62Ambiguous0.306Likely Benign-3.56Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.02Affected0.15550.7702210.323.04
c.946A>G
N316D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316D is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, Rosetta, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain and therefore not considered evidence. Overall, seven of the evaluated tools predict pathogenicity versus four predicting benignity, indicating that the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-11.672Likely Pathogenic0.777Likely PathogenicLikely Benign1.18Ambiguous0.10.46Likely Benign0.82Ambiguous0.69Ambiguous0.293Likely Benign-3.20Deleterious0.999Probably Damaging0.995Probably Damaging1.76Pathogenic0.25Tolerated0.19780.4596210.00.98
c.946A>T
N316Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316Y is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-11.226Likely Pathogenic0.767Likely PathogenicLikely Benign0.53Ambiguous0.5-0.09Likely Benign0.22Likely Benign0.50Likely Benign0.454Likely Benign-5.70Deleterious1.000Probably Damaging0.999Probably Damaging1.81Pathogenic0.01Affected0.05740.6971-2-22.249.07
c.947A>C
N316T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. The remaining tools (AlphaMissense‑Default, ESM1b, Foldetta, premPS, Rosetta) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta also yields an uncertain stability change. Overall, the majority of available predictions lean toward pathogenicity, and this assessment does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely pathogenic based on the current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.118441Structured0.385187Uncertain0.8170.2460.125-7.538In-Between0.550AmbiguousLikely Benign2.71Destabilizing0.21.27Ambiguous1.99Ambiguous0.57Ambiguous0.214Likely Benign-3.68Deleterious0.999Probably Damaging0.995Probably Damaging1.79Pathogenic0.08Tolerated0.14820.8474002.8-13.00
c.947A>G
N316S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316S is catalogued in gnomAD (ID 6‑33437852‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Stability‑related methods (FoldX, Rosetta, Foldetta, premPS) are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also indicates Likely Benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the absence of a ClinVar pathogenic classification, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.118441Structured0.385187Uncertain0.8170.2460.1256-33437852-A-G16.20e-7-4.512Likely Benign0.149Likely BenignLikely Benign1.19Ambiguous0.10.59Ambiguous0.89Ambiguous0.68Ambiguous0.151Likely Benign-2.22Neutral0.999Probably Damaging0.992Probably Damaging1.77Pathogenic0.38Tolerated3.38230.43330.7751112.7-27.03
c.947A>T
N316I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and premPS, whereas the majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. No prediction is missing or inconclusive beyond the uncertain AlphaMissense‑Optimized result. Based on the preponderance of pathogenic predictions and the high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-11.164Likely Pathogenic0.899Likely PathogenicAmbiguous2.74Destabilizing0.24.10Destabilizing3.42Destabilizing0.18Likely Benign0.318Likely Benign-6.37Deleterious1.000Probably Damaging0.999Probably Damaging2.00Pathogenic0.03Affected0.07340.7422-2-38.0-0.94
c.948C>A
N316K
2D
AIThe SynGAP1 missense variant N316K is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL and SIFT, whereas the majority of tools predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as uncertain. No other high‑confidence predictions are available. Overall, the preponderance of evidence points to a pathogenic effect for N316K, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-10.711Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.52Ambiguous0.70.86Ambiguous0.69Ambiguous0.67Ambiguous0.254Likely Benign-3.87Deleterious0.999Probably Damaging0.996Probably Damaging1.77Pathogenic0.13Tolerated0.22200.659310-0.414.07
c.948C>G
N316K
2D
AISynGAP1 missense variant N316K is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and SIFT, whereas a majority of tools predict pathogenicity: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, yields an uncertain result and is treated as unavailable evidence. Overall, the preponderance of computational predictions indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-10.711Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.52Ambiguous0.70.86Ambiguous0.69Ambiguous0.67Ambiguous0.254Likely Benign-3.87Deleterious0.999Probably Damaging0.996Probably Damaging1.77Pathogenic0.13Tolerated0.22200.659310-0.414.07
c.1288A>C
M430L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, FoldX, Rosetta, PolyPhen‑2 (HumDiv and HumVar), SIFT, and REVEL; no tool predicts pathogenicity. The high‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. With all available evidence pointing to a benign effect and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.000-5.873Likely Benign0.104Likely BenignLikely Benign0.33Likely Benign0.1-0.10Likely Benign0.12Likely Benign0.72Ambiguous0.107Likely Benign-1.07Neutral0.028Benign0.004Benign3.69Benign0.66Tolerated0.17670.5067421.9-18.03
c.1288A>G
M430V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign or tolerated changes. Only polyPhen‑2 HumDiv flags it as pathogenic, while the SGM‑Consensus score is Likely Benign. Stability‑based methods are inconclusive: FoldX and premPS return Uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports Uncertain. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized predicts Benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta remains Uncertain. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.000-3.555Likely Benign0.091Likely BenignLikely Benign1.48Ambiguous0.1-0.23Likely Benign0.63Ambiguous0.87Ambiguous0.103Likely Benign-1.35Neutral0.918Possibly Damaging0.185Benign3.53Benign0.51Tolerated0.33970.4953212.3-32.06
c.1288A>T
M430L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, FoldX, Rosetta, PolyPhen‑2 (HumDiv and HumVar), SIFT, and REVEL; no tool predicts pathogenicity. The high‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. With all available evidence pointing to a benign effect and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.000-5.873Likely Benign0.104Likely BenignLikely Benign0.33Likely Benign0.1-0.10Likely Benign0.12Likely Benign0.72Ambiguous0.107Likely Benign-1.07Neutral0.028Benign0.004Benign3.69Benign0.66Tolerated0.17670.5067421.9-18.03
c.1289T>A
M430K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized classifies the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors a pathogenic outcome; Foldetta remains uncertain. Overall, the majority of individual predictors lean toward a benign interpretation, whereas the SGM Consensus suggests pathogenicity. Given the lack of ClinVar evidence, there is no contradiction with existing clinical annotations. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not conflict with the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.071867Structured0.385298Uncertain0.9520.3060.000-10.816Likely Pathogenic0.494AmbiguousLikely Benign0.78Ambiguous0.10.44Likely Benign0.61Ambiguous0.86Ambiguous0.149Likely Benign-2.66Deleterious0.134Benign0.033Benign3.47Benign0.32Tolerated0.16600.12710-1-5.8-3.02
c.1289T>C
M430T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430T is reported in gnomAD (6‑33438194‑T‑C) and has no ClinVar entry. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, FoldX (uncertain), Rosetta, Foldetta (uncertain), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify it as benign or likely benign. No tool predicts pathogenicity. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is benign, the SGM Consensus is likely benign, and Foldetta is uncertain. Overall, the computational evidence strongly supports a benign classification, and this is consistent with the absence of a ClinVar pathogenic report. Thus, the variant is most likely benign, and this is not contradictory to ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.0006-33438194-T-C16.19e-7-3.430Likely Benign0.107Likely BenignLikely Benign1.89Ambiguous0.10.01Likely Benign0.95Ambiguous0.43Likely Benign0.103Likely Benign-1.48Neutral0.016Benign0.010Benign3.48Benign0.40Tolerated3.37290.20020.3184-1-1-2.6-30.09
c.1289T>G
M430R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of consensus tools lean toward a benign classification, while a subset of high‑accuracy methods suggest pathogenicity, leaving the variant’s impact ambiguous. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.071867Structured0.385298Uncertain0.9520.3060.000-10.636Likely Pathogenic0.558AmbiguousLikely Benign0.98Ambiguous0.10.47Likely Benign0.73Ambiguous0.83Ambiguous0.153Likely Benign-2.87Deleterious0.620Possibly Damaging0.046Benign3.48Benign0.38Tolerated0.17750.16520-1-6.424.99
c.1290G>A
M430I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430I is catalogued in gnomAD (6‑33438195‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments reinforce the benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.0006-33438195-G-A16.19e-7-4.655Likely Benign0.420AmbiguousLikely Benign1.22Ambiguous0.1-0.29Likely Benign0.47Likely Benign0.65Ambiguous0.068Likely Benign-1.62Neutral0.134Benign0.025Benign3.54Benign0.40Tolerated3.37290.15240.4116122.6-18.03
c.1290G>C
M430I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the remaining predictions (FoldX, premPS, AlphaMissense‑Default) are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also classifies the variant as benign. Taken together, the consensus of both general and high‑accuracy predictors is that M430I is most likely benign, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.000-4.655Likely Benign0.420AmbiguousLikely Benign1.22Ambiguous0.1-0.29Likely Benign0.47Likely Benign0.65Ambiguous0.068Likely Benign-1.62Neutral0.134Benign0.025Benign3.54Benign0.40Tolerated3.37290.15240.4116122.6-18.03
c.1290G>T
M430I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. Predictions that are inconclusive are FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, while Foldetta’s combined FoldX‑MD/Rosetta output is unavailable due to the uncertain FoldX result. Overall, the evidence overwhelmingly supports a benign classification for M430I, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.000-4.655Likely Benign0.420AmbiguousLikely Benign1.22Ambiguous0.1-0.29Likely Benign0.47Likely Benign0.65Ambiguous0.068Likely Benign-1.62Neutral0.134Benign0.025Benign3.54Benign0.40Tolerated3.37290.15240.4116122.6-18.03
c.856C>A
L286M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, PROVEAN, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Two tools (premPS and ESM1b) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions (seven pathogenic vs. five benign) and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.122885Structured0.385647Uncertain0.9320.2600.000-7.998In-Between0.781Likely PathogenicLikely Benign-0.06Likely Benign0.10.17Likely Benign0.06Likely Benign0.98Ambiguous0.663Likely Pathogenic-1.84Neutral1.000Probably Damaging0.999Probably Damaging1.54Pathogenic0.02Affected0.07890.337142-1.918.03
c.856C>G
L286V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286V is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—consistently predict a pathogenic impact; AlphaMissense‑Default and Rosetta are uncertain. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-9.986Likely Pathogenic0.500AmbiguousLikely Benign2.44Destabilizing0.51.63Ambiguous2.04Destabilizing1.26Destabilizing0.676Likely Pathogenic-2.76Deleterious0.999Probably Damaging0.994Probably Damaging1.71Pathogenic0.01Affected0.14920.3007210.4-14.03
c.857T>A
L286Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L286Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a deleterious effect. No tool predicts a benign outcome. Two tools, Rosetta and Foldetta, return uncertain results. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-13.056Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.37Destabilizing0.31.42Ambiguous1.90Ambiguous2.06Destabilizing0.852Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.48Pathogenic0.00Affected0.11230.0958-2-2-7.314.97
c.857T>C
L286P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-14.982Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.43Destabilizing0.96.38Destabilizing5.91Destabilizing2.10Destabilizing0.878Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.47Pathogenic0.00Affected0.37190.1182-3-3-5.4-16.04
c.857T>G
L286R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L286R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while Rosetta remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus (majority vote) is likely pathogenic; and Foldetta, which integrates FoldX‑MD (pathogenic) and Rosetta (uncertain), reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-15.563Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.90Destabilizing0.31.80Ambiguous2.35Destabilizing1.97Destabilizing0.868Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.49Pathogenic0.00Affected0.13700.0600-3-2-8.343.03
c.1495A>G
R499G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499G is listed in gnomAD (variant ID 6‑33438527‑A‑G) but has no ClinVar entry. Prediction tools that assess the variant’s effect on protein function overwhelmingly indicate a deleterious outcome: REVEL, FoldX‑MD (Rosetta component), Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify it as pathogenic. Only FoldX (overall) and AlphaMissense‑Optimized report uncertain results, which are treated as unavailable evidence. No tool predicts a benign effect. High‑accuracy assessments specifically show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as pathogenic. Taken together, the preponderance of evidence supports a pathogenic classification for R499G, and this conclusion is not contradicted by any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.0006-33438527-A-G31.86e-6-9.960Likely Pathogenic0.789Likely PathogenicAmbiguous1.55Ambiguous0.12.75Destabilizing2.15Destabilizing1.41Destabilizing0.681Likely Pathogenic-4.50Deleterious0.958Probably Damaging0.769Possibly Damaging-1.47Pathogenic0.01Affected3.37350.28880.1798-2-34.1-99.14
c.1496G>A
R499K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta, premPS) are inconclusive, providing no evidence for either direction. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign prediction; Foldetta remains uncertain. Overall, the preponderance of evidence points to a benign effect for R499K, and this conclusion is consistent with the absence of any ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.386723Uncertain0.8990.1460.0004.366Likely Benign0.091Likely BenignLikely Benign1.37Ambiguous0.10.53Ambiguous0.95Ambiguous-0.77Ambiguous0.248Likely Benign1.94Neutral0.001Benign0.008Benign-1.03Pathogenic1.00Tolerated0.35310.1881320.6-28.01
c.1496G>C
R499T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumVar and ESM1b, whereas a majority of tools (REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, SIFT, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic, AlphaMissense‑Optimized is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No evidence from ClinVar contradicts these predictions. Overall, the preponderance of computational evidence points to a pathogenic effect for R499T.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.000-6.797Likely Benign0.855Likely PathogenicAmbiguous2.47Destabilizing0.11.43Ambiguous1.95Ambiguous0.73Ambiguous0.664Likely Pathogenic-3.51Deleterious0.843Possibly Damaging0.403Benign-1.44Pathogenic0.02Affected0.17320.2074-1-13.8-55.08
c.1496G>T
R499I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely indicate a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all classify the change as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports it as likely pathogenic. No tool predicts a benign outcome; the remaining predictions (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) are uncertain or inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Taken together, the overwhelming majority of evidence supports a pathogenic effect, and this is consistent with the absence of a ClinVar entry; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.000-9.069Likely Pathogenic0.861Likely PathogenicAmbiguous1.53Ambiguous0.10.61Ambiguous1.07Ambiguous0.57Ambiguous0.713Likely Pathogenic-5.50Deleterious0.998Probably Damaging0.922Probably Damaging-1.47Pathogenic0.00Affected0.14010.2146-2-39.0-43.03
c.1497A>C
R499S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499S is catalogued in gnomAD (ID 6‑33438529‑A‑C) but has no ClinVar entry. Functional prediction tools largely converge on a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate pathogenicity. No tool reports a benign outcome. High‑accuracy assessments are mixed: AlphaMissense‑Optimized and Foldetta are uncertain, whereas the SGM‑Consensus remains likely pathogenic. Protein‑stability predictions are inconclusive (FoldX uncertain, Rosetta pathogenic, Foldetta uncertain). Taken together, the overwhelming majority of evidence supports a pathogenic classification for R499S. This conclusion is consistent with the absence of a ClinVar status, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.0006-33438529-A-C16.20e-7-9.559Likely Pathogenic0.935Likely PathogenicAmbiguous1.03Ambiguous0.02.19Destabilizing1.61Ambiguous1.40Destabilizing0.632Likely Pathogenic-2.69Deleterious0.958Probably Damaging0.702Possibly Damaging-1.43Pathogenic0.01Affected3.37350.24430.1649-103.7-69.11
c.1497A>T
R499S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499S is not reported in ClinVar and has no entry in gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and Rosetta all predict pathogenicity, while FoldX, AlphaMissense‑Optimized, and Foldetta are uncertain. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports likely pathogenic, and Foldetta likewise yields an uncertain result. Taken together, the overwhelming majority of reliable tools predict a pathogenic effect, and there is no ClinVar annotation to contradict this assessment. Therefore, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.000-9.559Likely Pathogenic0.935Likely PathogenicAmbiguous1.03Ambiguous0.02.19Destabilizing1.61Ambiguous1.40Destabilizing0.632Likely Pathogenic-2.69Deleterious0.958Probably Damaging0.702Possibly Damaging-1.43Pathogenic0.01Affected3.37350.24430.1649-103.7-69.11
c.3733G>A
E1245K
2D
AIThe SynGAP1 missense variant E1245K is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that E1245K is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-11.911Likely Pathogenic0.968Likely PathogenicLikely Pathogenic0.276Likely Benign-3.22Deleterious0.999Probably Damaging0.995Probably Damaging2.28Pathogenic0.00Affected0.16270.657401-0.4-0.94
c.3733G>C
E1245Q
2D
AIThe SynGAP1 missense change E1245Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and PROVEAN, whereas pathogenic predictions are made by polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to a likely pathogenic verdict (3 pathogenic vs. 1 benign). High‑accuracy assessments further support this: AlphaMissense‑Optimized is uncertain, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is not available. Consequently, the majority of evidence points to a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-11.323Likely Pathogenic0.804Likely PathogenicAmbiguous0.210Likely Benign-2.29Neutral0.999Probably Damaging0.996Probably Damaging2.32Pathogenic0.00Affected0.08190.5952220.0-0.98
c.3734A>C
E1245A
2D
AIThe SynGAP1 missense variant E1245A is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess the variant’s effect largely agree on a deleterious outcome: REVEL is the sole tool that predicts a benign effect, whereas PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus likewise indicates a likely pathogenic effect. Foldetta results are not available for this variant. Overall, the consensus of the available predictions indicates that E1245A is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-11.433Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.311Likely Benign-4.85Deleterious0.999Probably Damaging0.995Probably Damaging2.25Pathogenic0.00Affected0.25550.57210-15.3-58.04
c.3734A>G
E1245G
2D
AIThe SynGAP1 missense variant E1245G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. The high‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, while the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is classified as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-12.113Likely Pathogenic0.901Likely PathogenicAmbiguous0.299Likely Benign-5.65Deleterious1.000Probably Damaging0.996Probably Damaging2.22Pathogenic0.00Affected0.21450.54470-23.1-72.06
c.3734A>T
E1245V
2D
AIThe SynGAP1 missense change E1245V is not reported in ClinVar and is absent from gnomAD. Prediction tools that flag the variant as benign include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict it to be pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic effect. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus likewise reports a likely pathogenic outcome. Foldetta results are not available for this variant. Overall, the preponderance of computational evidence points to a pathogenic effect for E1245V, and this conclusion does not conflict with the current ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-12.988Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.319Likely Benign-5.65Deleterious1.000Probably Damaging0.998Probably Damaging2.21Pathogenic0.00Affected0.05180.6856-2-27.7-29.98
c.3735G>C
E1245D
2D
AIThe SynGAP1 missense variant E1245D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and no consensus could be drawn from the SGM Consensus (a tie between pathogenic and benign votes from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the balance of evidence from the available predictors leans toward a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation, as there is no reported ClinVar status to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-6.075Likely Benign0.928Likely PathogenicAmbiguous0.157Likely Benign-2.46Neutral0.997Probably Damaging0.992Probably Damaging2.30Pathogenic0.00Affected0.15850.3097320.0-14.03
c.3735G>T
E1245D
2D
AIThe SynGAP1 missense variant E1245D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and no consensus could be drawn from the SGM Consensus (a tie between pathogenic and benign votes from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the balance of evidence from the available predictors leans toward a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.712013Disordered0.387847Uncertain0.8690.5540.625-6.075Likely Benign0.928Likely PathogenicAmbiguous0.157Likely Benign-2.46Neutral0.997Probably Damaging0.992Probably Damaging2.30Pathogenic0.00Affected0.15850.3097320.0-14.03
c.2107C>A
L703I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and Rosetta. Predictions that are uncertain or inconclusive (FoldX, Foldetta, premPS, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of high‑confidence tools predict a benign impact, and this conclusion does not contradict the ClinVar status, which has no pathogenic classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.144935Structured0.388282Uncertain0.9290.3530.000-9.332Likely Pathogenic0.345AmbiguousLikely Benign1.44Ambiguous0.12.21Destabilizing1.83Ambiguous0.61Ambiguous0.108Likely Benign-1.50Neutral0.982Probably Damaging0.758Possibly Damaging3.38Benign0.00Affected0.09090.3079220.70.00
c.2107C>G
L703V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Because the variant is not present in ClinVar or gnomAD, there is no existing clinical classification to contradict. Overall, the majority of predictions and the two high‑accuracy benign assessments suggest the variant is most likely benign, although the Foldetta result indicates a potential pathogenic effect that warrants further functional investigation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.144935Structured0.388282Uncertain0.9290.3530.000-10.086Likely Pathogenic0.301Likely BenignLikely Benign2.32Destabilizing0.12.61Destabilizing2.47Destabilizing1.07Destabilizing0.080Likely Benign-2.22Neutral0.789Possibly Damaging0.352Benign3.19Benign0.00Affected0.13830.2621210.4-14.03
c.2107C>T
L703F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703F is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, premPS, FATHMM, and AlphaMissense‑Optimized, while those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta remains unavailable. Overall, the majority of reliable predictions lean toward pathogenicity, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-10.929Likely Pathogenic0.768Likely PathogenicLikely Benign1.03Ambiguous0.10.59Ambiguous0.81Ambiguous0.50Likely Benign0.247Likely Benign-3.25Deleterious0.994Probably Damaging0.806Possibly Damaging3.12Benign0.00Affected0.06000.255520-1.034.02
c.2108T>A
L703H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM‑Consensus itself is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts Pathogenic. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-12.886Likely Pathogenic0.957Likely PathogenicLikely Pathogenic2.52Destabilizing0.02.29Destabilizing2.41Destabilizing1.75Destabilizing0.420Likely Benign-5.71Deleterious1.000Probably Damaging0.993Probably Damaging3.09Benign0.00Affected0.10380.0288-2-3-7.023.98
c.2108T>C
L703P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic, while only FATHMM predicts it benign. The SGM‑Consensus, which is a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Pathogenic” result (3 pathogenic vs. 1 benign). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus is likely pathogenic; and Foldetta, integrating FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-13.766Likely Pathogenic0.990Likely PathogenicLikely Pathogenic4.44Destabilizing0.19.38Destabilizing6.91Destabilizing1.54Destabilizing0.559Likely Pathogenic-5.70Deleterious1.000Probably Damaging0.996Probably Damaging3.11Benign0.00Affected0.36980.1186-3-3-5.4-16.04
c.2108T>G
L703R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus) all classify the change as pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. The preponderance of pathogenic predictions, together with the high‑accuracy tools’ positive results, suggests that L703R is most likely pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-13.244Likely Pathogenic0.935Likely PathogenicAmbiguous2.85Destabilizing0.03.74Destabilizing3.30Destabilizing1.79Destabilizing0.459Likely Benign-4.92Deleterious0.994Probably Damaging0.806Possibly Damaging3.13Benign0.00Affected0.12230.0488-3-2-8.343.03
c.1063G>A
G355R
2D
AIThe SynGAP1 missense variant G355R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, and Foldetta. Tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are AlphaMissense‑Optimized, FoldX, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evaluated tools predict a pathogenic impact, whereas a minority predict benign. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.388832Uncertain0.8100.3540.125-11.022Likely Pathogenic0.922Likely PathogenicAmbiguous0.61Ambiguous1.40.10Likely Benign0.36Likely Benign0.60Ambiguous0.340Likely Benign-6.74Deleterious1.000Probably Damaging0.999Probably Damaging1.80Pathogenic0.02Affected0.10410.4567-3-2-4.199.14
c.1063G>C
G355R
2D
AIThe SynGAP1 missense variant G355R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, and Foldetta. Tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are AlphaMissense‑Optimized, FoldX, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evaluated tools predict a pathogenic impact, whereas a minority predict benign. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.388832Uncertain0.8100.3540.125-11.022Likely Pathogenic0.922Likely PathogenicAmbiguous0.61Ambiguous1.40.10Likely Benign0.36Likely Benign0.60Ambiguous0.340Likely Benign-6.74Deleterious1.000Probably Damaging0.999Probably Damaging1.80Pathogenic0.02Affected0.10410.4567-3-2-4.199.14
c.1063G>T
G355W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G355W is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL and premPS, and pathogenic predictions from SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, SGM‑Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.388832Uncertain0.8100.3540.125-12.316Likely Pathogenic0.938Likely PathogenicAmbiguous1.16Ambiguous0.50.88Ambiguous1.02Ambiguous0.18Likely Benign0.455Likely Benign-6.92Deleterious1.000Probably Damaging1.000Probably Damaging1.73Pathogenic0.00Affected0.07960.4360-7-2-0.5129.16
c.1064G>A
G355E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G355E is catalogued in gnomAD (6‑33437969‑G‑A) but has no ClinVar entry. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining evaluated algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is uncertain. Overall, the preponderance of evidence from standard pathogenicity predictors points to a deleterious effect, and this conclusion is not contradicted by any ClinVar classification (none is available). Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.388832Uncertain0.8100.3540.1256-33437969-G-A21.24e-6-9.395Likely Pathogenic0.891Likely PathogenicAmbiguous0.72Ambiguous0.60.63Ambiguous0.68Ambiguous0.54Ambiguous0.349Likely Benign-6.69Deleterious1.000Probably Damaging0.999Probably Damaging1.80Pathogenic0.04Affected3.38240.15900.4271-20-3.172.06
c.1064G>C
G355A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 G355A missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. FoldX and Foldetta are uncertain and therefore not counted as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta is uncertain. Consequently, the overall prediction leans toward a benign effect, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.155435Structured0.388832Uncertain0.8100.3540.125-5.431Likely Benign0.245Likely BenignLikely Benign0.88Ambiguous0.60.46Likely Benign0.67Ambiguous0.49Likely Benign0.286Likely Benign-4.80Deleterious0.999Probably Damaging0.996Probably Damaging1.80Pathogenic0.03Affected0.41110.5045102.214.03
c.1064G>T
G355V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G355V is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or unavailable results are reported for FoldX, premPS, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic effect. Foldetta’s stability prediction is unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.388832Uncertain0.8100.3540.125-10.111Likely Pathogenic0.675Likely PathogenicLikely Benign1.78Ambiguous0.60.14Likely Benign0.96Ambiguous0.53Ambiguous0.346Likely Benign-7.59Deleterious1.000Probably Damaging0.999Probably Damaging1.78Pathogenic0.04Affected0.12210.4685-1-34.642.08
c.859G>A
D287N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D287N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions (REVEL, FoldX, premPS, SIFT) and pathogenic predictions (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default). Two tools give uncertain results (Rosetta, AlphaMissense‑Optimized). High‑accuracy assessments further separate the evidence: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign impact. Overall, the majority of conventional predictors lean toward pathogenicity, while the most accurate stability‑based method suggests benign. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-10.167Likely Pathogenic0.944Likely PathogenicAmbiguous0.16Likely Benign0.3-0.54Ambiguous-0.19Likely Benign0.05Likely Benign0.372Likely Benign-4.60Deleterious0.999Probably Damaging0.997Probably Damaging1.62Pathogenic0.06Tolerated0.13380.8194210.0-0.98
c.859G>C
D287H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D287H missense variant is listed in ClinVar as Pathogenic (ClinVar ID 1700054.0) and is not reported in gnomAD. Functional prediction tools that assess the variant’s effect on protein function largely agree on a deleterious outcome. Benign predictions come from FoldX, Rosetta, and Foldetta, whereas pathogenic predictions are reported by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS remains uncertain. High‑accuracy assessments further support a pathogenic classification: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of evidence points to a pathogenic effect, consistent with the ClinVar designation and not contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000Likely Pathogenic 1-14.518Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.48Likely Benign0.30.32Likely Benign0.40Likely Benign0.63Ambiguous0.589Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.38230.16200.84871-10.322.05235.63.80.11.20.10.1XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop connecting two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the imidazole ring of the His287 side chain is unable to form a salt bridge with Arg324 or establish any other stable compensatory interactions, which could weaken the beta sandwich assembly of the C2 domain. This destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.859G>T
D287Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D287Y missense variant is reported in ClinVar as Pathogenic (ClinVar ID 2263930.0) and is not found in gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Rosetta, Foldetta, and premPS, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. High‑accuracy assessments give a pathogenic verdict from AlphaMissense‑Optimized, a Likely Pathogenic consensus from SGM, and a benign outcome from Foldetta. Overall, the majority of evidence points to a deleterious effect. Therefore, the variant is most likely pathogenic, in agreement with its ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000Likely Pathogenic 1-12.877Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.21Likely Benign0.20.48Likely Benign0.35Likely Benign0.27Likely Benign0.663Likely Pathogenic-8.27Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.38230.05970.7361-4-32.248.09257.8-44.4-0.61.60.20.3XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop linking two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the phenol group of the Tyr287 side chain is unable to form a salt bridge with the guanidinium group of Arg324, which could weaken the tertiary structure assembly of the C2 domain. However, the phenol group of Tyr287 frequently stacks with the Arg324 guanidinium side chain, which could help maintain the tertiary structure, especially compared to the D287H variant. The destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.860A>C
D287A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D287A is listed in ClinVar with an Uncertain significance status and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, FoldX, Rosetta, Foldetta, and premPS, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta) as benign. The overall tally favors pathogenicity (8 tools vs 5 benign), but the conflicting high‑accuracy results leave uncertainty. Thus, the variant is most likely pathogenic according to the majority of predictions, which does not contradict its ClinVar Uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000Uncertain 1-14.686Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.30Likely Benign0.1-0.04Likely Benign0.13Likely Benign0.40Likely Benign0.484Likely Benign-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.58Pathogenic0.01Affected3.38230.44480.7431-205.3-44.01
c.860A>G
D287G
2D
AIThe SynGAP1 missense variant D287G is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Foldetta, premPS, and Rosetta, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict it to be pathogenic; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of predictions indicates a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-13.558Likely Pathogenic0.967Likely PathogenicLikely Pathogenic0.61Ambiguous1.10.31Likely Benign0.46Likely Benign0.38Likely Benign0.521Likely Pathogenic-6.43Deleterious0.999Probably Damaging0.997Probably Damaging1.59Pathogenic0.01Affected0.46880.73901-13.1-58.04
c.860A>T
D287V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D287V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only premPS; all other evaluated algorithms (SGM‑Consensus, REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, while FoldX is uncertain and thus not counted as evidence. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-14.418Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.71Ambiguous0.43.94Destabilizing2.83Destabilizing0.25Likely Benign0.516Likely Pathogenic-8.27Deleterious1.000Probably Damaging0.999Probably Damaging1.57Pathogenic0.01Affected0.08840.7788-2-37.7-15.96
c.861T>A
D287E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D287E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, ESM1b, and the protein‑folding stability method Foldetta; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (pathogenic), and PROVEAN (pathogenic), also reports it as pathogenic. In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect on protein stability. No evidence is available from Rosetta alone. Overall, the majority of predictions, including the high‑accuracy methods, indicate a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-5.250Likely Benign0.990Likely PathogenicLikely Pathogenic0.35Likely Benign0.20.54Ambiguous0.45Likely Benign0.50Likely Benign0.416Likely Benign-3.68Deleterious0.997Probably Damaging0.994Probably Damaging1.54Pathogenic0.01Affected0.15410.7833320.014.03
c.861T>G
D287E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D287E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, ESM1b, and the protein‑folding stability method Foldetta; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (pathogenic), and PROVEAN (pathogenic), also reports it as pathogenic. In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect on protein stability. No evidence is available from Rosetta alone. Overall, the majority of predictions, including the high‑accuracy methods, indicate a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-5.250Likely Benign0.990Likely PathogenicLikely Pathogenic0.35Likely Benign0.20.54Ambiguous0.45Likely Benign0.50Likely Benign0.416Likely Benign-3.68Deleterious0.997Probably Damaging0.994Probably Damaging1.54Pathogenic0.01Affected0.15410.7833320.014.03
c.1282T>A
Y428N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are limited to FATHMM, which classifies the change as benign. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic or likely pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized reports pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-12.164Likely Pathogenic0.976Likely PathogenicLikely Pathogenic2.34Destabilizing0.03.81Destabilizing3.08Destabilizing1.85Destabilizing0.533Likely Pathogenic-8.59Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.03Affected0.26070.0971-2-2-2.2-49.07
c.1282T>C
Y428H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y428H is not reported in ClinVar but is present in gnomAD (ID 6‑33438187‑T‑C). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM Consensus score (Likely Pathogenic) all suggest a deleterious impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Consequently, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.0006-33438187-T-C16.19e-7-8.566Likely Pathogenic0.961Likely PathogenicLikely Pathogenic3.18Destabilizing0.12.20Destabilizing2.69Destabilizing1.80Destabilizing0.458Likely Benign-4.77Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.04Affected3.38250.26850.071120-1.9-26.03
c.1282T>G
Y428D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y428D is not reported in ClinVar and is absent from gnomAD. Across a broad panel of in silico predictors, 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) uniformly predict a deleterious effect, whereas only FATHMM classifies it as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote) is likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-13.473Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.24Destabilizing0.04.19Destabilizing3.72Destabilizing1.64Destabilizing0.554Likely Pathogenic-9.55Deleterious1.000Probably Damaging1.000Probably Damaging3.50Benign0.01Affected0.44580.1003-4-3-2.2-48.09
c.1283A>C
Y428S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM. All other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Based on the overwhelming majority of predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-10.936Likely Pathogenic0.928Likely PathogenicAmbiguous3.00Destabilizing0.03.42Destabilizing3.21Destabilizing2.00Destabilizing0.505Likely Pathogenic-8.59Deleterious1.000Probably Damaging1.000Probably Damaging3.45Benign0.03Affected0.46230.2352-3-20.5-76.10
c.1283A>G
Y428C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428C is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus—consistently predict a pathogenic impact. High‑accuracy assessments show the SGM‑Consensus result as “Likely Pathogenic,” Foldetta predicts a destabilizing, pathogenic effect, while AlphaMissense‑Optimized is uncertain. No prediction or stability result is missing; the only inconclusive outcome is the AlphaMissense‑Optimized score. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-11.312Likely Pathogenic0.852Likely PathogenicAmbiguous2.82Destabilizing0.02.99Destabilizing2.91Destabilizing2.02Destabilizing0.454Likely Benign-8.59Deleterious1.000Probably Damaging0.999Probably Damaging3.39Benign0.01Affected0.33220.22200-23.8-60.04
c.1283A>T
Y428F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas a majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b) predict a pathogenic impact. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as unavailable. Overall, the balance of evidence—five pathogenic versus three benign predictions, with a pathogenic SGM Consensus and a benign AlphaMissense‑Optimized—suggests that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.118441Structured0.389652Uncertain0.9650.2920.000-10.464Likely Pathogenic0.530AmbiguousLikely Benign0.82Ambiguous0.10.52Ambiguous0.67Ambiguous0.89Ambiguous0.366Likely Benign-3.82Deleterious0.999Probably Damaging0.985Probably Damaging3.41Benign0.04Affected0.27190.3146734.1-16.00
c.631A>C
S211R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a pathogenic signal is reported by SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of tools predict a pathogenic effect, and the high‑accuracy predictions reinforce this conclusion. The variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-14.126Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.49Likely Benign1.00.20Likely Benign0.35Likely Benign0.97Ambiguous0.132Likely Benign-4.00Deleterious0.995Probably Damaging0.829Possibly Damaging3.95Benign0.02Affected0.10030.35920-1-3.769.11
c.631A>G
S211G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 HumDiv, and ESM1b; Rosetta is uncertain. High‑accuracy methods give a benign result for AlphaMissense‑Optimized and for Foldetta. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign vs two pathogenic). No evidence from ClinVar contradicts these predictions. Overall, the balance of evidence—including the unanimous benign calls from the high‑accuracy tools—suggests that the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.209395Structured0.389893Uncertain0.8460.3000.125-9.895Likely Pathogenic0.265Likely BenignLikely Benign0.30Likely Benign0.20.54Ambiguous0.42Likely Benign1.07Destabilizing0.067Likely Benign-3.17Deleterious0.787Possibly Damaging0.404Benign3.92Benign0.07Tolerated0.25600.4337100.4-30.03
c.631A>T
S211C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, and premPS, whereas a separate group predicts pathogenicity: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Two tools (Rosetta and AlphaMissense‑Default) return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Because the consensus of the most reliable predictors is split (two benign, one pathogenic) and the overall tool distribution is evenly divided, the variant’s impact remains ambiguous. Based on the available predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.209395Structured0.389893Uncertain0.8460.3000.125-10.567Likely Pathogenic0.547AmbiguousLikely Benign0.28Likely Benign0.10.63Ambiguous0.46Likely Benign0.11Likely Benign0.263Likely Benign-4.14Deleterious0.999Probably Damaging0.908Possibly Damaging3.89Benign0.01Affected0.12920.56380-13.316.06
c.632G>A
S211N
2D
AIThe SynGAP1 S211N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and premPS. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Consequently, the overall prediction leans toward pathogenicity, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.209395Structured0.389893Uncertain0.8460.3000.125-9.995Likely Pathogenic0.794Likely PathogenicAmbiguous0.60Ambiguous1.21.39Ambiguous1.00Ambiguous1.21Destabilizing0.174Likely Benign-2.22Neutral0.982Probably Damaging0.747Possibly Damaging3.95Benign0.09Tolerated0.15340.486311-2.727.03
c.632G>C
S211T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Two tools, FoldX and Rosetta, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.209395Structured0.389893Uncertain0.8460.3000.125-10.301Likely Pathogenic0.678Likely PathogenicLikely Benign0.98Ambiguous0.5-0.78Ambiguous0.10Likely Benign0.50Likely Benign0.157Likely Benign-2.33Neutral0.948Possibly Damaging0.484Possibly Damaging3.95Benign0.07Tolerated0.16780.5960110.114.03
c.632G>T
S211I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 S211I missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. No evidence from FoldX or Rosetta is available. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-17.090Likely Pathogenic0.973Likely PathogenicLikely Pathogenic1.06Ambiguous1.11.05Ambiguous1.06Ambiguous0.12Likely Benign0.251Likely Benign-4.94Deleterious0.995Probably Damaging0.767Possibly Damaging3.90Benign0.01Affected0.09090.5220-1-25.326.08
c.633C>A
S211R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, FATHMM, and Foldetta. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled “Likely Pathogenic.” The premPS score is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions and the two high‑accuracy pathogenic calls suggest that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-14.126Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.49Likely Benign1.00.20Likely Benign0.35Likely Benign0.97Ambiguous0.144Likely Benign-4.00Deleterious0.995Probably Damaging0.829Possibly Damaging3.95Benign0.02Affected0.10030.35920-1-3.769.11
c.633C>G
S211R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S211R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, Rosetta, FATHMM, and the protein‑stability integrator Foldetta, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic, and premPS is uncertain. High‑accuracy assessments give conflicting signals: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus also predicts Likely Pathogenic, but Foldetta, which combines FoldX‑MD and Rosetta outputs, predicts Benign. Overall, the majority of tools and the consensus score point to a pathogenic effect, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.209395Structured0.389893Uncertain0.8460.3000.125-14.126Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.49Likely Benign1.00.20Likely Benign0.35Likely Benign0.97Ambiguous0.144Likely Benign-4.00Deleterious0.995Probably Damaging0.829Possibly Damaging3.95Benign0.02Affected0.10030.35920-1-3.769.11
c.2086C>A
L696I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L696I missense change is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. FoldX, Rosetta, Foldetta, and premPS give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is unavailable. Overall, the majority of conventional tools lean toward pathogenicity, and the high‑accuracy prediction that is available (AlphaMissense‑Optimized) indicates benign, leaving the evidence mixed. Thus, the variant is most likely pathogenic based on the preponderance of predictions, and this does not contradict the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.200174Structured0.390093Uncertain0.9620.2670.000-10.652Likely Pathogenic0.698Likely PathogenicLikely Benign1.01Ambiguous0.10.58Ambiguous0.80Ambiguous0.85Ambiguous0.250Likely Benign-1.86Neutral0.996Probably Damaging0.989Probably Damaging3.15Benign0.00Affected0.09210.2542220.70.00
c.2086C>G
L696V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L696V variant is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas the majority of other in silico predictors (FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) report a pathogenic outcome; Rosetta remains inconclusive. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts benign, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for the variant, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000Uncertain 1-11.909Likely Pathogenic0.745Likely PathogenicLikely Benign2.35Destabilizing0.11.85Ambiguous2.10Destabilizing1.46Destabilizing0.351Likely Benign-2.79Deleterious0.992Probably Damaging0.970Probably Damaging3.16Benign0.00Affected3.46130.13070.2830120.4-14.03
c.2086C>T
L696F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L696F has no ClinVar entry and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000-9.651Likely Pathogenic0.897Likely PathogenicAmbiguous0.14Likely Benign0.10.74Ambiguous0.44Likely Benign0.55Ambiguous0.422Likely Benign-3.79Deleterious0.999Probably Damaging0.988Probably Damaging3.05Benign0.00Affected0.06670.200820-1.034.02
c.2087T>A
L696H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L696H is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: all available predictors except FATHMM classify the variant as pathogenic (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized). Only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Taken together, the overwhelming majority of computational evidence supports a pathogenic classification, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000-17.042Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.56Destabilizing0.02.55Destabilizing2.56Destabilizing2.07Destabilizing0.569Likely Pathogenic-6.58Deleterious1.000Probably Damaging1.000Probably Damaging3.00Benign0.00Affected0.10090.0488-2-3-7.023.98
c.2087T>C
L696P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L696P is listed in ClinVar as Pathogenic (ClinVar ID 1699350.0) and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM; all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report it as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a pathogenic effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote) is pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a destabilizing, pathogenic outcome. Taken together, the overwhelming majority of predictions and the high‑accuracy tools classify the variant as pathogenic, fully consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000Likely Pathogenic 1-16.926Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.66Destabilizing0.210.84Destabilizing8.75Destabilizing2.13Destabilizing0.678Likely Pathogenic-6.58Deleterious1.000Probably Damaging1.000Probably Damaging3.00Benign0.00Affected3.46130.30650.1995-3-3-5.4-16.04180.665.90.10.0-0.60.1XPotentially PathogenicThe isobutyl side chain of Leu696, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu692, Leu714) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Leu692 in the same manner as Leu696 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro696 is not as optimal as Leu696 for hydrophobic packing in the inter-helix space.
c.2087T>G
L696R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L696R is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: all available predictors except FATHMM (which flags it as benign) report pathogenicity. The benign group contains only FATHMM; the pathogenic group includes SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000-19.609Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.67Destabilizing0.05.36Destabilizing4.52Destabilizing2.44Destabilizing0.624Likely Pathogenic-5.68Deleterious0.999Probably Damaging0.992Probably Damaging3.01Benign0.00Affected0.12000.0688-3-2-8.343.03
c.1285C>G
R429G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R429G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta’s stability analysis is uncertain. No evidence from FoldX or Rosetta is available. Overall, the predictions are evenly split, with no clear consensus. The variant is most likely of uncertain significance; it is not contradicted by ClinVar status, which has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.390504Uncertain0.9590.2900.000-9.157Likely Pathogenic0.333Likely BenignLikely Benign1.58Ambiguous0.01.68Ambiguous1.63Ambiguous1.21Destabilizing0.257Likely Benign-3.37Deleterious1.000Probably Damaging0.999Probably Damaging3.43Benign0.34Tolerated0.28880.2717-3-24.1-99.14
c.1285C>T
R429W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429W is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33438190‑C‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b; premPS and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.390504Uncertain0.9590.2900.000Conflicting 56-33438190-C-T654.03e-5-10.666Likely Pathogenic0.500AmbiguousLikely Benign0.31Likely Benign0.1-0.13Likely Benign0.09Likely Benign0.52Ambiguous0.282Likely Benign-3.19Deleterious1.000Probably Damaging0.990Probably Damaging3.41Benign0.03Affected3.38250.12320.34222-33.630.03252.345.50.00.00.20.1XPotentially PathogenicThe guanidinium group of Arg429, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or a H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, the indole ring of the Trp429 side chain cannot form ionic interactions with the acidic residues. Although it forms a H-bond with Ser471, the bonding is not as strong as that of arginine. The residue swap could affect the tertiary structure assembly during folding; however, no large-scale negative effects were seen during the simulations.
c.1286G>A
R429Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429Q is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33438191‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b, while premPS is inconclusive. The high‑accuracy consensus (SGM Consensus) – a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN – yields a “Likely Benign” result. AlphaMissense‑Optimized itself predicts benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Taken together, the preponderance of evidence points to a benign impact for R429Q, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.390504Uncertain0.9590.2900.000Uncertain 26-33438191-G-A106.20e-6-8.227Likely Pathogenic0.143Likely BenignLikely Benign0.45Likely Benign0.10.36Likely Benign0.41Likely Benign0.98Ambiguous0.156Likely Benign-1.25Neutral1.000Probably Damaging0.979Probably Damaging3.47Benign0.58Tolerated3.38250.25180.1985111.0-28.06235.859.50.00.0-0.30.4XPotentially PathogenicThe guanidinium group of the Arg429 side chain, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or an H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, Gln429 cannot form ionic interactions with the acidic residues; however, the carboxamide group can form multiple H-bonds. The H-bonding coordination of the Asn429 side chain varied between the replica simulations. In one simulation, three H-bonds were formed simultaneously with the Asp467 side chain, the backbone carbonyl group of Asn426, and the amide group of Met430 at the end of the same α helix. The residue swap could affect the tertiary structure assembly during folding due to weaker bond formation, but no large-scale negative effects were seen during the simulations.
c.1286G>C
R429P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; AlphaMissense‑Default and FoldX are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of tools and the high‑accuracy methods favor a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.390504Uncertain0.9590.2900.000-9.771Likely Pathogenic0.556AmbiguousLikely Benign1.53Ambiguous0.25.13Destabilizing3.33Destabilizing1.01Destabilizing0.265Likely Benign-2.89Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.25Tolerated0.18810.37900-22.9-59.07
c.1286G>T
R429L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. No contradictory evidence is present from ClinVar or gnomAD. **Based on the aggregate predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.390504Uncertain0.9590.2900.000-6.495Likely Benign0.408AmbiguousLikely Benign-0.05Likely Benign0.10.06Likely Benign0.01Likely Benign-0.12Likely Benign0.241Likely Benign-1.20Neutral1.000Probably Damaging0.998Probably Damaging3.59Benign0.37Tolerated0.15550.4025-3-28.3-43.03
c.628C>A
H210N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H210N missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, and FATHMM, while pathogenic predictions are made by premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus score (Likely Pathogenic). Two tools give uncertain results: Foldetta (combining FoldX‑MD and Rosetta outputs) and Rosetta alone. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as Likely Pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points toward a pathogenic effect for H210N. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-13.699Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.19Likely Benign0.31.24Ambiguous0.72Ambiguous1.12Destabilizing0.375Likely Benign-6.01Deleterious0.895Possibly Damaging0.533Possibly Damaging3.11Benign0.00Affected0.11660.183921-0.3-23.04
c.628C>G
H210D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H210D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain, and Rosetta alone is also uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for H210D, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-16.440Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.13Likely Benign0.41.23Ambiguous0.68Ambiguous1.23Destabilizing0.489Likely Benign-7.73Deleterious0.895Possibly Damaging0.533Possibly Damaging3.18Benign0.00Affected0.20250.12551-1-0.3-22.05
c.628C>T
H210Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H210Y missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as Benign. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar classification because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-12.828Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.27Likely Benign0.80.38Likely Benign0.33Likely Benign0.39Likely Benign0.427Likely Benign-5.12Deleterious0.963Probably Damaging0.628Possibly Damaging3.07Benign0.00Affected0.04970.3662021.926.03
c.629A>C
H210P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H210P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-14.634Likely Pathogenic0.983Likely PathogenicLikely Pathogenic2.26Destabilizing0.52.80Destabilizing2.53Destabilizing1.00Destabilizing0.512Likely Pathogenic-8.55Deleterious0.989Probably Damaging0.795Possibly Damaging3.09Benign0.00Affected0.18050.31750-21.6-40.02
c.629A>G
H210R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H210R missense variant is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and FoldX, whereas a majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). The high‑accuracy AlphaMissense‑Optimized result is pathogenic; the SGM Consensus, based on the same set of predictors, is also pathogenic; Foldetta’s stability assessment is uncertain and therefore not considered evidence. Overall, the balance of evidence points to a pathogenic effect for H210R. This prediction does not contradict the ClinVar “Uncertain” classification, which remains unresolved.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125Uncertain 1-14.254Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.40Likely Benign0.43.05Destabilizing1.73Ambiguous1.12Destabilizing0.431Likely Benign-6.74Deleterious0.808Possibly Damaging0.452Possibly Damaging3.09Benign0.00Affected0.14270.198220-1.319.05
c.629A>T
H210L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H210L missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools cluster into two groups: benign predictions come from REVEL, Foldetta, premPS, and FATHMM, while pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Rosetta provide uncertain results. High‑accuracy assessments further highlight the discrepancy: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, whereas Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-14.516Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.71Ambiguous0.11.35Ambiguous0.32Likely Benign0.49Likely Benign0.421Likely Benign-9.41Deleterious0.895Possibly Damaging0.614Possibly Damaging3.09Benign0.00Affected0.06170.4452-2-37.0-23.98
c.630C>A
H210Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H210Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign calls come from REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar) and FATHMM, whereas pathogenic calls are made by premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM and PROVEAN, favors a pathogenic outcome (3/4). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote) also predicts pathogenic. Foldetta, a protein‑folding stability predictor that integrates FoldX‑MD and Rosetta, is inconclusive and therefore not used as evidence. Overall, the majority of reliable predictors indicate a pathogenic effect for H210Q, and this conclusion does not conflict with any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-12.639Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.26Likely Benign0.31.96Ambiguous1.11Ambiguous1.20Destabilizing0.258Likely Benign-6.84Deleterious0.141Benign0.064Benign3.10Benign0.00Affected0.10160.285230-0.3-9.01
c.630C>G
H210Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H210Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls from REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar) and FATHMM, whereas pathogenic calls come from premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default and AlphaMissense‑Optimized. When predictions are grouped, five tools favor a benign effect and six favor a pathogenic effect. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenic, and the Foldetta stability analysis is inconclusive. No evidence from ClinVar contradicts these findings. Therefore, the variant is most likely pathogenic based on the aggregate computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.144935Structured0.390904Uncertain0.8720.2980.125-12.639Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.26Likely Benign0.31.96Ambiguous1.11Ambiguous1.20Destabilizing0.258Likely Benign-6.84Deleterious0.141Benign0.064Benign3.10Benign0.00Affected0.10160.285230-0.3-9.01
c.3757G>A
A1253T
2D
AISynGAP1 missense variant A1253T is predicted to be benign by all evaluated in‑silico tools. The consensus group of predictors—REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—uniformly classify the change as benign, with no tool indicating pathogenicity. High‑accuracy methods corroborate this view: AlphaMissense‑Optimized reports a benign effect, and the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also labels the variant as likely benign. Foldetta stability analysis is unavailable. ClinVar contains no entry for this variant, and it is not present in gnomAD. Overall, the predictive evidence strongly supports a benign classification, consistent with the lack of a ClinVar pathogenic report.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-4.116Likely Benign0.077Likely BenignLikely Benign0.046Likely Benign-0.08Neutral0.042Benign0.061Benign2.79Benign0.41Tolerated0.10160.533910-2.530.03
c.3757G>C
A1253P
2D
AIThe SynGAP1 missense variant A1253P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic, two benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy AlphaMissense‑Optimized predicts pathogenic, while AlphaMissense‑Default also predicts pathogenic; however, the majority of tools (five benign vs. four pathogenic) lean toward a benign classification. Thus, based on the current predictions, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-11.381Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.062Likely Benign-0.63Neutral0.568Possibly Damaging0.352Benign2.74Benign0.26Tolerated0.15650.35141-1-3.426.04
c.3757G>T
A1253S
2D
AIThe SynGAP1 missense variant A1253S is not reported in ClinVar and is absent from gnomAD, indicating no documented clinical or population data. Functional prediction tools uniformly classify the variant as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a benign effect. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized reports a benign outcome, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign status. Foldetta results are unavailable. Based on the consensus of all available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-3.639Likely Benign0.090Likely BenignLikely Benign0.041Likely Benign0.05Neutral0.081Benign0.111Benign2.81Benign0.33Tolerated0.20030.415911-2.616.00
c.3758C>A
A1253E
2D
AIThe SynGAP1 missense variant A1253E is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Functional prediction tools uniformly classify the variant as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a benign effect. No tool in the dataset predicts pathogenicity. High‑accuracy assessments corroborate this benign classification: AlphaMissense‑Optimized reports benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign.” Foldetta results are not available, so they do not influence the assessment. Overall, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-1.744Likely Benign0.166Likely BenignLikely Benign0.059Likely Benign2.03Neutral0.301Benign0.209Benign3.03Benign0.98Tolerated0.09480.17040-1-5.358.04
c.3758C>G
A1253G
2D
AIThe SynGAP1 missense variant A1253G is predicted to be benign by all evaluated in silico tools. Consensus predictions from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized uniformly indicate a benign effect. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports a likely benign outcome. No Foldetta stability analysis is available for this residue. The variant is not listed in ClinVar and has no entry in gnomAD, so there is no external evidence to contradict the computational predictions. Based on the collective predictions, the variant is most likely benign, and this assessment aligns with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-4.772Likely Benign0.134Likely BenignLikely Benign0.042Likely Benign-1.23Neutral0.151Benign0.148Benign2.76Benign0.26Tolerated0.16880.340710-2.2-14.03
c.3758C>T
A1253V
2D
AIThe SynGAP1 missense variant A1253V is predicted to be benign by every evaluated in‑silico tool. Benign predictions are reported by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments confirm this: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. ClinVar contains no entry for A1253V, and the variant is absent from gnomAD. Based on the unanimous benign predictions and lack of conflicting evidence, the variant is most likely benign, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-4.706Likely Benign0.060Likely BenignLikely Benign0.057Likely Benign0.20Neutral0.000Benign0.001Benign2.85Benign1.00Tolerated0.07840.4473002.428.05
c.982T>A
Y328N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-13.778Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.72Destabilizing0.13.88Destabilizing3.30Destabilizing2.06Destabilizing0.548Likely Pathogenic-8.07Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.01Affected0.23740.0703-2-2-2.2-49.07
c.982T>C
Y328H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-10.885Likely Pathogenic0.983Likely PathogenicLikely Pathogenic2.08Destabilizing0.02.43Destabilizing2.26Destabilizing1.35Destabilizing0.516Likely Pathogenic-4.53Deleterious1.000Probably Damaging0.999Probably Damaging1.54Pathogenic0.02Affected0.25720.070302-1.9-26.03
c.982T>G
Y328D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328D is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool examined (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classifies the substitution as pathogenic; no tool predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-13.701Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.32Destabilizing0.24.97Destabilizing4.65Destabilizing1.87Destabilizing0.680Likely Pathogenic-8.93Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.01Affected0.42330.0703-4-3-2.2-48.09
c.983A>C
Y328S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328S is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic impact on protein stability. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-12.358Likely Pathogenic0.984Likely PathogenicLikely Pathogenic3.13Destabilizing0.14.55Destabilizing3.84Destabilizing1.80Destabilizing0.586Likely Pathogenic-8.01Deleterious1.000Probably Damaging0.998Probably Damaging1.54Pathogenic0.01Affected0.49240.2449-3-20.5-76.10
c.983A>G
Y328C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (integrating FoldX‑MD and Rosetta outputs) also reports a pathogenic outcome. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-12.385Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.52Destabilizing0.13.74Destabilizing3.13Destabilizing1.40Destabilizing0.523Likely Pathogenic-8.01Deleterious1.000Probably Damaging0.999Probably Damaging1.55Pathogenic0.01Affected0.31540.28820-23.8-60.04
c.983A>T
Y328F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.411940Structured0.392519Uncertain0.9160.4970.000-6.770Likely Benign0.444AmbiguousLikely Benign0.34Likely Benign0.10.43Likely Benign0.39Likely Benign0.37Likely Benign0.330Likely Benign-3.21Deleterious0.999Probably Damaging0.992Probably Damaging1.67Pathogenic0.16Tolerated0.24090.3643734.1-16.00
c.2137C>A
P713T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further clarify the picture: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic, whereas AlphaMissense‑Optimized and Foldetta provide inconclusive results and are treated as unavailable. Taken together, the preponderance of evidence points to a pathogenic effect for P713T, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-9.915Likely Pathogenic0.819Likely PathogenicAmbiguous1.15Ambiguous0.00.46Likely Benign0.81Ambiguous0.65Ambiguous0.225Likely Benign-6.72Deleterious1.000Probably Damaging0.993Probably Damaging3.34Benign0.00Affected0.14170.38180-10.93.99
c.2137C>G
P713A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 P713A is not reported in ClinVar and is absent from gnomAD. Benign predictions are provided by REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default; the SGM‑Consensus score is labeled Likely Pathogenic. FoldX, Foldetta, and premPS give uncertain results. High‑accuracy tools: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-8.535Likely Pathogenic0.689Likely PathogenicLikely Benign1.04Ambiguous0.10.15Likely Benign0.60Ambiguous0.75Ambiguous0.235Likely Benign-6.80Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.00Affected0.31590.34751-13.4-26.04
c.2137C>T
P713S
2D
AIThe SynGAP1 missense variant P713S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, Rosetta, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are provided by FoldX, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this ambiguity: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates a likely pathogenic effect, and Foldetta likewise yields an uncertain stability change. Overall, the majority of tools lean toward a pathogenic interpretation, and this aligns with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-8.496Likely Pathogenic0.846Likely PathogenicAmbiguous0.91Ambiguous0.70.19Likely Benign0.55Ambiguous0.62Ambiguous0.261Likely Benign-6.60Deleterious1.000Probably Damaging0.998Probably Damaging3.29Benign0.00Affected0.32340.36741-10.8-10.04
c.2138C>A
P713Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P713Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain calls are made by Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this discordance: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of evidence leans toward a benign interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-10.253Likely Pathogenic0.875Likely PathogenicAmbiguous0.26Likely Benign0.0-0.77Ambiguous-0.26Likely Benign0.95Ambiguous0.364Likely Benign-6.38Deleterious1.000Probably Damaging0.997Probably Damaging3.37Benign0.00Affected0.12250.33880-1-1.931.01
c.2138C>G
P713R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools, premPS and AlphaMissense‑Optimized, are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of predictions lean toward pathogenicity, while the most accurate methods give conflicting results. Thus, the variant is most likely pathogenic based on the current evidence, and this assessment does not contradict ClinVar status, which has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-12.101Likely Pathogenic0.930Likely PathogenicAmbiguous0.29Likely Benign0.00.21Likely Benign0.25Likely Benign0.86Ambiguous0.331Likely Benign-7.42Deleterious1.000Probably Damaging0.998Probably Damaging3.29Benign0.00Affected0.13660.23350-2-2.959.07
c.2138C>T
P713L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-11.323Likely Pathogenic0.850Likely PathogenicAmbiguous0.18Likely Benign0.1-0.03Likely Benign0.08Likely Benign0.55Ambiguous0.324Likely Benign-8.60Deleterious1.000Probably Damaging0.998Probably Damaging3.34Benign0.00Affected0.19930.5261-3-35.416.04
c.1489T>A
Y497N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y497N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. Based on these concordant predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.393608Uncertain0.9500.1810.000-11.884Likely Pathogenic0.974Likely PathogenicLikely Pathogenic3.64Destabilizing0.13.97Destabilizing3.81Destabilizing2.49Destabilizing0.870Likely Pathogenic-8.85Deleterious1.000Probably Damaging0.999Probably Damaging-1.66Pathogenic0.01Affected0.21140.0612-2-2-2.2-49.07
c.1489T>C
Y497H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y497H is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.393608Uncertain0.9500.1810.000-10.970Likely Pathogenic0.981Likely PathogenicLikely Pathogenic2.46Destabilizing0.12.40Destabilizing2.43Destabilizing1.29Destabilizing0.819Likely Pathogenic-4.94Deleterious1.000Probably Damaging0.999Probably Damaging-1.65Pathogenic0.02Affected0.19830.061202-1.9-26.03
c.1489T>G
Y497D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y497D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a destabilizing, pathogenic effect. All available predictions are concordant and indicate a likely pathogenic impact. Thus, based on the collective computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.393608Uncertain0.9500.1810.000-12.128Likely Pathogenic0.994Likely PathogenicLikely Pathogenic4.70Destabilizing0.24.29Destabilizing4.50Destabilizing2.36Destabilizing0.918Likely Pathogenic-9.81Deleterious1.000Probably Damaging0.999Probably Damaging-1.67Pathogenic0.01Affected0.36210.0612-4-3-2.2-48.09
c.1490A>C
Y497S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y497S is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool examined (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized) classifies the change as pathogenic, leaving no benign predictions. High‑accuracy methods reinforce this assessment: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, indicates a destabilizing, pathogenic effect. No prediction or stability result is missing or inconclusive. Based on the unanimous pathogenic predictions and the absence of any ClinVar annotation, the variant is most likely pathogenic, with no contradictory ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.393608Uncertain0.9500.1810.000-13.171Likely Pathogenic0.980Likely PathogenicLikely Pathogenic3.65Destabilizing0.14.68Destabilizing4.17Destabilizing2.22Destabilizing0.814Likely Pathogenic-8.82Deleterious1.000Probably Damaging0.999Probably Damaging-1.64Pathogenic0.03Affected0.37700.1419-3-20.5-76.10
c.1490A>G
Y497C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y497C is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all return a deleterious signal: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict pathogenic. No tool reports a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM Consensus as “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) as “Pathogenic.” Overall, the variant is most likely pathogenic based on the consensus of predictive algorithms, which contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.393608Uncertain0.9500.1810.000Uncertain 1-11.872Likely Pathogenic0.948Likely PathogenicAmbiguous3.88Destabilizing0.14.76Destabilizing4.32Destabilizing1.40Destabilizing0.806Likely Pathogenic-8.82Deleterious1.000Probably Damaging0.995Probably Damaging-1.65Pathogenic0.03Affected3.37350.29050.14880-23.8-60.04209.959.1-0.10.0-0.30.1XXPotentially PathogenicTyr497 is located in the α-helix (res. Leu489-Glu519) within the inter-helix space of four α-helices (res. Leu489-Ile501, res. Val441-Ser457, res. Arg563-Glu578, res. Ala461-Val473). In the WT simulations, the phenol ring of Tyr497 hydrophobically packs with other residues in the inter-helix space (e.g., Leu465, Leu565, Val568). The hydroxyl group of Tyr497 also alternately forms hydrogen bonds with the carboxylate side chain of Gln456 and the backbone carbonyl of Glu564. Thus, Tyr497 plays a role in the folding and maintenance of the tertiary structure assembly between these four helices.In the variant simulations, the comparatively smaller residue, Cys497, cannot maintain any of the interactions seen with Tyr497 in the WT. Although no severe deleterious consequences are observed in the simulations, the structural effects could be more pronounced during actual protein folding. Indeed, the tertiary structure is seen to slightly break apart in the variant simulations.
c.1490A>T
Y497F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y497F is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, ESM1b, and FATHMM; premPS remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions lean toward a benign impact, and this conclusion does not contradict the absence of a ClinVar classification. Thus, the variant is most likely benign based on the current predictive evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.393608Uncertain0.9500.1810.000-8.566Likely Pathogenic0.199Likely BenignLikely Benign-0.27Likely Benign0.10.47Likely Benign0.10Likely Benign0.61Ambiguous0.578Likely Pathogenic-3.75Deleterious0.367Benign0.131Benign-1.15Pathogenic0.19Tolerated0.20740.2242734.1-16.00
c.1216T>A
Y406N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y406N is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also indicates pathogenicity. Taken together, the preponderance of evidence points to a pathogenic effect for Y406N, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-13.206Likely Pathogenic0.980Likely PathogenicLikely Pathogenic2.90Destabilizing0.12.88Destabilizing2.89Destabilizing1.58Destabilizing0.288Likely Benign-7.11Deleterious0.999Probably Damaging0.966Probably Damaging3.78Benign0.02Affected0.25320.1071-2-2-2.2-49.07
c.1216T>C
Y406H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y406H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently classify the substitution as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Taken together, the preponderance of evidence indicates that Y406H is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-9.015Likely Pathogenic0.858Likely PathogenicAmbiguous2.13Destabilizing0.12.15Destabilizing2.14Destabilizing1.03Destabilizing0.239Likely Benign-4.21Deleterious0.997Probably Damaging0.966Probably Damaging3.80Benign0.03Affected0.26660.081102-1.9-26.03
c.1216T>G
Y406D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y406D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. In contrast, the majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score is “Likely Pathogenic,” while premPS is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the preponderance of evidence, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-14.832Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.82Destabilizing0.34.28Destabilizing4.05Destabilizing0.98Ambiguous0.347Likely Benign-7.64Deleterious0.999Probably Damaging0.950Probably Damaging3.77Benign0.01Affected0.44390.0903-4-3-2.2-48.09
c.1217A>C
Y406S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y406S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FoldX, Rosetta, premPS, and Foldetta all indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-12.014Likely Pathogenic0.977Likely PathogenicLikely Pathogenic3.51Destabilizing0.34.08Destabilizing3.80Destabilizing1.40Destabilizing0.190Likely Benign-6.72Deleterious0.991Probably Damaging0.886Possibly Damaging3.80Benign0.06Tolerated0.47190.2817-3-20.5-76.10
c.1217A>G
Y406C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y406C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome, and the Foldetta stability assessment (combining FoldX‑MD and Rosetta) predicts a destabilizing, pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while both SGM‑Consensus and Foldetta are pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for Y406C, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.393707Uncertain0.9460.2910.000-9.954Likely Pathogenic0.810Likely PathogenicAmbiguous2.47Destabilizing0.23.22Destabilizing2.85Destabilizing1.27Destabilizing0.229Likely Benign-6.72Deleterious0.998Probably Damaging0.851Possibly Damaging3.78Benign0.01Affected0.30260.28610-23.8-60.04
c.1217A>T
Y406F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y406F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the variant as benign or likely benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.179055Structured0.393707Uncertain0.9460.2910.000-3.427Likely Benign0.080Likely BenignLikely Benign-0.01Likely Benign0.20.40Likely Benign0.20Likely Benign0.15Likely Benign0.079Likely Benign-0.93Neutral0.002Benign0.002Benign3.96Benign0.31Tolerated0.26730.3952734.1-16.00
c.949C>A
L317M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L317M missense variant is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools show a split: benign calls come from REVEL, FoldX, Foldetta, and PROVEAN, whereas pathogenic calls arise from polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta predicts a benign effect on protein stability. No evidence from ClinVar contradicts these findings. Overall, the preponderance of pathogenic predictions and the SGM‑Consensus result suggest that the variant is most likely pathogenic, though the benign signal from Foldetta and other tools indicates uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-9.558Likely Pathogenic0.788Likely PathogenicAmbiguous0.14Likely Benign0.10.84Ambiguous0.49Likely Benign0.94Ambiguous0.250Likely Benign-1.84Neutral1.000Probably Damaging0.999Probably Damaging1.71Pathogenic0.04Affected0.09370.312242-1.918.03
c.949C>G
L317V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L317V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely disagree: benign calls come from REVEL and AlphaMissense‑Optimized, while pathogenic calls are made by FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized predicting Benign, SGM‑Consensus predicting Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an Uncertain result. Overall, the majority of evidence points toward pathogenicity, with only two tools indicating benign. Because ClinVar contains no entry, there is no conflict with existing clinical interpretation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-8.406Likely Pathogenic0.403AmbiguousLikely Benign2.51Destabilizing0.10.97Ambiguous1.74Ambiguous1.12Destabilizing0.298Likely Benign-2.76Deleterious0.999Probably Damaging0.994Probably Damaging1.74Pathogenic0.03Affected0.15180.2950210.4-14.03
c.950T>A
L317Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-13.424Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.87Destabilizing0.22.47Destabilizing2.67Destabilizing1.61Destabilizing0.607Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.00Affected0.12520.1251-2-2-7.314.97
c.950T>C
L317P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tools predict a benign effect, so the benign group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-14.778Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.61Destabilizing1.44.29Destabilizing3.95Destabilizing1.26Destabilizing0.654Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.00Affected0.34050.1153-3-3-5.4-16.04
c.950T>G
L317R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-14.185Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.33Destabilizing0.22.01Destabilizing2.67Destabilizing1.63Destabilizing0.569Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.00Affected0.15010.0893-3-2-8.343.03
c.1279C>A
H427N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H427N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, Rosetta, and AlphaMissense‑Default all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a benign outcome. With all available evidence pointing to a neutral effect and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.0001.162Likely Benign0.045Likely BenignLikely Benign-0.11Likely Benign0.10.39Likely Benign0.14Likely Benign-0.48Likely Benign0.100Likely Benign1.63Neutral0.010Benign0.006Benign3.62Benign0.46Tolerated0.15070.241821-0.3-23.04
c.1279C>G
H427D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H427D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, SGM‑Consensus is likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. No evidence from the available tools suggests pathogenicity, and the absence of a ClinVar classification means there is no contradiction. Therefore, based on the current predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-3.684Likely Benign0.500AmbiguousLikely Benign0.76Ambiguous0.11.26Ambiguous1.01Ambiguous0.10Likely Benign0.163Likely Benign-1.43Neutral0.677Possibly Damaging0.236Benign3.58Benign0.12Tolerated0.22410.16781-1-0.3-22.05
c.1279C>T
H427Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H427Y missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen‑2 HumVar, as well as the SGM‑Consensus “Likely Benign” call. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, and SIFT. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta)—all uniformly indicate a benign effect. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-6.824Likely Benign0.328Likely BenignLikely Benign-0.08Likely Benign0.0-0.37Likely Benign-0.23Likely Benign0.18Likely Benign0.180Likely Benign-3.47Deleterious0.815Possibly Damaging0.073Benign3.44Benign0.01Affected0.09580.4029021.926.03
c.1280A>C
H427P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H427P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Two tools are uncertain: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both indicate a pathogenic effect. Overall, the preponderance of evidence points to a pathogenic classification for H427P, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.394261Uncertain0.9620.2870.000-11.098Likely Pathogenic0.950Likely PathogenicAmbiguous4.74Destabilizing0.17.61Destabilizing6.18Destabilizing0.68Ambiguous0.324Likely Benign-4.22Deleterious0.993Probably Damaging0.819Possibly Damaging3.51Benign0.01Affected0.20610.34420-21.6-40.02
c.1280A>G
H427R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H427R is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438185‑A‑G). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and SIFT, while premPS and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign stability change. No predictions or folding results are missing or inconclusive. Overall, the majority of evidence indicates the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.081712Structured0.394261Uncertain0.9620.2870.0006-33438185-A-G-3.259Likely Benign0.439AmbiguousLikely Benign-0.04Likely Benign0.10.48Likely Benign0.22Likely Benign0.72Ambiguous0.168Likely Benign-2.61Deleterious0.174Benign0.018Benign3.51Benign0.03Affected3.38250.21080.212102-1.319.05
c.1280A>T
H427L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H427L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: nine tools (REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Optimized) predict a benign effect, while five tools (SGM‑Consensus, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default) predict pathogenicity. High‑accuracy methods provide a more focused view: AlphaMissense‑Optimized indicates a benign outcome; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, remains pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Taken together, the majority of evidence supports a benign impact for H427L, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.394261Uncertain0.9620.2870.000-9.691Likely Pathogenic0.755Likely PathogenicLikely Benign-0.17Likely Benign0.00.05Likely Benign-0.06Likely Benign0.31Likely Benign0.272Likely Benign-5.38Deleterious0.299Benign0.033Benign3.42Benign0.01Affected0.09420.4953-2-37.0-23.98
c.1281T>A
H427Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H427Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and SIFT. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign effect for H427Q. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-5.858Likely Benign0.367AmbiguousLikely Benign0.77Ambiguous0.10.62Ambiguous0.70Ambiguous0.73Ambiguous0.142Likely Benign-2.41Neutral0.864Possibly Damaging0.088Benign3.52Benign0.02Affected0.15560.338230-0.3-9.01
c.1281T>G
H427Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H427Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and SIFT. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign effect for H427Q. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-5.858Likely Benign0.367AmbiguousLikely Benign0.77Ambiguous0.10.62Ambiguous0.70Ambiguous0.73Ambiguous0.142Likely Benign-2.41Neutral0.864Possibly Damaging0.088Benign3.52Benign0.02Affected0.15560.338230-0.3-9.01
c.1186G>A
G396S
2D
AIThe SynGAP1 missense variant G396S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, the SGM‑Consensus is benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. No tool predicts pathogenicity. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.394626Uncertain0.6400.5840.500-3.934Likely Benign0.088Likely BenignLikely Benign1.76Ambiguous1.61.12Ambiguous1.44Ambiguous0.10Likely Benign0.223Likely Benign-0.99Neutral0.004Benign0.003Benign3.93Benign0.56Tolerated0.26680.489410-0.430.03
c.1186G>C
G396R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 G396R missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign impact include REVEL, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Four tools (FoldX, Rosetta, Foldetta, premPS) returned uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the variant is more frequently predicted to be pathogenic (five tools) than benign (five tools), and the high‑accuracy consensus leans toward pathogenicity, though Foldetta does not provide a definitive verdict. Thus, the variant is most likely pathogenic based on the current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.394626Uncertain0.6400.5840.500-9.310Likely Pathogenic0.775Likely PathogenicLikely Benign1.68Ambiguous1.11.56Ambiguous1.62Ambiguous0.66Ambiguous0.319Likely Benign-2.65Deleterious0.718Possibly Damaging0.216Benign4.42Benign0.24Tolerated0.09860.4007-3-2-4.199.14
c.1186G>T
G396C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G396C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar; premPS is uncertain. The high‑accuracy consensus methods give a mixed signal: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Overall, the majority of individual predictors and the SGM‑Consensus lean toward a benign interpretation, and the two high‑accuracy tools that are available also favor benign over pathogenic. Therefore, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.394626Uncertain0.6400.5840.500-5.459Likely Benign0.115Likely BenignLikely Benign2.15Destabilizing0.72.52Destabilizing2.34Destabilizing0.59Ambiguous0.411Likely Benign-3.00Deleterious0.983Probably Damaging0.533Possibly Damaging3.89Benign0.08Tolerated0.11810.4541-3-32.946.09
c.1187G>A
G396D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G396D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all classify the substitution as benign, whereas only AlphaMissense‑Default predicts a pathogenic outcome. Tools that assess protein stability (FoldX, Rosetta, Foldetta) yield uncertain or inconclusive results. High‑accuracy consensus methods reinforce the benign assessment: the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports “Likely Benign”; AlphaMissense‑Optimized also predicts benign; Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.394626Uncertain0.6400.5840.500-4.148Likely Benign0.678Likely PathogenicLikely Benign1.92Ambiguous0.81.33Ambiguous1.63Ambiguous0.17Likely Benign0.272Likely Benign-1.49Neutral0.421Benign0.080Benign3.91Benign0.35Tolerated0.17020.11221-1-3.158.04
c.1187G>C
G396A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G396A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign verdict, while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Consequently, the variant is most likely benign based on the available predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.394626Uncertain0.6400.5840.500-3.655Likely Benign0.103Likely BenignLikely Benign1.74Ambiguous0.71.90Ambiguous1.82Ambiguous0.41Likely Benign0.274Likely Benign-1.28Neutral0.062Benign0.024Benign3.93Benign0.84Tolerated0.38460.5255102.214.03
c.1187G>T
G396V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G396V is catalogued in gnomAD (6‑33438092‑G‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are FoldX, Rosetta, Foldetta, and PROVEAN. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a pathogenic effect. Overall, the majority of predictions lean toward a benign impact, and this consensus does not contradict any ClinVar status (none reported). Thus, based on the available computational evidence, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.394626Uncertain0.6400.5840.5006-33438092-G-T63.72e-6-5.663Likely Benign0.120Likely BenignLikely Benign3.49Destabilizing1.75.28Destabilizing4.39Destabilizing0.34Likely Benign0.332Likely Benign-2.56Deleterious0.062Benign0.014Benign3.90Benign0.24Tolerated3.41150.12870.4337-3-14.642.08
c.1276A>C
N426H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Predictions that are uncertain or inconclusive are FoldX and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign; and Foldetta also predicts a benign outcome. No prediction tool is missing or inconclusive in this set. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-7.004In-Between0.248Likely BenignLikely Benign0.64Ambiguous0.0-0.14Likely Benign0.25Likely Benign0.24Likely Benign0.237Likely Benign-3.57Deleterious0.998Probably Damaging0.985Probably Damaging3.29Benign0.14Tolerated0.12670.3124210.323.04
c.1276A>G
N426D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Three tools (FoldX, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (six benign vs. four pathogenic) and the two high‑accuracy benign calls suggest the variant is most likely benign, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.159Likely Pathogenic0.554AmbiguousLikely Benign0.80Ambiguous0.00.18Likely Benign0.49Likely Benign0.64Ambiguous0.173Likely Benign-3.09Deleterious0.998Probably Damaging0.980Probably Damaging3.34Benign0.09Tolerated0.17300.1746210.00.98
c.1276A>T
N426Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two main groups: benign predictions come from REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b. Two tools remain uncertain: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on the current predictive landscape.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-8.510Likely Pathogenic0.541AmbiguousLikely Benign0.47Likely Benign0.0-0.50Ambiguous-0.02Likely Benign0.23Likely Benign0.341Likely Benign-5.48Deleterious0.999Probably Damaging0.993Probably Damaging3.30Benign0.25Tolerated0.05780.3338-2-22.249.07
c.1277A>C
N426T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change N426T lies in the GAP domain. It is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Predictions that are uncertain or inconclusive are FoldX, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, while Foldetta remains uncertain and is not taken as evidence. Overall, the majority of tools, including the high‑accuracy methods, predict a benign effect. This consensus does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-7.389In-Between0.194Likely BenignLikely Benign0.84Ambiguous0.00.38Likely Benign0.61Ambiguous0.12Likely Benign0.126Likely Benign-3.14Deleterious0.983Probably Damaging0.926Probably Damaging3.47Benign0.10Tolerated0.10900.3002002.8-13.00
c.1277A>G
N426S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy AlphaMissense‑Optimized score is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and the Foldetta stability assessment is inconclusive. No evidence from FoldX or Rosetta is available. Overall, the majority of predictions support a benign impact, and this is consistent with the absence of a ClinVar assertion. Therefore, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.042364Structured0.394941Uncertain0.9590.2870.000-5.215Likely Benign0.081Likely BenignLikely Benign0.81Ambiguous0.00.52Ambiguous0.67Ambiguous0.03Likely Benign0.131Likely Benign-2.37Neutral0.998Probably Damaging0.921Probably Damaging3.47Benign0.33Tolerated0.22240.3188112.7-27.03
c.1277A>T
N426I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N426I has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and the protein‑folding stability method Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicting pathogenicity, and Foldetta indicating a benign folding stability outcome. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-10.158Likely Pathogenic0.570Likely PathogenicLikely Benign0.67Ambiguous0.00.14Likely Benign0.41Likely Benign0.23Likely Benign0.216Likely Benign-5.71Deleterious0.998Probably Damaging0.991Probably Damaging3.31Benign0.09Tolerated0.06560.3244-2-38.0-0.94
c.1278C>A
N426K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426K resides in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which is currently unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.659Likely Pathogenic0.867Likely PathogenicAmbiguous0.03Likely Benign0.00.00Likely Benign0.02Likely Benign0.54Ambiguous0.197Likely Benign-3.86Deleterious0.998Probably Damaging0.978Probably Damaging3.38Benign0.12Tolerated0.19060.282210-0.414.07
c.1278C>G
N426K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N426K is located in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, SIFT, and FATHMM, while those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect on protein stability. Overall, the majority of predictions lean toward pathogenicity, with a split in the most reliable methods. Therefore, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.659Likely Pathogenic0.867Likely PathogenicAmbiguous0.03Likely Benign0.00.00Likely Benign0.02Likely Benign0.54Ambiguous0.197Likely Benign-3.86Deleterious0.998Probably Damaging0.978Probably Damaging3.38Benign0.12Tolerated0.19060.282210-0.414.07
c.1066C>A
R356S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R356S is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL and SIFT, whereas the remaining tools—premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized—predict it to be pathogenic. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is inconclusive. Taken together, the preponderance of evidence points to a pathogenic effect for R356S, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.250-13.059Likely Pathogenic0.965Likely PathogenicLikely Pathogenic1.00Ambiguous0.10.79Ambiguous0.90Ambiguous1.04Destabilizing0.292Likely Benign-5.28Deleterious0.993Probably Damaging0.982Probably Damaging1.84Pathogenic0.07Tolerated0.28910.44910-13.7-69.11
c.1066C>G
R356G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R356G missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and SIFT, while the majority of tools predict a pathogenic outcome: SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are uncertain and therefore treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the preponderance of pathogenic predictions indicates that the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.250-12.305Likely Pathogenic0.883Likely PathogenicAmbiguous1.02Ambiguous0.01.80Ambiguous1.41Ambiguous1.06Destabilizing0.271Likely Benign-6.20Deleterious0.993Probably Damaging0.982Probably Damaging1.95Pathogenic0.08Tolerated0.35050.3793-3-24.1-99.14
c.1066C>T
R356C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R356C is listed in ClinVar as Benign (ClinVar ID 469145.0) and is present in gnomAD (ID 6‑33437971‑C‑T). Functional prediction tools cluster into two groups: benign predictions from REVEL and AlphaMissense‑Optimized, and pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points to a pathogenic effect, contradicting the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.250Likely Benign 16-33437971-C-T53.10e-6-11.827Likely Pathogenic0.774Likely PathogenicLikely Benign0.76Ambiguous0.01.19Ambiguous0.98Ambiguous0.84Ambiguous0.312Likely Benign-7.12Deleterious1.000Probably Damaging0.990Probably Damaging1.67Pathogenic0.00Affected3.39220.32380.3618-4-37.0-53.05212.391.0-0.10.3-0.30.1XPotentially PathogenicArg356 is located in a loop that includes a short helical section and connects two anti-parallel β sheet strands (res. Gly341-Pro349, res. Thr359-Pro364). In the WT simulations, the guanidinium group of Arg356 alternately forms salt bridges with the carboxylate groups of the GAP domain residues, Glu446 and Glu698. Arg356 also forms hydrogen bonds with the hydroxyl group of the GAP domain residue Thr691 and interacts with Met409 at the C2-GAP interface.In the variant simulations, the Cys356 mutation fails to maintain any of the Arg356 interactions and only occasionally forms weak hydrogen bonds with nearby C2 domain residues (e.g., Gln407). Although no negative structural effects are observed during the simulations, Arg356 is located at the C2 and GAP domain interface, making the residue swap potentially detrimental to the tertiary structure assembly.
c.1067G>A
R356H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R356H is recorded in ClinVar as benign (ClinVar ID 2984966.0) and is present in the gnomAD database (6‑33437972‑G‑A). Prediction tools that indicate a benign effect include REVEL, Rosetta, Foldetta, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default, with the SGM‑Consensus also labeling it likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions support a pathogenic impact, which contradicts the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.250Likely Benign 16-33437972-G-A95.66e-6-11.453Likely Pathogenic0.614Likely PathogenicLikely Benign0.59Ambiguous0.1-0.27Likely Benign0.16Likely Benign1.17Destabilizing0.314Likely Benign-4.43Deleterious0.999Probably Damaging0.987Probably Damaging1.70Pathogenic0.01Affected3.39220.34930.2206021.3-19.05
c.1067G>C
R356P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R356P missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FoldX, whereas a majority of tools (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive are AlphaMissense‑Optimized, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for R356P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.250-12.956Likely Pathogenic0.919Likely PathogenicAmbiguous0.48Likely Benign0.10.72Ambiguous0.60Ambiguous1.05Destabilizing0.451Likely Benign-6.23Deleterious0.998Probably Damaging0.992Probably Damaging1.72Pathogenic0.02Affected0.22130.50330-22.9-59.07
c.1067G>T
R356L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R356L is not reported in ClinVar and is present in gnomAD (ID 6‑33437972‑G‑T). Functional prediction tools that agree on a benign effect include REVEL, FoldX, and Foldetta, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are AlphaMissense‑Optimized, Rosetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic effect for R356L, and this conclusion does not contradict ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.219301Structured0.395028Uncertain0.8020.3730.2506-33437972-G-T-13.957Likely Pathogenic0.911Likely PathogenicAmbiguous-0.04Likely Benign0.1-0.57Ambiguous-0.31Likely Benign0.68Ambiguous0.412Likely Benign-6.20Deleterious0.993Probably Damaging0.982Probably Damaging1.69Pathogenic0.02Affected3.39220.21100.5242-2-38.3-43.03
c.862G>A
D288N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D288N is listed in ClinVar with an uncertain significance (ClinVar ID 2572204.0) and is present in gnomAD (6‑33437767‑G‑A). Computational predictors are divided: benign calls come from REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized, while pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic. Because the majority of high‑accuracy tools predict benign and the overall split of predictions is even, the variant is most likely benign, which does not contradict the ClinVar status of uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000Uncertain 16-33437767-G-A21.24e-6-10.535Likely Pathogenic0.521AmbiguousLikely Benign-0.39Likely Benign0.10.01Likely Benign-0.19Likely Benign-0.03Likely Benign0.321Likely Benign-3.73Deleterious0.999Probably Damaging0.997Probably Damaging1.78Pathogenic0.05Affected3.38230.13980.5770120.0-0.98
c.862G>C
D288H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D288H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, and premPS. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling the variant as Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect on protein folding stability. Overall, the majority of tools (7/12) predict pathogenicity, and the high‑accuracy consensus leans toward pathogenic, with no conflict with ClinVar status. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-12.589Likely Pathogenic0.953Likely PathogenicAmbiguous0.08Likely Benign0.10.36Likely Benign0.22Likely Benign-0.02Likely Benign0.460Likely Benign-5.40Deleterious1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.01Affected0.16390.62541-10.322.05
c.862G>T
D288Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288Y missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, and premPS; pathogenic predictions from SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. No evidence from the available tools suggests a benign effect. Therefore, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-15.269Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.11Likely Benign0.21.10Ambiguous0.61Ambiguous0.10Likely Benign0.472Likely Benign-7.11Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.06350.5009-4-32.248.09
c.863A>C
D288A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, and SIFT. Those that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized, Foldetta, and Rosetta give uncertain results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also uncertain. Overall, seven tools predict pathogenicity while four predict benign, with no conflicting ClinVar evidence. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-13.470Likely Pathogenic0.908Likely PathogenicAmbiguous0.34Likely Benign0.11.27Ambiguous0.81Ambiguous0.10Likely Benign0.451Likely Benign-6.09Deleterious1.000Probably Damaging0.998Probably Damaging1.71Pathogenic0.07Tolerated0.40600.57880-25.3-44.01
c.863A>G
D288G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D288G is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, Rosetta, premPS, SIFT, AlphaMissense‑Optimized, and Foldetta. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. No folding‑stability result is available from FoldX. Overall, the balance of evidence slightly favors a pathogenic interpretation, with one high‑accuracy tool supporting benignity. The prediction does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-8.531Likely Pathogenic0.739Likely PathogenicLikely Benign-0.71Ambiguous0.40.21Likely Benign-0.25Likely Benign-0.15Likely Benign0.436Likely Benign-5.03Deleterious0.999Probably Damaging0.997Probably Damaging2.05Pathogenic0.13Tolerated0.41260.59341-13.1-58.04
c.863A>T
D288V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288V missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are provided by REVEL and premPS, whereas the remaining tools—FoldX (uncertain), Rosetta, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—all indicate a pathogenic effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic based on the aggregate predictions, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-15.812Likely Pathogenic0.981Likely PathogenicLikely Pathogenic1.74Ambiguous0.55.44Destabilizing3.59Destabilizing0.13Likely Benign0.481Likely Benign-7.14Deleterious1.000Probably Damaging0.999Probably Damaging1.63Pathogenic0.05Affected0.08380.5545-2-37.7-15.96
c.864C>A
D288E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.125101Structured0.395525Uncertain0.8730.2610.000-6.685Likely Benign0.350AmbiguousLikely Benign0.10Likely Benign0.00.74Ambiguous0.42Likely Benign-0.10Likely Benign0.203Likely Benign-2.84Deleterious0.997Probably Damaging0.994Probably Damaging1.74Pathogenic0.13Tolerated0.15590.5476320.014.03
c.864C>G
D288E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.125101Structured0.395525Uncertain0.8730.2610.000-6.685Likely Benign0.350AmbiguousLikely Benign0.10Likely Benign0.00.74Ambiguous0.42Likely Benign-0.10Likely Benign0.203Likely Benign-2.84Deleterious0.997Probably Damaging0.994Probably Damaging1.74Pathogenic0.13Tolerated0.15590.5476320.014.03
c.1189T>A
C397S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign, while Rosetta remains uncertain. When predictions are grouped, the benign category contains all available evidence and the pathogenic category is empty. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a benign effect. Consequently, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.395774Uncertain0.7780.5510.250-2.324Likely Benign0.178Likely BenignLikely Benign0.37Likely Benign0.10.59Ambiguous0.48Likely Benign0.43Likely Benign0.174Likely Benign-0.01Neutral0.276Benign0.066Benign4.68Benign0.53Tolerated0.52210.2474Weaken0-1-3.3-16.06
c.1189T>C
C397R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, and AlphaMissense‑Default. The remaining tools (FoldX, premPS, ESM1b) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (2 benign vs. 1 pathogenic, 1 uncertain), and Foldetta predicts a benign impact on protein folding stability. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.429200Structured0.395774Uncertain0.7780.5510.250-7.094In-Between0.708Likely PathogenicLikely Benign0.55Ambiguous0.80.40Likely Benign0.48Likely Benign0.96Ambiguous0.514Likely Pathogenic-1.46Neutral0.480Possibly Damaging0.226Benign4.65Benign0.11Tolerated0.17800.1853-4-3-7.053.05
c.1189T>G
C397G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that reach consensus all indicate a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the variant as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies it as “Likely Benign.” No tool predicts pathogenicity. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. No pathogenic predictions are present. Therefore, based on the available computational evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.395774Uncertain0.7780.5510.2501.244Likely Benign0.096Likely BenignLikely Benign0.68Ambiguous0.21.42Ambiguous1.05Ambiguous0.04Likely Benign0.272Likely Benign1.51Neutral0.276Benign0.066Benign5.93Benign0.60Tolerated0.36780.3729-3-3-2.9-46.09
c.1190G>A
C397Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, Rosetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and the combined Foldetta method. Uncertain results come from AlphaMissense‑Default and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as pathogenic. Overall, the majority of tools and the high‑accuracy consensus lean toward a benign interpretation, and this does not contradict any ClinVar classification (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.429200Structured0.395774Uncertain0.7780.5510.250-7.213In-Between0.397AmbiguousLikely Benign2.01Destabilizing2.38.64Destabilizing5.33Destabilizing0.12Likely Benign0.455Likely Benign-1.82Neutral0.952Possibly Damaging0.497Possibly Damaging4.64Benign0.07Tolerated0.12990.50840-2-3.860.04
c.1190G>C
C397S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). In silico prediction tools that assess pathogenicity largely agree on a benign outcome: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. No tool predicts pathogenicity; Rosetta’s assessment is uncertain and therefore treated as unavailable. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. Consequently, the variant is most likely benign based on the collective predictions, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.395774Uncertain0.7780.5510.250-2.324Likely Benign0.178Likely BenignLikely Benign0.37Likely Benign0.10.59Ambiguous0.48Likely Benign0.43Likely Benign0.253Likely Benign-0.01Neutral0.276Benign0.066Benign4.68Benign0.53Tolerated0.52210.2474Weaken0-1-3.3-16.06
c.1190G>T
C397F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397F is reported in gnomAD (6-33438095-G-T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, Rosetta, and the protein‑folding stability method Foldetta. FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as benign, while Foldetta indicates a pathogenic effect. Because the majority of tools (nine benign vs. four pathogenic) lean toward a benign outcome and the high‑accuracy consensus is split, the variant is most likely benign. This assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.395774Uncertain0.7780.5510.2506-33438095-G-T16.20e-7-6.571Likely Benign0.194Likely BenignLikely Benign1.31Ambiguous1.73.61Destabilizing2.46Destabilizing0.12Likely Benign0.493Likely Benign-1.95Neutral0.952Possibly Damaging0.497Possibly Damaging4.65Benign0.07Tolerated3.41150.14260.5231-2-40.344.04
c.1191C>G
C397W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397W is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign calls come from premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus, whereas pathogenic calls are made by REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, but Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts pathogenic. Overall, the majority of tools lean toward a benign effect, and this is consistent with the lack of ClinVar evidence. Therefore, the variant is most likely benign, and there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.395774Uncertain0.7780.5510.250-6.857Likely Benign0.614Likely PathogenicLikely Benign2.40Destabilizing2.34.46Destabilizing3.43Destabilizing0.19Likely Benign0.545Likely Pathogenic-1.87Neutral0.987Probably Damaging0.814Possibly Damaging4.64Benign0.02Affected0.16370.5092-8-2-3.483.07
c.646C>A
Q216K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q216K is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of tools lean toward a benign classification, but the presence of several pathogenic predictions and a high‑accuracy consensus that is pathogenic introduces uncertainty. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.206376Structured0.396100Uncertain0.8040.2740.000-10.908Likely Pathogenic0.826Likely PathogenicAmbiguous-0.35Likely Benign0.10.38Likely Benign0.02Likely Benign0.17Likely Benign0.617Likely Pathogenic-2.71Deleterious0.779Possibly Damaging0.351Benign5.92Benign0.12Tolerated0.24310.459111-0.40.04
c.646C>G
Q216E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q216E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as benign. No predictions or stability results are missing or inconclusive. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.206376Structured0.396100Uncertain0.8040.2740.000-9.215Likely Pathogenic0.550AmbiguousLikely Benign0.49Likely Benign0.30.30Likely Benign0.40Likely Benign0.35Likely Benign0.474Likely Benign-1.89Neutral0.779Possibly Damaging0.351Benign5.85Benign0.13Tolerated0.18720.3117220.00.98
c.647A>C
Q216P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q216P is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, which scores the variant as benign. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic or likely pathogenic impact. The high‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; SGM‑Consensus indicates likely pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. premPS is inconclusive and is treated as unavailable. Based on the collective predictions, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.206376Structured0.396100Uncertain0.8040.2740.000-13.128Likely Pathogenic0.987Likely PathogenicLikely Pathogenic4.35Destabilizing0.84.05Destabilizing4.20Destabilizing0.53Ambiguous0.830Likely Pathogenic-4.69Deleterious0.989Probably Damaging0.737Possibly Damaging5.84Benign0.01Affected0.26030.57360-11.9-31.01
c.647A>G
Q216R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q216R is not reported in ClinVar and has no gnomAD entry. Prediction tools that call the variant benign include FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM, while pathogenic calls come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as Benign. Overall, the predictions are split, with a slight edge toward pathogenicity. The variant is therefore most likely pathogenic based on the current computational evidence, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.206376Structured0.396100Uncertain0.8040.2740.000-10.149Likely Pathogenic0.821Likely PathogenicAmbiguous-0.42Likely Benign0.00.09Likely Benign-0.17Likely Benign-0.01Likely Benign0.513Likely Pathogenic-2.70Deleterious0.963Probably Damaging0.549Possibly Damaging6.00Benign0.19Tolerated0.19720.274811-1.028.06
c.647A>T
Q216L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q216L is not reported in ClinVar (ClinVar ID: None) and has no entry in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain (treated as unavailable), SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. Overall, the majority of tools (8 pathogenic vs. 5 benign) and the consensus high‑accuracy prediction lean toward pathogenicity. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.206376Structured0.396100Uncertain0.8040.2740.000-11.303Likely Pathogenic0.886Likely PathogenicAmbiguous-0.17Likely Benign0.30.28Likely Benign0.06Likely Benign0.30Likely Benign0.797Likely Pathogenic-5.58Deleterious0.963Probably Damaging0.452Possibly Damaging5.87Benign0.01Affected0.10360.6410-2-27.3-14.97
c.648G>C
Q216H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q216H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, and FATHMM, whereas those that predict a pathogenic impact are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.206376Structured0.396100Uncertain0.8040.2740.000-10.532Likely Pathogenic0.951Likely PathogenicAmbiguous0.29Likely Benign0.00.30Likely Benign0.30Likely Benign0.50Likely Benign0.638Likely Pathogenic-3.84Deleterious0.989Probably Damaging0.809Possibly Damaging5.85Benign0.01Affected0.19090.4660300.39.01
c.648G>T
Q216H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q216H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, and FATHMM, whereas a larger group predicts pathogenicity: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.206376Structured0.396100Uncertain0.8040.2740.000-10.532Likely Pathogenic0.951Likely PathogenicAmbiguous0.29Likely Benign0.00.30Likely Benign0.30Likely Benign0.50Likely Benign0.638Likely Pathogenic-3.84Deleterious0.989Probably Damaging0.809Possibly Damaging5.85Benign0.01Affected0.19090.4660300.39.01
c.1183G>A
G395R
2D
AIThe SynGAP1 missense variant G395R has no ClinVar record and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from SIFT, ESM1b, and AlphaMissense‑Default. Two tools, FoldX and Foldetta, yield uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta remains uncertain. Overall, the balance of evidence favors a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.513880Disordered0.396199Uncertain0.4740.6010.500-9.851Likely Pathogenic0.768Likely PathogenicLikely Benign1.26Ambiguous2.1-0.25Likely Benign0.51Ambiguous0.50Likely Benign0.430Likely Benign-2.01Neutral0.037Benign0.027Benign4.23Benign0.02Affected0.09530.4313-3-2-4.199.14
c.1183G>C
G395R
2D
AIThe SynGAP1 missense variant G395R has no ClinVar record and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from SIFT, ESM1b, and AlphaMissense‑Default. Two tools, FoldX and Foldetta, yield uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta remains uncertain. Overall, the balance of evidence favors a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.513880Disordered0.396199Uncertain0.4740.6010.500-9.851Likely Pathogenic0.768Likely PathogenicLikely Benign1.26Ambiguous2.1-0.25Likely Benign0.51Ambiguous0.50Likely Benign0.430Likely Benign-2.01Neutral0.037Benign0.027Benign4.23Benign0.02Affected0.09530.4313-3-2-4.199.14
c.1184G>A
G395E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G395E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome, while FoldX and Rosetta give uncertain results. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) predicts benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Taken together, the majority of evidence points to a benign effect. There is no ClinVar entry to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.513880Disordered0.396199Uncertain0.4740.6010.500-6.350Likely Benign0.594Likely PathogenicLikely Benign1.60Ambiguous0.6-0.88Ambiguous0.36Likely Benign0.30Likely Benign0.310Likely Benign-1.81Neutral0.037Benign0.010Benign4.25Benign0.12Tolerated0.13280.40890-2-3.172.06
c.1184G>C
G395A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G395A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX and Rosetta, which are treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Consequently, the variant is most likely benign based on the available predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.513880Disordered0.396199Uncertain0.4740.6010.500-3.964Likely Benign0.085Likely BenignLikely Benign1.51Ambiguous0.3-0.59Ambiguous0.46Likely Benign0.08Likely Benign0.160Likely Benign-0.72Neutral0.001Benign0.003Benign4.24Benign0.15Tolerated0.38480.5047102.214.03
c.1184G>T
G395V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G395V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only FoldX and SIFT predict pathogenic. The SGM‑Consensus score, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign outcome. High‑accuracy assessments further support this view: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and the Foldetta stability analysis is uncertain. Taken together, the preponderance of evidence points to a benign impact for G395V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.513880Disordered0.396199Uncertain0.4740.6010.500-5.617Likely Benign0.125Likely BenignLikely Benign2.83Destabilizing0.7-0.37Likely Benign1.23Ambiguous0.08Likely Benign0.288Likely Benign-1.49Neutral0.000Benign0.000Benign4.21Benign0.03Affected0.12900.4183-1-34.642.08
c.2104C>A
Q702K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-8.750Likely Pathogenic0.338Likely BenignLikely Benign-0.23Likely Benign0.00.26Likely Benign0.02Likely Benign0.08Likely Benign0.224Likely Benign-2.86Deleterious0.863Possibly Damaging0.773Possibly Damaging3.46Benign0.08Tolerated0.13460.252411-0.40.04
c.2104C>G
Q702E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Rosetta and Foldetta give uncertain results. High‑accuracy methods further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign; Foldetta remains inconclusive. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.397258Uncertain0.9070.3450.000-10.974Likely Pathogenic0.230Likely BenignLikely Benign0.48Likely Benign0.00.72Ambiguous0.60Ambiguous0.27Likely Benign0.196Likely Benign-2.27Neutral0.989Probably Damaging0.930Probably Damaging3.55Benign0.15Tolerated0.10210.1609220.00.98
c.2105A>C
Q702P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, more tools predict pathogenicity (7) than benignity (5), and the high‑accuracy pathogenic prediction from Foldetta further supports this. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-10.361Likely Pathogenic0.324Likely BenignLikely Benign1.76Ambiguous0.17.05Destabilizing4.41Destabilizing-0.04Likely Benign0.369Likely Benign-4.71Deleterious1.000Probably Damaging0.999Probably Damaging3.42Benign0.05Affected0.18770.33710-11.9-31.01
c.2105A>G
Q702R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q702R is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Predictions that remain inconclusive are Rosetta, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to equal benign and pathogenic signals. Overall, the majority of available predictions lean toward a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000Uncertain 1-7.894In-Between0.348AmbiguousLikely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign0.294Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.47100.12250.060511-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.2105A>T
Q702L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the balance of evidence leans toward a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-9.954Likely Pathogenic0.149Likely BenignLikely Benign-0.13Likely Benign0.00.09Likely Benign-0.02Likely Benign0.16Likely Benign0.392Likely Benign-5.66Deleterious0.939Possibly Damaging0.838Possibly Damaging3.42Benign0.00Affected0.05840.3628-2-27.3-14.97
c.2106G>C
Q702H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Uncertain results come from FoldX and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome (2 benign vs. 1 pathogenic vote), and Foldetta predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-7.966In-Between0.211Likely BenignLikely Benign0.55Ambiguous0.00.13Likely Benign0.34Likely Benign0.12Likely Benign0.233Likely Benign-4.11Deleterious0.982Probably Damaging0.947Probably Damaging3.45Benign0.00Affected0.08110.2555300.39.01
c.2106G>T
Q702H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Uncertain results come from FoldX and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome (2 benign vs. 1 pathogenic vote), and Foldetta predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-7.966In-Between0.211Likely BenignLikely Benign0.55Ambiguous0.00.13Likely Benign0.34Likely Benign0.12Likely Benign0.233Likely Benign-4.11Deleterious0.982Probably Damaging0.947Probably Damaging3.45Benign0.00Affected0.08110.2555300.39.01
c.625G>A
V209M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V209M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.247041Structured0.397624Uncertain0.8740.3310.125-8.112Likely Pathogenic0.932Likely PathogenicAmbiguous0.70Ambiguous0.40.77Ambiguous0.74Ambiguous0.78Ambiguous0.115Likely Benign-1.48Neutral0.995Probably Damaging0.880Possibly Damaging3.68Benign0.02Affected0.06690.398221-2.332.06
c.625G>C
V209L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V209L missense change is not reported in ClinVar and is absent from gnomAD. Consensus‐based predictors that agree on a benign outcome include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Predictors that flag a pathogenic effect are polyPhen‑2 HumDiv and AlphaMissense‑Default; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.247041Structured0.397624Uncertain0.8740.3310.125-5.516Likely Benign0.837Likely PathogenicAmbiguous0.26Likely Benign0.4-0.12Likely Benign0.07Likely Benign0.08Likely Benign0.084Likely Benign-0.96Neutral0.787Possibly Damaging0.259Benign4.08Benign0.39Tolerated0.08140.418821-0.414.03
c.625G>T
V209L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V209L is not reported in ClinVar and is absent from gnomAD. Consensus predictions from most in silico tools classify the change as benign: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Only two tools predict a pathogenic effect: polyPhen‑2 HumDiv and AlphaMissense‑Default. The AlphaMissense‑Optimized score is uncertain. High‑accuracy assessments further support a benign outcome: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.247041Structured0.397624Uncertain0.8740.3310.125-5.516Likely Benign0.837Likely PathogenicAmbiguous0.26Likely Benign0.4-0.12Likely Benign0.07Likely Benign0.08Likely Benign0.084Likely Benign-0.96Neutral0.787Possibly Damaging0.259Benign4.08Benign0.39Tolerated0.08140.418821-0.414.03
c.626T>A
V209E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V209E is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) all predict a pathogenic outcome. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, V209E is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.247041Structured0.397624Uncertain0.8740.3310.125-14.366Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.53Destabilizing1.32.35Destabilizing2.94Destabilizing1.52Destabilizing0.403Likely Benign-4.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.65Benign0.00Affected0.08260.1652-2-2-7.729.98
c.626T>C
V209A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V209A is reported in gnomAD (ID 6‑33435268‑T‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL and FATHMM. In contrast, a majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Stability‑based methods FoldX, Rosetta, and the combined Foldetta score are uncertain and therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence from multiple independent predictors indicates that V209A is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.247041Structured0.397624Uncertain0.8740.3310.1256-33435268-T-C16.20e-7-9.796Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.56Ambiguous0.31.85Ambiguous1.71Ambiguous1.60Destabilizing0.236Likely Benign-2.79Deleterious0.958Probably Damaging0.581Possibly Damaging3.70Benign0.02Affected3.41130.22370.191900-2.4-28.05
c.626T>G
V209G
2D
AIThe SynGAP1 missense variant V209G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a pathogenic classification; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a destabilizing, pathogenic effect. Taken together, the overwhelming majority of computational evidence indicates that V209G is likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.247041Structured0.397624Uncertain0.8740.3310.125-13.763Likely Pathogenic0.988Likely PathogenicLikely Pathogenic3.05Destabilizing0.53.99Destabilizing3.52Destabilizing1.27Destabilizing0.390Likely Benign-5.49Deleterious0.829Possibly Damaging0.995Probably Damaging3.65Benign0.04Affected0.16000.2035-1-3-4.6-42.08
c.1426T>A
F476I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F476I has no ClinVar entry and is not reported in gnomAD. Functional prediction tools fall into two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, and FATHMM; pathogenic predictions come from FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—remains inconclusive and is treated as unavailable. With seven tools indicating pathogenicity versus five indicating benign, and two high‑accuracy tools supporting pathogenicity, the evidence points to a likely pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.617Likely Pathogenic0.962Likely PathogenicLikely Pathogenic3.90Destabilizing0.13.09Destabilizing3.50Destabilizing0.39Likely Benign0.239Likely Benign-1.23Neutral0.997Probably Damaging0.989Probably Damaging3.50Benign0.37Tolerated0.13830.2202101.7-34.02
c.1426T>C
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No other tools provide definitive evidence. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous0.196Likely Benign-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.40220.16530.2916201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1426T>G
F476V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F476V variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM. Those that agree on a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and Foldetta. Tools with uncertain or mixed outputs are Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a pathogenic impact. Overall, the majority of evidence points toward a pathogenic effect. The variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.329Likely Pathogenic0.918Likely PathogenicAmbiguous3.01Destabilizing0.21.90Ambiguous2.46Destabilizing0.64Ambiguous0.353Likely Benign-1.63Neutral0.996Probably Damaging0.993Probably Damaging3.49Benign0.53Tolerated0.14780.2251-1-11.4-48.04
c.1427T>A
F476Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta predicts a benign outcome. Overall, the balance of evidence leans toward a benign impact for F476Y, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-9.707Likely Pathogenic0.576Likely PathogenicLikely Benign0.50Ambiguous0.20.30Likely Benign0.40Likely Benign1.10Destabilizing0.169Likely Benign-1.10Neutral0.965Probably Damaging0.919Probably Damaging3.46Benign0.90Tolerated0.11090.156873-4.116.00
c.1427T>C
F476S
2D
AIThe SynGAP1 missense variant F476S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields an equal split of pathogenic and benign signals. Overall, the balance of evidence favors a pathogenic effect for F476S, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.675Likely Pathogenic0.983Likely PathogenicLikely Pathogenic3.02Destabilizing0.94.07Destabilizing3.55Destabilizing1.23Destabilizing0.278Likely Benign-2.33Neutral1.000Probably Damaging1.000Probably Damaging3.56Benign0.44Tolerated0.33870.0558-3-2-3.6-60.10
c.1427T>G
F476C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476C is catalogued in gnomAD (ID 6‑33438459‑T‑G) but has no ClinVar entry. Functional prediction tools split in two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, seven tools predict pathogenicity versus six predicting benign, with no ClinVar evidence to contradict this assessment. Thus, the variant is most likely pathogenic based on the current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.0006-33438459-T-G-9.270Likely Pathogenic0.745Likely PathogenicLikely Benign2.05Destabilizing0.12.62Destabilizing2.34Destabilizing-0.30Likely Benign0.280Likely Benign2.69Neutral1.000Probably Damaging0.999Probably Damaging3.46Benign0.83Tolerated3.40220.20510.1251-2-4-0.3-44.04
c.1428C>A
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No other tools provide definitive evidence. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous0.180Likely Benign-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.40220.16530.2916201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1428C>G
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33438460‑C‑G). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that returned uncertain results—FoldX, Rosetta, Foldetta, and premPS—do not contribute to the assessment. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, with two pathogenic and two benign calls; Foldetta also reports an uncertain stability change. Overall, the balance of evidence favors a pathogenic effect for F476L, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000Uncertain 26-33438460-C-G42.48e-6-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous0.180Likely Benign-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.40220.16530.2916201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.817G>A
E273K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E273K is not reported in ClinVar and is present in gnomAD (ID 6‑33437722‑G‑A). Functional prediction tools that agree on benign impact include REVEL, Rosetta, Foldetta, premPS, polyPhen‑2 HumVar, and SIFT. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions marked uncertain are FoldX and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools lean toward a benign effect, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.398918Uncertain0.8630.1960.1256-33437722-G-A16.20e-7-12.690Likely Pathogenic0.917Likely PathogenicAmbiguous-0.57Ambiguous0.3-0.38Likely Benign-0.48Likely Benign0.23Likely Benign0.205Likely Benign-2.66Deleterious0.896Possibly Damaging0.415Benign1.77Pathogenic0.12Tolerated3.38180.23120.299610-0.4-0.94
c.817G>C
E273Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E273Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of individual predictors (seven benign vs. five pathogenic) lean toward a benign classification, while the SGM Consensus and AlphaMissense‑Optimized provide conflicting signals. Thus, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.071867Structured0.398918Uncertain0.8630.1960.125-9.865Likely Pathogenic0.503AmbiguousLikely Benign-0.29Likely Benign0.1-0.29Likely Benign-0.29Likely Benign-0.01Likely Benign0.168Likely Benign-1.84Neutral0.946Possibly Damaging0.671Possibly Damaging1.77Pathogenic0.04Affected0.12200.3130220.0-0.98
c.818A>C
E273A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E273A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, whereas AlphaMissense‑Optimized predicts Benign and Foldetta (combining FoldX‑MD and Rosetta) predicts Benign. Overall, the majority of individual tools are split evenly, but the two high‑accuracy methods favor a benign effect. Thus, the variant is most likely benign based on current computational predictions, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.398918Uncertain0.8630.1960.125-8.851Likely Pathogenic0.422AmbiguousLikely Benign0.29Likely Benign0.2-0.29Likely Benign0.00Likely Benign0.16Likely Benign0.240Likely Benign-3.61Deleterious0.896Possibly Damaging0.492Possibly Damaging1.73Pathogenic0.04Affected0.31600.36150-15.3-58.04
c.818A>G
E273G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E273G missense variant has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, premPS, SIFT, and ESM1b; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Four tools (FoldX, Rosetta, AlphaMissense‑Default, Foldetta) returned uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels it pathogenic; Foldetta remains uncertain. Given the split between benign and pathogenic signals and the lack of a ClinVar classification, the variant is best described as of uncertain significance, with a slight inclination toward benign based on the most reliable single‑tool prediction. This assessment does not contradict any existing ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.071867Structured0.398918Uncertain0.8630.1960.125-4.784Likely Benign0.373AmbiguousLikely Benign-0.65Ambiguous0.2-0.93Ambiguous-0.79Ambiguous-0.46Likely Benign0.225Likely Benign-2.71Deleterious0.896Possibly Damaging0.519Possibly Damaging1.95Pathogenic0.26Tolerated0.27630.33410-23.1-72.06
c.818A>T
E273V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E273V is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL and premPS. The majority of tools predict a pathogenic impact: Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, SGM‑Consensus (Likely Pathogenic), and Foldetta. Two tools give inconclusive results: AlphaMissense‑Optimized (Uncertain) and FoldX (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as Pathogenic. Overall, the consensus of pathogenic‑predicting tools outweighs the benign predictions, indicating that E273V is most likely pathogenic; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.398918Uncertain0.8630.1960.125-11.671Likely Pathogenic0.814Likely PathogenicAmbiguous1.93Ambiguous0.33.31Destabilizing2.62Destabilizing0.17Likely Benign0.361Likely Benign-4.66Deleterious0.984Probably Damaging0.825Possibly Damaging1.70Pathogenic0.01Affected0.08110.3813-2-27.7-29.98
c.819G>C
E273D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E273D missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools largely agree on a benign effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign or likely benign. Only FATHMM predicts a pathogenic outcome, while premPS remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of evidence supports a benign impact for E273D, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.071867Structured0.398918Uncertain0.8630.1960.125-1.811Likely Benign0.058Likely BenignLikely Benign0.26Likely Benign0.1-0.48Likely Benign-0.11Likely Benign-0.63Ambiguous0.094Likely Benign1.99Neutral0.004Benign0.010Benign2.00Pathogenic1.00Tolerated3.38180.17110.1859320.0-14.03223.122.10.20.00.00.1XPotentially BenignThe negatively charged residue Glu273, located in a β hairpin loop (res. Glu273-Lys278) that connects two anti-parallel β sheet strands, is replaced with another negatively charged residue, aspartate. Because the C2 domain loop faces the membrane surface, the potentially crucial role of the carboxylate group of Glu273 or Asp273 on SynGAP-membrane association cannot be fully explored via solvent-only simulations.As a minor note, the neighboring residue Arg272, which stacks with the indole ring of the Trp362 side chain and directly faces RasGTPase, forms a salt bridge more often with Asp273 than with the non-mutated Glu273 in the simulations. Regardless, due to the similar physicochemical properties of the WT and variant residues at the membrane interface, the residue swap is likely to be well tolerated.
c.819G>T
E273D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E273D is listed in ClinVar as Benign (ClinVar ID 1471608.0) and is present in gnomAD (variant ID 6‑33437724‑G‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while premPS is uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is Likely Benign. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) is benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. No prediction contradicts the ClinVar benign status; overall, the evidence strongly supports that E273D is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.071867Structured0.398918Uncertain0.8630.1960.125Benign 16-33437724-G-T21.24e-6-1.811Likely Benign0.058Likely BenignLikely Benign0.26Likely Benign0.1-0.48Likely Benign-0.11Likely Benign-0.63Ambiguous0.092Likely Benign1.99Neutral0.004Benign0.010Benign2.00Pathogenic1.00Tolerated3.38180.17110.1859320.0-14.03223.122.10.20.00.00.1XPotentially BenignThe negatively charged residue Glu273, located in a β hairpin loop (res. Glu273-Lys278) that connects two anti-parallel β sheet strands, is replaced with another negatively charged residue, aspartate. Because the C2 domain loop faces the membrane surface, the potentially crucial role of the carboxylate group of Glu273 or Asp273 on SynGAP-membrane association cannot be fully explored via solvent-only simulations.As a minor note, the neighboring residue Arg272, which stacks with the indole ring of the Trp362 side chain and directly faces RasGTPase, forms a salt bridge more often with Asp273 than with the non-mutated Glu273 in the simulations. Regardless, due to the similar physicochemical properties of the WT and variant residues at the membrane interface, the residue swap is likely to be well tolerated.
c.1069C>A
H357N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H357N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Taken together, the overwhelming majority of evidence points to a benign impact. There is no ClinVar annotation to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.399052Uncertain0.8610.4130.250-7.617In-Between0.103Likely BenignLikely Benign0.14Likely Benign0.20.31Likely Benign0.23Likely Benign0.31Likely Benign0.126Likely Benign-1.47Neutral0.495Possibly Damaging0.169Benign4.25Benign0.15Tolerated0.20520.326621-0.3-23.04
c.1069C>G
H357D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H357D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta also predicts a benign outcome. No prediction or folding‑stability result is missing or inconclusive. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.203355Structured0.399052Uncertain0.8610.4130.250-12.013Likely Pathogenic0.559AmbiguousLikely Benign-0.23Likely Benign0.4-0.27Likely Benign-0.25Likely Benign0.48Likely Benign0.208Likely Benign-1.90Neutral0.495Possibly Damaging0.169Benign4.22Benign0.08Tolerated0.27820.19761-1-0.3-22.05
c.1069C>T
H357Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H357Y is reported in gnomAD (variant ID 6‑33437974‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only polyPhen‑2 HumDiv indicates pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as likely benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.399052Uncertain0.8610.4130.2506-33437974-C-T16.21e-7-5.888Likely Benign0.168Likely BenignLikely Benign-0.33Likely Benign0.20.08Likely Benign-0.13Likely Benign-0.07Likely Benign0.140Likely Benign-1.71Neutral0.936Possibly Damaging0.388Benign4.19Benign0.14Tolerated3.39220.10100.4658201.926.03
c.1070A>C
H357P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H357P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are Rosetta, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Two tools give uncertain results: Foldetta (protein‑folding stability) and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect. Thus, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.203355Structured0.399052Uncertain0.8610.4130.250-7.953In-Between0.267Likely BenignLikely Benign0.17Likely Benign0.93.52Destabilizing1.85Ambiguous-0.06Likely Benign0.197Likely Benign-2.70Deleterious0.936Possibly Damaging0.469Possibly Damaging4.18Benign0.17Tolerated0.24330.44680-21.6-40.02
c.1070A>G
H357R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H357R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b. Two tools remain uncertain: Rosetta and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign majority; and Foldetta also predicts benign. No prediction or stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.203355Structured0.399052Uncertain0.8610.4130.250-9.212Likely Pathogenic0.348AmbiguousLikely Benign-0.10Likely Benign0.31.07Ambiguous0.49Likely Benign0.32Likely Benign0.107Likely Benign-1.03Neutral0.495Possibly Damaging0.095Benign4.22Benign0.59Tolerated0.21470.281820-1.319.05
c.1070A>T
H357L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H357L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv, while polyPhen‑2 HumVar and ESM1b are benign or uncertain, respectively. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (3 benign vs 1 pathogenic), and Foldetta also predicts benign. No predictions are missing or inconclusive. Overall, the variant is most likely benign based on the majority of computational evidence, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.203355Structured0.399052Uncertain0.8610.4130.250-7.281In-Between0.140Likely BenignLikely Benign-0.18Likely Benign0.10.14Likely Benign-0.02Likely Benign0.10Likely Benign0.203Likely Benign-3.39Deleterious0.704Possibly Damaging0.169Benign4.20Benign0.25Tolerated0.10840.5971-2-37.0-23.98
c.1071C>A
H357Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H357Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess sequence conservation, structural impact, or functional effect all converge on a benign outcome: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign. No tool predicts pathogenicity. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Based on the uniform predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.399052Uncertain0.8610.4130.250-4.370Likely Benign0.163Likely BenignLikely Benign0.06Likely Benign0.2-0.03Likely Benign0.02Likely Benign-0.35Likely Benign0.025Likely Benign1.42Neutral0.013Benign0.007Benign4.49Benign1.00Tolerated0.17160.385030-0.3-9.01
c.1071C>G
H357Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H357Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess sequence conservation, structural impact, or functional effect all converge on a benign outcome: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign. No tool predicts pathogenicity. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Based on the uniform predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.399052Uncertain0.8610.4130.250-4.370Likely Benign0.163Likely BenignLikely Benign0.06Likely Benign0.2-0.03Likely Benign0.02Likely Benign-0.35Likely Benign0.025Likely Benign1.42Neutral0.013Benign0.007Benign4.49Benign1.00Tolerated0.17160.385030-0.3-9.01
c.1180A>C
K394Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K394Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic outcome are SIFT and Rosetta. The remaining tools—Foldetta, premPS, ESM1b, and AlphaMissense‑Default—return uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also leans toward benign, with two benign votes and two uncertain votes. Foldetta’s stability prediction is uncertain and thus not considered. Overall, the majority of reliable predictions indicate a benign effect, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.505461Disordered0.399336Uncertain0.3870.6340.625-7.261In-Between0.468AmbiguousLikely Benign0.15Likely Benign0.02.00Destabilizing1.08Ambiguous0.64Ambiguous0.330Likely Benign-2.46Neutral0.001Benign0.009Benign4.61Benign0.01Affected0.53650.2106Weaken110.4-0.04
c.1180A>G
K394E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K394E is not listed in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438085‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Those that predict a pathogenic effect are premPS, PROVEAN, SIFT, and AlphaMissense‑Default. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. No prediction or folding‑stability result is available that decisively supports either outcome. Overall, the majority of tools (six benign vs four pathogenic) lean toward a benign interpretation, and this assessment does not contradict the absence of a ClinVar classification. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.505461Disordered0.399336Uncertain0.3870.6340.6256-33438085-A-G16.20e-7-6.903Likely Benign0.896Likely PathogenicAmbiguous0.07Likely Benign0.13.71Destabilizing1.89Ambiguous1.20Destabilizing0.446Likely Benign-2.54Deleterious0.063Benign0.038Benign4.61Benign0.04Affected3.44140.45560.1916100.40.94
c.1181A>C
K394T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K394T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Those that predict a pathogenic effect are PROVEAN, SIFT, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is also inconclusive. Overall, the balance of evidence (five benign versus three pathogenic predictions) suggests the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.505461Disordered0.399336Uncertain0.3870.6340.625-6.487Likely Benign0.599Likely PathogenicLikely Benign0.50Ambiguous0.12.46Destabilizing1.48Ambiguous0.57Ambiguous0.482Likely Benign-3.35Deleterious0.247Benign0.166Benign4.61Benign0.01Affected0.27270.44530-13.2-27.07
c.1181A>G
K394R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K394R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign. Only SIFT predicts a pathogenic outcome, while Rosetta and Foldetta are uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, SGM‑Consensus is Likely Benign, and Foldetta remains uncertain. Overall, the preponderance of evidence supports a benign classification for K394R, and this conclusion does not contradict the absence of a ClinVar report.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.505461Disordered0.399336Uncertain0.3870.6340.625-4.902Likely Benign0.097Likely BenignLikely Benign-0.01Likely Benign0.11.19Ambiguous0.59Ambiguous0.42Likely Benign0.335Likely Benign-1.97Neutral0.141Benign0.091Benign5.11Benign0.03Affected0.54880.2075Weaken32-0.628.01
c.1181A>T
K394I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K394I missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include premPS, polyPhen‑2 HumVar, and FATHMM, while a majority (seven) predict pathogenicity: SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) remains Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No evidence from these tools contradicts the ClinVar status, which is absent. Overall, the preponderance of pathogenic predictions suggests the variant is most likely pathogenic, with no conflict from ClinVar data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.505461Disordered0.399336Uncertain0.3870.6340.625-9.244Likely Pathogenic0.876Likely PathogenicAmbiguous0.78Ambiguous0.21.10Ambiguous0.94Ambiguous0.19Likely Benign0.519Likely Pathogenic-3.96Deleterious0.700Possibly Damaging0.403Benign4.59Benign0.00Affected0.17280.4123-2-38.4-15.01
c.1182A>C
K394N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K394N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, and polyPhen‑2 HumVar. Those that agree on a pathogenic effect are Rosetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are Foldetta, premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, Foldetta as uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.505461Disordered0.399336Uncertain0.3870.6340.625-7.408In-Between0.861Likely PathogenicAmbiguous0.08Likely Benign0.12.02Destabilizing1.05Ambiguous0.66Ambiguous0.299Likely Benign-3.17Deleterious0.535Possibly Damaging0.188Benign4.60Benign0.01Affected0.43530.2654100.4-14.07
c.1182A>T
K394N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K394N missense variant has no ClinVar entry and is not reported in gnomAD. Functional prediction tools show a mixed signal: benign calls come from REVEL, FoldX, FATHMM, and polyPhen‑2 HumVar, while pathogenic calls come from Rosetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, AlphaMissense‑Optimized) return uncertain results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as pathogenic; and Foldetta is uncertain. Taken together, the majority of evidence—including the high‑accuracy consensus—points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.505461Disordered0.399336Uncertain0.3870.6340.625-7.408In-Between0.861Likely PathogenicAmbiguous0.08Likely Benign0.12.02Destabilizing1.05Ambiguous0.66Ambiguous0.299Likely Benign-3.17Deleterious0.535Possibly Damaging0.188Benign4.60Benign0.01Affected0.43530.2654100.4-14.07
c.622C>A
P208T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta; premPS and Rosetta are uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts benign, but the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta also predicts pathogenic. With the majority of tools, including the high‑accuracy ones, indicating pathogenicity, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as the variant is currently unreported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-9.016Likely Pathogenic0.727Likely PathogenicLikely Benign3.20Destabilizing0.51.27Ambiguous2.24Destabilizing0.94Ambiguous0.270Likely Benign-6.80Deleterious1.000Probably Damaging0.994Probably Damaging3.76Benign0.01Affected0.18570.51970-10.93.99
c.622C>G
P208A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P208A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Predictions that are inconclusive are Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points toward a benign effect, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.271506Structured0.399506Uncertain0.8640.3450.125-5.623Likely Benign0.172Likely BenignLikely Benign2.19Destabilizing0.31.31Ambiguous1.75Ambiguous1.03Destabilizing0.245Likely Benign-6.80Deleterious0.999Probably Damaging0.991Probably Damaging3.80Benign0.04Affected0.37270.43901-13.4-26.04
c.622C>T
P208S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta. Rosetta’s output is uncertain and therefore not counted as evidence. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts benign, but the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to pathogenic, and Foldetta also predicts pathogenic. With no ClinVar annotation to contradict, the overall evidence strongly favors a pathogenic classification for P208S.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-8.363Likely Pathogenic0.587Likely PathogenicLikely Benign2.68Destabilizing0.31.53Ambiguous2.11Destabilizing1.21Destabilizing0.270Likely Benign-6.78Deleterious1.000Probably Damaging0.994Probably Damaging3.79Benign0.02Affected0.38080.45371-10.8-10.04
c.623C>A
P208Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM. The majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta. Two tools give uncertain results (AlphaMissense‑Optimized and Rosetta) and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as Pathogenic, reinforcing a deleterious prediction. Overall, the evidence strongly favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-9.746Likely Pathogenic0.906Likely PathogenicAmbiguous3.30Destabilizing0.70.75Ambiguous2.03Destabilizing1.23Destabilizing0.411Likely Benign-6.78Deleterious1.000Probably Damaging0.996Probably Damaging3.78Benign0.00Affected0.15700.46630-1-1.931.01
c.623C>G
P208R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM. The majority of other in silico predictors (FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score (Likely Pathogenic) all indicate a pathogenic impact, while Rosetta remains uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of any benign consensus, the variant is most likely pathogenic, with no contradiction to ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-11.929Likely Pathogenic0.966Likely PathogenicLikely Pathogenic5.25Destabilizing1.61.39Ambiguous3.32Destabilizing1.16Destabilizing0.472Likely Benign-7.50Deleterious1.000Probably Damaging0.996Probably Damaging3.75Benign0.00Affected0.16760.31180-2-2.959.07
c.623C>T
P208L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P208L has no ClinVar entry and is present in gnomAD (ID 6‑33435265‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, while those that agree on a pathogenic effect include FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions that are inconclusive are Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.1256-33435265-C-T16.20e-7-10.013Likely Pathogenic0.889Likely PathogenicAmbiguous2.35Destabilizing0.50.04Likely Benign1.20Ambiguous0.67Ambiguous0.466Likely Benign-8.49Deleterious1.000Probably Damaging0.996Probably Damaging3.75Benign0.01Affected3.44120.22190.6191-3-35.416.04
c.1492A>C
M498L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only FATHMM predicts a pathogenic outcome, while Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, so there is no contradiction with existing clinical databases.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.092881Structured0.399612Uncertain0.9320.1580.0002.556Likely Benign0.072Likely BenignLikely Benign-0.23Likely Benign0.1-0.89Ambiguous-0.56Ambiguous-0.53Ambiguous0.271Likely Benign0.62Neutral0.000Benign0.000Benign-1.24Pathogenic0.92Tolerated0.13190.3551421.9-18.03
c.1492A>G
M498V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M498V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign (REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic (FoldX, Foldetta, premPS, polyPhen‑2 HumDiv, SIFT, FATHMM). Rosetta is uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, while Foldetta predicts a pathogenic effect on protein stability. Overall, the majority of predictions lean toward a benign impact, and this is consistent with the lack of ClinVar evidence; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.092881Structured0.399612Uncertain0.9320.1580.000-3.229Likely Benign0.317Likely BenignLikely Benign2.74Destabilizing0.11.26Ambiguous2.00Destabilizing1.17Destabilizing0.483Likely Benign-1.82Neutral0.752Possibly Damaging0.279Benign-1.28Pathogenic0.04Affected0.27370.2737212.3-32.06
c.1492A>T
M498L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. Only FATHMM predicts a pathogenic outcome, while Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence supports a benign classification, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.092881Structured0.399612Uncertain0.9320.1580.0002.556Likely Benign0.072Likely BenignLikely Benign-0.23Likely Benign0.1-0.89Ambiguous-0.56Ambiguous-0.53Ambiguous0.271Likely Benign0.62Neutral0.000Benign0.000Benign-1.24Pathogenic0.92Tolerated0.13190.3551421.9-18.03
c.1493T>A
M498K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498K is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign calls come only from polyPhen‑2 HumDiv and HumVar, whereas the remaining 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict pathogenicity. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts a destabilizing, pathogenic effect. Taken together, the overwhelming majority of evidence indicates that M498K is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.399612Uncertain0.9320.1580.000-11.622Likely Pathogenic0.983Likely PathogenicLikely Pathogenic2.82Destabilizing0.12.86Destabilizing2.84Destabilizing1.79Destabilizing0.867Likely Pathogenic-4.53Deleterious0.287Benign0.120Benign-1.37Pathogenic0.00Affected0.12810.06560-1-5.8-3.02
c.1493T>C
M498T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498T is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: all but one (polyPhen‑2 HumVar) predict pathogenicity, while polyPhen‑2 HumVar alone predicts benign. Uncertain predictions (ESM1b and AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy methods reinforce the pathogenic view: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports the variant as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. AlphaMissense‑Optimized remains inconclusive. Overall, the preponderance of evidence indicates that M498T is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.399612Uncertain0.9320.1580.000-7.477In-Between0.869Likely PathogenicAmbiguous2.46Destabilizing0.12.62Destabilizing2.54Destabilizing1.41Destabilizing0.672Likely Pathogenic-3.80Deleterious0.803Possibly Damaging0.343Benign-1.19Pathogenic0.02Affected0.19250.1630-1-1-2.6-30.09
c.1493T>G
M498R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498R is listed in ClinVar as Pathogenic (ClinVar ID 3907767.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only polyPhen‑2 HumVar; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.399612Uncertain0.9320.1580.000Likely Pathogenic 1-8.812Likely Pathogenic0.988Likely PathogenicLikely Pathogenic3.85Destabilizing0.22.35Destabilizing3.10Destabilizing1.76Destabilizing0.869Likely Pathogenic-4.53Deleterious0.464Possibly Damaging0.120Benign-1.36Pathogenic0.00Affected0.14820.07570-1-6.424.99
c.1494G>A
M498I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498I has no ClinVar record (ClinVar ID None) and is not reported in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, SIFT, FATHMM, and AlphaMissense‑Default. Two tools, Rosetta and premPS, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of predictions lean toward a benign impact, and this is not contradicted by ClinVar status, which lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.092881Structured0.399612Uncertain0.9320.1580.000-4.796Likely Benign0.760Likely PathogenicLikely Benign2.56Destabilizing0.31.65Ambiguous2.11Destabilizing0.88Ambiguous0.418Likely Benign-1.09Neutral0.018Benign0.012Benign-1.28Pathogenic0.04Affected0.11840.2537212.6-18.03
c.1494G>C
M498I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498I has no ClinVar record (ClinVar ID None) and is not reported in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, SIFT, FATHMM, and AlphaMissense‑Default. Two tools, Rosetta and premPS, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of predictions lean toward a benign impact, and this is not contradicted by ClinVar status, which lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.092881Structured0.399612Uncertain0.9320.1580.000-4.796Likely Benign0.760Likely PathogenicLikely Benign2.56Destabilizing0.31.65Ambiguous2.11Destabilizing0.88Ambiguous0.418Likely Benign-1.09Neutral0.018Benign0.012Benign-1.28Pathogenic0.04Affected0.11840.2537212.6-18.03
c.1494G>T
M498I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498I has no ClinVar record (ClinVar ID None) and is not reported in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, SIFT, FATHMM, and AlphaMissense‑Default. Two tools, Rosetta and premPS, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of predictions lean toward a benign impact, and this is not contradicted by ClinVar status, which lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.092881Structured0.399612Uncertain0.9320.1580.000-4.796Likely Benign0.760Likely PathogenicLikely Benign2.56Destabilizing0.31.65Ambiguous2.11Destabilizing0.88Ambiguous0.414Likely Benign-1.09Neutral0.018Benign0.012Benign-1.28Pathogenic0.04Affected0.11840.2537212.6-18.03
c.868C>A
L290M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, FoldX, and PROVEAN, whereas pathogenic predictions are reported by polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Tools with uncertain outcomes include Foldetta, premPS, AlphaMissense‑Optimized, and Rosetta. High‑accuracy analyses indicate that AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) classifies the variant as Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the majority of evidence leans toward a pathogenic effect, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-8.393Likely Pathogenic0.901Likely PathogenicAmbiguous0.48Likely Benign0.20.98Ambiguous0.73Ambiguous0.59Ambiguous0.438Likely Benign-1.84Neutral1.000Probably Damaging0.999Probably Damaging1.92Pathogenic0.02Affected0.08230.416742-1.918.03
c.868C>G
L290V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L290V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and Rosetta, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, premPS, ESM1b, AlphaMissense‑Optimized, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools and the SGM Consensus suggests that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-7.392In-Between0.834Likely PathogenicAmbiguous1.17Ambiguous0.10.35Likely Benign0.76Ambiguous0.62Ambiguous0.366Likely Benign-2.76Deleterious0.999Probably Damaging0.994Probably Damaging1.98Pathogenic0.05Affected0.15740.4177210.4-14.03
c.869T>A
L290Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which itself is “Likely Pathogenic”). Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta’s stability prediction is unavailable. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-12.776Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.12Ambiguous0.11.38Ambiguous1.25Ambiguous0.68Ambiguous0.697Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.97Pathogenic0.06Tolerated0.10790.1014-2-2-7.314.97
c.869T>C
L290P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously favor a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict pathogenicity. No tool in the dataset predicts a benign outcome; the remaining tools (FoldX, Rosetta, Foldetta, premPS) return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is inconclusive. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-11.796Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.79Ambiguous0.11.10Ambiguous0.95Ambiguous0.56Ambiguous0.727Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging2.01Pathogenic0.03Affected0.36460.1703-3-3-5.4-16.04
c.869T>G
L290R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L290R is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions are limited to FoldX, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all classify the variant as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the consensus of the majority of evidence points to a pathogenic impact. This conclusion is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-13.938Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.48Likely Benign0.10.88Ambiguous0.68Ambiguous0.89Ambiguous0.705Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging2.03Pathogenic0.01Affected0.12150.1056-3-2-8.343.03
c.784A>C
N262H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. FoldX and Foldetta results are uncertain, providing no clear direction. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.399879Uncertain0.9120.2400.000-6.932Likely Benign0.154Likely BenignLikely Benign1.82Ambiguous0.50.41Likely Benign1.12Ambiguous0.33Likely Benign0.694Likely Pathogenic-3.44Deleterious0.999Probably Damaging0.994Probably Damaging5.81Benign0.41Tolerated0.11220.4860210.323.04
c.784A>G
N262D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262D is reported in gnomAD (ID 6‑33437689‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from FoldX, Rosetta, Foldetta, and FATHMM; pathogenic predictions from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is Uncertain, SGM‑Consensus remains Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.0006-33437689-A-G16.20e-7-13.363Likely Pathogenic0.848Likely PathogenicAmbiguous0.27Likely Benign0.10.36Likely Benign0.32Likely Benign1.16Destabilizing0.820Likely Pathogenic-4.31Deleterious0.997Probably Damaging0.980Probably Damaging5.85Benign0.05Affected3.40140.16960.2586120.00.98
c.784A>T
N262Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions (seven pathogenic vs. three benign) lean toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-12.177Likely Pathogenic0.490AmbiguousLikely Benign1.86Ambiguous0.50.52Ambiguous1.19Ambiguous0.36Likely Benign0.858Likely Pathogenic-6.48Deleterious0.999Probably Damaging0.996Probably Damaging5.85Benign0.01Affected0.04450.3877-2-22.249.07
c.785A>C
N262T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262T has no ClinVar record and is not reported in gnomAD. Functional prediction tools cluster into three groups: benign predictions come from SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; the remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta’s stability analysis is uncertain. Overall, the balance of evidence leans toward pathogenicity, with no conflict with ClinVar status (which is absent). Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-11.478Likely Pathogenic0.544AmbiguousLikely Benign1.40Ambiguous0.31.44Ambiguous1.42Ambiguous0.74Ambiguous0.723Likely Pathogenic-5.23Deleterious0.997Probably Damaging0.980Probably Damaging5.88Benign0.19Tolerated0.10550.5164002.8-13.00
c.785A>G
N262S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262S is not listed in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is uncertain. Consequently, the overall evidence is mixed, with a slight tilt toward pathogenicity because five tools predict pathogenic while four predict benign. The variant is most likely pathogenic based on the current predictions, and this assessment does not contradict ClinVar status, as the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-8.841Likely Pathogenic0.182Likely BenignLikely Benign0.91Ambiguous0.20.90Ambiguous0.91Ambiguous0.69Ambiguous0.638Likely Pathogenic-4.31Deleterious0.997Probably Damaging0.970Probably Damaging5.84Benign0.16Tolerated0.31010.5158112.7-27.03
c.785A>T
N262I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262I is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, whereas the majority of tools predict a pathogenic outcome: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are uncertain and therefore treated as unavailable. High‑accuracy methods give an uncertain result for AlphaMissense‑Optimized, a pathogenic consensus from SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an uncertain result for Foldetta. Overall, the evidence points to a pathogenic effect for the variant, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-15.203Likely Pathogenic0.868Likely PathogenicAmbiguous1.21Ambiguous0.40.54Ambiguous0.88Ambiguous0.09Likely Benign0.777Likely Pathogenic-7.79Deleterious0.999Probably Damaging0.994Probably Damaging5.88Benign0.01Affected0.04490.4638-2-38.0-0.94
c.786T>A
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not present in gnomAD. Prediction tools that indicate a benign effect include FoldX, premPS, and FATHMM. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points to a pathogenic impact for N262K. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign0.531Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected0.17990.341310-0.414.07
c.786T>G
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely disagree: benign predictions come from FoldX, premPS, and FATHMM, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and Foldetta. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Taken together, the majority of evidence points to a pathogenic effect for N262K. This conclusion is consistent with the absence of a ClinVar classification, as there is no existing report to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign0.532Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected0.17990.341310-0.414.07
c.2089T>A
W697R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic effect: SGM‑Consensus, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, PROVEAN, AlphaMissense‑Default, and premPS. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools indicates that W697R is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.400169Uncertain0.9450.2970.000-10.020Likely Pathogenic0.941Likely PathogenicAmbiguous1.14Ambiguous0.11.18Ambiguous1.16Ambiguous1.25Destabilizing0.401Likely Benign-9.50Deleterious1.000Probably Damaging0.994Probably Damaging3.45Benign0.02Affected3.46130.39440.06122-3-3.6-30.03254.4-41.20.00.0-0.70.0XPotentially BenignThe indole ring of Trp697, located on the outer surface of an α-helix (res. Leu685-Val699), is not involved in any long-lasting interactions in the WT simulations. In the variant simulations, the positively charged guanidinium side chain of Arg697 occasionally forms hydrogen bonds with nearby residues, such as Ser722 and Asn719. However, similar to Trp697 in the WT, Arg697 does not form any long-lasting interactions and thus does not induce any negative structural effects in the simulations.
c.2089T>C
W697R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697R is listed in ClinVar as Benign (ClinVar ID 703213.0) and is present in the gnomAD database (gnomAD ID 6‑33441348‑T‑C). Functional prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools suggests that the variant is most likely pathogenic, which contradicts its current ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.400169Uncertain0.9450.2970.000Likely Benign 16-33441348-T-C16.20e-7-10.020Likely Pathogenic0.941Likely PathogenicAmbiguous1.14Ambiguous0.11.18Ambiguous1.16Ambiguous1.25Destabilizing0.401Likely Benign-9.50Deleterious1.000Probably Damaging0.994Probably Damaging3.45Benign0.02Affected3.46130.39440.06122-3-3.6-30.03254.4-41.20.00.0-0.70.0XPotentially BenignThe indole ring of Trp697, located on the outer surface of an α-helix (res. Leu685-Val699), is not involved in any long-lasting interactions in the WT simulations. In the variant simulations, the positively charged guanidinium side chain of Arg697 occasionally forms hydrogen bonds with nearby residues, such as Ser722 and Asn719. However, similar to Trp697 in the WT, Arg697 does not form any long-lasting interactions and thus does not induce any negative structural effects in the simulations.
c.2089T>G
W697G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 W697G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. In contrast, a majority of tools predict a pathogenic outcome: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar). AlphaMissense‑Default and ESM1b are uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it receives one benign, one pathogenic, and two uncertain calls. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus remains unavailable. Overall, the preponderance of evidence from multiple independent pathogenicity predictors and the protein‑stability assessment by Foldetta indicates that W697G is most likely pathogenic. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-7.429In-Between0.480AmbiguousLikely Benign2.57Destabilizing0.12.38Destabilizing2.48Destabilizing1.21Destabilizing0.485Likely Benign-8.93Deleterious1.000Probably Damaging0.987Probably Damaging3.44Benign0.06Tolerated0.39650.1482-7-20.5-129.16
c.2090G>C
W697S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as unavailable due to uncertainty. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-4.900Likely Benign0.449AmbiguousLikely Benign1.90Ambiguous0.11.58Ambiguous1.74Ambiguous1.13Destabilizing0.322Likely Benign-8.89Deleterious1.000Probably Damaging0.992Probably Damaging3.53Benign0.13Tolerated0.37380.1089-2-30.1-99.14
c.2090G>T
W697L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. No predictions are missing or inconclusive. Overall, the majority of tools (seven pathogenic vs. six benign) lean toward a pathogenic interpretation, and this does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.400169Uncertain0.9450.2970.000-9.057Likely Pathogenic0.676Likely PathogenicLikely Benign0.20Likely Benign0.1-0.17Likely Benign0.02Likely Benign0.90Ambiguous0.280Likely Benign-8.48Deleterious1.000Probably Damaging0.991Probably Damaging3.58Benign0.02Affected0.22220.2848-2-24.7-73.05
c.2091G>C
W697C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 W697C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The remaining tools—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy assessments are likewise ambiguous: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Consequently, the evidence does not favor either outcome; the variant’s impact remains indeterminate. This lack of consensus does not contradict ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-5.683Likely Benign0.811Likely PathogenicAmbiguous1.84Ambiguous0.11.01Ambiguous1.43Ambiguous0.98Ambiguous0.318Likely Benign-8.65Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.10Tolerated0.35750.1015-8-23.4-83.07
c.2091G>T
W697C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 W697C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or missing results. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is a 2‑vs‑2 tie; and Foldetta is uncertain. Consequently, the evidence does not strongly favor either outcome. The variant is therefore best classified as of uncertain significance; this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-5.683Likely Benign0.811Likely PathogenicAmbiguous1.84Ambiguous0.11.01Ambiguous1.43Ambiguous0.98Ambiguous0.318Likely Benign-8.65Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.10Tolerated0.35750.1015-8-23.4-83.07
c.952C>A
P318T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P318T is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly favor a deleterious effect: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict pathogenic or likely pathogenic. No tool in the dataset predicts a benign outcome; the only inconclusive results come from Rosetta, Foldetta, and premPS, which are treated as unavailable evidence. High‑accuracy assessments confirm this trend: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is uncertain. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-10.759Likely Pathogenic0.962Likely PathogenicLikely Pathogenic2.03Destabilizing0.21.54Ambiguous1.79Ambiguous0.84Ambiguous0.680Likely Pathogenic-7.09Deleterious1.000Probably Damaging0.999Probably Damaging1.84Pathogenic0.01Affected0.15830.60440-10.93.99
c.952C>G
P318A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P318A missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign outcome. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while AlphaMissense‑Optimized remains uncertain and Foldetta is also uncertain. Taken together, the overwhelming majority of evidence points to a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-9.642Likely Pathogenic0.872Likely PathogenicAmbiguous1.90Ambiguous0.21.69Ambiguous1.80Ambiguous0.94Ambiguous0.546Likely Pathogenic-7.12Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.04Affected0.37600.55851-13.4-26.04
c.952C>T
P318S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P318S is present in gnomAD (variant ID 6‑33437857‑C‑T) but has no ClinVar entry. Functional prediction tools uniformly indicate a deleterious effect. Pathogenic predictions come from SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain predictions come from Rosetta and Foldetta. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta remains uncertain. Taken together, the overwhelming majority of evidence supports a pathogenic classification, and this conclusion is consistent with the absence of a ClinVar record rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.0006-33437857-C-T16.19e-7-9.954Likely Pathogenic0.956Likely PathogenicLikely Pathogenic2.22Destabilizing0.11.71Ambiguous1.97Ambiguous1.00Destabilizing0.626Likely Pathogenic-7.05Deleterious1.000Probably Damaging0.999Probably Damaging1.87Pathogenic0.03Affected3.38230.36920.5653-110.8-10.04
c.953C>A
P318Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P318Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity. Only FoldX, Rosetta, and Foldetta provide uncertain results and are therefore not considered evidence for benign impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Consequently, the variant is most likely pathogenic based on the consensus of predictive algorithms, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-11.403Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.64Ambiguous0.21.29Ambiguous1.47Ambiguous1.18Destabilizing0.638Likely Pathogenic-7.05Deleterious1.000Probably Damaging1.000Probably Damaging1.83Pathogenic0.01Affected0.14670.47310-1-1.931.01
c.953C>G
P318R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 P318R is not reported in ClinVar and is absent from gnomAD. In silico predictors that classify the variant as benign: none. Those that predict pathogenicity include SGM‑Consensus (Likely Pathogenic), REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictions from FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy tools give a consistent pathogenic signal: AlphaMissense‑Optimized reports pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic; Foldetta remains inconclusive. Overall, the consensus of the majority of predictors supports a pathogenic effect. This conclusion is not contradicted by ClinVar status, which is currently unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-14.132Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.20Ambiguous0.10.70Ambiguous0.95Ambiguous1.01Destabilizing0.643Likely Pathogenic-8.01Deleterious1.000Probably Damaging1.000Probably Damaging1.84Pathogenic0.01Affected0.13080.33100-2-2.959.07
c.953C>T
P318L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P318L is listed in ClinVar with an uncertain significance (ClinVar ID 956570.0) and is present in gnomAD (6‑33437858‑C‑T). Functional prediction tools that agree on a benign effect are Rosetta and premPS. The remaining tools—REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this view: AlphaMissense‑Optimized reports pathogenic, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Taken together, the preponderance of evidence points to a pathogenic effect for P318L, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000Uncertain 36-33437858-C-T31.86e-6-10.090Likely Pathogenic0.958Likely PathogenicLikely Pathogenic1.33Ambiguous0.10.26Likely Benign0.80Ambiguous0.43Likely Benign0.624Likely Pathogenic-8.96Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.03Affected3.38230.21660.6941-3-35.416.04228.6-68.9-0.70.7-0.40.1XPotentially BenignThe cyclic five-membered pyrrolidine ring of Pro318, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Asp330-Ala322, res. Thr305-Asn315), packs against the hydrophobic side chain of Ile205 at the end of the anti-parallel β sheet in the PH domain. In the variant simulations, the iso-butyl side chain of Leu318 is unable to do the same, potentially weakening the PH and C2 domain association. Importantly, the residue swap could also affect loop formation during folding, as proline can make tighter turns than leucine. Because the residue swap could affect the C2 domain stability, it could also negatively impact the SynGAP-membrane association.
c.1192C>A
P398T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P398T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, and SIFT. The remaining tools (Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy methods give a benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta is uncertain. Overall, the majority of high‑confidence predictions lean toward a benign impact, although several other predictors indicate pathogenicity. There is no conflict with ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.436924Structured0.401041Uncertain0.8910.5250.250-6.670Likely Benign0.536AmbiguousLikely Benign2.11Destabilizing0.41.57Ambiguous1.84Ambiguous0.78Ambiguous0.608Likely Pathogenic-5.70Deleterious0.816Possibly Damaging0.307Benign5.51Benign0.01Affected0.16710.66070-10.93.99
c.1192C>G
P398A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P398A is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438097‑C‑G). Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only PROVEAN predicts a pathogenic outcome. Tools with inconclusive results—FoldX, Rosetta, Foldetta, and premPS—are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign effect for P398A, and this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.436924Structured0.401041Uncertain0.8910.5250.2506-33438097-C-G21.24e-6-5.321Likely Benign0.184Likely BenignLikely Benign1.80Ambiguous0.21.15Ambiguous1.48Ambiguous0.92Ambiguous0.290Likely Benign-5.17Deleterious0.008Benign0.005Benign5.55Benign0.12Tolerated3.40160.36440.5487-113.4-26.04
c.1192C>T
P398S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P398S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include polyPhen‑2 (HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv), and SIFT. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of definitive predictions lean toward a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.436924Structured0.401041Uncertain0.8910.5250.250-6.757Likely Benign0.490AmbiguousLikely Benign1.86Ambiguous0.31.78Ambiguous1.82Ambiguous0.85Ambiguous0.544Likely Pathogenic-5.58Deleterious0.478Possibly Damaging0.130Benign5.68Benign0.03Affected0.36190.57371-10.8-10.04
c.1193C>A
P398Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P398Q has no ClinVar record (ClinVar ID None) and is not reported in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default) predict a pathogenic impact. Two tools report uncertainty: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic based on the collective evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.436924Structured0.401041Uncertain0.8910.5250.250-7.402In-Between0.792Likely PathogenicAmbiguous2.13Destabilizing0.12.01Destabilizing2.07Destabilizing1.01Destabilizing0.719Likely Pathogenic-5.57Deleterious0.996Probably Damaging0.724Possibly Damaging5.48Benign0.00Affected0.15220.51760-1-1.931.01
c.1193C>G
P398R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P398R variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include only FATHMM. All other evaluated predictors—SGM‑Consensus, REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—indicate a pathogenic effect, while Rosetta, premPS, and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.436924Structured0.401041Uncertain0.8910.5250.250-9.575Likely Pathogenic0.889Likely PathogenicAmbiguous3.01Destabilizing0.51.35Ambiguous2.18Destabilizing0.98Ambiguous0.755Likely Pathogenic-6.55Deleterious0.988Probably Damaging0.724Possibly Damaging5.49Benign0.00Affected0.14790.34720-2-2.959.07
c.1193C>T
P398L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P398L (ClinVar ID 2415189.0) is listed as Uncertain in ClinVar and is present in gnomAD (ID 6‑33438098‑C‑T). Functional prediction tools that agree on a benign effect include Foldetta, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, and SIFT. Predictions that are uncertain or inconclusive are FoldX, Rosetta, premPS, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. Based on the available predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status of Uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.436924Structured0.401041Uncertain0.8910.5250.250Uncertain 16-33438098-C-T84.96e-6-7.518In-Between0.547AmbiguousLikely Benign1.48Ambiguous0.2-0.54Ambiguous0.47Likely Benign0.62Ambiguous0.599Likely Pathogenic-7.10Deleterious0.961Probably Damaging0.256Benign5.72Benign0.01Affected3.40160.22480.7157-3-35.416.04245.8-68.6-0.10.0-0.30.2XPotentially PathogenicPro398 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. Although the residue swap does not influence the nearby secondary structure elements, proline is often found at the ends of β sheets due to its disfavored status during folding.Additionally, the Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone. Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Leu398 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1273A>C
T425P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as deleterious, while only FATHMM predicts a benign outcome; premPS is uncertain. High‑accuracy tools reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic effect. Taken together, the overwhelming majority of evidence supports a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-12.318Likely Pathogenic0.963Likely PathogenicLikely Pathogenic2.81Destabilizing0.36.49Destabilizing4.65Destabilizing0.77Ambiguous0.512Likely Pathogenic-5.16Deleterious1.000Probably Damaging0.999Probably Damaging3.37Benign0.03Affected0.18150.34690-1-0.9-3.99
c.1273A>G
T425A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Two tools (premPS and AlphaMissense‑Optimized) give uncertain results and are treated as unavailable. High‑accuracy assessments show SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign, and AlphaMissense‑Optimized as uncertain. Overall, the balance of evidence leans toward pathogenicity, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-8.945Likely Pathogenic0.799Likely PathogenicAmbiguous-0.31Likely Benign0.1-0.05Likely Benign-0.18Likely Benign0.70Ambiguous0.372Likely Benign-4.17Deleterious0.995Probably Damaging0.960Probably Damaging3.42Benign0.09Tolerated0.29710.2572102.5-30.03
c.1273A>T
T425S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, Rosetta) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.401218Uncertain0.9640.2800.000-7.420In-Between0.676Likely PathogenicLikely Benign0.22Likely Benign0.10.77Ambiguous0.50Ambiguous0.63Ambiguous0.275Likely Benign-3.05Deleterious0.998Probably Damaging0.994Probably Damaging3.42Benign0.07Tolerated0.25110.232411-0.1-14.03
c.1274C>A
T425N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, FoldX, and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions labeled uncertain (Foldetta, premPS, AlphaMissense‑Optimized, Rosetta) are treated as unavailable. High‑accuracy assessments further indicate a likely pathogenic outcome from the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and an uncertain result from AlphaMissense‑Optimized and Foldetta. Overall, the majority of definitive predictions support a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-10.709Likely Pathogenic0.925Likely PathogenicAmbiguous0.19Likely Benign0.10.81Ambiguous0.50Ambiguous0.82Ambiguous0.185Likely Benign-3.87Deleterious1.000Probably Damaging0.999Probably Damaging3.44Benign0.04Affected0.11690.284300-2.813.00
c.1274C>G
T425S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, Rosetta) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.401218Uncertain0.9640.2800.000-7.420In-Between0.676Likely PathogenicLikely Benign0.22Likely Benign0.10.77Ambiguous0.50Ambiguous0.63Ambiguous0.184Likely Benign-3.05Deleterious0.998Probably Damaging0.994Probably Damaging3.42Benign0.07Tolerated0.25110.232411-0.1-14.03
c.1274C>T
T425I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425I is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the balance of evidence slightly favors a pathogenic interpretation, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-10.443Likely Pathogenic0.982Likely PathogenicLikely Pathogenic-0.04Likely Benign0.20.07Likely Benign0.02Likely Benign0.30Likely Benign0.268Likely Benign-5.30Deleterious0.999Probably Damaging0.989Probably Damaging3.44Benign0.06Tolerated0.08270.40230-15.212.05
c.2140C>A
L714M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714M is not reported in ClinVar (no entry) and is absent from gnomAD. Benign predictions are provided by REVEL, FoldX, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (likely benign). Pathogenic predictions come from Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy tools give mixed results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign; Foldetta (combining FoldX‑MD and Rosetta) predicts pathogenic. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.314870Structured0.402311Uncertain0.9610.3690.000-0.989Likely Benign0.827Likely PathogenicAmbiguous0.45Likely Benign0.04.49Destabilizing2.47Destabilizing1.00Destabilizing0.249Likely Benign-1.86Neutral1.000Probably Damaging1.000Probably Damaging3.09Benign0.00Affected0.06870.262642-1.918.03
c.2140C>G
L714V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714V has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Overall, the majority of predictions (10 pathogenic vs. 4 benign) indicate a likely pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.314870Structured0.402311Uncertain0.9610.3690.000-4.966Likely Benign0.781Likely PathogenicLikely Benign3.91Destabilizing0.16.19Destabilizing5.05Destabilizing1.21Destabilizing0.259Likely Benign-2.76Deleterious0.995Probably Damaging0.970Probably Damaging3.16Benign0.00Affected0.14210.2689210.4-14.03
c.2141T>A
L714Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714Q is not reported in ClinVar (ClinVar: not reported) and is absent from gnomAD (gnomAD: not found). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated tools—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.145Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.91Destabilizing0.05.23Destabilizing4.07Destabilizing2.13Destabilizing0.378Likely Benign-5.56Deleterious1.000Probably Damaging1.000Probably Damaging3.11Benign0.00Affected0.10960.0558-2-2-7.314.97
c.2141T>C
L714P
2D
AIThe SynGAP1 missense variant L714P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the preponderance of evidence from these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.562Likely Pathogenic0.999Likely PathogenicLikely Pathogenic7.48Destabilizing1.913.54Destabilizing10.51Destabilizing2.26Destabilizing0.441Likely Benign-6.44Deleterious1.000Probably Damaging1.000Probably Damaging3.08Benign0.00Affected0.35720.1253-3-3-5.4-16.04
c.2141T>G
L714R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.763Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.38Destabilizing0.27.54Destabilizing5.96Destabilizing2.09Destabilizing0.402Likely Benign-5.62Deleterious0.999Probably Damaging0.992Probably Damaging3.09Benign0.00Affected0.11860.0558-3-2-8.343.03
c.1177G>A
G393S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G393S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from FoldX, polyPhen‑2 HumDiv, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta) as uncertain. No other tools provide decisive evidence. Overall, the majority of reliable predictors lean toward a benign effect, and this consensus does not conflict with the absence of ClinVar annotation. Therefore, G393S is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.538167Disordered0.402365Uncertain0.3330.6700.625-5.207Likely Benign0.117Likely BenignLikely Benign2.43Destabilizing0.7-0.78Ambiguous0.83Ambiguous0.24Likely Benign0.466Likely Benign-1.76Neutral0.889Possibly Damaging0.444Benign1.33Pathogenic0.07Tolerated0.30110.523210-0.430.03
c.1177G>C
G393R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G393R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include Rosetta and premPS, whereas the remaining tools—SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.538167Disordered0.402365Uncertain0.3330.6700.625-9.148Likely Pathogenic0.815Likely PathogenicAmbiguous3.88Destabilizing1.4-0.38Likely Benign1.75Ambiguous0.47Likely Benign0.596Likely Pathogenic-2.99Deleterious0.991Probably Damaging0.881Possibly Damaging1.32Pathogenic0.02Affected0.13530.4464-3-2-4.199.14
c.1177G>T
G393C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G393C is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Rosetta, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus (likely pathogenic), REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain (no definitive stability change). The majority of evidence points toward a pathogenic effect, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.538167Disordered0.402365Uncertain0.3330.6700.625-8.854Likely Pathogenic0.181Likely BenignLikely Benign2.99Destabilizing0.9-0.26Likely Benign1.37Ambiguous0.43Likely Benign0.769Likely Pathogenic-3.05Deleterious0.999Probably Damaging0.936Probably Damaging1.32Pathogenic0.01Affected0.15930.4408-3-32.946.09
c.1178G>A
G393D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G393D is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SIFT, ESM1b, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default all indicate pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized reports a benign outcome, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, yields an uncertain result and is treated as unavailable. Overall, the preponderance of evidence points to a pathogenic effect for G393D, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.538167Disordered0.402365Uncertain0.3330.6700.625-5.247Likely Benign0.717Likely PathogenicLikely Benign3.30Destabilizing1.4-1.00Ambiguous1.15Ambiguous0.57Ambiguous0.528Likely Pathogenic-2.60Deleterious0.991Probably Damaging0.831Possibly Damaging1.32Pathogenic0.19Tolerated0.20770.16451-1-3.158.04
c.1178G>C
G393A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G393A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, so they provide no evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of reliable predictions indicate a benign effect, and there is no ClinVar annotation to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.538167Disordered0.402365Uncertain0.3330.6700.625-4.507Likely Benign0.129Likely BenignLikely Benign1.93Ambiguous0.5-0.68Ambiguous0.63Ambiguous0.22Likely Benign0.381Likely Benign-1.89Neutral0.176Benign0.039Benign1.33Pathogenic0.08Tolerated0.41430.5193102.214.03
c.1178G>T
G393V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 G393V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Rosetta is uncertain and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while Foldetta predicts pathogenic. The SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Overall, the majority of evidence (8 pathogenic vs. 4 benign) points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.538167Disordered0.402365Uncertain0.3330.6700.625-6.358Likely Benign0.154Likely BenignLikely Benign5.56Destabilizing2.3-0.72Ambiguous2.42Destabilizing-0.01Likely Benign0.639Likely Pathogenic-2.69Deleterious0.982Probably Damaging0.648Possibly Damaging1.32Pathogenic0.01Affected0.17120.4144-1-34.642.08
c.664G>A
V222I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V222I missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The high‑accuracy consensus methods give a benign signal: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, while Foldetta’s stability assessment is uncertain. Overall, the majority of evidence points to a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.116183Structured0.402706Uncertain0.8850.3100.125-6.347Likely Benign0.604Likely PathogenicLikely Benign0.21Likely Benign0.21.45Ambiguous0.83Ambiguous0.09Likely Benign0.612Likely Pathogenic-0.87Neutral0.984Probably Damaging0.956Probably Damaging5.77Benign0.08Tolerated0.06370.3574430.314.03
c.664G>C
V222L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V222L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, FATHMM, and Foldetta, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (premPS and ESM1b) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic)—also predicts pathogenic; Foldetta, a protein‑folding stability method, predicts benign. Overall, the majority of evidence (seven pathogenic vs. four benign) points to a pathogenic effect. The variant’s predicted pathogenicity is not contradicted by any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.116183Structured0.402706Uncertain0.8850.3100.125-7.626In-Between0.987Likely PathogenicLikely Pathogenic0.00Likely Benign0.30.06Likely Benign0.03Likely Benign0.60Ambiguous0.617Likely Pathogenic-2.59Deleterious0.984Probably Damaging0.956Probably Damaging5.49Benign0.05Affected0.08630.434921-0.414.03
c.664G>T
V222L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V222L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, FATHMM, and Foldetta, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (premPS and ESM1b) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic)—also predicts pathogenic; Foldetta, a protein‑folding stability method, predicts benign. Overall, the majority of evidence (seven pathogenic vs. four benign) points to a pathogenic effect. The variant’s predicted pathogenicity is not contradicted by any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.116183Structured0.402706Uncertain0.8850.3100.125-7.626In-Between0.987Likely PathogenicLikely Pathogenic0.00Likely Benign0.30.06Likely Benign0.03Likely Benign0.60Ambiguous0.617Likely Pathogenic-2.59Deleterious0.984Probably Damaging0.956Probably Damaging5.49Benign0.05Affected0.08630.434921-0.414.03
c.665T>A
V222E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V222E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is consistent with the lack of ClinVar reporting (i.e., no contradictory evidence).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.116183Structured0.402706Uncertain0.8850.3100.125-18.017Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.04Destabilizing0.23.46Destabilizing3.75Destabilizing1.64Destabilizing0.960Likely Pathogenic-5.20Deleterious0.998Probably Damaging0.987Probably Damaging5.20Benign0.00Affected0.08330.1495-2-2-7.729.98
c.665T>C
V222A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V222A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity largely agree: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No predictions are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.116183Structured0.402706Uncertain0.8850.3100.125-10.248Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.89Destabilizing0.32.98Destabilizing2.94Destabilizing2.06Destabilizing0.894Likely Pathogenic-3.50Deleterious0.984Probably Damaging0.956Probably Damaging5.26Benign0.04Affected0.23860.208100-2.4-28.05
c.665T>G
V222G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V222G resides in the PH domain. ClinVar has no entry for this variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining eleven tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Thus, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict the ClinVar status, which currently contains no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.116183Structured0.402706Uncertain0.8850.3100.125-14.857Likely Pathogenic0.982Likely PathogenicLikely Pathogenic4.54Destabilizing0.45.25Destabilizing4.90Destabilizing2.05Destabilizing0.962Likely Pathogenic-6.05Deleterious0.987Probably Damaging0.998Probably Damaging5.21Benign0.00Affected0.16780.1996-1-3-4.6-42.08
c.1450T>A
F484I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are inconclusive or missing. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-16.197Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.62Destabilizing0.25.62Destabilizing5.62Destabilizing1.33Destabilizing0.399Likely Benign-5.70Deleterious0.894Possibly Damaging0.332Benign2.74Benign0.00Affected0.15160.1885101.7-34.02
c.1450T>C
F484L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM, while pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN (3 pathogenic vs. 1 benign) and therefore also indicates pathogenicity. AlphaMissense‑Optimized independently predicts pathogenicity. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, seven tools predict pathogenicity versus four predicting benign, and the high‑accuracy consensus supports a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-11.052Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.52Ambiguous0.01.32Ambiguous1.42Ambiguous1.20Destabilizing0.275Likely Benign-5.64Deleterious0.054Benign0.022Benign3.20Benign0.04Affected0.17370.2956201.0-34.02
c.1450T>G
F484V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-15.492Likely Pathogenic0.997Likely PathogenicLikely Pathogenic6.08Destabilizing0.16.07Destabilizing6.08Destabilizing1.28Destabilizing0.455Likely Benign-6.70Deleterious0.859Possibly Damaging0.526Possibly Damaging2.75Benign0.00Affected0.16960.1902-1-11.4-48.04
c.1451T>A
F484Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FATHMM, and polyPhen‑2 HumVar, whereas the majority of other in silico predictors (SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic effect. Stability‑based methods FoldX and Rosetta are inconclusive, and Foldetta likewise reports no definitive change. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence supports a pathogenic classification for F484Y, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-14.223Likely Pathogenic0.961Likely PathogenicLikely Pathogenic1.70Ambiguous0.10.92Ambiguous1.31Ambiguous1.26Destabilizing0.356Likely Benign-2.92Deleterious0.733Possibly Damaging0.344Benign2.66Benign0.02Affected0.10560.159573-4.116.00
c.1451T>C
F484S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-15.666Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.68Destabilizing0.14.42Destabilizing4.55Destabilizing2.26Destabilizing0.705Likely Pathogenic-7.76Deleterious1.000Probably Damaging0.986Probably Damaging2.66Benign0.00Affected0.39930.0200-3-2-3.6-60.10
c.1451T>G
F484C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-14.988Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.01Destabilizing0.03.54Destabilizing3.78Destabilizing2.07Destabilizing0.675Likely Pathogenic-7.73Deleterious1.000Probably Damaging0.969Probably Damaging2.66Benign0.00Affected0.24490.0902-4-2-0.3-44.04
c.1452C>A
F484L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM, while pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN (3 pathogenic vs. 1 benign) and therefore also indicates pathogenicity. AlphaMissense‑Optimized independently predicts pathogenicity. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, seven tools predict pathogenicity versus four predicting benign, and the high‑accuracy consensus supports a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-11.052Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.52Ambiguous0.01.32Ambiguous1.42Ambiguous1.20Destabilizing0.214Likely Benign-5.64Deleterious0.054Benign0.022Benign3.20Benign0.04Affected0.17370.2956201.0-34.02
c.1452C>G
F484L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F484L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM, while pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Overall, seven tools predict pathogenicity versus four predicting benign, and the high‑accuracy methods reinforce the pathogenic signal. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.182256Structured0.403079Uncertain0.7980.2450.125-11.052Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.52Ambiguous0.01.32Ambiguous1.42Ambiguous1.20Destabilizing0.214Likely Benign-5.64Deleterious0.054Benign0.022Benign3.20Benign0.04Affected0.17370.2956201.0-34.02
c.3760G>A
E1254K
2D
AIThe SynGAP1 missense variant E1254K is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include only REVEL, whereas the majority of tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for E1254K. This prediction is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-11.288Likely Pathogenic0.872Likely PathogenicAmbiguous0.290Likely Benign-2.97Deleterious0.999Probably Damaging0.995Probably Damaging2.36Pathogenic0.02Affected0.16530.548801-0.4-0.94
c.3760G>C
E1254Q
2D
AIThe SynGAP1 missense variant E1254Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessment shows AlphaMissense‑Optimized predicts benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—favors pathogenic (2 pathogenic vs. 1 benign). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-9.041Likely Pathogenic0.511AmbiguousLikely Benign0.207Likely Benign-2.18Neutral0.999Probably Damaging0.996Probably Damaging2.35Pathogenic0.03Affected0.07680.5258220.0-0.98
c.3761A>C
E1254A
2D
AIThe SynGAP1 missense variant E1254A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the remaining ten tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) all predict a pathogenic impact. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates it is likely pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-8.943Likely Pathogenic0.658Likely PathogenicLikely Benign0.270Likely Benign-4.35Deleterious0.999Probably Damaging0.995Probably Damaging2.35Pathogenic0.02Affected0.30290.55470-15.3-58.04
c.3761A>G
E1254G
2D
AIThe SynGAP1 missense variant E1254G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized indicates a benign change, but the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple prediction algorithms and the SGM Consensus suggests that the variant is most likely pathogenic, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-10.156Likely Pathogenic0.706Likely PathogenicLikely Benign0.315Likely Benign-4.52Deleterious1.000Probably Damaging0.996Probably Damaging2.34Pathogenic0.01Affected0.26360.50720-23.1-72.06
c.3761A>T
E1254V
2D
AIThe SynGAP1 missense variant E1254V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: REVEL scores the variant as benign, whereas the remaining seven tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict it to be pathogenic. Grouping by consensus, the benign prediction is represented only by REVEL, while the pathogenic predictions are supported by the majority of in silico methods. High‑accuracy assessments further reinforce a pathogenic interpretation: AlphaMissense‑Optimized is uncertain, but the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as likely pathogenic. Foldetta, a protein‑folding stability predictor, has no available result for this variant. Based on the preponderance of pathogenic predictions and the SGM‑Consensus outcome, the variant is most likely pathogenic, which is consistent with the lack of ClinVar annotation and gnomAD absence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-9.913Likely Pathogenic0.814Likely PathogenicAmbiguous0.350Likely Benign-5.15Deleterious1.000Probably Damaging0.998Probably Damaging2.31Pathogenic0.00Affected0.04810.5894-2-27.7-29.98
c.3762G>C
E1254D
2D
AIThe SynGAP1 missense change E1254D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as “Likely Benign.” In contrast, only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is “Likely Benign.” Foldetta results are not available, so they do not influence the overall assessment. Overall, the majority of evidence indicates that E1254D is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-4.648Likely Benign0.274Likely BenignLikely Benign0.112Likely Benign-0.44Neutral0.997Probably Damaging0.992Probably Damaging2.62Benign0.51Tolerated0.14020.3471320.0-14.03
c.3762G>T
E1254D
2D
AIThe SynGAP1 missense change E1254D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that E1254D is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.657645Disordered0.403242Uncertain0.8860.5550.625-4.648Likely Benign0.274Likely BenignLikely Benign0.112Likely Benign-0.44Neutral0.997Probably Damaging0.992Probably Damaging2.62Benign0.51Tolerated0.14020.3471320.0-14.03
c.865A>C
M289L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign. Only FATHMM predicts a pathogenic outcome. Grouping by consensus, the benign‑predicting tools outnumber the single pathogenic prediction. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a “Likely Benign” verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000-5.778Likely Benign0.157Likely BenignLikely Benign0.13Likely Benign0.0-0.10Likely Benign0.02Likely Benign0.39Likely Benign0.070Likely Benign-0.95Neutral0.136Benign0.033Benign1.79Pathogenic0.27Tolerated0.10920.3634421.9-18.03
c.865A>G
M289V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M289V is reported in ClinVar as Benign (ClinVar ID 2122760.0) and is not present in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus all predict benign, while only FATHMM predicts pathogenic. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also indicates benign. No prediction or stability result is inconclusive. Overall, the computational evidence strongly supports a benign classification, consistent with the ClinVar status and showing no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000Benign 1-4.239Likely Benign0.117Likely BenignLikely Benign1.09Ambiguous0.1-0.27Likely Benign0.41Likely Benign0.24Likely Benign0.150Likely Benign-0.36Neutral0.136Benign0.054Benign1.80Pathogenic1.00Tolerated3.38230.22800.2808212.3-32.06204.251.00.00.00.20.0XPotentially BenignThe hydrophobic residue Met289, located in a β hairpin linking two anti-parallel β sheet strands (res. Met289-Arg299, res. Arg272-Leu286), is swapped for another hydrophobic residue, valine. In the variant simulations, the branched hydrocarbon side chain of Val289 packs against the phenol group of the Tyr291 side chain but is unable to form methionine-aromatic interactions. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. However, based on the simulations, the residue swap does not cause adverse effects on the structure.
c.865A>T
M289L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not currently listed in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000-5.778Likely Benign0.157Likely BenignLikely Benign0.13Likely Benign0.0-0.10Likely Benign0.02Likely Benign0.39Likely Benign0.070Likely Benign-0.95Neutral0.136Benign0.033Benign1.79Pathogenic0.27Tolerated0.10920.3634421.9-18.03
c.866T>A
M289K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 M289K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Because the majority of consensus and individual predictors lean toward pathogenicity, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status since none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.403499Uncertain0.8860.2760.000-12.192Likely Pathogenic0.738Likely PathogenicLikely Benign0.36Likely Benign0.20.60Ambiguous0.48Likely Benign0.94Ambiguous0.229Likely Benign-2.52Deleterious0.891Possibly Damaging0.492Possibly Damaging1.94Pathogenic0.12Tolerated0.12710.08790-1-5.8-3.02
c.866T>C
M289T
2D
AIThe SynGAP1 missense variant M289T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled likely benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a benign effect. Taken together, the majority of evidence indicates that M289T is most likely benign, and this conclusion does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000Uncertain1-4.668Likely Benign0.238Likely BenignLikely Benign0.73Ambiguous0.10.17Likely Benign0.45Likely Benign-0.01Likely Benign0.222Likely Benign-0.47Neutral0.801Possibly Damaging0.315Benign1.83Pathogenic0.57Tolerated0.16570.1534-1-1-2.6-30.09
c.866T>G
M289R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289R has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions or stability results are missing or inconclusive. Overall, the majority of tools lean toward a pathogenic effect, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.403499Uncertain0.8860.2760.000-11.090Likely Pathogenic0.719Likely PathogenicLikely Benign0.04Likely Benign0.10.28Likely Benign0.16Likely Benign1.01Destabilizing0.228Likely Benign-2.84Deleterious0.989Probably Damaging0.767Possibly Damaging1.84Pathogenic0.08Tolerated0.14820.08280-1-6.424.99
c.867G>A
M289I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence indicates that M289I is most likely benign, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.127496Structured0.403499Uncertain0.8860.2760.000-6.010Likely Benign0.505AmbiguousLikely Benign0.62Ambiguous0.1-0.23Likely Benign0.20Likely Benign0.36Likely Benign0.040Likely Benign-0.72Neutral0.005Benign0.018Benign1.78Pathogenic0.31Tolerated0.10010.2758212.6-18.03
c.867G>C
M289I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence indicates that M289I is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.127496Structured0.403499Uncertain0.8860.2760.000-6.010Likely Benign0.505AmbiguousLikely Benign0.62Ambiguous0.1-0.23Likely Benign0.20Likely Benign0.36Likely Benign0.040Likely Benign-0.72Neutral0.005Benign0.018Benign1.78Pathogenic0.31Tolerated0.10010.2758212.6-18.03
c.867G>T
M289I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence indicates that M289I is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.127496Structured0.403499Uncertain0.8860.2760.000-6.010Likely Benign0.505AmbiguousLikely Benign0.62Ambiguous0.1-0.23Likely Benign0.20Likely Benign0.36Likely Benign0.040Likely Benign-0.72Neutral0.005Benign0.018Benign1.78Pathogenic0.31Tolerated0.10010.2758212.6-18.03
c.2101C>A
P701T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P701T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify the substitution as benign: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a tolerated change. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports benign. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive, and FoldX alone is uncertain, so these results are treated as unavailable. Overall, the evidence strongly supports a benign effect for P701T, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.404318Uncertain0.9180.3450.000-6.920Likely Benign0.272Likely BenignLikely Benign1.61Ambiguous0.00.11Likely Benign0.86Ambiguous-0.18Likely Benign0.144Likely Benign-0.43Neutral0.084Benign0.050Benign3.44Benign0.70Tolerated0.13980.41600-10.93.99
c.2101C>G
P701A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P701A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; all of these classify the substitution as benign. No tool predicts a pathogenic outcome. Predictions that are inconclusive are FoldX (uncertain) and Foldetta (uncertain). High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, while Foldetta remains uncertain. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.404318Uncertain0.9180.3450.000-6.836Likely Benign0.217Likely BenignLikely Benign1.35Ambiguous0.00.23Likely Benign0.79Ambiguous-0.16Likely Benign0.058Likely Benign-0.55Neutral0.002Benign0.011Benign3.50Benign0.82Tolerated0.31430.37651-13.4-26.04
c.2101C>T
P701S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P701S (ClinVar ID 2995856.0) is listed as “Uncertain” in ClinVar and is present in gnomAD (ID 6‑33441360‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). No tool in the dataset predicts a pathogenic outcome; all remaining predictions are either benign or uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which remains uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.404318Uncertain0.9180.3450.000Uncertain 16-33441360-C-T31.86e-6-4.375Likely Benign0.221Likely BenignLikely Benign1.33Ambiguous0.00.12Likely Benign0.73Ambiguous-0.36Likely Benign0.132Likely Benign0.78Neutral0.044Benign0.025Benign3.48Benign1.00Tolerated3.47100.31490.3782-110.8-10.0410.1016/j.ajhg.2020.11.011
c.2102C>A
P701H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P701H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Predictions that are uncertain or inconclusive are FoldX, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the balance of evidence favors a benign classification, and this conclusion does not contradict the ClinVar status, which contains no pathogenic assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.404318Uncertain0.9180.3450.000-8.786Likely Pathogenic0.553AmbiguousLikely Benign1.40Ambiguous0.0-0.41Likely Benign0.50Ambiguous0.62Ambiguous0.141Likely Benign-2.12Neutral0.936Possibly Damaging0.539Possibly Damaging3.38Benign0.03Affected0.14950.34950-2-1.640.02
c.2102C>G
P701R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P701R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Two tools (FoldX and premPS) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta (combining FoldX‑MD and Rosetta outputs) as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.404318Uncertain0.9180.3450.000-11.060Likely Pathogenic0.779Likely PathogenicLikely Benign0.54Ambiguous0.0-0.19Likely Benign0.18Likely Benign0.65Ambiguous0.088Likely Benign-2.09Neutral0.784Possibly Damaging0.278Benign3.41Benign0.08Tolerated0.13650.25000-2-2.959.07
c.2102C>T
P701L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P701L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. The remaining tools (FoldX, Rosetta, AlphaMissense‑Default) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (7 benign vs. 3 pathogenic) and the two high‑accuracy benign calls suggest that the variant is most likely benign. This conclusion does not contradict any ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.404318Uncertain0.9180.3450.000-10.185Likely Pathogenic0.515AmbiguousLikely Benign1.15Ambiguous0.0-0.68Ambiguous0.24Likely Benign0.12Likely Benign0.116Likely Benign-3.04Deleterious0.642Possibly Damaging0.087Benign3.50Benign0.09Tolerated0.20180.5546-3-35.416.04
c.1213C>A
R405S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R405S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM‑Consensus itself is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts Pathogenic. Taken together, the overwhelming majority of evidence indicates that R405S is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.404888Uncertain0.9490.3150.000-11.326Likely Pathogenic0.977Likely PathogenicLikely Pathogenic2.66Destabilizing0.52.08Destabilizing2.37Destabilizing1.22Destabilizing0.405Likely Benign-5.40Deleterious1.000Probably Damaging0.999Probably Damaging3.67Benign0.05Affected0.28290.46460-13.7-69.11
c.1213C>G
R405G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R405G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.404888Uncertain0.9490.3150.000-11.836Likely Pathogenic0.958Likely PathogenicLikely Pathogenic3.22Destabilizing0.53.26Destabilizing3.24Destabilizing1.38Destabilizing0.419Likely Benign-6.35Deleterious1.000Probably Damaging0.999Probably Damaging3.63Benign0.01Affected0.33810.4139-3-24.1-99.14
c.1213C>T
R405C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R405C is listed in ClinVar with an uncertain significance (ClinVar ID 1185858.0) and is present in gnomAD (ID 6‑33438118‑C‑T). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. FoldX and Rosetta individually return uncertain results. Overall, the balance of evidence favors a pathogenic interpretation, which does not conflict with the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.404888Uncertain0.9490.3150.000Conflicting 26-33438118-C-T63.72e-6-9.206Likely Pathogenic0.713Likely PathogenicLikely Benign0.72Ambiguous0.11.51Ambiguous1.12Ambiguous1.21Destabilizing0.427Likely Benign-7.27Deleterious1.000Probably Damaging1.000Probably Damaging3.61Benign0.02Affected3.38280.32270.3964-4-37.0-53.05221.382.6-0.10.0-0.20.3XXPotentially PathogenicThe guanidinium group of Arg405, located in an anti-parallel β sheet strand of the C2 domain (res. Ala399-Ile411), forms a salt bridge with the carboxylate group of the Glu446 side chain from an opposing α helix (res. Val441-Ser457) in the GAP domain. The positively charged Arg405 side chain also stacks with the aromatic ring of the Phe358 side chain from a loop preceding the β strand (res. Thr359-Thr366), which could assist in maintaining the anti-parallel strand arrangement.In the variant simulations, the thiol-containing side chain of Cys405 is neutral and smaller compared to the arginine side chain. The lack of Arg405-Phe358 stacking affects the loop structure, causing it to assume a β strand form—an effect that could be exacerbated during protein folding. Moreover, the inability of Cys405 to form a salt bridge with Glu446 could affect the tertiary structure assembly, although this is not apparent based on the variant simulations.
c.1214G>A
R405H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R405H is listed in ClinVar with an uncertain significance (ClinVar ID 863440.0) and is present in gnomAD (variant ID 6‑33438119‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized reports a benign change, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both predict pathogenicity. Overall, the preponderance of evidence indicates that R405H is most likely pathogenic, which does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.404888Uncertain0.9490.3150.000Conflicting 26-33438119-G-A42.48e-6-9.081Likely Pathogenic0.706Likely PathogenicLikely Benign2.79Destabilizing0.61.85Ambiguous2.32Destabilizing1.26Destabilizing0.371Likely Benign-4.54Deleterious1.000Probably Damaging0.991Probably Damaging3.65Benign0.01Affected3.38280.33950.2363201.3-19.05214.0102.2-0.10.0-0.70.1XPotentially PathogenicThe guanidinium group of Arg405, located in an anti-parallel β sheet strand of the C2 domain (res. Pro398-Ile411), forms a salt bridge with the carboxylate group of the Glu446 side chain from an opposing α helix (res. Val441-Ser457) in the GAP domain. The positively charged Arg405 side chain also stacks with the aromatic ring of the Phe358 side chain from a loop preceding the β strand (res. Thr359-Thr366), which could assist in maintaining the anti-parallel strand arrangement.In the variant simulations, the imidazole ring of His405 does not stack with the aromatic ring of Phe358 nor form any lasting H-bonds with the loop residues. The imidazole ring of His405 (neutral and epsilon protonated in the simulations) is unable to form a salt bridge with Glu446, which could affect the tertiary structure assembly, although this is not apparent based on the variant simulations.
c.1214G>C
R405P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R405P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict it to be pathogenic or likely pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores it as pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates it is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies it as pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.404888Uncertain0.9490.3150.000Uncertain 1-14.206Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.11Destabilizing0.35.19Destabilizing4.15Destabilizing1.26Destabilizing0.572Likely Pathogenic-6.32Deleterious1.000Probably Damaging1.000Probably Damaging3.62Benign0.01Affected3.38280.21400.5138-202.9-59.07
c.1214G>T
R405L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R405L missense change is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are Rosetta and FATHMM, while the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) indicate a pathogenic or likely pathogenic impact. Uncertain results come from FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta providing an inconclusive stability prediction. Overall, the preponderance of evidence points to a pathogenic effect for R405L, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.250310Structured0.404888Uncertain0.9490.3150.000-11.576Likely Pathogenic0.956Likely PathogenicLikely Pathogenic1.43Ambiguous0.70.40Likely Benign0.92Ambiguous0.72Ambiguous0.512Likely Pathogenic-6.35Deleterious1.000Probably Damaging0.998Probably Damaging3.64Benign0.01Affected0.21260.5555-3-28.3-43.03
c.649G>A
E217K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E217K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Computational predictions cluster into two groups: benign calls from premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and FATHMM; pathogenic calls from REVEL, Rosetta, polyPhen‑2 HumDiv, AlphaMissense‑Default, and AlphaMissense‑Optimized. Three tools give uncertain results: FoldX, Foldetta, and ESM1b. High‑accuracy methods give conflicting outcomes: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; Foldetta remains uncertain. Because the majority of standard tools are split evenly and the high‑accuracy predictions are discordant, the evidence does not decisively support either outcome. The variant is therefore most likely pathogenic based on the preponderance of pathogenic predictions, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.278302Structured0.404912Uncertain0.8230.2840.000-7.169In-Between0.990Likely PathogenicLikely Pathogenic0.52Ambiguous0.52.14Destabilizing1.33Ambiguous0.45Likely Benign0.563Likely Pathogenic-2.38Neutral0.900Possibly Damaging0.307Benign5.95Benign0.13Tolerated0.27420.821601-0.4-0.94
c.649G>C
E217Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E217Q is reported in gnomAD (ID 6‑33435291‑G‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With six benign versus three pathogenic calls and a benign consensus from the high‑accuracy panel, the variant is most likely benign. This conclusion does not contradict ClinVar, which contains no classification for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.278302Structured0.404912Uncertain0.8230.2840.0006-33435291-G-C16.20e-7-6.810Likely Benign0.949Likely PathogenicAmbiguous0.25Likely Benign0.21.61Ambiguous0.93Ambiguous0.67Ambiguous0.459Likely Benign-1.89Neutral0.900Possibly Damaging0.461Possibly Damaging5.83Benign0.14Tolerated3.41130.14740.8473220.0-0.98
c.650A>C
E217A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E217A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, AlphaMissense‑Default, and AlphaMissense‑Optimized. Four tools (FoldX, Rosetta, Foldetta, and ESM1b) returned uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; Foldetta’s stability prediction is uncertain. Overall, the majority of available predictions support a pathogenic impact for E217A. This conclusion is not contradicted by ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.278302Structured0.404912Uncertain0.8230.2840.000-7.294In-Between0.960Likely PathogenicLikely Pathogenic0.67Ambiguous0.50.61Ambiguous0.64Ambiguous0.50Likely Benign0.619Likely Pathogenic-3.88Deleterious0.900Possibly Damaging0.307Benign5.81Benign0.12Tolerated0.44420.80900-15.3-58.04
c.650A>G
E217G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E217G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumVar, SIFT, and FATHMM, while those that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized predicts a pathogenic impact, the SGM‑Consensus also indicates a likely pathogenic outcome, and Foldetta’s stability analysis is inconclusive. Overall, the majority of evidence points to a pathogenic effect for E217G, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.278302Structured0.404912Uncertain0.8230.2840.000-8.076Likely Pathogenic0.968Likely PathogenicLikely Pathogenic1.13Ambiguous0.41.87Ambiguous1.50Ambiguous0.59Ambiguous0.684Likely Pathogenic-3.93Deleterious0.816Possibly Damaging0.307Benign5.82Benign0.06Tolerated0.32780.69410-23.1-72.06
c.650A>T
E217V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E217V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include Rosetta, FATHMM, and premPS, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). FoldX and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E217V. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.278302Structured0.404912Uncertain0.8230.2840.000-10.194Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.76Ambiguous0.60.39Likely Benign0.58Ambiguous0.23Likely Benign0.723Likely Pathogenic-4.84Deleterious0.900Possibly Damaging0.461Possibly Damaging5.79Benign0.03Affected0.09190.8340-2-27.7-29.98
c.651G>C
E217D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E217D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all classify the change as benign. The only inconclusive result comes from AlphaMissense‑Default, which is listed as uncertain. High‑accuracy assessments corroborate this benign profile: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a benign outcome. No pathogenic predictions are present. Therefore, based on the available computational evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.278302Structured0.404912Uncertain0.8230.2840.000-2.268Likely Benign0.453AmbiguousLikely Benign0.24Likely Benign0.3-0.07Likely Benign0.09Likely Benign-0.34Likely Benign0.276Likely Benign0.66Neutral0.014Benign0.007Benign5.85Benign0.85Tolerated3.41130.20660.5976230.0-14.03
c.651G>T
E217D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E217D is present in gnomAD (6‑33435293‑G‑T) but has no ClinVar entry. Functional prediction tools uniformly classify it as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and Foldetta all report benign or benign‑like outcomes. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this: AlphaMissense‑Optimized indicates benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports benign. AlphaMissense‑Default remains uncertain and is treated as unavailable. Overall, the evidence strongly supports a benign effect for E217D, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.278302Structured0.404912Uncertain0.8230.2840.0006-33435293-G-T16.20e-7-2.268Likely Benign0.453AmbiguousLikely Benign0.24Likely Benign0.3-0.07Likely Benign0.09Likely Benign-0.34Likely Benign0.276Likely Benign0.66Neutral0.014Benign0.007Benign5.85Benign0.85Tolerated3.41130.20660.5976230.0-14.03
c.1261G>A
A421T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421T is not reported in ClinVar and is present in gnomAD (ID 6‑33438166‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” Uncertain results from FoldX and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of consensus predictions lean toward a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.0006-33438166-G-A16.19e-7-9.217Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.75Ambiguous0.20.18Likely Benign0.47Likely Benign0.99Ambiguous0.179Likely Benign-3.12Deleterious0.353Benign0.136Benign3.43Benign0.09Tolerated3.37290.13460.443901-2.530.03
c.1261G>C
A421P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A421P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL, FATHMM, and polyPhen‑2 HumVar, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, reports a pathogenic effect. Taken together, the overwhelming majority of evidence points to a pathogenic impact for A421P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-13.126Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.51Destabilizing0.28.77Destabilizing6.64Destabilizing1.17Destabilizing0.371Likely Benign-4.31Deleterious0.855Possibly Damaging0.420Benign3.39Benign0.04Affected0.19630.33431-1-3.426.04
c.1261G>T
A421S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A421S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions arise from PROVEAN, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves as Likely Pathogenic. High‑accuracy assessments indicate that AlphaMissense‑Optimized predicts a benign effect, the SGM‑Consensus predicts pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. Stability calculations from FoldX and Rosetta are uncertain, and premPS is unavailable. Overall, the majority of tools lean toward a pathogenic interpretation, and this aligns with the SGM‑Consensus result; there is no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-9.220Likely Pathogenic0.715Likely PathogenicLikely Benign0.66Ambiguous0.11.12Ambiguous0.89Ambiguous0.70Ambiguous0.155Likely Benign-2.50Deleterious0.058Benign0.072Benign3.46Benign0.08Tolerated0.22470.362111-2.616.00
c.1262C>A
A421E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas pathogenic calls are made by ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, premPS, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods give mixed results: FoldX is uncertain, Foldetta is uncertain, and Rosetta alone predicts pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence, including the high‑accuracy tools, points to a pathogenic impact for A421E, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-11.993Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.63Ambiguous0.22.07Destabilizing1.35Ambiguous1.30Destabilizing0.233Likely Benign-4.24Deleterious0.368Benign0.144Benign3.44Benign0.14Tolerated0.12880.18300-1-5.358.04
c.1262C>G
A421G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of tools and the SGM Consensus favor a pathogenic interpretation, while a minority suggest benign. Because there is no ClinVar entry, the predictions do not contradict existing clinical classification. The variant is most likely pathogenic based on the collective computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-9.699Likely Pathogenic0.757Likely PathogenicLikely Benign1.47Ambiguous0.12.13Destabilizing1.80Ambiguous1.19Destabilizing0.137Likely Benign-3.59Deleterious0.536Possibly Damaging0.176Benign3.41Benign0.05Affected0.16920.249910-2.2-14.03
c.1262C>T
A421V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A421V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) also predicts pathogenic, whereas Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, predicts benign. Rosetta alone is uncertain and is treated as unavailable. Overall, the majority of high‑confidence tools favor a pathogenic effect, so A421V is most likely pathogenic, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-8.167Likely Pathogenic0.984Likely PathogenicLikely Pathogenic-0.05Likely Benign0.1-0.82Ambiguous-0.44Likely Benign-0.06Likely Benign0.111Likely Benign-3.15Deleterious0.538Possibly Damaging0.113Benign3.50Benign0.14Tolerated0.10550.3738002.428.05
c.616A>C
I206L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and Foldetta. Those that predict a pathogenic effect are ESM1b and AlphaMissense‑Default. Uncertain or inconclusive results come from premPS, AlphaMissense‑Optimized, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta predicts a benign outcome. Overall, the majority of tools (seven benign vs two pathogenic) support a benign classification. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.298791Structured0.405123Uncertain0.8630.3910.125-9.488Likely Pathogenic0.790Likely PathogenicAmbiguous0.05Likely Benign0.10.75Ambiguous0.40Likely Benign0.78Ambiguous0.080Likely Benign-1.72Neutral0.004Benign0.012Benign3.78Benign0.08Tolerated0.06320.360822-0.70.00
c.616A>G
I206V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta. No tool predicts a pathogenic outcome; the only inconclusive results are from FoldX (uncertain) and Foldetta (uncertain). High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, while Foldetta remains uncertain. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.298791Structured0.405123Uncertain0.8630.3910.125-5.709Likely Benign0.165Likely BenignLikely Benign1.22Ambiguous0.10.24Likely Benign0.73Ambiguous0.40Likely Benign0.051Likely Benign-0.51Neutral0.001Benign0.007Benign4.27Benign0.53Tolerated0.08330.292043-0.3-14.03
c.616A>T
I206F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I206F missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and polyPhen‑2 HumVar. Those that predict a pathogenic effect comprise SGM‑Consensus, Foldetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta. Predictions that are uncertain or inconclusive are FoldX and premPS. High‑accuracy methods all support a deleterious outcome: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-12.669Likely Pathogenic0.961Likely PathogenicLikely Pathogenic1.82Ambiguous0.43.39Destabilizing2.61Destabilizing0.70Ambiguous0.133Likely Benign-3.40Deleterious0.838Possibly Damaging0.368Benign3.64Benign0.01Affected0.04280.272110-1.734.02
c.617T>A
I206N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL and FATHMM, while the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. No prediction or folding result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-15.211Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.98Destabilizing0.22.57Destabilizing2.78Destabilizing2.04Destabilizing0.334Likely Benign-5.55Deleterious0.940Possibly Damaging0.641Possibly Damaging3.62Benign0.00Affected0.06890.0340-2-3-8.00.94
c.617T>C
I206T
2D
AIThe SynGAP1 I206T missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give consistent results: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overall evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not currently listed.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-10.812Likely Pathogenic0.973Likely PathogenicLikely Pathogenic2.43Destabilizing0.52.68Destabilizing2.56Destabilizing1.94Destabilizing0.252Likely Benign-3.78Deleterious0.421Benign0.156Benign3.65Benign0.00Affected0.08300.06690-1-5.2-12.05
c.617T>G
I206S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I206S missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and polyPhen‑2 HumVar. All other evaluated algorithms (SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. Based on the preponderance of evidence from these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-13.711Likely Pathogenic0.993Likely PathogenicLikely Pathogenic3.73Destabilizing0.33.89Destabilizing3.81Destabilizing1.74Destabilizing0.251Likely Benign-4.86Deleterious0.838Possibly Damaging0.368Benign3.63Benign0.00Affected0.21890.0728-1-2-5.3-26.08
c.618C>G
I206M
2D
AIThe SynGAP1 I206M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, and FATHMM, whereas tools that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With six pathogenic predictions versus four benign and three uncertain, the overall evidence leans toward pathogenicity. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.298791Structured0.405123Uncertain0.8630.3910.125-10.008Likely Pathogenic0.878Likely PathogenicAmbiguous0.42Likely Benign0.61.21Ambiguous0.82Ambiguous1.08Destabilizing0.085Likely Benign-2.42Neutral0.838Possibly Damaging0.467Possibly Damaging3.64Benign0.01Affected0.05760.271621-2.618.03
c.1174A>C
K392Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K392Q has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL and polyPhen‑2 HumDiv. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.541878Disordered0.405672Uncertain0.3190.7020.750-4.243Likely Benign0.377AmbiguousLikely Benign0.13Likely Benign0.00.05Likely Benign0.09Likely Benign0.23Likely Benign0.525Likely Pathogenic-2.09Neutral0.652Possibly Damaging0.161Benign4.61Benign0.06Tolerated0.56120.2106Weaken110.4-0.04
c.1174A>G
K392E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K392E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and the SGM‑Consensus score. Tools that predict a pathogenic effect are REVEL, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score is uncertain, while the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both indicate a benign outcome. Overall, the majority of evidence supports a benign classification, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.541878Disordered0.405672Uncertain0.3190.7020.750-4.392Likely Benign0.850Likely PathogenicAmbiguous0.09Likely Benign0.0-0.04Likely Benign0.03Likely Benign0.28Likely Benign0.529Likely Pathogenic-1.92Neutral0.276Benign0.083Benign4.60Benign0.02Affected0.48120.1916010.40.94
c.1175A>C
K392T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K392T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, PROVEAN, and SIFT. Two tools—FoldX and AlphaMissense‑Default—return uncertain results and are treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign; and Foldetta, a protein‑folding stability method, also predicts benign. No ClinVar entry exists to contradict these predictions. Based on the collective evidence, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.541878Disordered0.405672Uncertain0.3190.7020.750-3.224Likely Benign0.481AmbiguousLikely Benign0.52Ambiguous0.1-0.29Likely Benign0.12Likely Benign0.05Likely Benign0.512Likely Pathogenic-3.14Deleterious0.276Benign0.045Benign4.60Benign0.02Affected0.28070.40530-13.2-27.07
c.1175A>G
K392R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K392R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). All available in silico predictors classify the change as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign effect. The high‑accuracy folding‑stability tool Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a benign impact. No tool predicts pathogenicity. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.541878Disordered0.405672Uncertain0.3190.7020.750-4.006Likely Benign0.091Likely BenignLikely Benign-0.03Likely Benign0.00.44Likely Benign0.21Likely Benign0.23Likely Benign0.131Likely Benign-1.44Neutral0.436Benign0.112Benign7.12Benign0.08Tolerated0.56860.1875Weaken32-0.628.01
c.1175A>T
K392M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K392M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, ESM1b, and FATHMM, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The remaining tools—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy methods give no definitive signal: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie and thus unavailable, and Foldetta is uncertain. Overall, the majority of available predictions (six pathogenic vs. three benign) lean toward a pathogenic impact. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.541878Disordered0.405672Uncertain0.3190.7020.750-3.856Likely Benign0.788Likely PathogenicAmbiguous0.52Ambiguous0.10.67Ambiguous0.60Ambiguous-0.09Likely Benign0.665Likely Pathogenic-3.24Deleterious0.952Possibly Damaging0.496Possibly Damaging4.59Benign0.00Affected0.17990.49410-15.83.02
c.1176G>C
K392N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K392N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. Overall, the majority of evidence (9 benign vs 3 pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.541878Disordered0.405672Uncertain0.3190.7020.750-4.136Likely Benign0.780Likely PathogenicLikely Benign0.24Likely Benign0.1-0.01Likely Benign0.12Likely Benign0.20Likely Benign0.229Likely Benign-2.61Deleterious0.276Benign0.083Benign4.60Benign0.02Affected0.45860.2454100.4-14.07
c.1176G>T
K392N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K392N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split and is therefore treated as unavailable. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence (nine benign vs. three pathogenic predictions) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.541878Disordered0.405672Uncertain0.3190.7020.750-4.136Likely Benign0.780Likely PathogenicLikely Benign0.24Likely Benign0.1-0.01Likely Benign0.12Likely Benign0.20Likely Benign0.229Likely Benign-2.61Deleterious0.276Benign0.083Benign4.60Benign0.02Affected0.45860.2454100.4-14.07
c.619A>C
K207Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K207Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; AlphaMissense‑Optimized is uncertain; Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign impact. Folding‑stability scores from FoldX and Rosetta are inconclusive, and premPS is unavailable. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-9.544Likely Pathogenic0.874Likely PathogenicAmbiguous0.57Ambiguous0.1-0.57Ambiguous0.00Likely Benign0.61Ambiguous0.250Likely Benign-2.95Deleterious0.995Probably Damaging0.829Possibly Damaging4.00Benign0.10Tolerated0.40100.1797110.4-0.04
c.619A>G
K207E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K207E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a larger group predicts pathogenicity: premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. The remaining stability predictions (FoldX and Rosetta) are uncertain. Overall, the majority of evidence points to a pathogenic effect for K207E, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-14.387Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.39Ambiguous0.11.21Ambiguous1.30Ambiguous1.09Destabilizing0.265Likely Benign-3.00Deleterious0.982Probably Damaging0.679Possibly Damaging4.02Benign0.07Tolerated0.35040.1557010.40.94
c.620A>C
K207T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K207T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain predictions come from Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic; Foldetta’s stability analysis is inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for K207T, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-11.002Likely Pathogenic0.974Likely PathogenicLikely Pathogenic2.15Destabilizing0.80.57Ambiguous1.36Ambiguous0.78Ambiguous0.239Likely Benign-4.57Deleterious0.982Probably Damaging0.747Possibly Damaging3.99Benign0.07Tolerated0.16360.40310-13.2-27.07
c.620A>G
K207R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change K207R is not listed in ClinVar and has no reported allele in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign or likely benign outcome. In contrast, polyPhen‑2 HumDiv and HumVar classify the variant as pathogenic. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, providing no definitive support for either outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.374039Structured0.406823Uncertain0.8470.3590.125-5.157Likely Benign0.217Likely BenignLikely Benign-0.58Ambiguous0.1-1.07Ambiguous-0.83Ambiguous0.37Likely Benign0.140Likely Benign-1.77Neutral0.982Probably Damaging0.679Possibly Damaging4.09Benign0.20Tolerated0.46400.170432-0.628.01
c.620A>T
K207M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K207M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) predict a pathogenic impact; premPS is uncertain. High‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.596Likely Pathogenic0.977Likely PathogenicLikely Pathogenic-0.22Likely Benign0.0-0.47Likely Benign-0.35Likely Benign0.59Ambiguous0.336Likely Benign-4.67Deleterious0.985Probably Damaging0.832Possibly Damaging3.94Benign0.03Affected0.09820.47050-15.83.02
c.621G>C
K207N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K207N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicating likely pathogenic, while Foldetta’s stability prediction is unavailable. Overall, the preponderance of evidence points to a pathogenic effect for K207N, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.881Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.72Ambiguous0.11.48Ambiguous1.10Ambiguous1.00Destabilizing0.123Likely Benign-3.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.98Benign0.07Tolerated0.31840.2335100.4-14.07
c.621G>T
K207N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K207N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions arise from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, and the SGM Consensus (majority vote) also predicts Pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence indicates that K207N is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.881Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.72Ambiguous0.11.48Ambiguous1.10Ambiguous1.00Destabilizing0.124Likely Benign-3.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.98Benign0.07Tolerated0.31840.2335100.4-14.07
c.1072T>A
F358I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F358I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports an uncertain impact. Overall, the preponderance of evidence points to a pathogenic effect for F358I, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.407113Uncertain0.9120.4410.250-10.636Likely Pathogenic0.884Likely PathogenicAmbiguous0.93Ambiguous0.21.66Ambiguous1.30Ambiguous0.95Ambiguous0.393Likely Benign-4.45Deleterious0.993Probably Damaging0.977Probably Damaging4.07Benign0.13Tolerated0.23310.2821101.7-34.02
c.1072T>C
F358L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F358L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results are reported for Rosetta, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, while Foldetta’s stability prediction is unavailable due to inconclusiveness. Overall, the majority of available evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.222385Structured0.407113Uncertain0.9120.4410.250-7.865In-Between0.964Likely PathogenicLikely Pathogenic0.18Likely Benign0.11.62Ambiguous0.90Ambiguous0.97Ambiguous0.290Likely Benign-4.21Deleterious0.982Probably Damaging0.952Probably Damaging4.12Benign0.22Tolerated0.25550.3602201.0-34.02
c.1072T>G
F358V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F358V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is also uncertain. Overall, the preponderance of evidence points to a pathogenic effect for F358V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.407113Uncertain0.9120.4410.250-9.021Likely Pathogenic0.847Likely PathogenicAmbiguous1.42Ambiguous0.21.68Ambiguous1.55Ambiguous0.93Ambiguous0.408Likely Benign-5.32Deleterious0.993Probably Damaging0.968Probably Damaging4.09Benign0.18Tolerated0.22220.2978-1-11.4-48.04
c.1073T>A
F358Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F358Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, ESM1b, FATHMM, PROVEAN, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The high‑accuracy consensus methods reinforce the benign assessment: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a Likely Benign result (3 benign vs. 1 pathogenic), and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a benign effect. premPS is uncertain and is treated as unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.222385Structured0.407113Uncertain0.9120.4410.250-6.458Likely Benign0.606Likely PathogenicLikely Benign0.42Likely Benign0.10.21Likely Benign0.32Likely Benign0.84Ambiguous0.231Likely Benign-2.17Neutral0.993Probably Damaging0.952Probably Damaging4.05Benign0.36Tolerated0.14670.269773-4.116.00
c.1073T>C
F358S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F358S variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of algorithms predict a pathogenic outcome: FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Rosetta’s assessment is uncertain and is not taken as evidence. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the preponderance of pathogenic predictions and the agreement of the high‑accuracy tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.407113Uncertain0.9120.4410.250-9.316Likely Pathogenic0.977Likely PathogenicLikely Pathogenic2.32Destabilizing0.21.97Ambiguous2.15Destabilizing1.14Destabilizing0.493Likely Benign-6.48Deleterious0.998Probably Damaging0.986Probably Damaging4.07Benign0.20Tolerated0.38910.1333-3-2-3.6-60.10
c.1073T>G
F358C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F358C is not reported in ClinVar and is absent from gnomAD. Consensus from standard in‑silico predictors shows a split: benign calls come from REVEL, SIFT, and FATHMM, whereas pathogenic calls arise from Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default. High‑accuracy assessments are less definitive: AlphaMissense‑Optimized is inconclusive, Foldetta is inconclusive, and the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans toward pathogenic. Because the majority of available predictions favor a damaging effect, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.222385Structured0.407113Uncertain0.9120.4410.250-7.966In-Between0.927Likely PathogenicAmbiguous1.68Ambiguous0.12.19Destabilizing1.94Ambiguous1.18Destabilizing0.460Likely Benign-6.36Deleterious0.999Probably Damaging0.993Probably Damaging4.02Benign0.06Tolerated0.23640.1800-4-2-0.3-44.04
c.1074C>A
F358L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F358L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results are reported for Rosetta, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, while Foldetta’s stability prediction is unavailable due to inconclusiveness. Overall, the majority of available evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.222385Structured0.407113Uncertain0.9120.4410.250-7.865In-Between0.964Likely PathogenicLikely Pathogenic0.18Likely Benign0.11.62Ambiguous0.90Ambiguous0.97Ambiguous0.215Likely Benign-4.21Deleterious0.982Probably Damaging0.952Probably Damaging4.12Benign0.22Tolerated0.25550.3602201.0-34.02
c.1074C>G
F358L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F358L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from Rosetta, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, while Foldetta’s stability prediction is unavailable. Overall, the majority of reliable tools predict a pathogenic impact for F358L. This conclusion does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.222385Structured0.407113Uncertain0.9120.4410.250-7.865In-Between0.964Likely PathogenicLikely Pathogenic0.18Likely Benign0.11.62Ambiguous0.90Ambiguous0.97Ambiguous0.215Likely Benign-4.21Deleterious0.982Probably Damaging0.952Probably Damaging4.12Benign0.22Tolerated0.25550.3602201.0-34.02
c.1195G>A
A399T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A399T is listed in ClinVar (ID 1990638.0) as Benign and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX, Rosetta, and Foldetta, which are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the variant is most likely benign, and this conclusion aligns with its ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.394753Structured0.407674Uncertain0.9390.4900.125Benign 1-5.236Likely Benign0.114Likely BenignLikely Benign1.24Ambiguous0.10.91Ambiguous1.08Ambiguous0.49Likely Benign0.272Likely Benign-0.40Neutral0.131Benign0.039Benign5.41Benign0.69Tolerated3.38260.13350.647710-2.530.03211.4-41.40.00.00.60.4XPotentially PathogenicThe methyl group of Ala399, located in an anti-parallel β sheet strand (res. Ala399-Ile411), is swapped for a hydroxyl-containing threonine. In the variant simulations, the hydroxyl group of Thr399 can form H-bonds with the backbone atoms of the residues in the membrane-facing loops (e.g., Gly382) in the C2 domain. Consequently, the ability of the Thr399 side chain to form H-bonds with the membrane-facing loops could adversely affect the dynamics and stability of the SynGAP-membrane association. However, since the effects on the dynamics of the membrane-facing loops can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1195G>C
A399P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A399P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, FATHMM, and polyPhen‑2 HumVar; pathogenic predictions come from FoldX, Rosetta, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a pathogenic effect. Overall, the majority of evidence points toward a deleterious impact. The variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.394753Structured0.407674Uncertain0.9390.4900.125-8.809Likely Pathogenic0.942Likely PathogenicAmbiguous2.29Destabilizing0.14.00Destabilizing3.15Destabilizing0.74Ambiguous0.498Likely Benign-1.82Neutral0.596Possibly Damaging0.188Benign5.56Benign0.10Tolerated0.18470.54721-1-3.426.04
c.1195G>T
A399S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A399S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify the variant as benign: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a benign effect, while FoldX, Rosetta, and Foldetta are inconclusive. Grouping by agreement, all available predictors fall into the benign category; none predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, whereas Foldetta’s stability analysis remains uncertain. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.394753Structured0.407674Uncertain0.9390.4900.125-4.256Likely Benign0.100Likely BenignLikely Benign0.65Ambiguous0.11.13Ambiguous0.89Ambiguous-0.33Likely Benign0.161Likely Benign0.81Neutral0.001Benign0.001Benign5.65Benign0.86Tolerated0.24940.489711-2.616.00
c.1196C>A
A399D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A399D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that agree on a pathogenic effect are REVEL, FoldX, SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools—Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy methods give no definitive verdict: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie and thus unavailable, and Foldetta is uncertain. Overall, the majority of available predictions (five pathogenic vs. four benign) lean toward pathogenicity. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.394753Structured0.407674Uncertain0.9390.4900.125-10.441Likely Pathogenic0.943Likely PathogenicAmbiguous2.45Destabilizing0.21.17Ambiguous1.81Ambiguous0.91Ambiguous0.525Likely Pathogenic-1.84Neutral0.421Benign0.054Benign5.38Benign0.05Affected0.15330.17600-2-5.344.01
c.1196C>G
A399G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A399G is not reported in ClinVar and is absent from gnomAD. Across a panel of in silico predictors, all available pathogenicity scores classify the substitution as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. Uncertain results from FoldX, Rosetta, Foldetta, and premPS are treated as unavailable. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates benign. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive and therefore not considered evidence. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.394753Structured0.407674Uncertain0.9390.4900.125-6.513Likely Benign0.215Likely BenignLikely Benign1.03Ambiguous0.11.77Ambiguous1.40Ambiguous0.74Ambiguous0.153Likely Benign-1.59Neutral0.062Benign0.024Benign5.39Benign0.13Tolerated0.21740.453210-2.2-14.03
c.1196C>T
A399V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A399V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). No tool predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the evidence overwhelmingly supports a benign classification, and this is consistent with the lack of ClinVar reporting.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.394753Structured0.407674Uncertain0.9390.4900.125-4.943Likely Benign0.170Likely BenignLikely Benign0.49Likely Benign0.20.56Ambiguous0.53Ambiguous0.22Likely Benign0.305Likely Benign-1.18Neutral0.421Benign0.073Benign5.37Benign0.24Tolerated0.11450.6807002.428.05
c.1024T>A
Y342N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342N has no ClinVar entry (ClinVar status: None) and is not reported in gnomAD (gnomAD ID: None). Prediction tools that assess the variant’s effect are overwhelmingly in agreement that it is deleterious: SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. No tool predicts a benign effect. High‑accuracy assessments further support this view: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic impact. Taken together, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250-9.685Likely Pathogenic0.940Likely PathogenicAmbiguous1.76Ambiguous0.12.89Destabilizing2.33Destabilizing1.02Destabilizing0.554Likely Pathogenic-6.65Deleterious1.000Probably Damaging0.999Probably Damaging1.71Pathogenic0.03Affected0.21890.0862-2-2-2.2-49.07
c.1024T>C
Y342H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342H is reported in gnomAD (ID 6‑33437929‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. Five tools predict pathogenicity versus three predicting benign, with the remaining five (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yielding uncertain or inconclusive results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the preponderance of evidence indicates that Y342H is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.2506-33437929-T-C16.20e-7-6.459Likely Benign0.944Likely PathogenicAmbiguous1.63Ambiguous0.11.33Ambiguous1.48Ambiguous0.73Ambiguous0.453Likely Benign-3.61Deleterious1.000Probably Damaging0.999Probably Damaging1.72Pathogenic0.06Tolerated3.37250.24910.086220-1.9-26.03
c.1024T>G
Y342D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342D is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include premPS and SIFT, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict it to be pathogenic. FoldX reports an uncertain effect, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta is pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250-10.940Likely Pathogenic0.985Likely PathogenicLikely Pathogenic1.60Ambiguous0.12.70Destabilizing2.15Destabilizing0.13Likely Benign0.668Likely Pathogenic-7.19Deleterious1.000Probably Damaging0.999Probably Damaging1.71Pathogenic0.07Tolerated0.39250.0862-4-3-2.2-48.09
c.1025A>C
Y342S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant Y342S is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the majority of algorithms predict a pathogenic impact: FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and the Foldetta stability assessment (combining FoldX‑MD and Rosetta). Uncertain results come from premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy methods specifically give AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which contradicts the ClinVar uncertain classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250Uncertain 2-7.996In-Between0.925Likely PathogenicAmbiguous3.03Destabilizing0.12.87Destabilizing2.95Destabilizing0.93Ambiguous0.407Likely Benign-6.60Deleterious1.000Probably Damaging0.998Probably Damaging1.75Pathogenic0.04Affected3.37250.46170.2637-3-20.5-76.10200.177.80.00.0-0.20.1Potentially PathogenicThe phenol ring of Tyr342, located at the end of an anti-parallel β sheet strand (res. Gly341-Pro349), faces outward in the C2 domain. In the WT simulations, the phenol ring of Tyr342 contributes to a triple tyrosine stack (Tyr342, Tyr328, and Tyr281) that links together three anti-parallel β sheet strands. Additionally, it shields Gly344 from the solvent, reducing its exposure and providing stability for the β-sandwich. This motif also contributes to a twist formation in the β sheet.In the variant simulations, the Ser342 side chain cannot participate in the stack formation. Instead, the hydroxyl group of the Ser342 side chain forms a hydrogen bond with the imidazole ring of His326 in a neighboring β strand (res. Ala322-Asp330). This disrupts the formation of a hydrogen bond between His326 and the carboxylate group of the Glu283 side chain from another β strand (res. Arg279-Cys285). Although these changes in surface interactions could weaken the characteristic twist that strengthens the β sheet fold, no major structural effects are observed in the variant simulations. The residue swap could also affect the SynGAP-membrane association, as the hydroxyl group of Ser342 could form hydrogen bonds with membrane-facing loop residues. However, this phenomenon cannot be addressed using solvent-only simulations.
c.1025A>G
Y342C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y342C is listed in ClinVar as Benign (ClinVar ID 1213078.0) and is observed in gnomAD (ID 6‑33437930‑A‑G). Across general prediction tools, benign calls are made by REVEL and AlphaMissense‑Optimized, whereas pathogenic calls are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by premPS and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized predicting Benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting Pathogenic. Overall, the majority of predictions support a pathogenic effect, contradicting the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250Benign/Likely benign 26-33437930-A-G211.30e-5-7.596In-Between0.682Likely PathogenicLikely Benign2.48Destabilizing0.12.73Destabilizing2.61Destabilizing0.92Ambiguous0.404Likely Benign-6.67Deleterious1.000Probably Damaging0.999Probably Damaging1.72Pathogenic0.02Affected3.37250.28360.28700-23.8-60.04242.462.80.10.0-0.10.2Potentially PathogenicThe phenol ring of Tyr342, located at the end of an anti-parallel β sheet strand (res. Gly341-Pro349), faces outward in the C2 domain. This phenol ring contributes to a triple tyrosine stack (Tyr342, Tyr328, and Tyr281) that links together three anti-parallel β sheet strands. Additionally, it shields Gly344 from the solvent, reducing its exposure and providing stability for the β-sandwich. This motif also contributes to a twist formation in the β sheet.In the variant simulations, the Cys342 side chain cannot participate in the stack formation. Instead, its thiol group forms a hydrogen bond with the backbone carbonyl group of Leu327. Although these changes in surface interactions could weaken the characteristic twist that strengthens the β sheet fold, no major structural effects are observed in the variant simulations. The residue swap could also affect the SynGAP-membrane association; however, this phenomenon cannot be addressed using solvent-only simulations. Notably, the thiol group of cysteine is not a particularly strong hydrogen-bonding partner, which could mitigate the negative effects of the residue swap.
c.1025A>T
Y342F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive and therefore treated as unavailable. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.366687Structured0.408200Uncertain0.8660.4870.250-6.987Likely Benign0.145Likely BenignLikely Benign-0.13Likely Benign0.10.42Likely Benign0.15Likely Benign0.05Likely Benign0.160Likely Benign-2.67Deleterious0.999Probably Damaging0.992Probably Damaging2.03Pathogenic0.26Tolerated0.26260.3615734.1-16.00
c.1429A>C
M477L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that uniformly indicate a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome; premPS is uncertain and therefore not counted as evidence. High‑accuracy assessments are consistent: AlphaMissense‑Optimized reports Benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Overall, the preponderance of evidence supports a benign classification for M477L, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.000-4.772Likely Benign0.139Likely BenignLikely Benign0.10Likely Benign0.00.19Likely Benign0.15Likely Benign0.58Ambiguous0.236Likely Benign-1.25Neutral0.000Benign0.001Benign-1.18Pathogenic0.17Tolerated0.15860.4220421.9-18.03
c.1429A>G
M477V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477V is listed in ClinVar with no submitted interpretation and is present in the gnomAD database (variant ID 6‑33438461‑A‑G). Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. Only two tools predict a pathogenic outcome: polyPhen2_HumDiv and FATHMM. Predictions from FoldX and Foldetta are uncertain. High‑accuracy methods reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, while Foldetta remains inconclusive. Taken together, the majority of evidence supports a benign classification for M477V, and this assessment does not contradict the ClinVar status, which currently has no pathogenic claim.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.0006-33438461-A-G16.20e-7-3.995Likely Benign0.127Likely BenignLikely Benign1.64Ambiguous0.30.42Likely Benign1.03Ambiguous0.24Likely Benign0.209Likely Benign-1.04Neutral0.716Possibly Damaging0.204Benign-1.19Pathogenic0.22Tolerated3.37340.30930.3445122.3-32.0610.1016/j.ajhg.2020.11.011
c.1429A>T
M477L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The high‑accuracy methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta)—all uniformly indicate a benign effect. No prediction or folding‑stability result is missing or inconclusive. Based on the consensus of the available evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.000-4.772Likely Benign0.139Likely BenignLikely Benign0.10Likely Benign0.00.19Likely Benign0.15Likely Benign0.58Ambiguous0.236Likely Benign-1.25Neutral0.000Benign0.001Benign-1.18Pathogenic0.17Tolerated0.15860.4220421.9-18.03
c.1430T>A
M477K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS and FATHMM. Predictions that are uncertain or inconclusive are FoldX, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is unavailable due to mixed or uncertain inputs. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict the current ClinVar status, which contains no report of pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-7.519In-Between0.553AmbiguousLikely Benign0.54Ambiguous0.10.37Likely Benign0.46Likely Benign1.12Destabilizing0.371Likely Benign-1.32Neutral0.254Benign0.122Benign-1.15Pathogenic0.14Tolerated0.18170.08470-1-5.8-3.02
c.1430T>C
M477T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477T has no ClinVar entry and is present in gnomAD (ID 6‑33438462‑T‑C). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Default) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign (2 benign vs. 1 pathogenic votes); Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.0006-33438462-T-C21.24e-6-2.509Likely Benign0.373AmbiguousLikely Benign1.62Ambiguous0.20.16Likely Benign0.89Ambiguous0.51Ambiguous0.273Likely Benign-1.33Neutral0.765Possibly Damaging0.363Benign-1.10Pathogenic0.40Tolerated3.37340.21770.1950-1-1-2.6-30.09
c.1430T>G
M477R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, and FATHMM. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain and is not taken as evidence. Overall, the majority of reliable predictors indicate a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-6.786Likely Benign0.552AmbiguousLikely Benign0.48Likely Benign0.20.77Ambiguous0.63Ambiguous1.24Destabilizing0.442Likely Benign-1.12Neutral0.720Possibly Damaging0.242Benign-1.22Pathogenic0.11Tolerated0.19010.08280-1-6.424.99
c.1431G>A
M477I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, indicating no contradiction with existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-2.662Likely Benign0.467AmbiguousLikely Benign0.72Ambiguous0.10.36Likely Benign0.54Ambiguous0.45Likely Benign0.291Likely Benign-1.57Neutral0.000Benign0.001Benign-1.21Pathogenic0.09Tolerated0.13680.3176212.6-18.03
c.1431G>C
M477I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts pathogenic, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-2.662Likely Benign0.467AmbiguousLikely Benign0.72Ambiguous0.10.36Likely Benign0.54Ambiguous0.45Likely Benign0.290Likely Benign-1.57Neutral0.000Benign0.001Benign-1.21Pathogenic0.09Tolerated0.13680.3176212.6-18.03
c.1431G>T
M477I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts pathogenic, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-2.662Likely Benign0.467AmbiguousLikely Benign0.72Ambiguous0.10.36Likely Benign0.54Ambiguous0.45Likely Benign0.291Likely Benign-1.57Neutral0.000Benign0.001Benign-1.21Pathogenic0.09Tolerated0.13680.3176212.6-18.03
c.652T>A
F218I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218I is reported in gnomAD (variant ID 6‑33435294‑T‑A) but has no ClinVar entry. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while benign predictions are limited to polyPhen‑2 (HumVar), SIFT, and FATHMM. High‑accuracy assessments reinforce the pathogenic view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.0006-33435294-T-A16.20e-7-12.211Likely Pathogenic0.987Likely PathogenicLikely Pathogenic4.69Destabilizing0.25.93Destabilizing5.31Destabilizing1.18Destabilizing0.612Likely Pathogenic-3.81Deleterious0.510Possibly Damaging0.066Benign5.85Benign0.08Tolerated3.41130.21060.2459011.7-34.02
c.652T>C
F218L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect comprise REVEL, Rosetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta provide uncertain results and are therefore considered unavailable for interpretation. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for F218L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.861Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.96Ambiguous0.42.36Destabilizing1.66Ambiguous1.08Destabilizing0.546Likely Pathogenic-3.80Deleterious0.158Benign0.025Benign5.90Benign0.15Tolerated0.23310.3241201.0-34.02
c.652T>G
F218V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; pathogenic predictions arise from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus agrees on a likely pathogenic outcome, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenicity. No predictions or stability results are missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion aligns with the absence of a ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-10.081Likely Pathogenic0.978Likely PathogenicLikely Pathogenic4.18Destabilizing0.26.35Destabilizing5.27Destabilizing1.15Destabilizing0.691Likely Pathogenic-4.14Deleterious0.300Benign0.066Benign5.81Benign0.08Tolerated0.21730.2258-1-11.4-48.04
c.653T>A
F218Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All available in silico predictors classify the substitution as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign effect. The high‑accuracy folding‑stability tool Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a benign impact. No tool predicts pathogenicity, and no contradictory evidence exists in ClinVar. **Based on the consensus of all predictions, the variant is most likely benign, and this assessment does not conflict with ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.281712Structured0.408725Uncertain0.8480.2720.000-3.596Likely Benign0.104Likely BenignLikely Benign0.26Likely Benign0.1-0.40Likely Benign-0.07Likely Benign-0.44Likely Benign0.229Likely Benign0.63Neutral0.001Benign0.002Benign5.95Benign0.52Tolerated0.15320.272573-4.116.00
c.653T>C
F218S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218S has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumVar, SIFT, and FATHMM, whereas the remaining tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.882Likely Pathogenic0.989Likely PathogenicLikely Pathogenic2.35Destabilizing0.13.00Destabilizing2.68Destabilizing1.22Destabilizing0.731Likely Pathogenic-4.62Deleterious0.808Possibly Damaging0.225Benign5.80Benign0.07Tolerated0.38020.0454-3-2-3.6-60.10
c.653T>G
F218C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33435295‑T‑G). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools (REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default) predict a pathogenic impact. Results that are uncertain or unavailable are FoldX, ESM1b, AlphaMissense‑Optimized, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic prediction (2 pathogenic vs. 1 benign votes); and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for F218C, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.281712Structured0.408725Uncertain0.8480.2720.0006-33435295-T-G16.20e-7-7.234In-Between0.948Likely PathogenicAmbiguous1.49Ambiguous0.12.20Destabilizing1.85Ambiguous1.02Destabilizing0.744Likely Pathogenic-4.92Deleterious0.994Probably Damaging0.667Possibly Damaging5.78Benign0.03Affected3.41130.23300.1321-2-4-0.3-44.04
c.654C>A
F218L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that agree on a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), Rosetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Foldetta are inconclusive and are treated as unavailable. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts Likely Pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact. There is no ClinVar annotation to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.861Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.96Ambiguous0.42.36Destabilizing1.66Ambiguous1.08Destabilizing0.477Likely Benign-3.80Deleterious0.158Benign0.025Benign5.90Benign0.15Tolerated0.23310.3241201.0-34.02
c.654C>G
F218L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that agree on a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), Rosetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Foldetta are inconclusive and are treated as unavailable. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts Likely Pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact. There is no ClinVar annotation to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.861Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.96Ambiguous0.42.36Destabilizing1.66Ambiguous1.08Destabilizing0.477Likely Benign-3.80Deleterious0.158Benign0.025Benign5.90Benign0.15Tolerated0.23310.3241201.0-34.02
c.2380C>A
P794T
2D
AIThe SynGAP1 missense variant P794T is catalogued in gnomAD (ID 6‑33442932‑C‑A) but has no ClinVar entry. Functional prediction tools uniformly indicate a benign effect: SGM‑Consensus (Likely Benign), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool in the dataset predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized reports a benign outcome, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign prediction. The Foldetta stability analysis is not available for this variant. Overall, the consensus of all available predictions is benign, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.8756-33442932-C-A16.20e-7-4.838Likely Benign0.060Likely BenignLikely Benign0.046Likely Benign-0.34Neutral0.245Benign0.138Benign4.25Benign0.66Tolerated4.0730.17390.6207-100.93.99
c.2380C>G
P794A
2D
AIThe SynGAP1 missense variant P794A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). All evaluated in‑silico predictors classify the change as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign effect. Foldetta results are unavailable, so they do not influence the assessment. Overall, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.875-3.766Likely Benign0.056Likely BenignLikely Benign0.038Likely Benign-0.63Neutral0.124Benign0.089Benign4.27Benign0.09Tolerated0.36920.52091-13.4-26.04
c.2380C>T
P794S
2D
AIThe SynGAP1 missense variant P794S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign.” Foldetta results are not available, so they do not influence the assessment. Overall, the consensus of all available predictions is that the variant is most likely benign, and this conclusion is consistent with the lack of ClinVar evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.875-5.086Likely Benign0.079Likely BenignLikely Benign0.041Likely Benign-0.21Neutral0.025Benign0.010Benign4.29Benign0.13Tolerated0.36660.56041-10.8-10.04
c.2381C>A
P794Q
2D
AIThe SynGAP1 missense variant P794Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect for P794Q, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.875-4.641Likely Benign0.101Likely BenignLikely Benign0.058Likely Benign-0.31Neutral0.918Possibly Damaging0.601Possibly Damaging4.24Benign0.02Affected0.15810.49710-1-1.931.01
c.2381C>G
P794R
2D
AIThe SynGAP1 missense variant P794R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available. Overall, the majority of evidence points to a benign effect for P794R, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.875-5.136Likely Benign0.260Likely BenignLikely Benign0.083Likely Benign-0.73Neutral0.918Possibly Damaging0.522Possibly Damaging4.25Benign0.02Affected0.14670.36620-2-2.959.07
c.2381C>T
P794L
2D
AIThe SynGAP1 missense variant P794L is listed in ClinVar as Benign (ClinVar ID 859213.0) and is present in the gnomAD database (gnomAD ID 6‑33442933‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as benign, while Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Overall, the consensus of available predictions indicates that P794L is most likely benign, and this conclusion is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.875Benign/Likely benign 26-33442933-C-T734.52e-5-3.808Likely Benign0.079Likely BenignLikely Benign0.075Likely Benign-0.80Neutral0.761Possibly Damaging0.321Benign4.24Benign0.03Affected4.0730.24170.6733-3-35.416.04
c.979C>A
L327M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L327M missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, AlphaMissense‑Optimized, and Foldetta, whereas those that predict a pathogenic outcome are SGM‑Consensus, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta predicting a benign effect. Overall, the majority of tools indicate a pathogenic effect, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-10.320Likely Pathogenic0.727Likely PathogenicLikely Benign0.20Likely Benign0.00.72Ambiguous0.46Likely Benign1.07Destabilizing0.320Likely Benign-1.61Neutral1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.01Affected0.08060.380742-1.918.03
c.979C>G
L327V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327V is reported in gnomAD (ID 6‑33437884‑C‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.335645Structured0.409189Uncertain0.9390.4900.0006-33437884-C-G31.86e-6-8.978Likely Pathogenic0.148Likely BenignLikely Benign1.38Ambiguous0.10.67Ambiguous1.03Ambiguous1.31Destabilizing0.208Likely Benign-1.87Neutral0.999Probably Damaging0.994Probably Damaging2.66Benign0.13Tolerated3.38230.16480.4206120.4-14.03
c.980T>A
L327Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. With all available evidence pointing to a harmful impact and no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-14.243Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.03Destabilizing0.12.17Destabilizing2.60Destabilizing2.11Destabilizing0.605Likely Pathogenic-5.26Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected0.11310.1042-2-2-7.314.97
c.980T>C
L327P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327P (ClinVar ID 660421) is classified as Pathogenic in ClinVar and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, leaving no tools in the benign category. High‑accuracy assessments further support this: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is Pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000Pathogenic/Likely path. 4-16.602Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.38Destabilizing0.14.00Destabilizing4.69Destabilizing2.62Destabilizing0.658Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.01Affected3.38230.39210.1703-3-3-5.4-16.04221.769.40.10.00.60.1XPotentially PathogenicThe backbone amide group of Leu327, located in the middle of an anti-parallel β sheet strand (res. Ala322-Asp330), forms a hydrogen bond with the carbonyl group of Gly344 on a neighboring β strand (res. Lys336-Pro349) in the WT simulations. In contrast, in the variant simulations, the introduction of Pro327 destabilizes the hydrogen bonding between the two anti-parallel β strands because proline lacks the backbone amide group altogether. Additionally, in the WT simulations, the iso-butyl side chain of Leu327 packs against multiple hydrophobic residues (e.g., Leu274, V400, Val343), whereas the less bulky cyclic five-membered pyrrolidine ring of Pro327 cannot fill the same space as effectively. Thus, although no large-scale unfolding is observed during the variant simulations, the residue swap is likely to cause severe problems for the correct C2 domain folding, which could also affect the SynGAP-membrane association.10.1016/j.ajhg.2020.11.011
c.980T>G
L327R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a destabilizing, pathogenic effect. All available predictions are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-13.403Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.46Destabilizing0.34.75Destabilizing4.61Destabilizing1.95Destabilizing0.619Likely Pathogenic-5.28Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected0.12810.1085-3-2-8.343.03
c.1171G>A
G391S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G391S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and FoldX. Rosetta and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as likely benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact for G391S, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.637480Disordered0.409509Uncertain0.2790.7410.750-5.531Likely Benign0.096Likely BenignLikely Benign2.14Destabilizing0.61.01Ambiguous1.58Ambiguous0.06Likely Benign0.462Likely Benign-0.54Neutral0.978Probably Damaging0.777Possibly Damaging1.33Pathogenic0.35Tolerated0.28200.509710-0.430.03
c.1171G>C
G391R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G391R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that classify the variant as benign include premPS, PROVEAN, and SIFT, whereas those that predict pathogenicity comprise REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further show AlphaMissense‑Optimized labeling the variant as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.637480Disordered0.409509Uncertain0.2790.7410.750-9.115Likely Pathogenic0.709Likely PathogenicLikely Benign2.80Destabilizing1.33.86Destabilizing3.33Destabilizing0.32Likely Benign0.628Likely Pathogenic-0.95Neutral0.999Probably Damaging0.960Probably Damaging1.32Pathogenic0.17Tolerated0.13130.4124-3-2-4.199.14
c.1171G>T
G391C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G391C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include AlphaMissense‑Default, AlphaMissense‑Optimized, premPS, and PROVEAN, whereas the remaining tools—REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—predict it to be pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a pathogenic effect. This prediction does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.637480Disordered0.409509Uncertain0.2790.7410.750-8.596Likely Pathogenic0.123Likely BenignLikely Benign2.65Destabilizing0.75.03Destabilizing3.84Destabilizing0.11Likely Benign0.640Likely Pathogenic-1.29Neutral1.000Probably Damaging0.970Probably Damaging1.32Pathogenic0.03Affected0.14830.4225-3-32.946.09
c.1172G>A
G391D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G391D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default. Two tools, Rosetta and Foldetta, return uncertain results. High‑accuracy methods give a benign call from AlphaMissense‑Optimized; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is also inconclusive. Overall, six tools favor pathogenicity while five favor benignity, with two uncertain. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.637480Disordered0.409509Uncertain0.2790.7410.750-4.651Likely Benign0.674Likely PathogenicLikely Benign2.59Destabilizing1.11.26Ambiguous1.93Ambiguous0.22Likely Benign0.562Likely Pathogenic-0.95Neutral0.999Probably Damaging0.960Probably Damaging1.32Pathogenic0.29Tolerated0.19000.13051-1-3.158.04
c.1172G>C
G391A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G391A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are FoldX, polyPhen‑2 HumDiv, and FATHMM. Predictions that are inconclusive are Rosetta and Foldetta. The high‑accuracy consensus from AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is also likely benign, and Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect, and this is consistent with the lack of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.637480Disordered0.409509Uncertain0.2790.7410.750-5.712Likely Benign0.120Likely BenignLikely Benign2.02Destabilizing0.51.92Ambiguous1.97Ambiguous0.11Likely Benign0.442Likely Benign-0.76Neutral0.633Possibly Damaging0.219Benign1.33Pathogenic0.19Tolerated0.38280.4870102.214.03
c.1172G>T
G391V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G391V is listed in ClinVar as Benign (ClinVar ID 1014488.0) and is present in gnomAD (variant ID 6‑33438077‑G‑T). Prediction tools that classify the variant as benign include premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. Tools that predict pathogenicity are REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. With two high‑accuracy tools supporting benign and one supporting pathogenic, the overall prediction leans toward a benign effect. This conclusion aligns with the ClinVar benign classification, so there is no contradiction with the existing clinical annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.637480Disordered0.409509Uncertain0.2790.7410.750Likely Benign 16-33438077-G-T31.86e-6-6.642Likely Benign0.133Likely BenignLikely Benign4.23Destabilizing1.34.81Destabilizing4.52Destabilizing-0.11Likely Benign0.595Likely Pathogenic-0.98Neutral0.994Probably Damaging0.887Possibly Damaging1.32Pathogenic0.10Tolerated3.6980.16210.3821-1-34.642.08228.6-69.00.00.8-0.50.3UncertainGly387 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. This loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Val391 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.2143C>A
P715T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions arise from FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus. Two tools, Foldetta and premPS, returned uncertain results. High‑accuracy analyses further clarify the picture: AlphaMissense‑Optimized predicts a benign effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates pathogenicity; Foldetta remains inconclusive. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-10.501Likely Pathogenic0.744Likely PathogenicLikely Benign2.55Destabilizing0.10.29Likely Benign1.42Ambiguous0.72Ambiguous0.368Likely Benign-7.23Deleterious1.000Probably Damaging0.993Probably Damaging3.37Benign0.01Affected0.13570.40720-10.93.99
c.2143C>G
P715A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P715A has no ClinVar entry and is not reported in gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions are reported by FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further indicate AlphaMissense‑Optimized predicts Benign, whereas the SGM‑Consensus remains Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is Uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-9.261Likely Pathogenic0.597Likely PathogenicLikely Benign2.69Destabilizing0.00.28Likely Benign1.49Ambiguous0.77Ambiguous0.229Likely Benign-7.13Deleterious1.000Probably Damaging0.999Probably Damaging3.45Benign0.02Affected0.29930.35601-13.4-26.04
c.2143C>T
P715S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P715S is listed in ClinVar as pathogenic (ClinVar ID 1804065.0) and is present in gnomAD (ID 6‑33441608‑C‑T). Functional prediction tools that agree on a benign effect are REVEL and FATHMM. Those that predict a pathogenic effect include FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. Predictions that are inconclusive are Rosetta, premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a pathogenic impact, which is consistent with the ClinVar classification and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.409757Uncertain0.9560.3620.000Likely Pathogenic 16-33441608-C-T16.20e-7-7.635In-Between0.787Likely PathogenicAmbiguous3.54Destabilizing0.00.81Ambiguous2.18Destabilizing0.94Ambiguous0.277Likely Benign-7.17Deleterious1.000Probably Damaging0.998Probably Damaging3.43Benign0.01Affected3.5090.29770.37551-10.8-10.04231.8-14.0-0.10.0-0.80.1XUncertainPro715, along with Gly712 and Pro713, are located in a hinge region of an α-helix making a ~90-degree turn (res. Lys705-Leu725). In the WT simulations, the pyrrolidine side chain of Pro715, lacking the backbone amide groups altogether, forces the tight helix turn to take place while also hydrophobically packing with nearby residues (e.g., Leu700, Leu708, Leu714, and Leu718). Leu715, with a normal amide backbone, could potentially affect protein folding and turn formation, although this was not observed in the variant simulations. Additionally, the hydroxyl group of the Ser715 side chain can form hydrogen bonds with the backbone carbonyl group of Gly712 and disrupt the hydrophobic packing arrangement of the leucine residues from the neighboring α-helices, impacting the GAP domain tertiary assembly.
c.2144C>A
P715H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas a majority of predictors (FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) indicate a pathogenic impact. Tools with inconclusive results (Foldetta, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the consensus of the majority of evidence points to a pathogenic effect for P715H. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-10.523Likely Pathogenic0.906Likely PathogenicAmbiguous2.80Destabilizing0.00.28Likely Benign1.54Ambiguous0.56Ambiguous0.271Likely Benign-7.73Deleterious1.000Probably Damaging0.998Probably Damaging3.37Benign0.00Affected0.14130.36840-2-1.640.02
c.2144C>G
P715R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) classify the change as pathogenic. High‑accuracy assessments show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts a likely pathogenic outcome, AlphaMissense‑Optimized is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. Because the pathogenic predictions outnumber the benign ones and the high‑accuracy consensus supports a deleterious effect, the variant is most likely pathogenic. This assessment does not contradict ClinVar, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-12.191Likely Pathogenic0.940Likely PathogenicAmbiguous2.19Destabilizing0.10.53Ambiguous1.36Ambiguous0.87Ambiguous0.324Likely Benign-8.09Deleterious1.000Probably Damaging0.998Probably Damaging3.53Benign0.01Affected0.13890.26200-2-2.959.07
c.2144C>T
P715L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX and premPS give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Because the majority of consensus and individual predictors indicate pathogenicity, the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for P715L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-12.207Likely Pathogenic0.764Likely PathogenicLikely Benign1.43Ambiguous0.10.06Likely Benign0.75Ambiguous0.58Ambiguous0.318Likely Benign-9.10Deleterious1.000Probably Damaging0.998Probably Damaging3.39Benign0.01Affected0.19440.5105-3-35.416.04
c.613A>C
I205L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the variant as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM Consensus predicts likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No contradictory evidence exists. Based on the collective predictions, the variant is most likely benign, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-5.474Likely Benign0.105Likely BenignLikely Benign0.07Likely Benign0.20.02Likely Benign0.05Likely Benign0.30Likely Benign0.112Likely Benign-0.86Neutral0.004Benign0.012Benign4.17Benign0.34Tolerated0.06820.270222-0.70.00
c.613A>G
I205V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the variant as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM Consensus predicts likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Based on the consensus of all available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-2.232Likely Benign0.063Likely BenignLikely Benign0.45Likely Benign0.0-0.18Likely Benign0.14Likely Benign0.11Likely Benign0.113Likely Benign-0.11Neutral0.001Benign0.007Benign4.20Benign0.84Tolerated0.08970.279143-0.3-14.03
c.613A>T
I205F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205F missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: SGM‑Consensus, REVEL, FoldX, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, FATHMM, and polyPhen‑2 HumVar all classify it as benign. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. Uncertain results from Foldetta, premPS, ESM1b, and Rosetta are treated as unavailable. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, while Foldetta remains uncertain. Overall, the consensus of the majority of tools indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-7.913In-Between0.271Likely BenignLikely Benign0.30Likely Benign0.30.89Ambiguous0.60Ambiguous0.52Ambiguous0.113Likely Benign-1.80Neutral0.838Possibly Damaging0.368Benign4.08Benign0.10Tolerated0.04610.220510-1.734.02
c.614T>A
I205N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. No evidence from these tools contradicts the lack of ClinVar annotation. Overall, the majority of predictions (five pathogenic vs. four benign) and the pathogenic SGM Consensus suggest the variant is most likely pathogenic, with no ClinVar status to conflict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.264545Structured0.409933Uncertain0.8210.4140.125-10.928Likely Pathogenic0.552AmbiguousLikely Benign0.66Ambiguous0.11.16Ambiguous0.91Ambiguous1.57Destabilizing0.138Likely Benign-3.56Deleterious0.940Possibly Damaging0.641Possibly Damaging4.06Benign0.07Tolerated0.08020.0212-2-3-8.00.94
c.614T>C
I205T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the remaining predictions (FoldX, premPS, AlphaMissense‑Default) are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, classifies the variant as benign. Taken together, the consensus of both general and high‑accuracy predictors indicates that I205T is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-6.869Likely Benign0.450AmbiguousLikely Benign0.65Ambiguous0.00.28Likely Benign0.47Likely Benign0.81Ambiguous0.118Likely Benign-2.19Neutral0.421Benign0.156Benign4.16Benign0.15Tolerated0.09330.05410-1-5.2-12.05
c.614T>G
I205S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. Tools with uncertain or inconclusive results (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of available predictions lean toward a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.264545Structured0.409933Uncertain0.8210.4140.125-8.694Likely Pathogenic0.518AmbiguousLikely Benign1.17Ambiguous0.20.95Ambiguous1.06Ambiguous0.88Ambiguous0.178Likely Benign-2.73Deleterious0.838Possibly Damaging0.368Benign4.12Benign0.24Tolerated0.23460.0800-1-2-5.3-26.08
c.615T>G
I205M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Uncertain results come from Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta as benign. Based on the majority of predictions and the high‑accuracy tools, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-6.693Likely Benign0.142Likely BenignLikely Benign0.20Likely Benign0.20.63Ambiguous0.42Likely Benign0.65Ambiguous0.119Likely Benign-1.16Neutral0.838Possibly Damaging0.467Possibly Damaging4.07Benign0.07Tolerated0.05930.200021-2.618.03
c.2383C>A
P795T
2D
AIThe SynGAP1 missense variant P795T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity, and the only uncertain result comes from ESM1b. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” consensus. High‑accuracy assessments further support this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign; Foldetta results are not available. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.875-7.030In-Between0.060Likely BenignLikely Benign0.068Likely Benign-0.63Neutral0.036Benign0.026Benign4.26Benign0.09Tolerated0.17130.63810-10.93.99
c.2383C>G
P795A
2D
AIThe SynGAP1 missense variant P795A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tool predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign effect. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the evidence strongly suggests that P795A is most likely benign, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.875-5.348Likely Benign0.049Likely BenignLikely Benign0.053Likely Benign-0.52Neutral0.016Benign0.011Benign4.32Benign0.16Tolerated0.36720.53711-13.4-26.04
c.2383C>T
P795S
2D
AIThe SynGAP1 missense variant P795S is catalogued in gnomAD (6‑33442935‑C‑T) but has no entry in ClinVar. Across the spectrum of in‑silico predictors, every tool listed—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently scores the variant as benign. No pathogenic predictions are reported. Grouping by agreement, all available tools fall into the benign category, with no tools indicating pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely benign. Foldetta results are not provided, so they are treated as unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.8756-33442935-C-T16.20e-7-5.846Likely Benign0.067Likely BenignLikely Benign0.056Likely Benign-0.23Neutral0.001Benign0.002Benign4.30Benign0.24Tolerated4.3220.35170.5766-110.8-10.04
c.2384C>A
P795H
2D
AIThe SynGAP1 missense variant P795H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic outcome. ESM1b is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.875-7.717In-Between0.121Likely BenignLikely Benign0.069Likely Benign-0.61Neutral0.898Possibly Damaging0.477Possibly Damaging4.24Benign0.05Affected0.19470.51840-2-1.640.02
c.2384C>G
P795R
2D
AIThe SynGAP1 missense variant P795R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only SIFT classifies the change as pathogenic, but this is the sole discordant call. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” consensus. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that P795R is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.875-6.536Likely Benign0.221Likely BenignLikely Benign0.059Likely Benign-1.02Neutral0.290Benign0.114Benign4.25Benign0.05Affected0.14300.40650-2-2.959.07
c.2384C>T
P795L
2D
AIThe SynGAP1 missense variant P795L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while only SIFT predicts it to be pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a “Likely Benign” status. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) confirms a benign outcome. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the preponderance of evidence indicates that P795L is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.875-2.677Likely Benign0.070Likely BenignLikely Benign0.047Likely Benign-0.45Neutral0.016Benign0.010Benign4.27Benign0.04Affected0.23720.6499-3-35.416.04
c.955G>A
A319T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen2_HumVar. Those that predict a pathogenic effect are polyPhen2_HumDiv and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of reliable predictors classify the variant as benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.125-7.841In-Between0.098Likely BenignLikely Benign0.55Ambiguous0.30.70Ambiguous0.63Ambiguous0.30Likely Benign0.116Likely Benign-1.35Neutral0.775Possibly Damaging0.306Benign1.92Pathogenic0.09Tolerated0.12740.608310-2.530.03
c.955G>C
A319P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319P is catalogued in gnomAD (ID 6‑33437860‑G‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive are Rosetta, ESM1b, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.1256-33437860-G-C31.86e-6-7.213In-Between0.109Likely BenignLikely Benign-0.02Likely Benign0.9-1.18Ambiguous-0.60Ambiguous0.22Likely Benign0.286Likely Benign0.11Neutral0.999Probably Damaging0.977Probably Damaging1.97Pathogenic1.00Tolerated3.38230.18390.5067-11-3.426.04
c.955G>T
A319S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as benign. No prediction or stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.125-7.109In-Between0.093Likely BenignLikely Benign0.16Likely Benign0.20.02Likely Benign0.09Likely Benign0.13Likely Benign0.165Likely Benign-0.58Neutral0.978Probably Damaging0.754Possibly Damaging2.02Pathogenic0.12Tolerated0.25370.470311-2.616.00
c.956C>A
A319D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A319D missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a likely pathogenic verdict (3/4 pathogenic votes). High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, whereas the SGM‑Consensus remains pathogenic. Foldetta, which integrates FoldX‑MD (benign) and Rosetta (uncertain), is considered unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.410405Uncertain0.8790.2540.125-11.144Likely Pathogenic0.752Likely PathogenicLikely Benign-0.02Likely Benign0.2-0.84Ambiguous-0.43Likely Benign0.30Likely Benign0.373Likely Benign-2.38Neutral0.998Probably Damaging0.966Probably Damaging2.01Pathogenic0.20Tolerated0.15040.13600-2-5.344.01
c.956C>G
A319G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict pathogenicity, while Rosetta remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.179055Structured0.410405Uncertain0.8790.2540.125-6.505Likely Benign0.148Likely BenignLikely Benign0.11Likely Benign0.40.56Ambiguous0.34Likely Benign0.39Likely Benign0.219Likely Benign-1.83Neutral0.994Probably Damaging0.900Possibly Damaging1.89Pathogenic0.09Tolerated0.23450.453210-2.2-14.03
c.956C>T
A319V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A319V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is also inconclusive. Overall, the majority of evidence points to a benign effect, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.125-8.179Likely Pathogenic0.141Likely BenignLikely Benign0.58Ambiguous0.40.63Ambiguous0.61Ambiguous0.23Likely Benign0.329Likely Benign-2.32Neutral0.989Probably Damaging0.824Possibly Damaging1.88Pathogenic0.10Tolerated0.10940.6390002.428.05
c.1018G>A
A340T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A340T is reported in gnomAD (ID 6‑33437923‑G‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus all classify the change as benign or likely benign. Only two tools predict pathogenicity—polyPhen‑2 HumDiv and FATHMM—while stability‑based methods (FoldX, Rosetta, premPS, Foldetta) return uncertain or inconclusive results. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely benign, and Foldetta provides no definitive stability change. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.390993Structured0.410781Uncertain0.5580.4850.2506-33437923-G-A-3.286Likely Benign0.086Likely BenignLikely Benign0.84Ambiguous0.20.96Ambiguous0.90Ambiguous-0.54Ambiguous0.105Likely Benign0.62Neutral0.454Possibly Damaging0.192Benign1.93Pathogenic0.47Tolerated3.42130.17400.729701-2.530.03
c.1018G>C
A340P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A340P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, and the SGM‑Consensus (majority vote). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The high‑accuracy predictors—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta—each report a benign outcome. No prediction or folding‑stability result is missing or inconclusive; all available evidence points to a benign impact. Consequently, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.390993Structured0.410781Uncertain0.5580.4850.250-4.983Likely Benign0.264Likely BenignLikely Benign0.32Likely Benign0.5-0.58Ambiguous-0.13Likely Benign0.46Likely Benign0.279Likely Benign-1.48Neutral0.891Possibly Damaging0.575Possibly Damaging1.91Pathogenic0.25Tolerated0.21780.54681-1-3.426.04
c.1018G>T
A340S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A340S is reported in gnomAD (variant ID 6‑33437923‑G‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only FATHMM predicts pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a benign majority (3 benign vs. 1 pathogenic). High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign; the SGM‑Consensus is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.390993Structured0.410781Uncertain0.5580.4850.2506-33437923-G-T16.20e-7-0.705Likely Benign0.083Likely BenignLikely Benign0.15Likely Benign0.00.27Likely Benign0.21Likely Benign-0.46Likely Benign0.083Likely Benign1.62Neutral0.007Benign0.008Benign1.93Pathogenic0.51Tolerated3.42130.28520.630911-2.616.00
c.1019C>A
A340E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A340E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic outcome, while the protein‑folding stability method Foldetta is uncertain. AlphaMissense‑Optimized also yields an uncertain result. Overall, the majority of evidence points toward a pathogenic impact, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.390993Structured0.410781Uncertain0.5580.4850.250-8.225Likely Pathogenic0.803Likely PathogenicAmbiguous0.63Ambiguous0.41.55Ambiguous1.09Ambiguous0.06Likely Benign0.138Likely Benign-0.33Neutral0.625Possibly Damaging0.252Benign1.91Pathogenic0.39Tolerated0.14180.21600-1-5.358.04
c.1019C>G
A340G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A340G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, so they provide no evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of reliable predictors indicate a benign effect, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.390993Structured0.410781Uncertain0.5580.4850.250-3.763Likely Benign0.099Likely BenignLikely Benign0.66Ambiguous0.21.44Ambiguous1.05Ambiguous0.50Likely Benign0.044Likely Benign-0.34Neutral0.267Benign0.127Benign1.92Pathogenic0.42Tolerated0.23550.447010-2.2-14.03
c.1019C>T
A340V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A340V variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) is uncertain and therefore unavailable for interpretation. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.390993Structured0.410781Uncertain0.5580.4850.250-6.427Likely Benign0.174Likely BenignLikely Benign0.69Ambiguous0.30.32Likely Benign0.51Ambiguous0.40Likely Benign0.102Likely Benign-1.81Neutral0.801Possibly Damaging0.315Benign2.09Pathogenic0.57Tolerated0.11970.5780002.428.05
c.2197C>A
Q733K
2D
AIThe SynGAP1 missense variant Q733K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact for Q733K, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-6.779Likely Benign0.274Likely BenignLikely Benign0.112Likely Benign-1.66Neutral0.797Possibly Damaging0.312Benign2.61Benign0.05Affected0.15720.279011-0.40.04
c.2197C>G
Q733E
2D
AIThe SynGAP1 missense variant Q733E is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign predictions from REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 (HumDiv and HumVar) and SIFT; ESM1b is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus itself is Benign. Foldetta results are not available, so they do not influence the assessment. Overall, the majority of evidence points to a benign effect, and this conclusion is consistent with the absence of ClinVar pathogenic reports. Thus, the variant is most likely benign, and this is not contradictory to ClinVar, which has no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-7.651In-Between0.152Likely BenignLikely Benign0.117Likely Benign-1.38Neutral0.983Probably Damaging0.637Possibly Damaging2.60Benign0.03Affected0.13630.1130220.00.98
c.2198A>C
Q733P
2D
AIThe SynGAP1 missense variant Q733P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-4.249Likely Benign0.075Likely BenignLikely Benign0.172Likely Benign-1.91Neutral0.220Benign0.308Benign2.52Benign0.04Affected0.21820.38940-11.9-31.01
c.2198A>G
Q733R
2D
AIThe SynGAP1 missense variant Q733R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for Q733R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-5.986Likely Benign0.291Likely BenignLikely Benign0.117Likely Benign-1.96Neutral0.950Possibly Damaging0.612Possibly Damaging2.57Benign0.04Affected0.14190.127911-1.028.06
c.2198A>T
Q733L
2D
AIThe SynGAP1 missense variant Q733L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also reports Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-3.465Likely Benign0.093Likely BenignLikely Benign0.128Likely Benign-2.04Neutral0.905Possibly Damaging0.408Benign2.55Benign1.00Tolerated0.07360.4291-2-27.3-14.97
c.2199G>C
Q733H
2D
AIThe SynGAP1 missense variant Q733H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; the Foldetta stability analysis is not available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-5.741Likely Benign0.207Likely BenignLikely Benign0.140Likely Benign-2.47Neutral0.990Probably Damaging0.780Possibly Damaging2.52Benign0.02Affected0.13410.2263300.39.01
c.2199G>T
Q733H
2D
AIThe SynGAP1 missense variant Q733H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for Q733H, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.410831Uncertain0.3310.6860.875-5.741Likely Benign0.207Likely BenignLikely Benign0.140Likely Benign-2.47Neutral0.990Probably Damaging0.780Possibly Damaging2.52Benign0.02Affected0.13410.2263300.39.01
c.3730A>C
S1244R
2D
AIThe SynGAP1 missense variant S1244R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as likely pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote) confirms a likely pathogenic status. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-10.986Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.309Likely Benign-3.49Deleterious0.999Probably Damaging0.996Probably Damaging2.09Pathogenic0.04Affected0.07780.30980-1-3.769.11
c.3730A>G
S1244G
2D
AIThe SynGAP1 missense variant S1244G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy evidence therefore comes only from AlphaMissense‑Optimized, which predicts benign, while the other high‑accuracy tools are unavailable. Overall, the balance of evidence (five benign vs four pathogenic predictions, with the most reliable tool indicating benign) suggests that the variant is most likely benign. This conclusion does not contradict ClinVar status, as the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-8.304Likely Pathogenic0.221Likely BenignLikely Benign0.130Likely Benign-1.77Neutral0.992Probably Damaging0.987Probably Damaging2.12Pathogenic0.65Tolerated0.22670.3678100.4-30.03
c.3730A>T
S1244C
2D
AIThe SynGAP1 missense variant S1244C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Benign predictions are limited to REVEL and AlphaMissense‑Optimized. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts benign, whereas the SGM‑Consensus (majority vote) predicts likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-9.792Likely Pathogenic0.625Likely PathogenicLikely Benign0.270Likely Benign-3.63Deleterious1.000Probably Damaging0.998Probably Damaging2.07Pathogenic0.04Affected0.08750.46160-13.316.06
c.3731G>A
S1244N
2D
AIThe SynGAP1 missense variant S1244N is listed in ClinVar with an “Uncertain” status (ClinVar ID 931075.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and AlphaMissense‑Optimized, whereas PolyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—indicates pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence leans toward a pathogenic effect, which does not contradict the ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500Uncertain 1-9.008Likely Pathogenic0.751Likely PathogenicLikely Benign0.154Likely Benign-1.87Neutral0.997Probably Damaging0.992Probably Damaging2.10Pathogenic0.15Tolerated3.7750.10330.346411-2.727.03
c.3731G>C
S1244T
2D
AISynGAP1 missense variant S1244T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on benign effect include REVEL, PROVEAN, SIFT, and AlphaMissense‑Optimized. Tools that agree on pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments give AlphaMissense‑Optimized a benign score, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence leans toward pathogenicity, with four high‑confidence pathogenic predictions versus four benign predictions, and the SGM Consensus tipping the scale. This conclusion does not contradict ClinVar status, as the variant has not yet been classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-9.020Likely Pathogenic0.405AmbiguousLikely Benign0.149Likely Benign-1.82Neutral0.992Probably Damaging0.987Probably Damaging2.24Pathogenic0.11Tolerated0.11290.4603110.114.03
c.3731G>T
S1244I
2D
AIThe SynGAP1 missense variant S1244I is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as likely pathogenic; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-13.073Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.284Likely Benign-4.39Deleterious0.999Probably Damaging0.998Probably Damaging2.08Pathogenic0.02Affected0.07800.4684-1-25.326.08
c.3732T>A
S1244R
2D
AIThe SynGAP1 missense variant S1244R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-10.986Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.274Likely Benign-3.49Deleterious0.999Probably Damaging0.996Probably Damaging2.09Pathogenic0.04Affected0.07780.30980-1-3.769.11
c.3732T>G
S1244R
2D
AIThe SynGAP1 missense variant S1244R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.648219Disordered0.411055Uncertain0.8330.5490.500-10.986Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.274Likely Benign-3.49Deleterious0.999Probably Damaging0.996Probably Damaging2.09Pathogenic0.04Affected0.07780.30980-1-3.769.11
c.2200C>A
P734T
2D
AIThe SynGAP1 missense variant P734T is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. The high‑accuracy consensus (SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as “Likely Benign,” and AlphaMissense‑Optimized also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no result available for this variant. Based on the unanimous benign predictions and the lack of any pathogenic evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.879233Disordered0.411273Uncertain0.3680.7210.875-4.469Likely Benign0.066Likely BenignLikely Benign0.042Likely Benign-2.08Neutral0.040Benign0.013Benign2.78Benign0.09Tolerated0.17640.40760-10.93.99
c.2200C>G
P734A
2D
AIThe SynGAP1 missense variant P734A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect. Consensus predictors such as SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and high‑accuracy methods including AlphaMissense‑Optimized all classify the variant as benign. Additional in silico assessments—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—also predict a benign outcome. No tool in the dataset suggests pathogenicity. Protein‑stability analysis via Foldetta is unavailable for this variant. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.879233Disordered0.411273Uncertain0.3680.7210.875-3.907Likely Benign0.058Likely BenignLikely Benign0.031Likely Benign-2.19Neutral0.022Benign0.074Benign2.74Benign0.24Tolerated0.38010.33061-13.4-26.04
c.2200C>T
P734S
2D
AIThe SynGAP1 missense variant P734S is listed in ClinVar with an uncertain significance (ClinVar ID 2283225.0) and is present in the gnomAD database (gnomAD ID 6‑33441665‑C‑T). Functional prediction tools uniformly classify the variant as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report benign effects. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this benign assessment: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. Foldetta, a protein‑folding stability predictor combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant, so its status is unavailable. Overall, the computational evidence strongly supports a benign classification, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.879233Disordered0.411273Uncertain0.3680.7210.875Uncertain 26-33441665-C-T21.24e-6-4.291Likely Benign0.077Likely BenignLikely Benign0.030Likely Benign-2.44Neutral0.344Benign0.048Benign2.77Benign0.11Tolerated3.6460.37750.36501-10.8-10.0410.1016/j.ajhg.2020.11.011
c.2201C>A
P734Q
2D
AIThe SynGAP1 missense variant P734Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.879233Disordered0.411273Uncertain0.3680.7210.875-4.392Likely Benign0.121Likely BenignLikely Benign0.080Likely Benign-1.92Neutral0.959Probably Damaging0.569Possibly Damaging2.87Benign0.06Tolerated0.16080.33640-1-1.931.01
c.2201C>G
P734R
2D
AIThe SynGAP1 missense variant P734R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.879233Disordered0.411273Uncertain0.3680.7210.875-6.099Likely Benign0.288Likely BenignLikely Benign0.115Likely Benign-3.00Deleterious0.984Probably Damaging0.682Possibly Damaging2.71Benign0.07Tolerated0.16640.24640-2-2.959.07
c.2201C>T
P734L
2D
AIThe SynGAP1 missense variant P734L is reported in gnomAD (variant ID 6‑33441666‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv flags it as pathogenic, creating a single discordant call. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is Likely Benign; Foldetta results are not available. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.879233Disordered0.411273Uncertain0.3680.7210.8756-33441666-C-T31.86e-6-3.472Likely Benign0.095Likely BenignLikely Benign0.069Likely Benign-2.11Neutral0.897Possibly Damaging0.330Benign2.69Benign1.00Tolerated3.6460.23900.5059-3-35.416.04
c.1270G>A
V424I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V424I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as tolerated or benign. The only inconclusive results come from FoldX (uncertain) and Foldetta (uncertain). When high‑accuracy methods are considered separately, AlphaMissense‑Optimized predicts benign, the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also predicts benign, while Foldetta remains uncertain. No tool predicts pathogenicity. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.050641Structured0.411431Uncertain0.9730.2480.000-3.814Likely Benign0.095Likely BenignLikely Benign-1.04Ambiguous0.1-0.48Likely Benign-0.76Ambiguous0.02Likely Benign0.084Likely Benign-0.15Neutral0.013Benign0.006Benign3.50Benign0.63Tolerated0.08740.2609430.314.03
c.1270G>C
V424L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V424L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome, while SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely benign classification. Stability‑based methods are inconclusive: FoldX is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.050641Structured0.411431Uncertain0.9730.2480.000-4.941Likely Benign0.742Likely PathogenicLikely Benign-0.90Ambiguous0.2-0.41Likely Benign-0.66Ambiguous0.43Likely Benign0.159Likely Benign-1.68Neutral0.327Benign0.026Benign4.50Benign0.59Tolerated0.10180.268021-0.414.03
c.1270G>T
V424F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V424F is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or unavailable results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-10.947Likely Pathogenic0.939Likely PathogenicAmbiguous1.99Ambiguous0.3-0.37Likely Benign0.81Ambiguous0.55Ambiguous0.275Likely Benign-3.66Deleterious0.995Probably Damaging0.775Possibly Damaging3.40Benign0.01Affected0.08160.2094-1-1-1.448.04
c.1271T>A
V424D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V424D is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy tools reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-15.531Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.60Destabilizing0.13.50Destabilizing3.55Destabilizing2.13Destabilizing0.615Likely Pathogenic-5.87Deleterious1.000Probably Damaging0.992Probably Damaging3.33Benign0.00Affected0.15360.0845-2-3-7.715.96
c.1271T>C
V424A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 V424A is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on benign impact are REVEL and FATHMM, whereas the remaining tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as unavailable, SGM‑Consensus as likely pathogenic, and Foldetta as pathogenic. Based on the collective evidence, the variant is most likely pathogenic; this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-9.665Likely Pathogenic0.904Likely PathogenicAmbiguous2.31Destabilizing0.12.54Destabilizing2.43Destabilizing2.10Destabilizing0.245Likely Benign-3.45Deleterious0.997Probably Damaging0.961Probably Damaging3.39Benign0.01Affected0.21050.135500-2.4-28.05
c.1271T>G
V424G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V424G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic consensus (3 pathogenic vs. 1 benign); and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.050641Structured0.411431Uncertain0.9730.2480.000-13.697Likely Pathogenic0.978Likely PathogenicLikely Pathogenic3.90Destabilizing0.14.84Destabilizing4.37Destabilizing2.44Destabilizing0.622Likely Pathogenic-6.26Deleterious0.994Probably Damaging1.000Probably Damaging3.34Benign0.00Affected0.13960.2029-1-3-4.6-42.08
c.2203A>C
S735R
2D
AIThe SynGAP1 missense variant S735R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, while the SGM‑Consensus (majority vote) remains Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. The variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.318Likely Benign0.784Likely PathogenicAmbiguous0.126Likely Benign-1.25Neutral0.997Probably Damaging0.933Probably Damaging2.66Benign0.72Tolerated0.09130.28610-1-3.769.11
c.2203A>G
S735G
2D
AIThe SynGAP1 missense variant S735G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Based on the majority of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-5.986Likely Benign0.083Likely BenignLikely Benign0.097Likely Benign-0.55Neutral0.953Possibly Damaging0.744Possibly Damaging2.68Benign0.23Tolerated0.27770.4089100.4-30.03
c.2203A>T
S735C
2D
AIThe SynGAP1 missense variant S735C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. ESM1b is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S735C, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-7.291In-Between0.102Likely BenignLikely Benign0.174Likely Benign-2.22Neutral1.000Probably Damaging0.983Probably Damaging2.60Benign0.05Affected0.11360.54640-13.316.06
c.2204G>A
S735N
2D
AIThe SynGAP1 missense variant S735N is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. No pathogenic predictions are present among the evaluated tools. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are unavailable. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.697Likely Benign0.142Likely BenignLikely Benign0.068Likely Benign-0.68Neutral0.400Benign0.138Benign2.65Benign0.18Tolerated0.13750.382711-2.727.03
c.2204G>C
S735T
2D
AIThe SynGAP1 missense variant S735T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-5.340Likely Benign0.082Likely BenignLikely Benign0.118Likely Benign-1.03Neutral0.980Probably Damaging0.799Possibly Damaging2.67Benign0.46Tolerated0.14640.5321110.114.03
c.2204G>T
S735I
2D
AIThe SynGAP1 missense variant S735I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S735I, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-5.669Likely Benign0.167Likely BenignLikely Benign0.117Likely Benign-1.71Neutral0.999Probably Damaging0.977Probably Damaging2.64Benign0.09Tolerated0.09330.5069-1-25.326.08
c.2205C>A
S735R
2D
AIThe SynGAP1 missense variant S735R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) supports a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.318Likely Benign0.784Likely PathogenicAmbiguous0.108Likely Benign-1.25Neutral0.997Probably Damaging0.933Probably Damaging2.66Benign0.72Tolerated0.09130.28610-1-3.769.11
c.2205C>G
S735R
2D
AIThe SynGAP1 missense variant S735R has no ClinVar record and is not listed in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) remains Benign; Foldetta results are unavailable. Overall, the balance of evidence—five benign versus three pathogenic predictions, a benign SGM‑Consensus, and no contradictory ClinVar annotation—indicates that the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.916840Disordered0.412174Uncertain0.2900.7520.875-6.318Likely Benign0.784Likely PathogenicAmbiguous0.108Likely Benign-1.25Neutral0.997Probably Damaging0.933Probably Damaging2.66Benign0.72Tolerated0.09130.28610-1-3.769.11
c.2194A>G
R732G
2D
AIThe SynGAP1 R732G missense variant is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (ID 6‑33441659‑A‑G). Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, whereas tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 benign vs. 2 pathogenic), and Foldetta results are unavailable. Overall, the majority of standard predictors lean toward pathogenicity, while the most accurate single predictor (AlphaMissense‑Optimized) suggests a benign outcome. Given the lack of ClinVar evidence, there is no contradiction; the variant is most likely pathogenic based on the collective predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.7506-33441659-A-G16.20e-7-9.348Likely Pathogenic0.295Likely BenignLikely Benign0.145Likely Benign-2.98Deleterious1.000Probably Damaging0.982Probably Damaging2.56Benign0.03Affected3.5970.30800.2942-2-34.1-99.14
c.2194A>T
R732W
2D
AIThe SynGAP1 missense variant R732W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, five tools predict pathogenicity versus four predicting benign, with no ClinVar evidence to contradict these computational findings. Thus, the variant is most likely pathogenic based on the current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.750-11.976Likely Pathogenic0.252Likely BenignLikely Benign0.161Likely Benign-3.57Deleterious1.000Probably Damaging0.973Probably Damaging2.53Benign0.01Affected0.13320.27482-33.630.03
c.2195G>A
R732K
2D
AIThe SynGAP1 missense variant R732K is listed in ClinVar (ID 537019.0) with an “Uncertain” clinical significance and is present in gnomAD (6‑33441660‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; no Foldetta stability result is available. Overall, the majority of evidence points to a benign impact, and this consensus does not conflict with the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.846163Disordered0.412403Uncertain0.4270.6730.750Conflicting 26-33441660-G-A42.48e-6-5.278Likely Benign0.240Likely BenignLikely Benign0.045Likely Benign-0.82Neutral0.973Probably Damaging0.943Probably Damaging2.69Benign0.21Tolerated3.5970.41940.3923320.6-28.01
c.2195G>C
R732T
2D
AISynGAP1 missense variant R732T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign (REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Optimized) and pathogenic (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b). AlphaMissense‑Default remains uncertain. The high‑accuracy AlphaMissense‑Optimized predicts a benign effect, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also favors a benign outcome. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a benign impact, which does not contradict the current ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.750Uncertain 1-8.545Likely Pathogenic0.434AmbiguousLikely Benign0.075Likely Benign-1.96Neutral0.999Probably Damaging0.892Possibly Damaging2.59Benign0.12Tolerated3.5970.19150.3153-1-13.8-55.08
c.2195G>T
R732M
2D
AIThe SynGAP1 missense variant R732M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and ESM1b. AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors a benign outcome. Foldetta results are unavailable. Overall, the balance of evidence (5 benign vs 3 pathogenic predictions) indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.750-9.956Likely Pathogenic0.414AmbiguousLikely Benign0.098Likely Benign-1.42Neutral0.840Possibly Damaging0.357Benign2.55Benign0.01Affected0.14320.29800-16.4-24.99
c.2196G>C
R732S
2D
AIThe SynGAP1 missense variant R732S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the balance of evidence (five benign versus four pathogenic predictions) favors a benign classification. This conclusion does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.750-8.019Likely Pathogenic0.599Likely PathogenicLikely Benign0.115Likely Benign-1.81Neutral1.000Probably Damaging0.982Probably Damaging2.61Benign0.14Tolerated0.28500.31290-13.7-69.11
c.2196G>T
R732S
2D
AIThe SynGAP1 missense variant R732S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign impact for R732S, and this conclusion does not contradict any ClinVar annotation because the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.750-8.019Likely Pathogenic0.599Likely PathogenicLikely Benign0.115Likely Benign-1.81Neutral1.000Probably Damaging0.982Probably Damaging2.61Benign0.14Tolerated0.28500.31290-13.7-69.11
c.2686G>A
G896S
2D
AIThe SynGAP1 missense variant G896S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic effect. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence supports a benign impact, and there is no conflict with ClinVar status (which has no entry). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.412816Uncertain0.3140.9230.625-2.712Likely Benign0.119Likely BenignLikely Benign0.103Likely Benign-0.63Neutral0.896Possibly Damaging0.334Benign2.59Benign0.41Tolerated0.26840.491110-0.430.03
c.2686G>C
G896R
2D
AIThe SynGAP1 missense variant G896R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and ESM1b, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Consequently, the evidence is evenly split between benign and pathogenic predictions, with no decisive support from the high‑accuracy or folding‑stability analyses. The variant is therefore most likely of uncertain significance; it does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.675549Disordered0.412816Uncertain0.3140.9230.625-4.511Likely Benign0.897Likely PathogenicAmbiguous0.218Likely Benign-2.45Neutral0.999Probably Damaging0.967Probably Damaging2.44Pathogenic0.14Tolerated0.09310.4228-3-2-4.199.14
c.2686G>T
G896C
2D
AIThe SynGAP1 missense variant G896C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.412816Uncertain0.3140.9230.625-5.607Likely Benign0.245Likely BenignLikely Benign0.193Likely Benign-2.59Deleterious1.000Probably Damaging0.983Probably Damaging2.50Benign0.10Tolerated0.12700.4369-3-32.946.09
c.2687G>A
G896D
2D
AIThe SynGAP1 missense variant G896D is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and ESM1b, whereas polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. The high‑accuracy AlphaMissense‑Optimized score is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive, and Foldetta stability analysis is unavailable. Consequently, the evidence is evenly split between benign and pathogenic predictions, with no decisive support from the most reliable methods. The variant is therefore classified as of uncertain significance; it does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.675549Disordered0.412816Uncertain0.3140.9230.625-4.500Likely Benign0.905Likely PathogenicAmbiguous0.159Likely Benign-2.39Neutral0.997Probably Damaging0.934Probably Damaging2.44Pathogenic0.16Tolerated0.17070.18421-1-3.158.04
c.2687G>C
G896A
2D
AIThe SynGAP1 missense variant G896A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and there is no conflict with ClinVar status because no ClinVar claim exists. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.412816Uncertain0.3140.9230.625-3.562Likely Benign0.147Likely BenignLikely Benign0.077Likely Benign-0.95Neutral0.561Possibly Damaging0.139Benign2.54Benign0.79Tolerated0.37990.4963102.214.03
c.2687G>T
G896V
2D
AIThe SynGAP1 missense variant G896V is reported in gnomAD (6-33443239-G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome. Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect for G896V, and this conclusion is not contradicted by any ClinVar classification (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.412816Uncertain0.3140.9230.6256-33443239-G-T16.20e-7-2.936Likely Benign0.285Likely BenignLikely Benign0.165Likely Benign-1.96Neutral0.997Probably Damaging0.912Probably Damaging2.46Pathogenic0.30Tolerated4.3240.12640.4026-3-14.642.08
c.1168G>A
G390R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G390R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both predict pathogenicity. Overall, the majority of tools and the high‑accuracy methods indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.626927Disordered0.413274Uncertain0.3040.7630.875-9.242Likely Pathogenic0.686Likely PathogenicLikely Benign2.43Destabilizing0.94.85Destabilizing3.64Destabilizing0.16Likely Benign0.605Likely Pathogenic-0.92Neutral0.480Possibly Damaging0.163Benign1.32Pathogenic0.08Tolerated0.11900.4524-3-2-4.199.14
c.1168G>C
G390R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G390R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both predict pathogenicity. Overall, the majority of tools and the high‑accuracy methods indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.626927Disordered0.413274Uncertain0.3040.7630.875-9.242Likely Pathogenic0.686Likely PathogenicLikely Benign2.43Destabilizing0.94.85Destabilizing3.64Destabilizing0.16Likely Benign0.605Likely Pathogenic-0.92Neutral0.480Possibly Damaging0.163Benign1.32Pathogenic0.08Tolerated0.11900.4524-3-2-4.199.14
c.1168G>T
G390W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G390W is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include AlphaMissense‑Optimized, premPS, and PROVEAN, whereas the remaining tools—REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts benign, but the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict, and Foldetta also indicates pathogenic. With the majority of evidence pointing to a deleterious effect, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.626927Disordered0.413274Uncertain0.3040.7630.875-9.405Likely Pathogenic0.487AmbiguousLikely Benign3.69Destabilizing1.95.31Destabilizing4.50Destabilizing0.14Likely Benign0.639Likely Pathogenic-1.11Neutral0.987Probably Damaging0.744Possibly Damaging1.31Pathogenic0.00Affected0.09170.4368-7-2-0.5129.16
c.1169G>A
G390E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G390E is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Optimized. Those that predict pathogenicity are REVEL, FoldX, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Default. A high‑accuracy assessment shows AlphaMissense‑Optimized as benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of predictions support a pathogenic effect, and this aligns with the ClinVar designation of uncertain significance rather than contradicting it. Thus, the variant is most likely pathogenic based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.626927Disordered0.413274Uncertain0.3040.7630.875Uncertain 1-7.913In-Between0.646Likely PathogenicLikely Benign2.61Destabilizing0.94.28Destabilizing3.45Destabilizing0.47Likely Benign0.575Likely Pathogenic-0.87Neutral0.276Benign0.045Benign1.32Pathogenic0.05Affected4.3280.15950.43090-2-3.172.06241.5-108.40.60.5-0.10.1UncertainGly390 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. This loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play significant roles in protein functions that require flexibility, and so they are rich in glycine residues, prolines, and to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Glu390 may not be as well tolerated in the Ω loop. Additionally, the carboxylate group of Glu390 occasionally forms H-bonds with other loop residues in the variant simulations. The interaction between the acidic carboxylate side chain and the acidic membrane lipids may further influence the SynGAP-membrane complex. However, since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1169G>C
G390A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G390A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT, FATHMM, and Rosetta. The high‑accuracy assessment shows AlphaMissense‑Optimized as benign, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) as pathogenic. FoldX alone is inconclusive. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.626927Disordered0.413274Uncertain0.3040.7630.875-6.768Likely Benign0.100Likely BenignLikely Benign1.96Ambiguous0.42.03Destabilizing2.00Destabilizing0.02Likely Benign0.402Likely Benign-0.55Neutral0.143Benign0.028Benign1.33Pathogenic0.05Affected0.41300.5053102.214.03
c.1169G>T
G390V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G390V has no ClinVar entry and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, FoldX, Rosetta, Foldetta, SIFT, and FATHMM, while ESM1b remains uncertain. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default (benign), ESM1b (uncertain), FATHMM (pathogenic), and PROVEAN (benign), also yields a benign verdict; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, indicates pathogenic. With two high‑accuracy tools supporting benign and one supporting pathogenic, the overall evidence leans toward a benign effect. This conclusion does not contradict ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.626927Disordered0.413274Uncertain0.3040.7630.875-7.137In-Between0.146Likely BenignLikely Benign3.74Destabilizing0.64.88Destabilizing4.31Destabilizing-0.16Likely Benign0.509Likely Pathogenic-0.88Neutral0.002Benign0.002Benign1.32Pathogenic0.01Affected0.15370.4004-1-34.642.08
c.661G>A
E221K
2D
AIThe SynGAP1 E221K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Rosetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. FoldX and Foldetta give uncertain results. High‑accuracy methods show AlphaMissense‑Optimized as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts pathogenic (3 pathogenic vs 1 benign). Foldetta remains uncertain. Overall, the majority of reliable predictors indicate a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.127496Structured0.413334Uncertain0.8910.2830.000-12.331Likely Pathogenic0.997Likely PathogenicLikely Pathogenic-1.01Ambiguous0.4-0.18Likely Benign-0.60Ambiguous0.19Likely Benign0.815Likely Pathogenic-2.92Deleterious0.131Benign0.058Benign5.92Benign0.02Affected0.24910.800201-0.4-0.94
c.661G>C
E221Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E221Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Two tools predict a pathogenic outcome: ESM1b and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic vs two benign), and Foldetta predicts a benign effect. Overall, the majority of evidence (10 benign vs 2 pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.127496Structured0.413334Uncertain0.8910.2830.000-8.243Likely Pathogenic0.825Likely PathogenicAmbiguous-0.26Likely Benign0.1-0.33Likely Benign-0.30Likely Benign0.12Likely Benign0.455Likely Benign-1.64Neutral0.028Benign0.015Benign6.13Benign0.23Tolerated0.12070.7690220.0-0.98
c.662A>C
E221A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E221A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as benign. Overall, the predictions are split, but the two high‑confidence pathogenic calls outweigh the single high‑confidence benign call, suggesting the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.127496Structured0.413334Uncertain0.8910.2830.000-12.906Likely Pathogenic0.964Likely PathogenicLikely Pathogenic0.31Likely Benign0.0-0.11Likely Benign0.10Likely Benign0.52Ambiguous0.796Likely Pathogenic-4.70Deleterious0.231Benign0.081Benign5.82Benign0.01Affected0.34860.73350-15.3-58.04
c.662A>G
E221G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E221G missense variant is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumVar and FATHMM, while the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) indicate a pathogenic impact; FoldX, Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Based on the collective evidence, the variant is most likely pathogenic, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.127496Structured0.413334Uncertain0.8910.2830.000Uncertain 1-12.221Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.40Ambiguous0.11.74Ambiguous1.57Ambiguous0.71Ambiguous0.863Likely Pathogenic-5.56Deleterious0.596Possibly Damaging0.201Benign5.79Benign0.00Affected0.26110.63700-23.1-72.06
c.662A>T
E221V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E221V missense variant is reported in ClinVar as Pathogenic (ClinVar ID 2413181.0) and is not found in gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Benign predictions are limited to premPS, polyPhen‑2 HumVar, and FATHMM. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments reinforce the pathogenic interpretation: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus also indicates Likely Pathogenic, while Foldetta remains Uncertain. Taken together, the preponderance of evidence supports a pathogenic effect for E221V, and this conclusion aligns with the ClinVar classification, showing no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.127496Structured0.413334Uncertain0.8910.2830.000Likely Pathogenic 1-14.954Likely Pathogenic0.987Likely PathogenicLikely Pathogenic-0.66Ambiguous0.2-0.89Ambiguous-0.78Ambiguous0.49Likely Benign0.875Likely Pathogenic-5.54Deleterious0.596Possibly Damaging0.203Benign5.86Benign0.00Affected3.41130.08060.8138-2-27.7-29.98234.550.60.00.0-0.40.2XUncertainThe introduced residue Val221 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the carboxylate group of Glu221, Val221 cannot form hydrogen bonds with Thr223 or a salt bridge with the amino group of the Lys207 side chain. Despite this, the WT simulations containing Glu221 do not show significant differences compared to the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.663G>C
E221D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E221D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that agree on a pathogenic effect are REVEL, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Four tools (FoldX, Rosetta, Foldetta, premPS) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta remains uncertain. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.127496Structured0.413334Uncertain0.8910.2830.000-12.237Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.59Ambiguous0.11.07Ambiguous1.33Ambiguous0.84Ambiguous0.750Likely Pathogenic-2.43Neutral0.421Benign0.107Benign5.80Benign0.02Affected0.17550.5228320.0-14.03
c.663G>T
E221D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E221D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that agree on a pathogenic effect are REVEL, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Four tools (FoldX, Rosetta, Foldetta, premPS) returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2), and Foldetta is uncertain. Overall, the majority of available predictions lean toward pathogenicity, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.127496Structured0.413334Uncertain0.8910.2830.000-12.237Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.59Ambiguous0.11.07Ambiguous1.33Ambiguous0.84Ambiguous0.750Likely Pathogenic-2.43Neutral0.421Benign0.107Benign5.80Benign0.02Affected0.17550.5228320.0-14.03
c.811G>A
A271T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining evidence—premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—consistently predict pathogenicity. FoldX, Rosetta, and Foldetta are inconclusive, and AlphaMissense‑Optimized also yields an uncertain result. High‑accuracy assessments show that the SGM‑Consensus (majority vote) predicts pathogenicity, while AlphaMissense‑Optimized and Foldetta remain unavailable. Taken together, the overwhelming majority of reliable predictors classify the variant as pathogenic, and this conclusion does not conflict with the ClinVar status, which currently has no entry for A271T.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-9.564Likely Pathogenic0.934Likely PathogenicAmbiguous0.59Ambiguous0.10.54Ambiguous0.57Ambiguous1.00Destabilizing0.498Likely Benign-3.68Deleterious0.999Probably Damaging0.997Probably Damaging0.66Pathogenic0.01Affected0.10760.469110-2.530.03
c.811G>C
A271P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (integrating FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-14.699Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.06Destabilizing0.22.97Destabilizing3.52Destabilizing1.15Destabilizing0.680Likely Pathogenic-4.60Deleterious1.000Probably Damaging0.999Probably Damaging0.62Pathogenic0.01Affected0.17050.32671-1-3.426.04
c.811G>T
A271S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A271S is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are Foldetta and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for A271S, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125Uncertain 1-9.552Likely Pathogenic0.629Likely PathogenicLikely Benign0.19Likely Benign0.11.47Ambiguous0.83Ambiguous1.14Destabilizing0.453Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging0.64Pathogenic0.03Affected0.22600.331211-2.616.00
c.812C>A
A271D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271D is listed in ClinVar as Pathogenic (ClinVar ID 2019732.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125Pathogenic 1-18.590Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.71Destabilizing0.42.67Destabilizing3.69Destabilizing1.59Destabilizing0.706Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.62Pathogenic0.00Affected3.38190.15650.15410-2-5.344.01226.2-63.40.00.00.90.1XXXXPotentially PathogenicThe methyl group of Ala271, located near the end of an anti-parallel β sheet strand (res. Arg259-Arg272), packs against multiple hydrophobic residues such as Val400, Val306, and Leu274 in the WT simulations. In the variant simulations, the carboxylate group of Asp271 is not suitable for the hydrophobic niche, causing the hydrophobic residues to make room for the swapped residue. Additionally, the carboxylate group of the Asp271 side chain forms hydrogen bonds with the backbone amide groups of Arg272 and Ala399 in the β sheet, or even forms a salt bridge with the amino group of the Lys394 side chain. This directly affects the integrity of the anti-parallel β sheet at the end. In short, the residue swap disrupts the C2 domain packing during folding, which could weaken the stability of the SynGAP-membrane association.
c.812C>G
A271G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. FoldX, Rosetta, and Foldetta provide uncertain or unavailable stability results and are not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta as unavailable. Overall, the balance of evidence (seven pathogenic versus three benign predictions) indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-9.508Likely Pathogenic0.183Likely BenignLikely Benign1.73Ambiguous0.11.43Ambiguous1.58Ambiguous1.31Destabilizing0.434Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging0.89Pathogenic0.01Affected0.18690.238810-2.2-14.03
c.812C>T
A271V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, and Foldetta, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains inconclusive; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-8.185Likely Pathogenic0.940Likely PathogenicAmbiguous-0.22Likely Benign0.20.78Ambiguous0.28Likely Benign0.37Likely Benign0.466Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging0.69Pathogenic0.02Affected0.09860.4409002.428.05
c.1432G>A
E478K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478K is not reported in ClinVar (ClinVar ID: None) and has no entries in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SGM‑Consensus (Likely Pathogenic), PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as benign. Overall, the majority of evidence (eight benign versus five pathogenic predictions) points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-12.654Likely Pathogenic0.899Likely PathogenicAmbiguous0.23Likely Benign0.00.12Likely Benign0.18Likely Benign-0.02Likely Benign0.309Likely Benign-3.45Deleterious0.320Benign0.117Benign3.49Benign0.05Affected0.20660.619201-0.4-0.94
c.1432G>C
E478Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478Q is listed in gnomAD (ID 6‑33438464‑G‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Overall, the majority of evidence (nine benign vs three pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.0006-33438464-G-C16.20e-7-9.881Likely Pathogenic0.603Likely PathogenicLikely Benign-0.04Likely Benign0.00.31Likely Benign0.14Likely Benign0.07Likely Benign0.222Likely Benign-2.49Neutral0.623Possibly Damaging0.199Benign3.40Benign0.14Tolerated3.37340.10270.5867220.0-0.98
c.1433A>C
E478A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions are missing or inconclusive. Overall, the majority of high‑confidence tools lean toward a benign classification, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-8.499Likely Pathogenic0.612Likely PathogenicLikely Benign0.46Likely Benign0.00.45Likely Benign0.46Likely Benign0.02Likely Benign0.342Likely Benign-4.74Deleterious0.585Possibly Damaging0.505Possibly Damaging3.42Benign0.05Affected0.35160.58470-15.3-58.04
c.1433A>G
E478G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv. Uncertain predictions come from Rosetta, ESM1b, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to equal benign and pathogenic signals and two uncertain calls; Foldetta likewise yields an uncertain result. Overall, the majority of evaluated tools (seven benign vs. two pathogenic) support a benign classification. This consensus does not contradict any ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.000-7.897In-Between0.418AmbiguousLikely Benign0.40Likely Benign0.00.73Ambiguous0.57Ambiguous0.02Likely Benign0.306Likely Benign-4.91Deleterious0.923Possibly Damaging0.427Benign3.41Benign0.15Tolerated0.27580.55720-23.1-72.06
c.1433A>T
E478V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478V missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), FATHMM, and premPS; pathogenic predictions from SGM‑Consensus, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: FoldX (uncertain) and AlphaMissense‑Optimized (uncertain). High‑accuracy assessments further split the signal: the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. With six benign versus five pathogenic calls and no ClinVar evidence, the overall evidence slightly favors a benign interpretation, and there is no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-10.322Likely Pathogenic0.831Likely PathogenicAmbiguous0.55Ambiguous0.00.33Likely Benign0.44Likely Benign0.04Likely Benign0.385Likely Benign-5.84Deleterious0.434Benign0.199Benign3.35Benign0.01Affected0.05860.6604-2-27.7-29.98
c.1434A>C
E478D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.264545Structured0.414660Uncertain0.7870.2490.000-1.004Likely Benign0.085Likely BenignLikely Benign-0.04Likely Benign0.0-0.65Ambiguous-0.35Likely Benign-0.28Likely Benign0.175Likely Benign0.55Neutral0.000Benign0.001Benign3.53Benign0.70Tolerated0.17680.3315320.0-14.03
c.1434A>T
E478D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.264545Structured0.414660Uncertain0.7870.2490.000-1.004Likely Benign0.085Likely BenignLikely Benign-0.04Likely Benign0.0-0.65Ambiguous-0.35Likely Benign-0.28Likely Benign0.175Likely Benign0.55Neutral0.000Benign0.001Benign3.53Benign0.70Tolerated0.17680.3315320.0-14.03
c.1075A>C
T359P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.250-6.884Likely Benign0.319Likely BenignLikely Benign0.97Ambiguous0.11.27Ambiguous1.12Ambiguous0.68Ambiguous0.248Likely Benign-2.36Neutral0.627Possibly Damaging0.091Benign1.78Pathogenic0.14Tolerated0.23520.56110-1-0.9-3.99
c.1075A>G
T359A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only FATHMM predicts a pathogenic outcome, while Rosetta remains uncertain. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.250-2.948Likely Benign0.062Likely BenignLikely Benign0.09Likely Benign0.00.73Ambiguous0.41Likely Benign0.45Likely Benign0.103Likely Benign-0.73Neutral0.000Benign0.001Benign1.79Pathogenic0.34Tolerated0.42150.4713102.5-30.03
c.1075A>T
T359S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T359S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. Only FATHMM predicts a pathogenic outcome, while FoldX, Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also favors benign. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is uncertain. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.250-4.624Likely Benign0.091Likely BenignLikely Benign0.50Ambiguous0.00.73Ambiguous0.62Ambiguous0.66Ambiguous0.100Likely Benign-1.87Neutral0.146Benign0.024Benign1.76Pathogenic0.27Tolerated0.36370.499611-0.1-14.03
c.1076C>A
T359K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T359K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are ESM1b and FATHMM. The remaining tools—FoldX, Rosetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (seven benign vs. two pathogenic) support a benign classification, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.281712Structured0.414952Uncertain0.9390.4800.250-10.822Likely Pathogenic0.517AmbiguousLikely Benign-0.65Ambiguous0.10.66Ambiguous0.01Likely Benign0.75Ambiguous0.163Likely Benign-2.23Neutral0.255Benign0.045Benign1.79Pathogenic0.24Tolerated0.16180.34830-1-3.227.07
c.1076C>G
T359R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T359R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign effects include REVEL, Rosetta, Foldetta, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and FATHMM. Uncertain results come from FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, more tools favor a benign outcome, but a significant minority predict pathogenicity, leaving the variant’s clinical significance unresolved. The variant is most likely benign based on the prevailing predictions, and this does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.281712Structured0.414952Uncertain0.9390.4800.250-8.675Likely Pathogenic0.402AmbiguousLikely Benign-0.74Ambiguous0.1-0.20Likely Benign-0.47Likely Benign0.54Ambiguous0.157Likely Benign-2.86Deleterious0.627Possibly Damaging0.091Benign1.75Pathogenic0.23Tolerated0.13230.3748-1-1-3.855.08
c.1076C>T
T359I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359I is reported in gnomAD (variant ID 6‑33437981‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. Uncertain results are reported for FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign effect. There is no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.2506-33437981-C-T16.22e-7-2.594Likely Benign0.181Likely BenignLikely Benign-0.66Ambiguous0.1-0.64Ambiguous-0.65Ambiguous-0.63Ambiguous0.085Likely Benign0.77Neutral0.070Benign0.006Benign1.80Pathogenic0.23Tolerated3.38240.11230.5921-105.212.05
c.2683A>C
S895R
2D
AIThe SynGAP1 missense variant S895R is reported in ClinVar as not yet classified and is present in gnomAD (ID 6‑33443235‑A‑C). Consensus from multiple in silico predictors shows a split: benign calls come from REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic calls arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. When grouping by agreement, the benign group contains five tools, whereas the pathogenic group contains four. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts pathogenicity, whereas the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points toward a benign effect, and this conclusion does not conflict with the current ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.7506-33443235-A-C16.20e-7-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.167Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2683A>G
S895G
2D
AIThe SynGAP1 missense variant S895G is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a benign outcome, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also classifies it as likely benign. In contrast, two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign effect, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-3.728Likely Benign0.150Likely BenignLikely Benign0.149Likely Benign-1.25Neutral0.979Probably Damaging0.982Probably Damaging2.67Benign0.90Tolerated0.26750.5087100.4-30.03
c.2683A>T
S895C
2D
AIThe SynGAP1 missense variant S895C is reported in ClinVar as “None” and is not present in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-8.006Likely Pathogenic0.259Likely BenignLikely Benign0.182Likely Benign-2.44Neutral0.999Probably Damaging0.997Probably Damaging2.60Benign0.08Tolerated0.10720.63500-13.316.06
c.2684G>A
S895N
2D
AIThe SynGAP1 missense variant S895N is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (majority vote) also leans benign. No Foldetta (protein‑folding stability) result is available, so it does not influence the assessment. Overall, the preponderance of predictions indicates the variant is most likely benign, which is consistent with its ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750Uncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.3240.12710.498411-2.727.03
c.2684G>C
S895T
2D
AIThe SynGAP1 missense variant S895T is reported in gnomAD (variant ID 6-33443236‑G‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign, and AlphaMissense‑Optimized also scores benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. The variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.7506-33443236-G-C16.20e-7-5.515Likely Benign0.199Likely BenignLikely Benign0.132Likely Benign-1.14Neutral0.979Probably Damaging0.982Probably Damaging2.75Benign0.26Tolerated4.3240.14050.6392110.114.03
c.2684G>T
S895I
2D
AIThe SynGAP1 missense variant S895I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors a benign outcome; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for S895I, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-6.315Likely Benign0.697Likely PathogenicLikely Benign0.144Likely Benign-2.34Neutral0.997Probably Damaging0.996Probably Damaging2.65Benign0.04Affected0.10100.6248-1-25.326.08
c.2685T>A
S895R
2D
AIThe SynGAP1 missense variant S895R is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.123Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2685T>G
S895R
2D
AIThe SynGAP1 missense variant S895R is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.750-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.123Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2191C>A
Q731K
2D
AIThe SynGAP1 missense variant Q731K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-6.686Likely Benign0.349AmbiguousLikely Benign0.066Likely Benign-1.58Neutral0.490Possibly Damaging0.149Benign2.67Benign0.20Tolerated0.19980.393211-0.40.04
c.2191C>G
Q731E
2D
AIThe SynGAP1 missense variant Q731E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while ESM1b is uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-7.371In-Between0.161Likely BenignLikely Benign0.056Likely Benign-1.21Neutral0.935Possibly Damaging0.405Benign2.66Benign0.17Tolerated0.14260.2479220.00.98
c.2192A>C
Q731P
2D
AIThe SynGAP1 missense variant Q731P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic effect. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also likely benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-4.103Likely Benign0.066Likely BenignLikely Benign0.125Likely Benign-2.08Neutral1.000Probably Damaging0.987Probably Damaging2.64Benign0.26Tolerated0.22850.53850-11.9-31.01
c.2192A>G
Q731R
2D
AIThe SynGAP1 missense variant Q731R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic effect. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the majority of prediction tools and the high‑accuracy methods indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-5.873Likely Benign0.267Likely BenignLikely Benign0.082Likely Benign-1.63Neutral0.604Possibly Damaging0.293Benign2.66Benign0.14Tolerated0.15710.177511-1.028.06
c.2192A>T
Q731L
2D
AIThe SynGAP1 missense variant Q731L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign and the SGM‑Consensus is Likely Benign; Foldetta results are not available. Overall, the preponderance of evidence points to a benign impact for Q731L, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-4.251Likely Benign0.110Likely BenignLikely Benign0.161Likely Benign-1.27Neutral0.825Possibly Damaging0.270Benign2.75Benign0.12Tolerated0.08790.5694-2-27.3-14.97
c.2193A>C
Q731H
2D
AIThe SynGAP1 missense variant Q731H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign effect. The prediction is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-5.268Likely Benign0.171Likely BenignLikely Benign0.034Likely Benign-1.46Neutral0.003Benign0.004Benign2.64Benign0.05Affected0.15200.3830300.39.01
c.2193A>T
Q731H
2D
AIThe SynGAP1 missense variant Q731H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign effect. The prediction is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.415202Uncertain0.5070.6540.750-5.268Likely Benign0.171Likely BenignLikely Benign0.034Likely Benign-1.46Neutral0.003Benign0.004Benign2.64Benign0.05Affected0.15200.3830300.39.01
c.2206C>A
R736S
2D
AIThe SynGAP1 missense variant R736S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools (polyPhen‑2 HumDiv and SIFT) predict pathogenicity. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.926919Disordered0.415259Uncertain0.3050.7710.875-3.864Likely Benign0.223Likely BenignLikely Benign0.073Likely Benign-1.17Neutral0.653Possibly Damaging0.361Benign2.63Benign0.00Affected0.34220.21630-13.7-69.11
c.2206C>G
R736G
2D
AIThe SynGAP1 missense variant R736G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv and SIFT predict pathogenicity. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. Therefore, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.926919Disordered0.415259Uncertain0.3050.7710.875-4.100Likely Benign0.121Likely BenignLikely Benign0.089Likely Benign-2.05Neutral0.653Possibly Damaging0.361Benign2.51Benign0.00Affected0.37080.2554-3-24.1-99.14
c.2206C>T
R736C
2D
AISynGAP1 missense variant R736C is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441671‑C‑T). Functional prediction tools cluster into two groups: benign predictions from REVEL, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM, while ESM1b remains uncertain. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized scores benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also returns benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence indicates a benign effect, which does not conflict with the ClinVar uncertain designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.926919Disordered0.415259Uncertain0.3050.7710.875Conflicting 36-33441671-C-T84.96e-6-7.113In-Between0.120Likely BenignLikely Benign0.190Likely Benign-2.06Neutral0.999Probably Damaging0.825Possibly Damaging2.48Pathogenic0.00Affected4.0730.37400.1691-4-37.0-53.05
c.2207G>A
R736H
2D
AIThe SynGAP1 missense variant R736H is listed in ClinVar (ID 1351080.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33441672‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Only SIFT predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign. Foldetta results are not available. Overall, the majority of computational evidence indicates a benign impact, and this does not contradict the ClinVar “Uncertain” classification. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.926919Disordered0.415259Uncertain0.3050.7710.875Uncertain 16-33441672-G-A63.72e-6-5.409Likely Benign0.067Likely BenignLikely Benign0.029Likely Benign-0.12Neutral0.004Benign0.001Benign2.50Benign0.00Affected4.0730.28460.0921201.3-19.05
c.2207G>C
R736P
2D
AIThe SynGAP1 missense variant R736P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the overall assessment. Overall, the majority of evidence points to a benign effect for R736P, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.926919Disordered0.415259Uncertain0.3050.7710.875-5.246Likely Benign0.152Likely BenignLikely Benign0.085Likely Benign-1.83Neutral0.966Probably Damaging0.638Possibly Damaging2.50Benign0.00Affected0.23960.32370-22.9-59.07
c.2207G>T
R736L
2D
AIThe SynGAP1 missense variant R736L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools (polyPhen‑2 HumDiv and SIFT) predict pathogenicity, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the majority of prediction tools and the high‑accuracy methods points to a benign classification, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.926919Disordered0.415259Uncertain0.3050.7710.875-4.173Likely Benign0.133Likely BenignLikely Benign0.061Likely Benign-1.27Neutral0.653Possibly Damaging0.361Benign2.60Benign0.00Affected0.18560.3180-3-28.3-43.03
c.1198G>A
V400M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V400M is reported in gnomAD (ID 6‑33438103‑G‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. In contrast, only three tools—polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default—predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, SGM‑Consensus is likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. No evidence from FoldX or premPS is available. Overall, the preponderance of predictions, including the high‑accuracy methods, supports a benign classification, which is consistent with the absence of a ClinVar pathogenic report.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.398279Structured0.415488Uncertain0.9510.4510.0006-33438103-G-A31.86e-6-5.438Likely Benign0.573Likely PathogenicLikely Benign-1.12Ambiguous0.1-0.16Likely Benign-0.64Ambiguous0.55Ambiguous0.443Likely Benign-1.44Neutral0.868Possibly Damaging0.289Benign5.26Benign0.01Affected3.38270.08510.464312-2.332.06
c.1198G>C
V400L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V400L is listed in ClinVar as Benign (ClinVar ID 1166313.0) and is present in gnomAD (variant ID 6‑33438103‑G‑C). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive result is from FoldX, which is treated as unavailable. High‑accuracy assessments confirm benignity: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. Overall, the computational evidence strongly supports a benign classification, consistent with the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.398279Structured0.415488Uncertain0.9510.4510.000Benign 16-33438103-G-C221.36e-5-1.000Likely Benign0.137Likely BenignLikely Benign-0.71Ambiguous0.20.39Likely Benign-0.16Likely Benign-0.29Likely Benign0.325Likely Benign-0.60Neutral0.001Benign0.001Benign5.33Benign0.64Tolerated3.38270.10060.524221-0.414.03251.0-30.10.00.00.70.1XPotentially BenignThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). Val400 is swapped for another hydrophobic residue, leucine, whose branched hydrocarbon side chain is of a comparable size and thus packs favorably within the C2 domain. In short, the residue swap has no apparent negative effect on the structure based on the variant simulations.10.1016/j.ajhg.2020.11.011
c.1198G>T
V400L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V400L is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Functional prediction tools that agree on a benign effect include REVEL, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, premPS, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta. No tool predicts a pathogenic outcome; the only inconclusive result is from FoldX (Uncertain). High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Based on the collective evidence, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.398279Structured0.415488Uncertain0.9510.4510.000-1.000Likely Benign0.137Likely BenignLikely Benign-0.71Ambiguous0.20.39Likely Benign-0.16Likely Benign-0.29Likely Benign0.325Likely Benign-0.60Neutral0.001Benign0.001Benign5.33Benign0.64Tolerated3.38270.10060.524221-0.414.03251.0-30.10.00.00.70.1XPotentially BenignThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). Val400 is swapped for another hydrophobic residue, leucine, whose branched hydrocarbon side chain is of a comparable size and thus packs favorably within the C2 domain. In short, the residue swap has no apparent negative effect on the structure based on the variant simulations.10.1016/j.ajhg.2020.11.011
c.1199T>A
V400E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V400E is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect are polyPhen‑2 HumVar and FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.398279Structured0.415488Uncertain0.9510.4510.000Uncertain 1-13.686Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.70Destabilizing0.22.46Destabilizing3.08Destabilizing2.29Destabilizing0.810Likely Pathogenic-4.88Deleterious0.920Possibly Damaging0.335Benign5.31Benign0.00Affected3.38270.10440.1922-2-2-7.729.98249.1-38.8-0.10.11.00.0XXXPotentially PathogenicThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). In the variant simulations, the negatively charged carboxylate group of the Glu400 side chain is not suitable for occupying the hydrophobic niche. Consequently, the side chain escapes the center of the C2 domain and interacts with the backbone amide groups of Leu402 in the same β strand and/or Ile269 and Glu270 in a neighboring β strand (res. Arg259-Arg272). This residue swap disrupts the hydrophobic packing and generally has extensive negative effects on the C2 domain structure. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.1199T>C
V400A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 V400A is not reported in ClinVar and is absent from gnomAD. Consensus from standard predictors shows a split: benign calls from REVEL, polyPhen‑2 (HumDiv and HumVar) and FATHMM, while pathogenic calls come from FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT and AlphaMissense‑Default. Two high‑accuracy tools give a clear signal: AlphaMissense‑Optimized is uncertain, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta also predicts pathogenic. With most evidence pointing to deleterious effects, the variant is most likely pathogenic, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.398279Structured0.415488Uncertain0.9510.4510.000-7.564In-Between0.871Likely PathogenicAmbiguous3.14Destabilizing0.13.12Destabilizing3.13Destabilizing2.29Destabilizing0.479Likely Benign-3.12Deleterious0.435Benign0.049Benign5.32Benign0.01Affected0.32910.276700-2.4-28.05
c.1199T>G
V400G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V400G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are polyPhen‑2 HumDiv and FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.398279Structured0.415488Uncertain0.9510.4510.000-11.508Likely Pathogenic0.969Likely PathogenicLikely Pathogenic4.84Destabilizing0.15.40Destabilizing5.12Destabilizing2.40Destabilizing0.819Likely Pathogenic-5.70Deleterious0.335Benign0.920Probably Damaging5.27Benign0.00Affected0.22960.2522-1-3-4.6-42.08
c.1210G>A
A404T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A404T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: SGM‑Consensus (Likely Benign), REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only FoldX and premPS are inconclusive, so they are treated as unavailable. High‑accuracy methods corroborate this: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta) is benign. Overall, the evidence strongly supports a benign classification, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.232838Structured0.415505Uncertain0.9650.3550.000-6.674Likely Benign0.279Likely BenignLikely Benign0.74Ambiguous0.1-0.01Likely Benign0.37Likely Benign0.56Ambiguous0.060Likely Benign-1.74Neutral0.049Benign0.011Benign4.12Benign0.09Tolerated0.17100.736710-2.530.03
c.1210G>C
A404P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A404P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, Rosetta, both polyPhen‑2 versions, and FATHMM, while pathogenic calls arise from FoldX, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic verdict. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.415505Uncertain0.9650.3550.000-11.819Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.03Destabilizing0.10.24Likely Benign1.64Ambiguous1.17Destabilizing0.227Likely Benign-3.16Deleterious0.433Benign0.080Benign4.02Benign0.03Affected0.22710.63661-1-3.426.04
c.1210G>T
A404S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A404S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tool predicts a pathogenic outcome. The high‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a benign effect. No inconclusive or missing predictions are present. Based on the unanimous benign predictions and the lack of ClinVar evidence, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.232838Structured0.415505Uncertain0.9650.3550.000-1.937Likely Benign0.194Likely BenignLikely Benign0.13Likely Benign0.00.83Ambiguous0.48Likely Benign0.28Likely Benign0.078Likely Benign-0.07Neutral0.000Benign0.001Benign4.18Benign0.22Tolerated0.29700.617811-2.616.00
c.1211C>A
A404E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A404E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.415505Uncertain0.9650.3550.000-13.639Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.16Destabilizing0.13.04Destabilizing2.60Destabilizing1.51Destabilizing0.163Likely Benign-2.77Deleterious0.179Benign0.033Benign4.02Benign0.02Affected0.14230.23830-1-5.358.04
c.1211C>G
A404G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A404G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS and SIFT. FoldX, Rosetta, and Foldetta give uncertain or inconclusive results and are treated as unavailable. The high‑accuracy consensus (SGM‑Consensus) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains uncertain. Overall, the majority of evidence points to a benign impact for A404G, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.232838Structured0.415505Uncertain0.9650.3550.000-5.277Likely Benign0.137Likely BenignLikely Benign0.92Ambiguous0.01.88Ambiguous1.40Ambiguous1.18Destabilizing0.099Likely Benign-2.34Neutral0.045Benign0.013Benign4.03Benign0.00Affected0.23700.505410-2.2-14.03
c.1211C>T
A404V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A404V missense variant is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438116‑C‑T). Prediction tools that agree on a benign effect include REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN and ESM1b. Four tools (FoldX, Rosetta, AlphaMissense‑Default, Foldetta) give uncertain or inconclusive results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the majority of predictions lean toward a benign impact, though a key consensus method suggests pathogenicity, leaving the variant’s effect unresolved. **The variant is most likely benign based on the prevailing predictions, and this assessment does not contradict ClinVar status, as no ClinVar classification exists.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.232838Structured0.415505Uncertain0.9650.3550.0006-33438116-C-T16.20e-7-8.219Likely Pathogenic0.343AmbiguousLikely Benign0.56Ambiguous0.3-1.55Ambiguous-0.50Ambiguous-0.05Likely Benign0.118Likely Benign-2.96Deleterious0.345Benign0.018Benign4.20Benign0.47Tolerated3.38280.12880.6842002.428.05
c.1447A>C
I483L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree that the substitution is benign: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a neutral effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign.” In contrast, polyPhen‑2 (HumDiv and HumVar) and ESM1b predict a pathogenic impact, and premPS remains uncertain. High‑accuracy assessments are uniformly benign: AlphaMissense‑Optimized is benign, the SGM‑Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Taken together, the majority of evidence, including the high‑accuracy tools, supports a benign classification for I483L. This conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.206376Structured0.415850Uncertain0.7980.2540.000-10.258Likely Pathogenic0.332Likely BenignLikely Benign0.31Likely Benign0.10.38Likely Benign0.35Likely Benign0.67Ambiguous0.341Likely Benign-1.86Neutral0.879Possibly Damaging0.970Probably Damaging4.09Benign0.31Tolerated0.06640.246122-0.70.00
c.1447A>G
I483V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions are reported by premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Predictions marked as uncertain include FoldX, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign, whereas Foldetta remains uncertain. Overall, the balance of evidence from both general and high‑accuracy tools leans toward a benign effect, which does not contradict the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.206376Structured0.415850Uncertain0.7980.2540.000Conflicting 2-10.121Likely Pathogenic0.523AmbiguousLikely Benign1.00Ambiguous0.00.27Likely Benign0.64Ambiguous1.02Destabilizing0.228Likely Benign-0.86Neutral0.914Possibly Damaging0.921Probably Damaging3.23Benign0.03Affected3.37320.08760.269134-0.3-14.03
c.1447A>T
I483L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree that the substitution is benign: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a neutral effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign.” In contrast, polyPhen‑2 (HumDiv and HumVar) and ESM1b predict a pathogenic impact, and premPS remains uncertain. High‑accuracy assessments are uniformly benign: AlphaMissense‑Optimized is benign, the SGM‑Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Taken together, the majority of evidence, including the high‑accuracy tools, supports a benign classification for I483L. This conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.206376Structured0.415850Uncertain0.7980.2540.000-10.258Likely Pathogenic0.332Likely BenignLikely Benign0.31Likely Benign0.10.38Likely Benign0.35Likely Benign0.67Ambiguous0.342Likely Benign-1.86Neutral0.879Possibly Damaging0.970Probably Damaging4.09Benign0.31Tolerated0.06640.246122-0.70.00
c.1448T>A
I483K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-18.260Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.53Destabilizing0.15.15Destabilizing4.34Destabilizing2.01Destabilizing0.585Likely Pathogenic-6.50Deleterious0.962Probably Damaging0.991Probably Damaging3.14Benign0.00Affected0.08680.0670-2-3-8.415.01
c.1448T>C
I483T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts a pathogenic effect. Based on the preponderance of pathogenic predictions and the absence of any benign consensus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-10.692Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.32Destabilizing0.02.05Destabilizing2.19Destabilizing1.77Destabilizing0.474Likely Benign-4.24Deleterious1.000Probably Damaging1.000Probably Damaging3.15Benign0.05Affected0.08880.08400-1-5.2-12.05
c.1448T>G
I483R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-17.066Likely Pathogenic0.995Likely PathogenicLikely Pathogenic5.14Destabilizing0.44.09Destabilizing4.62Destabilizing1.97Destabilizing0.595Likely Pathogenic-6.50Deleterious0.997Probably Damaging0.991Probably Damaging3.14Benign0.00Affected0.11200.0870-2-3-9.043.03
c.1449A>G
I483M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I483M missense variant is not reported in ClinVar (ClinVar status: not present) but is catalogued in gnomAD (gnomAD ID: 6‑33438481‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta as benign. No conclusive folding‑stability result is available from Rosetta. Overall, the majority of high‑accuracy tools (two benign, one pathogenic) lean toward a benign interpretation, and this assessment is not contradicted by any ClinVar annotation. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.0006-33438481-A-G16.20e-7-8.839Likely Pathogenic0.777Likely PathogenicLikely Benign0.02Likely Benign0.00.73Ambiguous0.38Likely Benign1.06Destabilizing0.261Likely Benign-2.78Deleterious1.000Probably Damaging1.000Probably Damaging3.26Benign0.05Affected3.37320.06070.195912-2.618.03
c.2098C>A
L700M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only Rosetta predicts a pathogenic outcome, while Foldetta’s stability assessment is uncertain. The high‑accuracy consensus (SGM Consensus) is derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, all of which are benign, yielding a “Likely Benign” classification. AlphaMissense‑Optimized also predicts benign, whereas Foldetta remains inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.113710Structured0.416255Uncertain0.9270.3310.000-4.617Likely Benign0.139Likely BenignLikely Benign0.11Likely Benign0.02.79Destabilizing1.45Ambiguous0.35Likely Benign0.039Likely Benign-0.32Neutral0.211Benign0.081Benign3.29Benign0.08Tolerated0.07330.239742-1.918.03
c.2098C>G
L700V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely benign outcome. In contrast, protein‑stability methods predict a deleterious impact: FoldX and Rosetta both score the variant as pathogenic, and the combined Foldetta analysis (FoldX‑MD + Rosetta) also reports a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, while Foldetta remains pathogenic. Overall, the majority of predictions support a benign classification, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.113710Structured0.416255Uncertain0.9270.3310.000-3.703Likely Benign0.192Likely BenignLikely Benign2.52Destabilizing0.03.16Destabilizing2.84Destabilizing0.13Likely Benign0.056Likely Benign0.37Neutral0.003Benign0.005Benign3.46Benign0.76Tolerated0.14240.2460210.4-14.03
c.2099T>A
L700Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. All other evaluated tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates a benign change, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. No predictions are missing or inconclusive. Overall, the preponderance of evidence from the majority of tools points to a pathogenic effect, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-10.522Likely Pathogenic0.783Likely PathogenicLikely Benign2.41Destabilizing0.14.02Destabilizing3.22Destabilizing1.35Destabilizing0.321Likely Benign-3.79Deleterious0.994Probably Damaging0.896Possibly Damaging3.34Benign0.01Affected0.10740.0488-2-2-7.314.97
c.2099T>C
L700P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while only FATHMM predicts it benign. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Pathogenic” verdict (3 pathogenic vs. 1 benign). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-13.092Likely Pathogenic0.982Likely PathogenicLikely Pathogenic7.29Destabilizing0.512.85Destabilizing10.07Destabilizing1.84Destabilizing0.541Likely Pathogenic-4.31Deleterious0.999Probably Damaging0.966Probably Damaging3.30Benign0.01Affected0.36030.1025-3-3-5.4-16.04
c.2099T>G
L700R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L700R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls are made by Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive, SGM Consensus remains Likely Pathogenic, and Foldetta predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-12.389Likely Pathogenic0.938Likely PathogenicAmbiguous1.82Ambiguous0.14.19Destabilizing3.01Destabilizing1.89Destabilizing0.485Likely Benign-4.29Deleterious0.728Possibly Damaging0.249Benign3.35Benign0.01Affected0.12100.0488-3-2-8.343.03
c.1165T>A
S389T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S389T is not reported in ClinVar and is present in gnomAD (variant ID 6‑33438070‑T‑A). Functional prediction tools that converge on a benign outcome include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 HumVar and SIFT predict a pathogenic effect. The high‑accuracy consensus methods reinforce the benign assessment: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign outcome. Taken together, the majority of evidence supports a benign classification for S389T, and this conclusion is consistent with the absence of a ClinVar pathogenic report.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.703578Disordered0.417444Uncertain0.3060.8030.8756-33438070-T-A-5.403Likely Benign0.089Likely BenignLikely Benign0.36Likely Benign0.20.11Likely Benign0.24Likely Benign-0.04Likely Benign0.242Likely Benign-0.26Neutral0.140Benign0.481Possibly Damaging5.07Benign0.03Affected4.3280.23170.6656110.114.03
c.1165T>C
S389P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S389P is listed in gnomAD (variant ID 6‑33438070‑T‑C) and has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.703578Disordered0.417444Uncertain0.3060.8030.8756-33438070-T-C-5.286Likely Benign0.130Likely BenignLikely Benign1.85Ambiguous2.0-0.99Ambiguous0.43Likely Benign0.16Likely Benign0.460Likely Benign-0.44Neutral0.676Possibly Damaging0.693Possibly Damaging5.05Benign0.01Affected4.3280.30980.7002-11-0.810.04
c.1165T>G
S389A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S389A is reported in gnomAD (ID 6‑33438070‑T‑G) and has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is Benign; the SGM‑Consensus is Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports Benign. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.703578Disordered0.417444Uncertain0.3060.8030.8756-33438070-T-G-4.199Likely Benign0.081Likely BenignLikely Benign0.01Likely Benign0.00.37Likely Benign0.19Likely Benign0.03Likely Benign0.326Likely Benign-0.39Neutral0.140Benign0.355Benign5.08Benign0.04Affected4.3280.50370.5963Strenghten112.6-16.00
c.1166C>T
S389L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S389L is catalogued in gnomAD (6‑33438071‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, and the SGM‑Consensus score (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments are consistent with the benign consensus: AlphaMissense‑Optimized reports Benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.703578Disordered0.417444Uncertain0.3060.8030.8756-33438071-C-T74.40e-6-6.040Likely Benign0.165Likely BenignLikely Benign0.04Likely Benign0.10.69Ambiguous0.37Likely Benign-0.23Likely Benign0.456Likely Benign-0.75Neutral0.462Possibly Damaging0.693Possibly Damaging5.05Benign0.01Affected4.3280.18440.5871-2-34.626.08
c.2092G>A
E698K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a benign impact. Because the high‑accuracy predictions are split, the overall evidence is inconclusive, but the majority of tools lean toward pathogenicity. The variant is therefore most likely pathogenic based on the preponderance of predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-8.881Likely Pathogenic0.963Likely PathogenicLikely Pathogenic0.23Likely Benign0.10.38Likely Benign0.31Likely Benign-0.07Likely Benign0.466Likely Benign-3.79Deleterious0.991Probably Damaging0.951Probably Damaging3.37Benign0.01Affected0.22180.438301-0.4-0.94
c.2092G>C
E698Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698Q is not reported in ClinVar and has no entries in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the evidence is split, with an equal number of benign and pathogenic calls; the high‑accuracy tools lean toward benign but are not definitive. Thus, the variant’s pathogenicity remains uncertain and does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-8.369Likely Pathogenic0.714Likely PathogenicLikely Benign0.00Likely Benign0.10.35Likely Benign0.18Likely Benign-0.02Likely Benign0.326Likely Benign-2.86Deleterious0.987Probably Damaging0.946Probably Damaging3.35Benign0.01Affected0.10290.3702220.0-0.98
c.2093A>C
E698A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. No prediction or folding result is missing. Overall, the majority of tools (seven versus six) favor a pathogenic interpretation, and this does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-10.962Likely Pathogenic0.822Likely PathogenicAmbiguous0.31Likely Benign0.00.26Likely Benign0.29Likely Benign0.25Likely Benign0.476Likely Benign-5.57Deleterious0.997Probably Damaging0.991Probably Damaging3.35Benign0.01Affected0.31470.41600-15.3-58.04
c.2093A>G
E698G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698G missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM. In contrast, a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all indicate deleteriousness. FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive, providing no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E698G. This prediction aligns with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-10.617Likely Pathogenic0.786Likely PathogenicAmbiguous0.57Ambiguous0.01.25Ambiguous0.91Ambiguous0.29Likely Benign0.439Likely Benign-6.37Deleterious1.000Probably Damaging0.993Probably Damaging3.31Benign0.01Affected0.25290.32860-23.1-72.06
c.2093A>T
E698V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698V missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Tools with inconclusive results are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts a likely pathogenic outcome. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports an uncertain result. Overall, the majority of evidence points to a pathogenic impact for E698V, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-12.797Likely Pathogenic0.945Likely PathogenicAmbiguous0.76Ambiguous0.00.39Likely Benign0.58Ambiguous0.26Likely Benign0.480Likely Benign-6.51Deleterious0.992Probably Damaging0.967Probably Damaging3.33Benign0.00Affected0.05770.4546-2-27.7-29.98
c.2094G>C
E698D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.120615Structured0.417514Uncertain0.9220.3150.000-6.716Likely Benign0.207Likely BenignLikely Benign0.21Likely Benign0.10.35Likely Benign0.28Likely Benign0.16Likely Benign0.155Likely Benign-2.45Neutral0.977Probably Damaging0.921Probably Damaging3.35Benign0.03Affected0.16430.2597320.0-14.03
c.2094G>T
E698D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.120615Structured0.417514Uncertain0.9220.3150.000-6.716Likely Benign0.207Likely BenignLikely Benign0.21Likely Benign0.10.35Likely Benign0.28Likely Benign0.16Likely Benign0.155Likely Benign-2.45Neutral0.977Probably Damaging0.921Probably Damaging3.35Benign0.03Affected0.16430.2597320.0-14.03
c.3763A>C
K1255Q
2D
AIThe SynGAP1 missense variant K1255Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. In contrast, the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus also reports a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect for K1255Q, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-12.680Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.282Likely Benign-3.19Deleterious1.000Probably Damaging0.998Probably Damaging1.87Pathogenic0.00Affected0.36250.1102110.4-0.04
c.3763A>G
K1255E
2D
AIThe SynGAP1 missense variant K1255E is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are not available. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-15.072Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.308Likely Benign-3.12Deleterious0.999Probably Damaging0.995Probably Damaging1.88Pathogenic0.00Affected0.30940.0877010.40.94
c.3764A>C
K1255T
2D
AIThe SynGAP1 missense variant K1255T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as pathogenic; Foldetta results are unavailable. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-9.745Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.360Likely Benign-4.79Deleterious1.000Probably Damaging0.998Probably Damaging1.85Pathogenic0.00Affected0.17550.26280-13.2-27.07
c.3764A>G
K1255R
2D
AIThe SynGAP1 K1255R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and PROVEAN, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all classify the change as damaging. The high‑accuracy consensus approach (SGM‑Consensus) – a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN – yields a pathogenic verdict (3 pathogenic vs. 1 benign). AlphaMissense‑Optimized is uncertain, and Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for K1255R. This prediction is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-9.687Likely Pathogenic0.866Likely PathogenicAmbiguous0.171Likely Benign-2.43Neutral0.999Probably Damaging0.995Probably Damaging1.93Pathogenic0.00Affected0.37270.087832-0.628.01
c.3764A>T
K1255M
2D
AIThe SynGAP1 missense variant K1255M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign change, whereas all other evaluated algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus confirms a likely pathogenic status. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect, and this conclusion is consistent with the absence of any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-10.554Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.393Likely Benign-4.82Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.00Affected0.07760.31540-15.83.02
c.3765G>C
K1255N
2D
AIThe SynGAP1 missense variant K1255N is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-12.586Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.210Likely Benign-3.99Deleterious1.000Probably Damaging0.998Probably Damaging1.85Pathogenic0.00Affected0.29930.1302100.4-14.07
c.3765G>T
K1255N
2D
AIThe SynGAP1 missense variant K1255N is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the absence of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.637480Disordered0.417615Uncertain0.8800.5630.625-12.586Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.210Likely Benign-3.99Deleterious1.000Probably Damaging0.998Probably Damaging1.85Pathogenic0.00Affected0.29930.1302100.4-14.07
c.976C>A
H326N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326N has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and SIFT, whereas a majority (seven) predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence points to a pathogenic impact for H326N, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.914Likely Pathogenic0.925Likely PathogenicAmbiguous0.81Ambiguous0.21.48Ambiguous1.15Ambiguous0.97Ambiguous0.409Likely Benign-5.63Deleterious0.997Probably Damaging0.992Probably Damaging1.95Pathogenic0.11Tolerated0.19290.255221-0.3-23.04
c.976C>G
H326D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326D missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only SIFT, which scores the variant as benign. All other evaluated algorithms—REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. Tools with inconclusive results are FoldX, Foldetta, and premPS, which are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, reports an uncertain result. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-13.000Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.87Ambiguous0.62.00Destabilizing1.44Ambiguous0.96Ambiguous0.561Likely Pathogenic-7.67Deleterious0.997Probably Damaging0.994Probably Damaging2.04Pathogenic0.10Tolerated0.26120.16111-1-0.3-22.05
c.976C>T
H326Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas a majority of tools (REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic effect for H326Y, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.896Likely Pathogenic0.855Likely PathogenicAmbiguous0.03Likely Benign0.40.25Likely Benign0.14Likely Benign0.07Likely Benign0.562Likely Pathogenic-5.32Deleterious0.997Probably Damaging0.992Probably Damaging1.92Pathogenic0.02Affected0.07960.4323021.926.03
c.977A>C
H326P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; pathogenic predictions are reported by REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). The only inconclusive result is premPS, which is listed as Uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Pathogenic. Based on the consensus of these predictions, the variant is most likely pathogenic, and this conclusion is consistent with the absence of ClinVar evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-18.452Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.67Destabilizing0.32.59Destabilizing2.63Destabilizing0.88Ambiguous0.711Likely Pathogenic-8.73Deleterious0.999Probably Damaging0.998Probably Damaging1.92Pathogenic0.03Affected0.23830.44920-21.6-40.02
c.977A>G
H326R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326R missense variant is not listed in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT and Foldetta, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as likely pathogenic; Foldetta, a protein‑folding stability approach that integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. Because the majority of evidence points to a deleterious change, the variant is most likely pathogenic, and this assessment is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-12.369Likely Pathogenic0.980Likely PathogenicLikely Pathogenic-0.65Ambiguous0.11.40Ambiguous0.38Likely Benign0.83Ambiguous0.601Likely Pathogenic-6.89Deleterious0.997Probably Damaging0.994Probably Damaging1.97Pathogenic0.10Tolerated0.18320.241320-1.319.05
c.977A>T
H326L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326L missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT, premPS, Rosetta, and Foldetta. Tools that agree on a pathogenic effect include REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) predicts benign. No evidence is available from FoldX or AlphaMissense‑Optimized to support either outcome. Overall, the majority of predictions (nine pathogenic vs. four benign) indicate that H326L is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.421Likely Pathogenic0.888Likely PathogenicAmbiguous-0.85Ambiguous0.20.36Likely Benign-0.25Likely Benign0.44Likely Benign0.627Likely Pathogenic-9.64Deleterious0.999Probably Damaging0.996Probably Damaging1.95Pathogenic0.08Tolerated0.09920.5799-2-37.0-23.98
c.978T>A
H326Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, whereas a majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Foldetta (combining FoldX‑MD and Rosetta) and Rosetta alone, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for H326Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.688Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.46Likely Benign0.11.67Ambiguous1.07Ambiguous1.00Destabilizing0.444Likely Benign-6.89Deleterious0.999Probably Damaging0.996Probably Damaging2.07Pathogenic0.10Tolerated0.14850.350030-0.3-9.01
c.978T>G
H326Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, whereas a majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Foldetta (combining FoldX‑MD and Rosetta) and Rosetta alone, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus also indicates likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for H326Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.688Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.46Likely Benign0.11.67Ambiguous1.07Ambiguous1.00Destabilizing0.444Likely Benign-6.89Deleterious0.999Probably Damaging0.996Probably Damaging2.07Pathogenic0.10Tolerated0.14850.350030-0.3-9.01
c.2689T>A
S897T
2D
AIThe SynGAP1 missense variant S897T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence points to a benign effect, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.418474Uncertain0.2920.9280.500-4.930Likely Benign0.145Likely BenignLikely Benign0.086Likely Benign-0.69Neutral0.790Possibly Damaging0.535Possibly Damaging2.68Benign0.04Affected0.14800.6392110.114.03
c.2689T>C
S897P
2D
AIThe SynGAP1 missense variant S897P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.418474Uncertain0.2920.9280.500-4.088Likely Benign0.216Likely BenignLikely Benign0.097Likely Benign-0.21Neutral0.990Probably Damaging0.856Possibly Damaging2.64Benign0.04Affected0.20140.59331-1-0.810.04
c.2689T>G
S897A
2D
AIThe SynGAP1 missense variant S897A is not reported in ClinVar and is absent from gnomAD. All evaluated in‑silico predictors—including REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as benign. No tool predicts pathogenicity. The high‑accuracy consensus methods likewise support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta results are unavailable. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.418474Uncertain0.2920.9280.500-3.959Likely Benign0.122Likely BenignLikely Benign0.060Likely Benign-0.48Neutral0.288Benign0.208Benign2.71Benign0.81Tolerated0.45390.5684112.6-16.00
c.2690C>T
S897L
2D
AIThe SynGAP1 missense variant S897L is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (derived from the same four high‑accuracy tools) also as benign. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence points to a benign effect, and this conclusion does not conflict with the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.699094Disordered0.418474Uncertain0.2920.9280.500Uncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected0.12800.5770-3-24.626.08
c.2146C>G
R716G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R716G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. Other stability predictors (FoldX, Rosetta, premPS) are also Uncertain. Overall, the balance of evidence from the majority of tools and the SGM‑Consensus indicates a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.000-9.927Likely Pathogenic0.728Likely PathogenicLikely Benign1.32Ambiguous0.11.63Ambiguous1.48Ambiguous0.72Ambiguous0.359Likely Benign-5.70Deleterious1.000Probably Damaging1.000Probably Damaging3.36Benign0.01Affected0.34370.2466-3-24.1-99.14
c.2146C>T
R716W
2D
3DClick to see structure in 3D Viewer
AIClinVar has no entry for this SynGAP1 R716W variant, and it is present in the gnomAD database (ID 6‑33441611‑C‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, premPS, and Foldetta, while those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic. With two high‑accuracy tools supporting benign and one supporting pathogenic, the overall prediction leans toward a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.0006-33441611-C-T53.10e-6-11.543Likely Pathogenic0.766Likely PathogenicLikely Benign-0.11Likely Benign0.00.87Ambiguous0.38Likely Benign0.31Likely Benign0.339Likely Benign-6.72Deleterious1.000Probably Damaging0.995Probably Damaging3.32Benign0.00Affected3.5090.13030.3252-323.630.03
c.2147G>A
R716Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R716Q is listed in ClinVar with an uncertain significance (ClinVar ID 411585.0) and is present in gnomAD (ID 6‑33441612‑G‑A). Functional prediction tools that report a benign effect include REVEL, FoldX, Rosetta, Foldetta, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b, while premPS is inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the balance of evidence leans toward a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.247041Structured0.419135Uncertain0.9620.3790.000Conflicting 26-33441612-G-A42.48e-6-8.338Likely Pathogenic0.308Likely BenignLikely Benign-0.01Likely Benign0.00.47Likely Benign0.23Likely Benign0.58Ambiguous0.210Likely Benign-3.14Deleterious1.000Probably Damaging0.990Probably Damaging3.35Benign0.02Affected3.5090.28340.2180111.0-28.06250.048.90.00.0-0.50.0XUncertainThe guanidinium group of Arg716, located on the outer surface of an α-helix (res. Leu714-Arg726), forms a salt bridge with the carboxylate group of Asp720. In the variant simulations, the carboxamide group of Gln716 also forms a hydrogen bond with the carboxylate group of Asp720, although this bond is weaker than the Arg716 salt bridge in the WT. Overall, no adverse effects on the protein structure are observed in the simulations. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2147G>C
R716P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R716P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, and FATHMM; pathogenic predictions come from AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, Rosetta, Foldetta, and the SGM‑Consensus score. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.000-10.744Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.18Likely Benign0.15.67Destabilizing2.93Destabilizing0.49Likely Benign0.320Likely Benign-5.75Deleterious1.000Probably Damaging1.000Probably Damaging3.33Benign0.01Affected0.21400.35760-22.9-59.07
c.2147G>T
R716L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R716L is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, premPS, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions (7/13) lean toward pathogenicity, with a near‑even split and a slight edge for pathogenic. The variant is therefore most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists for R716L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.000-10.690Likely Pathogenic0.713Likely PathogenicLikely Benign0.31Likely Benign0.00.51Ambiguous0.41Likely Benign0.37Likely Benign0.289Likely Benign-5.70Deleterious1.000Probably Damaging0.999Probably Damaging3.46Benign0.01Affected0.17010.3775-3-28.3-43.03
c.1435C>G
R479G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479G is reported in gnomAD (ID 6-33438467-C-G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, Rosetta, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta, which assess protein‑folding stability, returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta as inconclusive. Overall, the majority of computational evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation. Therefore, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.0006-33438467-C-G16.20e-7-8.600Likely Pathogenic0.624Likely PathogenicLikely Benign0.97Ambiguous0.02.51Destabilizing1.74Ambiguous0.71Ambiguous0.228Likely Benign-2.82Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.42Tolerated3.39320.29110.2707-2-34.1-99.14
c.1435C>T
R479W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479W is not reported in ClinVar and is present in gnomAD (ID 6‑33438467‑C‑T). Functional prediction tools show a split opinion: benign calls come from REVEL, premPS, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments indicate that AlphaMissense‑Optimized predicts a benign effect, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as likely pathogenic; Foldetta remains inconclusive. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.0006-33438467-C-T63.72e-6-11.356Likely Pathogenic0.783Likely PathogenicLikely Benign0.60Ambiguous0.10.72Ambiguous0.66Ambiguous0.42Likely Benign0.249Likely Benign-4.75Deleterious1.000Probably Damaging0.995Probably Damaging3.35Benign0.02Affected3.39320.10460.2933-323.630.03
c.1436G>A
R479Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R479Q is listed in ClinVar with an “Uncertain” significance and is present in gnomAD (variant ID 6‑33438468‑G‑A). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 HumDiv and HumVar both predict a pathogenic impact. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as likely benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect, and this consensus does not contradict the ClinVar “Uncertain” status; thus the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.216401Structured0.419256Uncertain0.8200.2490.000Uncertain 16-33438468-G-A74.34e-6-7.109In-Between0.259Likely BenignLikely Benign0.54Ambiguous0.10.57Ambiguous0.56Ambiguous0.49Likely Benign0.191Likely Benign-1.16Neutral1.000Probably Damaging0.991Probably Damaging3.42Benign0.31Tolerated3.39320.24480.1812111.0-28.06
c.1436G>C
R479P
2D
3DClick to see structure in 3D Viewer
AIClinVar lists the SynGAP1 R479P variant as Uncertain, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. Those that predict a pathogenic effect are FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Predictions that are inconclusive are AlphaMissense‑Optimized and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as pathogenic. Overall, the majority of tools and the high‑accuracy methods support a pathogenic classification, which is in contrast to the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.000Uncertain 1-11.795Likely Pathogenic0.938Likely PathogenicAmbiguous2.86Destabilizing0.23.88Destabilizing3.37Destabilizing0.81Ambiguous0.277Likely Benign-3.52Deleterious1.000Probably Damaging1.000Probably Damaging3.41Benign0.18Tolerated0.19930.37470-22.9-59.07
c.1436G>T
R479L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM) and pathogenic predictions (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). AlphaMissense‑Optimized is uncertain. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized remains uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. No single metric dominates, and the overall evidence is balanced. Therefore, the variant’s pathogenicity is inconclusive; it is not contradicted by ClinVar status, which has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.000-11.118Likely Pathogenic0.832Likely PathogenicAmbiguous0.45Likely Benign0.10.12Likely Benign0.29Likely Benign0.39Likely Benign0.265Likely Benign-4.21Deleterious1.000Probably Damaging0.999Probably Damaging3.38Benign0.15Tolerated0.13260.3624-3-28.3-43.03
c.958G>A
V320I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320I is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while Rosetta remains inconclusive. High‑accuracy assessments corroborate the benign trend: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the preponderance of evidence points to a benign effect for V320I, and this conclusion does not conflict with the current ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.185198Structured0.419626Uncertain0.9050.2660.125Uncertain 1-5.220Likely Benign0.111Likely BenignLikely Benign-0.27Likely Benign0.20.66Ambiguous0.20Likely Benign0.01Likely Benign0.027Likely Benign-0.21Neutral0.198Benign0.114Benign1.77Pathogenic0.45Tolerated3.38230.05140.3207340.314.03
c.958G>C
V320L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320L is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33437863‑G‑C). Functional prediction tools that agree on benign impact include REVEL, FoldX, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Optimized. Pathogenic predictions come from polyPhen‑2 HumDiv and FATHMM, while Rosetta, Foldetta, premPS, and AlphaMissense‑Default are inconclusive. The high‑accuracy consensus (SGM Consensus) derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN yields a benign verdict. AlphaMissense‑Optimized also predicts benign, whereas Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.185198Structured0.419626Uncertain0.9050.2660.125Uncertain 26-33437863-G-C63.72e-6-6.207Likely Benign0.362AmbiguousLikely Benign-0.26Likely Benign0.21.33Ambiguous0.54Ambiguous0.51Ambiguous0.096Likely Benign-1.02Neutral0.900Possibly Damaging0.373Benign1.78Pathogenic0.92Tolerated3.38230.06610.386321-0.414.03245.8-10.20.30.90.10.3XPotentially BenignThe isopropyl side chain of Val310, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Thr305-Asn315, res. Ala322-Asp330), hydrophobically packs with the side chains of nearby residues (e.g., Leu286, Val350, Pro318). The hydrophobic Leu320 side chain mostly forms the same interactions; hence, the residue swap does not seem to negatively affect the protein structure based on the variant simulations.
c.958G>T
V320F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V320F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on benign impact include REVEL, premPS, and SIFT, whereas tools that agree on pathogenic impact include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as inconclusive. Because the majority of available predictions and the SGM‑Consensus favor pathogenicity, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for V320F.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.419626Uncertain0.9050.2660.125-9.958Likely Pathogenic0.877Likely PathogenicAmbiguous1.49Ambiguous1.41.55Ambiguous1.52Ambiguous0.44Likely Benign0.237Likely Benign-3.26Deleterious0.994Probably Damaging0.944Probably Damaging1.79Pathogenic0.06Tolerated0.04730.3064-1-1-1.448.04
c.959T>A
V320D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL and SIFT; pathogenic predictions from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods FoldX and Rosetta returned uncertain results, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also yielded an uncertain prediction. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect, which is consistent with the lack of ClinVar annotation and gnomAD absence. Thus, the variant is most likely pathogenic, and this prediction does not contradict ClinVar status because ClinVar has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.419626Uncertain0.9050.2660.125-11.269Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.99Ambiguous1.01.67Ambiguous1.83Ambiguous1.50Destabilizing0.405Likely Benign-5.58Deleterious0.999Probably Damaging0.972Probably Damaging1.93Pathogenic0.07Tolerated0.11010.0482-2-3-7.715.96
c.959T>C
V320A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V320A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Four tools (AlphaMissense‑Default, FoldX, Rosetta, Foldetta) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, more tools (five) predict pathogenicity than benign (four), and the high‑accuracy consensus leans toward pathogenic. Thus, the variant is most likely pathogenic, with no contradiction to ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.185198Structured0.419626Uncertain0.9050.2660.125-5.488Likely Benign0.545AmbiguousLikely Benign1.26Ambiguous0.71.48Ambiguous1.37Ambiguous1.27Destabilizing0.179Likely Benign-3.05Deleterious0.948Possibly Damaging0.761Possibly Damaging1.84Pathogenic0.35Tolerated0.24050.190300-2.4-28.05
c.959T>G
V320G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two agreement groups: the single benign prediction comes from REVEL, while the pathogenic group includes FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is uncertain; the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—returns pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts pathogenic. Overall, the preponderance of evidence indicates that V320G is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.185198Structured0.419626Uncertain0.9050.2660.125-9.043Likely Pathogenic0.816Likely PathogenicAmbiguous2.15Destabilizing1.11.87Ambiguous2.01Destabilizing1.48Destabilizing0.438Likely Benign-5.74Deleterious0.958Probably Damaging0.999Probably Damaging1.89Pathogenic0.02Affected0.16880.1949-1-3-4.6-42.08
c.2188A>C
I730L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730L is reported as “Likely Benign” in ClinVar and is not present in gnomAD. All available in‑silico predictors classify the change as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a benign effect. Consequently, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-1.681Likely Benign0.069Likely BenignLikely Benign-0.05Likely Benign0.0-0.31Likely Benign-0.18Likely Benign-0.17Likely Benign0.028Likely Benign-0.63Neutral0.000Benign0.005Benign3.53Benign0.47Tolerated0.07390.286922-0.70.00
c.2188A>G
I730V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730V is reported as “Likely Benign” in ClinVar and is not present in gnomAD. All available in‑silico predictors classify the change as benign: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-3.960Likely Benign0.091Likely BenignLikely Benign0.25Likely Benign0.10.04Likely Benign0.15Likely Benign0.03Likely Benign0.028Likely Benign-0.14Neutral0.112Benign0.033Benign3.48Benign0.39Tolerated0.10100.230343-0.3-14.03
c.2188A>T
I730F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730F has no ClinVar entry and is not reported in gnomAD. Prediction tools largely agree on a benign effect: SGM‑Consensus (Likely Benign), REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign or tolerated. Only polyPhen2_HumDiv classifies the change as pathogenic. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, reports a benign effect. No prediction tool or stability analysis is inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-4.953Likely Benign0.173Likely BenignLikely Benign-0.54Ambiguous0.1-0.01Likely Benign-0.28Likely Benign-0.01Likely Benign0.055Likely Benign-1.86Neutral0.699Possibly Damaging0.152Benign3.45Benign0.08Tolerated0.05090.208210-1.734.02
c.2189T>A
I730N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730N is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and SIFT. The remaining tools—premPS, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.733139Disordered0.420109Uncertain0.5910.6190.750-7.987In-Between0.369AmbiguousLikely Benign0.09Likely Benign0.20.04Likely Benign0.07Likely Benign0.70Ambiguous0.080Likely Benign-1.60Neutral1.000Probably Damaging0.986Probably Damaging3.46Benign0.02Affected0.09690.0533-2-3-8.00.94
c.2189T>C
I730T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I730T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are premPS and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign classification, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a benign effect. Overall, the consensus of both general and high‑accuracy predictors points to a benign impact, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-5.641Likely Benign0.404AmbiguousLikely Benign0.18Likely Benign0.20.12Likely Benign0.15Likely Benign0.54Ambiguous0.103Likely Benign-0.83Neutral0.995Probably Damaging0.934Probably Damaging3.49Benign0.08Tolerated0.10740.08850-1-5.2-12.05
c.2189T>G
I730S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar; AlphaMissense‑Default remains uncertain. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta outputs)—all uniformly predict a benign impact. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-6.220Likely Benign0.349AmbiguousLikely Benign0.25Likely Benign0.2-0.12Likely Benign0.07Likely Benign0.47Likely Benign0.123Likely Benign-0.51Neutral1.000Probably Damaging0.967Probably Damaging3.60Benign0.34Tolerated0.26460.0903-1-2-5.3-26.08
c.2190C>G
I730M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730M is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta outputs)—all uniformly indicate a benign impact. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-3.149Likely Benign0.110Likely BenignLikely Benign-0.15Likely Benign0.10.31Likely Benign0.08Likely Benign-0.15Likely Benign0.042Likely Benign-0.77Neutral0.993Probably Damaging0.914Probably Damaging3.43Benign0.09Tolerated0.06980.215921-2.618.03
c.1162G>A
G388S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G388S is catalogued in gnomAD (ID 6‑33438067‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that converge on a pathogenic interpretation are FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, while the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. In contrast, the protein‑folding stability predictor Foldetta, which integrates FoldX‑MD and Rosetta outputs, indicates a pathogenic effect. No prediction is available from Rosetta alone, and the SGM‑Consensus result aligns with the benign consensus. Overall, the majority of evidence points to a benign impact, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.736850Disordered0.420316Uncertain0.3190.8270.7506-33438067-G-A16.21e-7-5.036Likely Benign0.089Likely BenignLikely Benign3.42Destabilizing3.51.69Ambiguous2.56Destabilizing0.18Likely Benign0.446Likely Benign-0.52Neutral0.980Probably Damaging0.968Probably Damaging1.33Pathogenic0.05Affected4.3230.29010.498501-0.430.03
c.1162G>C
G388R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G388R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, PROVEAN, and AlphaMissense‑Optimized, whereas the remaining eleven tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) uniformly predict a pathogenic impact. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized indicates benign, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overall consensus of the majority of tools and the high‑accuracy predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.736850Disordered0.420316Uncertain0.3190.8270.750-9.142Likely Pathogenic0.694Likely PathogenicLikely Benign6.54Destabilizing8.54.79Destabilizing5.67Destabilizing0.31Likely Benign0.606Likely Pathogenic-0.74Neutral0.994Probably Damaging0.990Probably Damaging1.32Pathogenic0.02Affected0.12960.4417-3-2-4.199.14
c.1162G>T
G388C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 G388C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from AlphaMissense‑Default, AlphaMissense‑Optimized, premPS, and PROVEAN, while pathogenic predictions arise from REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign, Foldetta predicts pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. Because the majority of evidence points to pathogenicity and there is no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.736850Disordered0.420316Uncertain0.3190.8270.750-8.088Likely Pathogenic0.121Likely BenignLikely Benign4.01Destabilizing3.74.95Destabilizing4.48Destabilizing0.03Likely Benign0.603Likely Pathogenic-0.98Neutral0.998Probably Damaging0.993Probably Damaging1.32Pathogenic0.01Affected0.14970.4112-3-32.946.09

Found 8751 rows. Show 800 rows per page. Page 4/11 « Previous | Next »